Page last updated: 2024-08-24

lamivudine and Hepatitis B Virus Infection

lamivudine has been researched along with Hepatitis B Virus Infection in 1171 studies

Research

Studies (1,171)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's102 (8.71)18.2507
2000's706 (60.29)29.6817
2010's333 (28.44)24.3611
2020's30 (2.56)2.80

Authors

AuthorsStudies
Gochfeld, DJ; Hamann, MT1
Hosmane, RS; Korba, BE; Zhang, N; Zhang, P1
Chen, JJ; Cheng, P; Jiang, ZY; Ma, YB; Zhang, FX; Zhang, Q; Zhang, XM1
Huang, RL; Janmanchi, D; Lin, CH; Tseng, YP; Wang, KC; Yeh, SF1
Coughlin, JE; Govardhan, CP; Green, CE; Iyer, RP; Kirk, CJ; Korba, BE; Mirsalis, J; Morrey, JD; O'Loughlin, K; Padmanabhan, S; Zhang, G1
Cen, S; Han, YX; He, HW; Hong, B; Jiang, JD; Kreiswirth, B; Li, BW; Li, ZR; Liu, F; Peng, ZG; Perlin, D; Shao, RG; Song, DQ; Sun, CH; Wang, YP; You, XF; Yu, LY; Zhao, LX1
Feng, CL; Lu, W; Luo, Y; Tang, W; Wang, GF; Yang, L; Yao, JP; Zuo, JP1
Duan, WH; Qu, SJ; Tan, CH; Wang, GF; Yao, SY; Zhu, DY; Zuo, JP1
Campos, RH; Cavallaro, LV; Gagey, D; Lantaño, B; Moglioni, AG; Moltrasio, GY; Ugliarolo, EA1
Agrawal, B; Kumar, R; Liang, C; Shakya, N; Tyrrell, DL; Vedi, S1
Han, A; Hou, L; Li, L; Luo, X; Qi, X; Qing, K; Shi, S; Ye, F1
Wang, G; Zhang, F1
Chang, YC; Chou, BH; Huang, TJ; Kuo, YC; Lin, SJ; Yang, CL; Yang, LM1
Chang, J; Kang, J; Niu, P; Peng, Y; Qiao, Y; Wan, N; Wang, Q; Wang, SQ; Wang, XJ; Wu, J; Yang, Q; Yu, W; Zheng, L1
Chang, J; Liu, B; Liu, Y; Lu, J; Ma, H; Peng, Y; Qiao, Y; Song, C; Wang, J; Wu, J; Yu, W1
Chen, X; Cheng, W; Li, X; Lin, W; Liu, H; Lu, F; Wang, J; Zhang, H1
Gu, X; Guan, M; Li, X; Qiu, J; Zhang, Y; Zhou, Q; Zou, Y1
Chen, WC; Cheng, JS; Kao, SS; Li, YD; Li, YR; Lin, HS; Lu, CM; Sun, WC; Tsai, TJ; Tsai, WL; Tsay, FW; Wang, HM; Yin, CH1
Musyoki, SK; Onyango, DM; Wandera, BO1
Chen, Y; Huang, H; Lai, X; Lan, J; Lu, Y; Luo, Y; Ni, L; Shi, J; Si, T; Tan, Y; Wu, Y; Ye, B; Yu, J; Zhao, Y; Zhu, P1
Anderson, M; Badal-Faesen, S; Bhattacharya, D; Chinula, L; Cloherty, G; Gaseitsiwe, S; Hawkins, C; Holzmayer, V; Kang, M; Kuhns, M; Lama, J; Matining, R; Mulinda, N; Murphy, R; Peters, M; Samaneka, W; Sugandhavesa, P; Thio, C1
Dieterich, D; Roediger, R; Smyth, EK1
Bhat, R; Jayaram, B; Kiruthika, S; Vivekanandan, P1
Araujo, NM; Araújo, ORC; da Motta de Mello, V; de Almeida Ribeiro, CR; de Paula, VS; Lewis-Ximenez, LL; Martinelli, KG; Spitz, N1
Chandiwana, P; Duri, K; Gumbo, FZ; Marere, T; Mataramvura, H; Mazengera, LR; Mazhandu, AJ; Munjoma, PT1
Gao, S; Gui, X; Ke, H; Xiong, Y; Yang, R1
Bai, X; Qian, X; Su, C; Yang, X; Zhao, P1
Huang, YS; Hung, CC; Ko, WC; Lee, YC; Lee, YT; Li, CW; Lin, JJ; Lin, KY; Lin, SP; Liu, CE; Tang, HJ; Wang, NC; Yang, HJ1
Buzo, BF; de Seixas Santos Nastri, AC; Marques Rossetti, RA; Mendrone-Júnior, A; Ramos, JF; Rocha, V; Salles, N1
Kogure, T; Niizuma, K; Ogawa, Y; Tominaga, T1
Cai, H; Duan, X; Fu, D; Gao, X; Hu, Y; Kang, K; Li, Z; Liu, M; Yi, W; Zhou, M1
Choi, YM; Kim, BJ; Kim, H; Lee, SA; Lee, SY1
Astbury, S; Costa Nunes Soares, MM; Irving, WL; Jalal, P; Jardim, ACG; King, B; McClure, CP; Peprah, E; Sabeer, FT; Saeed, CH; Shimizu, JF; Tarr, AW1
Amponsah-Dacosta, E; Blackard, JT; Burnett, RJ; Gededzha, MP; Kyaw, T; Lukhwareni, A; Mphahlele, MJ; Selabe, SG1
Chan, A; Cheung, TT; Chu, KW; Dai, WC; Fung, J; Lo, CM; Ma, KW; Mak, LY; Seto, WK; She, WH; Sin, SL; Wong, T; Yuen, MF1
Cai, WP; Deng, XZ; Hu, FY; Lan, Y; Li, F; Li, LH; Nie, Y1
Boye, CS; Chemin, I; Cissé, AM; Cohen, D; Diop-Ndiaye, H; Dramé, A; Kébé-Fall, K; Laborde-Balen, G; Lô, G; Mboup, S; Ndiaye, AJS; Pujol, FH; Taverne, B; Touré-Kane, C; Toyé, RM1
Chan, HLY; Gaggar, A; Ganova-Raeva, L; Khudyakov, Y; Kitrinos, K; Lara, J; Thai, H; Xia, GL; Xu, X1
Dunn, D; Gilks, C; Gilson, R; Hakim, J; Kaleebu, P; Kityo, C; Musoro, G; Pillay, D; Price, H; Vudriko, T1
Shen, M; Sun, X; Wang, B; Wang, C; Xu, H; Yang, X; Zhu, K1
Asaftei, SD; Biasin, E; Calvo, PL; Carpino, A; Catalano, S; Cisarò, F; Dell'Olio, D; Fagioli, F; Opramolla, A; Peruzzi, L; Pinon, M; Pizzol, A; Quarello, P; Rigazio, C1
Enomoto, M; Kawada, N; Nishiguchi, S; Tamori, A; Yoshida, K1
Kuczaj, A; Przybyłowski, P; Warwas, S; Zembala, M1
Chen, J; Fan, Y; Qi, J; Shen, Y; Wang, Y; Wu, D; Xu, Y1
Chayama, K; Chung, TL; Dahari, H; Durso-Cain, K; Ishida, Y; Perelson, AS; Reinharz, V; Tateno, C; Tsuge, M; Uprichard, SL1
Khamadi, SA; Lihana, RW; Mabeya, SN; Ngugi, C; Nyamache, AK1
Buzzetti, E; Davidson, BR; Gurusamy, KS; Mantzoukis, K; Rodríguez-Perálvarez, M; Thorburn, D; Tsochatzis, E1
Deng, J; Li, T; Li, Y; Su, MZ; Wang, QY; Wang, S; Xiang, KH; Xu, XZ; Zhao, CY; Zhuang, H1
Lao, XM; Lin, GL; Miao, B1
Gane, EJ1
Gore, ML; Jatta, A; Lemoine, M; Ndow, G; Njie, R; Sabally, S; Sadiq, F; Shimakawa, Y; Sow, A; Suso, P; Tamba, S; Thursz, MR; Touré-Kane, C1
Chen, CL; Li, WF; Lin, CC; Lin, LM; Lin, TL; Lin, YH; Loh, PY; Wang, SH1
Ahir, BK; Li, LQ; Wu, GB; Zhang, CY; Zhong, JH1
Battisti, A; Cerretti, R; Cerva, C; Colagrossi, L; Cudillo, L; Maffongelli, G; Mariotti, B; Salpini, R; Sarmati, L; Svicher, V1
Agarwal, A; Alexander, PE; Chang, Y; Foroutan, F; Guyatt, GH; Hepworth, E; Lee, Y; Lesi, O; Mah Ming, J; Merglen, A; Mir, H; Mirza, R; Siemieniuk, RA; Zeraatkar, D; Zhang, Y1
Cathcart, AL; Delaney, WE; Kitrinos, KM; Liu, Y1
Chang, CS; Lee, SW; Lee, TY; Li, YC; Liao, YJ; Wu, CY; Yang, SS; Yeh, HZ1
Adinolfi, LE; Boemio, A; Capoluongo, N; Coppola, N; D'Amore, C; Esposito, M; Guastafierro, S; Macera, M; Marrone, A; Mastrullo, L; Minichini, C; Onorato, L; Pisaturo, M; Rinaldi, L; Sagnelli, E; Siniscalchi, I1
Aw, PPK; Burkholder, WF; de Sessions, PF; Hibberd, M; Hong, LZ; Hong, S; Hue, S; Li, CH; Lim, SG; Nagarajan, N; See, LX; Wilm, A; Zhu, YO1
Han, Z; Huang, M; Liu, J; Shi, H; Xia, J; Xue, J; Zhang, S; Zhu, Z1
Endo, T; Ito, K; Saitoh, S; Sugiura, T; Suzuki, M; Tajiri, H; Tanaka, Y; Wakano, Y1
Arshad, B; Chen, HR; Dai, W; Kong, LQ; Li, X; Wu, H; Wu, KN; Wu, YT; Xu, Z1
Arai, M; Fujiwara, K; Haga, Y; Kanda, T; Kato, N; Nakamura, M; Oda, S; Yasui, S; Yokosuka, O; Yonemitsu, Y1
Padma, UD; Surendran, S; Udayakumar, VP1
Chen, Q; Liu, W; Liu, YT; Wang, FL; Zhu, GY1
Andersson, MI; Chotun, N; Maponga, TG; Nel, ER; Strobele, S1
Abdou Chekaraou, M; Anglaret, X; Boyd, A; Danel, C; Delaugerre, C; Eholié, SP; Gabillard, D; Lacombe, K; Mahjoub, N; Maylin, S; Moh, R; Zoulim, F1
Butler, EK; Cloherty, GA; de Medina, M; Gersch, J; Holzmayer, V; Kuhns, M; Luk, KC; McNamara, A; Schiff, E1
Alkım, C; Alkım, H; Colak, T; İyisoy, MS; Karayakar, F; Koksal, AR; Sahin, M; Şen, İ; Yetim, A1
Calò, F; Coppola, N; Di Caprio, G; Martini, S; Pisaturo, M; Portunato, F1
Jiang, X; Luo, A; Ren, H1
Han, Y; Xia, S; Zhou, J1
Angelucci, E; Bruzzone, B; Caligiuri, P; Di Grazia, C; Dominietto, A; Gualandi, F; Lamparelli, T; Mikulska, M; Nicolini, LA; Viscoli, C; Zappulo, E1
Baldini, L; Corradini, P; Facchetti, F; Farina, L; Goldaniga, M; Grossi, G; Labanca, S; Lampertico, P; Loglio, A; Lunghi, G; Pompa, A; Rumi, M; Viganò, M1
Chen, QY; Fang, ZL; Harrison, TJ; Hu, LP; Jia, HH; Li, KW; Liang, SJ; Ren, CC; Wang, C; Wang, XY; Yang, QL1
Naing, C; Poovorawan, Y; Tong, KS1
Bell, TG; Kramvis, A; Singh, L; Yousif, M1
Agyingi, K; Domkam, I; Joyce, AN; Keou, CK; Mbu, RE; Moudourou, S; Nanfack, A; Njefi, K; Sosso, S; Takang, W; Takou, D; Torimiro, JN1
Foaud, HM; Gmal El Din, A; Mahmoud, F; Maklad, S1
Gao, X; Jia, J; Li, M; Li, T; Liu, W; Ma, N; Tang, L; Yan, L; Yang, L; Yu, F; Zhang, X1
Li, T; Lin, C; Qu, Y; Wang, L; Wang, Y; Yang, B1
Dong, Y; Liu, W; Wang, L; Zhao, P; Zhu, S1
Beggel, B; Kaiser, R; Neumann-Fraune, M; Pfister, H; Verheyen, J1
David, E; Marengo, A; Marzano, A; Rizzetto, M1
Angus, PW; Gane, EJ; McCaughan, GW; Patterson, S; Strasser, SI1
Chen, Y; Gao, Z; Han, Y; Han, Z; Jia, G; Li, C; Liu, J; Luo, G; Shi, Y; Xia, L; Yin, F; Zhou, X; Zhu, J1
Gupta, S; Healy, SA; Melvin, AJ1
Cheung, KW; Seto, MT; Wong, SF1
Gatanaga, H; Hayashida, T; Oka, S; Tanuma, J1
Özenirler, S; Sucak, GT; Suyanı, E; Yaşar, DG1
Bohorquez, HE; Bruce, DS; Carmody, IC; Cohen, AJ; Girgrah, N; Joshi, S; Loss, GE; Mason, AL; Reichman, TW; Therapondos, G1
Cook, L; Day, SL; Graham, SM; Jerome, KR; Kim, HN; Mandaliya, KN; Masese, LN; McClelland, RS; Odem-Davis, K; Scott, J1
Brown, RS; Brubaker, WD; Chang, MS; Emond, JC; Guarrera, JV; Olsen, SK; Pichardo, EM; Rosenthal-Cogan, L; Stiles, JB1
Jiang, B; Li, L; Li, ZF; Song, SB; Xiu, DR; Yuan, CH; Zhang, TL1
Angeletti, C; Antonucci, G; Armignacco, O; Cassola, G; De Stefano, G; Girardi, E; Grossi, P; Mazzotta, F; Orani, A; Pagano, G; Petrosillo, N; Puoti, M; Sagnelli, C; Sagnelli, E1
Chen, GC; Chen, QK; Huang, KH; Min, XH; Qing, Q; Su, H; Yu, T; Yuan, YH; Zhan, J; Zhao, LN1
Hu, RH; Lee, CY; Lee, PH; Tsai, MK; Yang, YW1
Chew, E; Seymour, JF; Thursky, K1
Goyal, N; Gupta, S; Kumar, A; Taneja, S; Wadhawan, M1
Alessio, L; Brunetto, M; Cavallone, D; Colombatto, P; Coppola, N; Messina, V; Moriconi, F; Pisaturo, M; Sagnelli, C; Sagnelli, E; Tonziello, G1
Chen, Y; Li, LJ; Lv, GC; Sheng, JF; Yang, YD; Yao, JM; Zheng, L1
Botes, ME; Hamers, RL; Hoepelman, AI; Ive, P; Rinke de Wit, TF; Sigaloff, KC; Siwale, M; Stevens, WS; Wallis, CL; Zaaijer, HL1
Arase, Y; Ichida, T; Imazeki, F; Ito, K; Karino, Y; Kurosaki, M; Maeshiro, T; Masaki, N; Michitaka, K; Mita, E; Mizokami, M; Murata, K; Saito, T; Sugiyama, M; Takikawa, Y; Tanaka, Y; Tanuma, J; Toyoda, H; Umemura, T; Yamamoto, K; Yatsuhashi, H; Yoneda, M; Yotsuyanagi, H1
Chang, SC; Chang, SY; Chuang, YC; Hung, CC; Sheng, WH; Sun, HY; Tsai, MS1
Fung, JY; Lo, CM; Wong, TC1
Chen, JY; Hu, JH; Jia, HY; Li, LJ; Lian, JS; Lu, YF; Xiang, DR; Yang, YD; Yu, L; Zeng, LY; Zhang, YM; Zheng, L1
Gao, YJ; Jin, B; Li, HW; Liu, ZW; Ma, XM; Meng, FP; Su, HB; Zhang, M; Zhao, JM1
Choi, JY; Choi, Y; Hong, G; Kim, H; Lee, HW; Lee, K; Lee, KW; Mori, S; Park, MS; Suh, KS; Suh, SW; Yi, NJ; Yoo, T1
Su, QM; Ye, XG1
Abdallah, HB; Abdelli, MN; Bouali, R; El Kossai, I; Haddad, W; Haloues, M; Harzallah, K; Hmida, J; Manaa, J; Romdhane, NB1
Bock, CT; Brosteanu, O; Fiedler, GM; Franke, A; Manns, MP; Römmele, U; Rößler, S; Ruf, B; Spengler, U; Teuber, G; Thiery, J; Tillmann, HL; Trautwein, C; Wächtler, M; Wedemeyer, H; Wiegand, J; Zeuzem, S1
Ayres, A; Bayliss, J; Bowden, DS; Glass, A; Hong, SP; Jackson, KM; Kim, SO; Levy, MT; Locarnini, SA; Luciani, F; Maley, M; Manoharan, S; Yoo, W; Yuen, L1
Ahn, SH; Chon, CY; Han, KH; Kim, DY; Kim, HS; Kim, MN; Kim, SU; Lee, CK; Lee, S; Park, JY1
Chen, CY; Chien, RN; Chuang, WL; Hsieh, TY; Hu, CT; Hu, TH; Kao, JH; Lin, CC; Lin, HC; Peng, CY1
Calvaruso, V; Craxì, A1
Chen, SR; Ke, WM; Lai, J; Lin, CS; Yang, L; Zhang, YQ1
Chung, RT; Fishman, JA; Wright, AJ1
Forde, J; Hews, S; Kuang, Y; Packer, A1
Choun, K; De Weggheleire, A; Lynen, L; Phirum, L; Thai, S; van Griensven, J1
De Renzo, A; La Mura, V; Masarone, M; Pane, F; Perna, F; Persico, M; Romano, M; Rosato, V; Sasso, FC; Signoriello, G1
Gil, E; Hewitt, P; Manson, J; Parker, S; Reyal, Y; Ward, K; Wilson, S1
Gu, XB; Huang, LH; Jiang, XH; Qiu, YW; Wang, D; Wu, HY; Xiao-Juan, Y; Yu, P; Zhu, YF1
Amorosa, VK; Chang, KM; De La Torre, P; Frank, I; Gross, R; Hafkin, JS; Kostman, JR; Lo Re, V; Localio, AR; Mounzer, K; Osborn, MK; Stern, JJ1
Aykas, F; Basak, M; Karahan, S; Karaman, A; Oguz, A; Unal, D; Uslu, E1
Aberg, JA; Hollabaugh, K; Kang, M; Koletar, SL; Pham, V; Smurzynski, M; Wu, K1
Li, LQ; Ma, L; Zhong, JH1
Chatterjee, U; Davison, S; Glass, A; Greenup, AJ; Holdaway, S; Jackson, K; Levy, MT; Locarnini, SA; Nguyen, V; Samarasinghe, D; Tan, PK1
Cheng, L; Geng, L; Wang, W; Wu, L; Yan, S; Ye, Y; Yu, J; Yu, S; Yu, Z; Zhang, W; Zheng, S1
Coffin, CS; Gill, MJ; Michalak, TI; Mulrooney-Cousins, PM; Nishikawa, S; Osiowy, C; van der Meer, F; van Marle, G1
Alexopoulos, S; Kasraianfard, A; Lindberg, L; Rezaei, N; Watt, KD1
Chan, GC; Chan, TM; Choy, BY; Kwan, LP; Ma, MK; Mok, MM; Seto, WK; Tang, CS; Yap, DY; Yuen, MF; Yung, S1
de Zoysa, JR; Gane, EJ; Ow, MM1
Lin, GN; Liu, DY; Peng, JW; Xia, ZJ; Xiao, JJ1
Barone, M; Di Leo, A; Iannone, A1
Cho, M; Choi, JY; Han, KH; Hwang, JS; Kim, BI; Kim, DJ; Lee, CK; Lee, HJ; Paik, SW; Suh, DJ; Um, SH; Woo, HY; Yoon, SK1
Patel, K; Tillmann, HL1
Aoudjane, S; Beloukas, A; Chaponda, M; Geretti, AM; González Del Castillo, AA; Hopkins, M; Khoo, S; Noguera, M; O'Connor, J; van Oosterhout, JJ1
Cao, H; Han, J; Jiao, Z; Zhang, D1
Amici, R; Andreotti, M; Buonomo, E; Ceffa, S; Giuliano, M; Jere, H; Leone, P; Mancinelli, S; Mancini, MG; Marazzi, MC; Palombi, L; Pirillo, MF; Sagno, JB; Scarcella, P; Vella, S1
Jin, S; Lv, H; Wang, Z; Xu, H; Yuan, Y; Zhang, W; Zheng, L1
Chen, L; Chen, LF; Chen, YQ; Hu, HD; Li, H; Ren, H; Zhang, HM1
Chen, X; Gao, W; Li, D; Peng, J; Wen, F; Xia, J; Xu, C; Xu, M; Yao, Z1
Cho, YK; Cui, XJ; Jeong, SU; Song, BC1
Rosenthal, P1
Ehrhardt, S; Guo, N; Nelson, K; Thio, CL; Xie, C1
Jiao, Z; Yan, L; Zhang, D1
Avihingsanon, Y; Chancharoenthana, W; Eiam-Ong, S; Kittikowit, W; Kittiskulnam, P; Leelahavanichkul, A; Pongpirul, K; Praditpornsilpa, K; Suankratay, C; Townamchai, N; Tungsanga, K; Wattanatorn, S1
Hong, R; Lang, X; Li, Z; Xiang-Hui, Y; Xiao-Feng, S; Yan, Z1
Hamada-Tsutsumi, S; Imamura, J; Sugiura, W; Tanaka, Y; Watanabe, T; Yokomaku, Y1
Abramson, JS; Chung, RT1
Cao, Y; Huang, H; Li, H; Li, X; Lin, S; Lin, T; Lin, Y; Liu, Q; Peng, J; Wang, W; Wu, X; Xu, B; Ye, S; Zhang, H; Zhu, J1
Changchien, CS; Chen, CH; Hsu, MC; Hu, TH; Hung, CH; Lee, CM; Lu, SN; Wang, JH; Yao, CC1
Geipel, A; Gerlich, WH; Glebe, D; Kaiser, R; Neumann-Fraune, M; Niekamp, H; Protzer, U; Seiz, PL; Zhang, K1
Kim, DY; Kim, KM; Lee, SG; Lee, YJ; Namgoong, JM; Oh, SH; Song, SM1
Ding, XC; Hu, HD; Hu, P; Liao, Y; Liu, JY; Ren, H; Sheng, YJ; Tang, H; Tong, SW; Zhang, DZ; Zhou, Z1
Choudhary, NS; Goja, S; Menon, PB; Mohanka, R; Rastogi, A; Saigal, S; Saraf, N; Soin, AS1
Bagal, B; Bhat, V; Gawande, J; Gupta, A; Kannan, S; Khattry, N; Mathew, L; Punatar, S1
Abbott, K; Ahn, J; Avery, RK; Bloom, RD; Blumberg, E; Brown, K; Dadhania, DM; Danziger-Isakov, L; Doucette, KE; Grossi, P; Horslen, S; Huprikar, S; Korenblat, K; Kotton, CN; Koval, C; Kumar, D; Kumar, V; Laskin, BL; Lease, ED; Levitsky, J; Lu, K; McDermott, JK; Mone, T; Morris, MI; Mougdil, A; Naugler, S; Orlowski, JP; Pillai, A; Venkat, VL1
Hong, SP; Hwang, SG; Jang, ES; Jeong, SH; Kang, SK; Lee, JH; Park, SJ1
Yuen, MF1
Dong, H; Guan, GJ; Jiang, W; Liu, LQ; Liu, T; Liu, XC; Xu, Y1
Akarca, US; Bademkiran, F; Duman, S; Ersoz, G; Gunsar, F; Karasu, Z; Kose, T; Ozutemiz, O; Sozbilen, M; Turan, I; Yapali, S1
Chan, HN; Ha, CY; Lai, HK; Law, MF; Ng, C; Yeung, YM; Yip, SF1
Ahmadinejad, Z; Dashti, H; Jafarian, A; Kasraianfard, A; Moini, M; Najafi, A; Nassiri-Toosi, M; Salimi, J1
Bowden, S; Chang, TT; Chao, YC; de Man, RA; Gish, RG; Han, KH; Llamoso, C; Locarnini, S; Tang, H; Yu, M1
Fong, TL; Hsieh, MJ; Khemichian, S; Kim, J; Limurti, J; Zhang, SR1
Cui, X; Dai, J; Huang, M; Jiang, X; Li, J; Ning, H; Su, F; Yang, S1
Chen, L; Gao, J; Pan, L; Tang, W; Ye, X; Zhang, X; Zheng, R; Zheng, W1
Apica, B; Ocama, P; Opio, K; Seremba, E1
Battegay, M; Bernasconi, E; Bihl, F; Calmy, A; Caminada, AP; Cavassini, M; Ledergeber, B; Martinetti, G; Rickenbach, M; Vernazza, P; Wandeler, G; Weber, R1
Cao, F; Chen, T; He, Y; Jin, L; Liu, J; Qi, C; Wang, J; Yan, T; Yang, Y; Zhang, S; Zhao, Y1
Gao, GF; Gohda, J; Gu, L; Guan, S; Han, Y; Hosoya, N; Huang, Y; Ishida, T; Iwamoto, A; Kawana-Tachikawa, A; Li, T; Li, Y; Liu, W; Song, X; Xie, J; Yang, F; Zhu, T1
Anglaret, X; Boyd, A; Danel, C; Delaugerre, C; Eholié, SP; Gabillard, D; Girard, PM; Lacombefor, K; Mahjoub, N; Maylin, S; Moh, R; Zoulim, F1
Gao, Y; Guo, X; Li, H; Li, J; Liu, Y; Liu, Z; Yang, M; Zhang, M; Zhao, J1
Choi, GH; Choi, JS; Joo, DJ; Ju, MK; Kim, MS; Kim, SI; Lee, J; Lee, JG; Lee, JJ; Song, SH1
Min, L; Pian, J; Zhang, P1
Chuang, WL; Dai, CY; Hsieh, MH; Hsieh, MY; Huang, CF; Huang, CI; Huang, JF; Yeh, ML; Yu, ML1
Chen, CL; Lin, CC; Yong, CC1
Aliosmanoglu, I; Cetinkaya, R; Erbis, H; Kocak, H; Suleymanlar, G; Ulger, BV; Yilmaz, VT1
Choe, YH; Choi, GS; Joh, JW; Kim, JM; Kwon, CH; Lee, S; Lee, SK; Park, JB1
Cai, XF; Guo, H; Hu, JL; Huang, AL; Long, QX; Luo, YY; Tao, Y; Zhang, WL1
Du, S; Guo, F; Han, Y; Li, T; Li, Y; Lv, W; Qiu, Z; Song, X; Thio, CL; Wang, H; Wang, N; Xie, J; Zhu, T1
Dai, M; Fan, Z; Huang, F; Jiang, Q; Lin, R; Liu, Q; Shang, J; Sun, J; Wang, H; Xu, N; Zhang, Y1
Ohdan, H; Onoe, T; Tahara, H; Tanaka, Y1
Archampong, TN; Boamah, I; Flanigan, T; Gillani, FS; Kenu, E; Kwara, A; Lartey, M; Obo-Akwa, A; Sagoe, KW; Yang, H1
Rund, D1
Gosnell, BI; John, MA; Manzini, TC; Moosa, MS; Ramdial, P1
Beck, IA; Frenkel, LM; Jourdain, G; Khamduang, W; Laomanit, L; Ngo-Giang-Huong, N; Payant, R1
Casarin, P; Castelnovo, L; Dal Maso, L; Gattei, V; Mauro, E; Mazzaro, C; Monti, G; Pozzato, G; Urraro, T; Zignego, AL1
Chen, FY; Cheng, Z; Huang, HH; Shi, KQ; Zhang, MY; Zheng, JN; Zheng, MH; Zhu, GQ; Zou, ZL1
Lai, F; Min, T; Wu, H; Wu, X; Zhang, M; Zhang, X1
Archampong, TN; Blackard, JT; Boyce, CL; Kenu, E; Kwara, A; Lartey, M; Obo-Akwa, A; Sagoe, KW1
Battegay, M; Bernasconi, E; Braun, DL; Darling, K; Günthard, HF; Hirzel, C; Hoffmann, M; Kouyos, RD; Kovari, H; Marzel, A; Rougemont, M; Scherrer, AU; Shilaih, M1
Luis, AP; Luo, H; Pan, M; Shuai, P; Xiong, Z; Yu, S; Zhang, Z1
Andreoni, M; Arcese, W; Battisti, A; Bianchi, A; Cantonetti, M; Cerretti, R; Cerva, C; Colagrossi, L; Cudillo, L; De Angelis, G; Di Carlo, D; Maffongelli, G; Malagnino, V; Perno, CF; Picardi, A; Pollicita, M; Ricciardi, A; Salpini, R; Sarmati, L; Svicher, V1
Chmura, A; Cieciura, T; Jonas, M; Małkowski, P; Wasiak, D; Łągiewska, B1
He, CX; Hua, BL; Jin, HZ; Li, L; Liu, YH; Yan, TM; Zuo, YG1
Andreone, P; Conti, F; Cucchetti, A; Ercolani, G; Loggi, E; Pinna, AD1
Brescia Morra, V; De Rosa, A; Matarazzo, M; Pane, C; Saccà, F1
Makvandi, M1
Caccamo, L1
Brancaccio, G; Ciardiello, F; Dallio, M; Del Prete, S; Fabozzi, A; Federico, A; Gaeta, GB; Iodice, P; Loguercio, C1
Dong, C; Gao, W; Ma, N; Shen, ZY; Sun, C; Wang, K; Zheng, WP1
Aurpibul, L; Bunupuradah, T; Hansudewechakul, R; Kanjanavanit, S; Kosalaraksa, P; Lumbiganon, P; Puthanakit, T; Taeprasert, P1
Chang, SC; Chang, SY; Chuang, YC; Huang, YS; Hung, CC; Lee, KY; Liu, WC; Sheng, WH; Su, YC; Sun, HY1
Boyd, A; Lacombe, K; Miailhes, P; Zoulim, F1
Arcaini, L; Gotti, M; Merli, M; Rattotti, S1
Bessong, PO; Gachara, G; Kimbi, HK; Lum, E; Magoro, T; Mavhandu, L; Ndip, RN1
Maki, N; Matsumoto, A; Tanaka, E; Yoshizawa, K1
Amouri, A; Chtourou, L; Mnif, L; Tahri, N1
Calabresi, A; Carosi, G; Cologni, G; Costarelli, S; Lapadula, G; Puoti, M; Quiros-Roldan, E; Tirelli, V; Torti, C; Zaltron, S1
Huang, HJ; Li, GY; Sheng, JL1
Li, MW; Wang, YM; Xie, SF; Yang, DH; Zhao, NF1
Chan, HL; Chan, HY; Chim, AM; Sung, JJ; Wong, GL; Wong, VW1
Rong-Rong, Y; Shi-Cheng, G; Xi-En, G; Yong-Xi, Z1
Hino, T; Hisamochi, A; Ide, T; Koga, H; Koga, Y; Kumashiro, R; Kuwahara, R; Ogata, K; Sata, M; Takao, Y; Tanaka, K1
Fujioka, S; Ikeda, H; Iwasaki, Y; Kobashi, H; Miyake, Y; Sakaguchi, K; Shiratori, Y; Takaguchi, K; Takaki, A1
Jeong, S; Kim, HG; Kim, YS; Kwon, KS; Lee, DH; Lee, JI; Lee, JW; Park, HJ; Shin, YW1
Ba, MC; Cui, SZ; Li, ML; Lu, Q; Shi, HJ; Tang, YQ; Wang, B; Wang, JK; Wu, YB; Zhang, XL; Zhao, HY; Zhu, XF1
Aberer, E; Gruber, MJ; Gruber-Wackernagel, A; Hermann, J; Scarpatetti, M1
Bock, CT; Finger, A; Heidrich, B; Manns, MP; Michel, G; Rosenau, J; Tillmann, HL; Wedemeyer, H; Wiegand, J1
Lu, AW; Shen, Y; Wu, MP; Yang, RW; Zheng, SS1
Amin, J; Avihingsanon, A; Bowden, S; Cooper, DA; Dore, GJ; Lewin, SR; Locarnini, S; Marks, P; Matthews, GV; Petcharapirat, P; Rerknimitr, R; Ruxrungtham, K; Sasadeusz, J1
Itoh, A; Naoki, H; Sugiura, K; Sugiura, M; Takashi, T1
Bellini, C; Bernasconi, E; Cavassini, M; Chave, JP; Evison, J; Fehr, J; Kaiser, L; Keiser, O; Telenti, A; Vernazza, P; Weber, R1
Beckebaum, S; Cicinnati, VR; Gerken, G; Sotiropoulos, GC1
Bacq, Y; Baty, G; de Muret, A; Dubois, F; Negreanu, L1
Angus, PW; Patterson, SJ2
Akay, S; Karasu, Z1
Angus, PW; Gane, E; McCaughan, GW; Patterson, SJ; Strasser, SI1
Bhattacharya, D; Donovan, RM; Imperial, JC; Israelski, D; Katzenstein, D; Keeffe, EB; Wong, A1
Liu, M; Wang, L; Yang, S1
Cai, CJ; Chen, GH; Jiang, H; Jiang, N; Li, H; Li, X; Lu, MQ; Wang, GS; Xu, C; Yang, Q; Yang, Y; Yi, HM; Yi, SH; Zhang, J; Zhang, JF1
Alessandrelli, F; Azzaroli, F; Buonfiglioli, F; Lisotti, A; Mazzella, G; Montagnani, M1
Cassola, G; Feasi, M; Torresin, A2
Rao, W; Wu, X; Xiu, D1
Degertekin, B; Hussain, M; Lok, AS; Oberhelman, K; Tan, J1
Arslan, U; Artac, M; Basaranoglu, M; Boruban, MC; Eren, OO; Yavas, O1
Fais, VC; Gonçales Junior, FL; Gonçales, NS; Jardim, RN; Pereira, JS1
Cappelli, B; Faraci, M; Fioredda, F; Giacchino, R; Giudice, CL; Lanino, E; Morreale, G1
Akdogan, A; Bayraktar, Y; Bilgen, SA; Calguneri, M; Ersoy, O; Ertenli, I; Kalyoncu, U; Karadag, O; Kiraz, S; Yonem, O1
Apalla, Z; Ioannides, D; Lazaridou, E; Patsatsi, A; Trigoni, A1
Benhamou, Y; Dominguez, S; Duvivier, C; Ingiliz, P; Katlama, C; Poynard, T; Thibault, V; Valantin, MA1
Kumar, M; Sarin, SK1
Degertekin, B; Lok, AS2
García Buey, L; González Mateos, F; Moreno Otero, R1
Barreiro, P; García-Samaniego, J; Martín-Carbonero, L1
Dorobantu, B; Gangone, E; Gheorghe, L; Hrehoret, D; Iacob, S; Matei, E; Popescu, I1
Fontana, RJ2
Avihingsanon, A; Bowden, S; Dore, GJ; Lewin, SR; Locarnini, SA; Marks, P; Matthews, G; Perelson, AS; Ribeiro, RM; Ruxrungtham, K1
Chan, TM; Tang, C; Tse, KC; Yip, TP; Yung, S1
Agarwal, SK; Das, P; Dinda, AK; Khaira, A; Mahajan, S; Makhariya, G; Sharma, A; Tiwari, SC; Upadhyay, BK1
Atkins, M; Campbell, F; Chang, CN; Cui, YT; Gardner, S; Li, XM; Liang, ZQ; Qiao, FY; Wang, L; Xu, WM; Yang, H; Zhang, SL1
Perrillo, R1
Arrifin, N; Audsley, J; Ayres, A; Bartholomeusz, A; Crowe, SM; Lewin, SR; Locarnini, SA; Mijch, A; Sasadeusz, J; Yuen, LK1
Cheong, JY; Cho, SW; Choi, JM; Hong, SP; Kim, SO; Kwon, HC; Yoo, WD1
Kurbegov, AC; Sokol, RJ1
Alvarez-Uria, G; Ratcliffe, L; Vilar, J1
Baumert, TF; Doffoel, M; Fafi-Kremer, S; Gut, JP; Habersetzer, F; Pastor, R; Schvoerer, E; Stoll-Keller, F1
Amini-Bavil-Olyaee, S; Herbers, U; Luedde, T; Sheldon, J; Tacke, F; Trautwein, C1
Deeney, HN; Dusheiko, GM1
Ahmed, A; Babrzadeh, F; Egholm, M; Gharizadeh, B; Hanczaruk, B; Holmes, SP; Liu, T; Margeridon-Thermet, S; Shafer, RW; Shahriar, R; Shulman, NS; Simen, BB; Wang, C1
Chen, L; Wan, MB; Yu, DM; Zhang, Q; Zhang, XX1
Blázquez de Castro, AM; García Rodríguez, JA; González San Martín, F; Gutiérrez-Zufiaurre, N; Muñoz Bellido, JL; Muñoz-Criado, S; Pérez-Grande, R; Vázquez López, L1
Chen, ZY; Li, B; Li, G; Ma, YK; Wang, WT; Wen, TF; Wu, H; Xu, MQ; Yan, LN; Yang, JY; Zeng, Y; Zhao, JC1
Boricić, I; Delić, D; Nesić, Z; Prostran, M; Svirtlih, N1
Chiba, T; Ichinohe, T; Kadowaki, N; Marusawa, H; Uchiyama, T; Ueda, Y1
Bocket, L; Boulanger, L; Canva, V; Coursier, J; Dharancy, S; Dieu, E; Gonzalez, F; Mathurin, P1
Burnett, RJ; Mphahlele, MJ; Selabe, SG; Song, E1
Abdel Razek, W; Belghiti, J; Durand, F; Francoz, C; Lada, O; Marcellin, P; Moucari, R; Valla, D1
Airò, P; Bazzani, C; Frassi, M; Puoti, M; Scarsi, M; Zingarelli, S1
Karsaliakos, P; Mylonakis, E; Ziakas, PD1
D'Andrea, M; Dessanti, ML; Miglioresi, L; Morrone, A; Nosotti, L; Paviglianiti, A; Petti, MC; Pimpinelli, F1
Gao, DM; Guo, QL; Li, N; Liu, Y; Lu, SC; Wang, ML; Wu, JS; Xia, RP; Zhang, Y1
Rizzetto, M2
Samuel, D4
Mas, A1
Biemond, BJ; Jansen, PL; Reesink, HW; Takkenberg, RB; ten Cate, DF; Zaaijer, HL1
Aoki, T; Fujiwara, H; Iwama, K; Kimura, S; Matsue, K; Odawara, J; Takeuch, M; Yamakura, M1
Childs, R; John Barrett, A; Koklanaris, E; Le, Q; Savani, BN; Shenoy, A1
Borro, P; Sumberaz, A; Testino, G1
Fan, LY; Ling, N; Ren, H; Shi, XF; Wang, ZY; Zhang, DZ; Zhong, S; Zhou, Z1
Bowden, S; Dore, GJ; Goodman, Z; Lewin, SR; Locarnini, S; Marks, P; Matthews, GV; Philp, FH; Sasadeusz, J; Seaberg, E; Tang, Y; Thio, CL1
Deterding, K; Manns, M; Potthoff, A; Rifai, K; Strassburg, C; Wedemeyer, H1
Mullen, JE; Tong, CY; Wong, T1
Enomoto, M; Habu, D; Imanishi, Y; Iwai, S; Kawada, N; Kobayashi, S; Morikawa, H; Sakaguchi, H; Shiomi, S; Tamori, A1
Chen, CH; Hu, TH; Kuo, CY; Lee, CM; Ma, MC; Pei, SN; Wang, MC1
Baka-Cwierz, B; Chudek, J; Ficek, J; Karkoszka, H; Kolonko, A; Wiecek, A1
Jia, JD; Wang, BE; Zhang, FK; Zhang, JY; Zhang, Y1
Eguchi, K; Eguchi, S; Fujimoto, M; Ichikawa, T; Kanematsu, T; Miyaaki, H; Nagaoka, S; Nakao, K; Shibata, H; Takatsuki, M; Yatsuhashi, H1
Cai, Q; Gao, Y; Huang, H; Lin, T; Lin, X; Liu, Y; Peng, R1
Eugenidis, N; Giouleme, O; Gkisakis, D; Grammatikos, N; Katsinelos, P; Koumaras, H; Koumerkeridis, G; Mpoumponaris, A; Panderi, A; Patsiaoura, K; Theodoropoulos, K; Tziomalos, K; Vassiliadis, TG1
He, XS; Hu, AB; Ma, Y; Tai, Q; Wang, GD1
Lo, GH1
Acar, A; Aydin, A; Eken, A; Eyigün, CP; Görenek, L; Pahsa, A; Sayal, A1
Aghemo, A; Agnelli, F; Colombo, M; Donato, MF; Iavarone, M; Lampertico, P; Rumi, MG; Viganò, M1
Figueiredo, FF; Gomes, SA; Lago, BV; Mello, FC; Motta, JS; Perez, RM1
Albrecht, H; Jorgensen, P; Marcus, U; Schürmann, D; Suttorp, N1
Evans, J; Jarrin, I; Lafuente-Lafuente, C; Mazeron, MC; Parrinello, M; Schnepf, N; Sellier, P; Simoneau, G1
Chow, WC; Koo, YX; Lim, ST; Tan, DS; Tan, IB; Tao, M1
Chen, CW; Chen, CX; Fu, QC; He, CL; Liu, B; Ma, Y; Pan, XN; Wang, MR; Wang, QC; Zhen, RD; Zhou, YJ1
Baqai, S; Inoue, M; Karino, Y; Kurbanov, F; Lai, CL; Mizokami, M; Mukaide, M; Orito, E; Sakaguchi, K; Sata, M; Shin-I, T; Tanaka, Y; Yamada, G; Yokosuka, O; Yuen, MF1
Belem, AM; Bisseye, C; Gnoula, C; Ilboudo, D; Kabre, GB; Karou, DS; Nikiema, JB; Onadja, SM; Ouermi, D; Pietra, V; Pignatelli, S; Sanou, DS; Simpore, J1
Kang, P; Li, SC; Sun, LJ; Yu, JW; Zhao, YH2
Cheng, YA; Dang, SS; Jia, XL; Liu, EQ; Song, P; Sun, MZ; Zhang, X1
Berg, T; Böcher, WO; Buggisch, P; de Man, RA; Deterding, K; Erhardt, A; Feucht, HH; Hüppe, D; Möller, B; Petersen, J; Reinders, JG; Rhode, P; Sarrazin, C; Spengler, U; Stein, K; Trojan, J; van Bömmel, F; Wasmuth, HE; Wedemeyer, H; Wiedenmann, B1
Guy, DG; Katz, LH; Paul, M; Tur-Kaspa, R2
Gervain, J; Horváth, G; Hunyady, B; Makara, M; Pár, A; Szalay, F; Telegdy, L; Tornai, I1
Burroughs, AK; Cholongitas, E; Papatheodoridis, GV1
Boland, GJ; Boot, HJ; Janssen, HL; van der Eijk, AA; Veldhuijzen, IK; Wouters, MG1
Ikeda, K2
Boccadoro, M; Bruno, B; Festuccia, M; Fiore, F; Giaccone, L; Marengo, A; Marzano, A; Pittaluga, F; Resta, I; Rizzetto, M; Sorasio, R1
Fukai, K; Ise, M; Kojima, H; Kumagai, K; Mimura, N; Sakai, C; Takagi, T; Tsujimura, H; Yokosuka, O1
Goto, H; Hayashi, K; Hirooka, Y; Ishigami, M; Itoh, A; Katano, Y; Kumada, T; Nakano, I; Toyoda, H; Yano, M; Yoshioka, K1
Jie, YS; Li, G; Shu, X; Wei, ZW; Xie, QF; Xu, QH; Zhang, K1
Chen, LY; Li, B; Li, XH; Liu, SY; Luo, RL; Peng, JF; Tang, W; Wang, ZQ; Xu, LM; Yin, ZH; Zhang, W; Zhou, BP1
Cao, Q; Tang, YT; Zhang, DZ1
Wang, FY; Yin, XL; Zhang, Y; Zhou, JH1
Bruno, S; Maisonneuve, P; Mondelli, MU; Raimondi, S1
Mutimer, D5
Chi, AC; Saab, S; Tong, MJ; Waterman, B1
Berg, CL; Coffin, CS; Curry, MP; Dove, LM; Nissen, NN; Ragni, M; Regenstein, FG; Roland, ME; Sherman, KE; Stock, PG; Terrault, NA1
Kiertiburanakul, S; Manosuthi, W; Sungkanuparph, S; Wongprasit, P1
Khedmat, H; Taheri, S1
Kaita, K; Mendoza, K; Osiowy, C; Solar, K1
Chee, GM; Poordad, F1
Fukushima, K; Inoue, J; Kakazu, E; Kimura, O; Kondo, Y; Obara, N; Shimosegawa, T; Ueno, Y; Wakui, Y1
Locarnini, S2
Chiba, T; Nakanishi, Y; Seno, H; Yamashita, Y1
Boroń-Kaczmarska, A; Cianciara, J; Flisiak, R; Gładysz, A; Halota, W; Juszczyk, J; Kryczka, W; Małkowski, P; Pawłowska, M; Simon, K1
Jiang, L; Yan, LN1
Di Bisceglie, AM; Firnhaber, C; Maskew, M; McNamara, L; Reyneke, A; Schulze, D1
Chen, J; Jia, JD; Ma, H; Yi, L; You, H1
Pár, A1
Li, X; Ma, L; Schreiber, A; Shi, Z; Yang, Y1
Choi, JJ; Jang, H; Kim, J; Park, H; Son, Y1
Chen, L; Liu, Y; Ren, X; Si, L; Wang, Y; Xu, D; Xu, T; Xu, Z; Zhao, J; Zhong, Y1
Castaing, D; Delvart, V; Duclos-Vallee, JC; Roche, B; Roque-Afonso, AM; Samuel, D; Sebagh, M1
Li, JG; Liu, L; Tang, YZ; Wang, XH; Wang, YM; Zhou, JJ1
Alavian, SM; Fallahian, F; Fallahian, V; Zamani, F1
Chae, HB; Goo, JC; Hong, SP; Jeong, JI; Kim, BU; Kim, SO; Park, BC; Park, SM; Youn, SJ1
Coffin, CS; Michalak, TI; Mulrooney-Cousins, PM; Peters, MG; Roberts, JP; Terrault, NA; van Marle, G1
Chun, J; Kim, BG; Kim, W; Kim, YJ; Lee, HS; Lee, KL; Park, KU; Suh, KS; Yi, NJ; Yoon, JH1
Gianini, RJ; Gomes-Gouvêa, MS; Leite, OM; Locarnini, S; Martins, LG; Mendes-Correa, MC; Pinho, JR; Santana, RA; Silva, MH; Sitnik, R; Uip, DE; Yuen, L1
Brock, GN; Buell, JF; Eng, M; Marvin, MR; Ouseph, R; Ravindra, K1
Gane, E1
Cheng, N; Jiang, L; Li, B; Wang, W; Wei, Y; Wen, T; Xu, M; Yan, L; Yang, J; Zhao, J1
Dixit, V; Fabrizi, F; Martin, P; Messa, P1
Aki, Z; Haznedar, R; Ozkurt, ZN; Sucak, GT; Yağci, M; Yeğin, ZA1
Du, Z; Gao, YT; Hang, T; Jing, L; Li, Y; Liu, L; Liu, T; Wu, ZP1
Gong, HY; Liu, ZG; Zhang, HY; Zhang, Z1
Bock, CT; Damerow, H; Locarnini, S; Tillmann, HL; Walker, C; Wiegand, J; Yuen, L1
Li, Q; Li, X; Liu, Y; Wang, L; Wong, VW; Xin, S; Xu, D; Xu, Z; Zhao, J; Zhong, Y1
Bouzas, MB; Cassino, L; Giuliano, SF; Laufer, N; Quarleri, J1
Asaka, M; Chuma, M; Hige, S; Horimoto, H; Kobayashi, T; Nakanishi, M; Natsuizaka, M; Sho, T; Yamamoto, K; Yamamoto, Y; Yoshida, S1
Chang, PY; Chao, TY; Chen, YC; Dai, MS; Ho, CL; Kao, WY; Tsai, SH; Wu, YY; Yu, JC1
Cui, X; Fang, D; Inagaki, Y; Kokudo, N; Qi, F; Tang, W; Wang, D; Xu, H1
Chen, Z; Shi, Y; Shu, ZY; Wu, YH; Yang, J; Zhang, WJ1
Gomes-Gouvêa, MS; Guastini, Cde F; Lemos, MF; Mendes-Correa, MC; Oba, IT; Pinho, JR; Silva, AC; Spina, AM1
Egashira, T; Kobayashi, M; Kumada, H; Nagano, M; Suzuki, F; Tadokoro, K; Yamaguchi, T1
Chang, MH; Chen, CY; Chen, HL; Lu, FL; Ni, YH1
Cheung, CK; Lau, GK; Lo, CM; Man, K1
Guo, CC; Guo, HQ; Huang, JJ; Huang, Y; Li, HR; Lin, TY; Pu, XX; Xie, Y; Zhai, LZ; Zhang, X; Zhu, HL1
Boot, HJ; Cuypers, HT; Koppelman, MH; van Swieten, P; Zaaijer, HL1
Christodoulou, DK; Katsanos, KH; Tsianos, EV; Tsianos, VE; Vagias, I; Zervou, E; Zioga, H; Zois, CD1
Deutsch, M; Hatziyanni, E; Manolakopoulos, S; Papadopoulos, N; Vassilopoulos, D1
Bansal, S; Carey, I; D'Antiga, L; Longhi, MS; Ma, Y; Mesa, IR; Mieli-Vergani, G; Vergani, D1
Bartels, M; Berg, T; Hartmann, J; Jonas, S; Karlas, T; Maier, M; Mössner, J; Tillmann, HL; Weimann, A; Wiegand, J1
Andreone, P; Bacci, M; Burra, P; Canova, D; Cursaro, C; Fiorentino, B; Guazzini, S; Marengo, A; Marzano, A; Riili, A; Volpes, R1
Roche, B; Samuel, D3
Mallet, V; Pol, S; Vallet-Pichard, A1
Afzal, S; Ali, L; Ali, M; Badar, S; Butt, S; Hussain, A; Idrees, M; Munir, S; Rehman, IU; Saleem, S1
Ahn, JS; Choi, MS; Gwak, GY; Im, YH; Kang, ES; Kim, KH; Lee, JE; Nam, SJ; Park, YH; Yang, JH; Yun, J1
Awi, D; Cavenaugh, JS; Hill, AV; McConkey, SJ; Mendy, M; Whittle, H1
Kang, P; Sun, LJ; Yan, BZ; Yu, JW; Zhao, YH1
Brock, GN; Buell, JF; Carrubba, CJ; Eng, M; Ferguson, N; Marvin, MR; Mostajabi, F1
Andersen, ES; Christensen, PB; Frigstad, SO; Kjær, M; Konopski, Z; Krarup, H; Leutscher, P; Moessner, B; Weiland, O; Weis, N; Westin, J1
Akbas, E; Aktas, S; Atiq, A; Haberal, M; Karakayali, H; Selcuk, H; Sevmis, S; Zia, HH1
Chen, K; Deng, H; Feng, H; Jia, W; Jin, L; Li, S; Liu, F; Long, M; Rao, N; Song, E; Su, F; Wu, J1
Arcaini, L; Bruno, R; Lucioni, M; Merli, M; Paulli, M; Rattotti, S; Riboni, R; Vercelli, A1
Goh, YT; Han, ST; Hwang, WY; Linn, YC; Mya, DH; Tan, DC1
Chen, XQ; Li, M; Lin, GN; Peng, JW; Xia, ZJ1
Chen, XY; Gui, X; Yang, RR; Zhu, Y1
Ji, Y; Jiang, H; Ju, L; Kan, N; Wu, K; Yu, M1
Ladapo, TA; Lesi, AE; Lesi, OA; Onifade, EU1
Kawano, K; Nampei, A; Shi, K; Takeuchi, E; Tsuboi, H; Tsujii, A; Yoshihara, H1
Akriviadis, E; Cholongitas, E; Goulis, J; Papatheodoridis, GV1
Aghasadeghi, MR; Ardestani, MS; Bahramali, G; Davar Siadat, S; Delbaz, SA; Farahani, A; Memarnejadian, A; Mohraz, M; Mostafavi, E; Sadat, SM; Saraji, AA; Vahabpour, R1
Gonzalez-García, J; Labarga, P; Pineda, JA; Poveda, E; Rodriguez, C; Santos, J; Sobrino, P; Soriano, V; Tuma, P; Tural, C; Vidal, F1
Deng, L; Gao, S; Gui, X; Liang, K; Rong, Y; Xiong, Y; Yan, Y; Yang, R; Zhang, Y1
Block, TM; Clearfield, E; Cuconati, A; Goddard, C; Guo, H; Mills, C; Morrey, JD; Motter, NE; Xiao, T; Xu, X; Yu, W; Zhao, K1
Giles, M; Sasadeusz, J; Visvanathan, K1
Arat, M; Idilman, R1
Goetzl, L; Lazenby, GB; Lintzenich, AE; Newman, R; Simpson, KN; Unal, ER1
Cent, A; Chung, MH; Cook, L; Jerome, KR; John-Stewart, G; Kim, HN; Lule, G; Morrow, RA; Richardson, B; Scott, J; Tapia, K1
Cao, J; Li, SY; Lu, XJ; Qin, L; Song, XB; Wang, J; Wang, LL; Ying, BW; Zhang, L; Zhou, J; Zhou, Y1
Lim, Z; Moses, SE; Zuckerman, MA1
Chien, RN; Hu, CC; Lai, MW; Lin, CL; Yeh, CT1
Chen, T; He, Y; Liu, H; Liu, X; Wang, K; Yan, Z; Zhang, S; Zhao, Y1
Chen, HH; Hung, HF1
Cao, GW; Han, L; Wang, HY; Xie, JX; Zhang, HW; Zhang, Q1
Deutsch, M; Ketikoglou, I; Manesis, EK; Manolakopoulos, S; Mela, M; Papatheodoridis, GV; Striki, A; Tzourmakliotis, D1
Branger, M; Collin, G; Fraqueiro, G; Gervais, A; Hamet, G; Lada, O; Marcellin, P; Martinot-Peignoux, M; Matheron, S; Moucari, R; Peytavin, G; Roquebert, B1
An, H; Byun, KS; Hyun, JJ; Jung, ES; Kang, HS; Kim, CD; Kim, DJ; Kim, JH; Kim, TH; Lee, HS; Ryu, HS; Seo, YS; Um, SH; Yeon, JE; Yim, HJ; Yoon, E1
Dalekos, GN; Tillmann, HL; Zachou, K1
García-Alonso, FJ; Martín-Mateos, RM; Moreira Vicente, V1
Andreoni, M; Bertoli, A; Ceccarelli, L; Perno, CF; Ricciardi, A; Salpini, R; Sarmati, L; Sarrecchia, C; Sordillo, P; Svicher, V1
Wong, GL1
Fontana, RJ; Singal, AK1
Aghokeng, AF; Bourgeois, A; Delaporte, E; Ducos, J; Kenfack, A; Kouanfack, C; Laurent, C; Mondain, AM; Mpoudi-Ngolé, E1
Gharebaghiyan, A; Sharifi, Z; Yari, F1
Chen, H; Deng, SP; Guan, XL; Li, J; Niu, XT; Su, XJ; Tang, MT; Wu, Q; Yang, RY1
Ji, Y; Jiang, H; Jiang, Q; Ju, L; Tang, X; Wu, K; Wu, M; Yu, M1
Bae, SC; Choi, IA; Kim, SI; Lee, EB; Lee, EY; Lee, YJ; Park, MC; Park, YB; Ryu, HH; Shin, K; Song, YW; Yoo, B; Yoo, WH1
Chang, MH; Changchien, CS; Chen, CH; Hu, TH; Hung, CH; Lee, CM; Lu, SN; Wang, JH1
Allweiss, L; Bierwolf, J; Dandri, M; Lütgehetmann, M; Matthes, E; Petersen, J; Pollok, JM; Volz, T; Warlich, M1
Gervain, J; Horváth, G; Hunyady, B; Makara, M; Pár, A; Szalay, F; Telegdy, L; Tornai, I; Ujhelyi, E1
Jiang, JH; Ma, F; Sun, CY; Wang, N; Wang, QD; Wang, YF; Yang, XA; Yin, DT; Zhang, Y; Zheng, LY; Zhou, YB1
Chen, GF; Dai, JZ; Ji, D; Li, L; Li, X; Liu, Y; Si, LL; Wang, L; Xin, SJ; Xu, D; Xu, Z; Yao, Z1
Ahn, SH; Chon, CY; Han, KH; Kim, DY; Lee, JM; Lee, MH; Park, JY; Ryu, HJ; Son, CY1
An, H; Chang, J; Chen, L; Dong, L; Guo, X; Li, Y; Tao, L; Wang, Q; Yang, X; Yu, X; Zheng, L1
Deng, YL; Gao, W; Jiang, WT; Qu, W; Rao, W; Shen, ZY; Sun, LY; Sun, XY; Zhang, JJ; Zhang, YM; Zhu, ZJ1
Alavian, SM; Jazayeri, SM1
Campo, DS; Dimitrova, Z; Ganova-Raeva, L; Khudyakov, Y; Lara, J; Lok, A; Ramachandran, S; Teo, CG; Thai, H; Xia, G1
Dusheiko, G2
Chen, YC; Chen, YS; Chi, NH; Chou, NK; Chuang, MK; Huang, SC; Ko, WJ; Tsao, CI; Wang, CH; Wang, SS; Wu, IH; Yu, HY1
Guyatt, G; Heels-Ansdell, D; Sun, X; Walter, SD1
Han, Y; Li, T; Li, Y; Wang, H; Zhang, C; Zhang, X; Zhu, T1
Akriviadis, E; Antoniadis, N; Cholongitas, E; Goulis, I; Papanikolaou, V; Vasiliadis, T1
Chandrasekar, PH; Liu, CY; Masood, A; Schiffer, CA1
Arberas-Diez, B; Casals-Seoane, F; Moreno-Otero, R1
Fernandes, CA; Gomes, SA; Lago, BV; Lewis-Ximenez, LL; Mello, FC1
Aparicio, M; Chamorro, C1
Ko, SY; Lee, HC; Lee, JE; Oh, HB; Park, CW1
Aguilar, C; Brown, RS; Buti, M; Fagan, EA; Leu, CS; Pereira, MR; Tilson, HH; Verna, EC1
Alvarez, F; Beland, K; Bouron Dal Soglio, D; Lapierre, P; Mas, E; Yousef, Y1
Buranabanjasatean, S; Buranawanitchakorn, Y; Gaudy-Graffin, C; Goudeau, A; Halue, G; Jourdain, G; Khamduang, W; Kunkongkapan, S; Lallemant, M; Luekamlung, N; Moreau, A; Ngo-Giang-Huong, N; Sirirungsi, W1
Ankcorn, M; Appiah, L; Chadwick, D; Foster, G; Geretti, AM; Phillips, R; Sarfo, S; Schwab, U; Stanley, A1
Kim, BG; Kim, D; Kim, IK; Kim, W; Kim, YJ; Lee, HS; Yoon, JH1
Berg, T; Bock, FJ; Deterding, K; Feucht, HH; Hüppe, D; Möller, B; Trojan, J; van Bömmel, F; Wasmuth, HE; Wedemeyer, H1
Boxall, E; Kaskar, S; Kelly, D; Sira, J; Workman, J1
Amici, R; Andreotti, M; Ceffa, S; Erba, F; Galluzzo, C; Giuliano, M; Jere, H; Liotta, G; Luhanga, R; Mancinelli, S; Marazzi, MC; Maulidi, M; Palombi, L; Pirillo, M; Sagno, JB; Vella, S1
Hu, Z; Huang, P; Lu, W; Luo, Q; Xiong, Q; Yang, Y; Zhang, N; Zhong, Y1
Babiker, ZOE; Hogan, C; Ustianowski, A; Wilkins, E1
Baxa, DM; Borroto-Esoda, K; Chappell, BJ; Golembieski, A; Gordon, SC; Jovanovich, J; Kizy, A; Krishnan, PV; Sharif, O; Shetron-Rama, L; Snow-Lampart, A; Thekdi, AD1
Grabmeier-Pfistershammer, K; Kosi, L; Payer, BA; Peck-Radosavljevic, M; Reiberger, T; Rieger, A; Strassl, R1
Fu, D; Huang, Y; Ma, Y; Shen, X; Wu, H; Wu, S1
Han, SW; Im, SA; Jeong, SH; Keam, B; Kim, DY; Kim, JH; Kim, JW; Kim, TY; Kim, YJ; Lee, HJ; Lee, JH; Lee, JS; Lee, KW; Oh, DY; Yoon, JH1
Calise, F; Cordone, G; De Luca, M; Di Costanzo, GG; Imparato, M; Lanza, AG; Migliaccio, C; Picciotto, FP; Scuderi, V; Tortora, R; Utech, W1
Fan, L; Fang, C; Li, JY; Wang, L; Wang, YH; Xu, J; Xu, W; Zhang, R1
Angeli, P; Cavallin, M; Fasolato, S; Gatta, A; Gola, E; Morando, F; Rosi, S1
Banerjee, A; Biswas, A; Chakrabarti, S; Chakravarty, R; Datta, S; Guha, SK; Pal, A; Panigrahi, R; Saha, B; Sarkar, N1
Chen, J; Chen, ZH; Dong, M; Li, X; Lin, Q; Lin, ZX; Ma, XK; Ruan, DY; Wan, XB; Wang, TT; Wei, L; Wen, JY; Wu, XY; Xing, YF1
Baik, SK; Chae, HB; Hong, SP; Kim, CW; Kim, JH; Kim, MY; Kim, YS; Lee, CD; Lee, JI; Lee, JW; Lee, MS; Park, CK; Park, SH; Seo, YS; Um, SH; Yim, HJ; Yoon, EL1
Candusso, M; Iorio, R; Liccardo, D; Riva, S; Torre, G; Tufano, M1
Girndt, M; Köhler, H1
Agnes, S; De Martini, D; Flore, R; Gasbarrini, A; Gentiloni Silveri, N; Migneco, A; Ojetti, V; Pola, P; Santoliquido, A1
Davis, GL; Keeffe, EB1
Angus, PW1
Huang, D; Liang, T; Lu, A; Wang, W; Wu, J; Zheng, S1
Abdelhamed, AM; Furman, PA; Isom, HC; Kelley, CM; Miller, TG1
Berg, T; Schürmann, D; van Bömmel, F; Wünsche, T1
de Man, RA; Janssen, HL; Niesters, HG; Sprengers, D; van Gelder, T; Zondervan, PE1
Arat, M; Bozdayi, AM; Bozkaya, H; Cinar, K; Erekul, S; Koç, H; Törüner, M; Uzunalimoğlu, O; Yurdaydin, C1
Hollander, A; Lindh, G; Sangfelt, P; Uhnoo, I; Weiland, O1
Chan, FK; Chan, HL; Chui, AK; Lau, WY; Rao, AR; Sung, JJ; Tse, CH; Wong, J; Wong, ML1
Berg, T; Müller, AR; Neuhaus, P; Neuhaus, R; Rayes, N; Seehofer, D; Steinmüller, T1
Fischer, L; Meier, D; Rogiers, X; Sterneck, M; Zöllner, B1
Engler, S; Kallinowski, B; Klar, E; Sauer, P; Stremmel, W1
Bozdayi, AM; Bozkaya, H; Erkan, O; Karayalcin, S; Uzunalimoglu, O; Yurdaydin, C1
Allende, H; Buti, M; Castells, L; Esteban, R; Guardia, J; Jardí, R; Margarit, C; Pumarola, T; Rodríguez, F; Sánchez-Avila, JF; Vargas, V1
Lok, AS1
Terrault, NA1
Muñoz, SJ1
Pruett, T2
Torresi, J1
Cutz, E; Petric, M; Roberts, EA; Yeung, LT1
Hanada, S; Harada, M; Kaji, R; Kumashiro, R; Sata, M1
Cuchacovich, R; Espinoza, LR; Menon, Y; Singh, R1
Lau, GK; Liang, R; Lie, A1
Chan, TM; Cheng, IK; Fang, GX; Ho, SK; Lai, KN; Tang, CS1
Dieterich, DT1
Alloway, RR; Bagous, T; Egidi, MF; Gaber, AO; Grewal, HP; Hardinger, KL; Honaker, MR; Kizilisik, AT; Shokouh-Amiri, MH; Stratta, RJ; Trofe, J; Vera, SR1
Fontana, RJ; Lok, AS2
Beigelman, L; Blatt, LM; Bowman, K; Conrad, A; Johnson, DA; Lee, PA; Macejak, DG; Maloney, L; McSwiggen, JA; Mokler, VR; Morrey, JD; Morrissey, DV; O'Brien, JT; Overly, SL; Pavco, PA; Schmid, P; Shaffer, CS; Vargeese, C1
Chen, CL; Chen, YS; Cheng, YF; Chiu, KW; de Villa, VH; Huang, TL; Jawan, B; Wang, CC; Wang, SH1
Andreone, P; Bernardi, M; Biselli, M; Cursaro, C; Di Giammarino, L; Felline, F; Gramenzi, A; Lorenzini, S; Morelli, MC; Porzio, F; Sama, C; Spinucci, G1
Broelsch, CE; Gerken, G; Karliova, M; Malago, M; Rothaar, T; Treichel, U; Trippler, M; Valentin-Gamazo, C1
Luo, K; Yu, L; Zhu, Y1
Chung, YH; Jung, S; Lee, HC; Lee, YS; Park, HJ; Park, YH; Song, HG; Suh, DJ1
Ahn, BM; Bae, SH; Cho, SH; Choi, JY; Han, NI; Jang, JW; Lee, CD; Lee, YS; Nam, SW; Park, DH; Park, TW; Park, YM; Yang, JM; Yoon, SK1
Anschuetz, G; Baker, A; Brown, N; Everson, G; Fontana, RJ; Gardner, SD; Griffiths, D; Hann, HW; Riely, C; Schiff, ER; Wright, T1
Benhamou, Y; Thibault, V; Tubiana, R1
Aikawa, A; Akima, M; Hasegawa, A; Ishii, K; Matsumaru, K; Nonaka, H; Shinohara, M; Sumino, Y1
Busuttil, RW; Durazo, F; Edelstein, M; Farmer, D; Ghobrial, RM; Goldstein, L; Han, SH; Holt, C; Hu, R; Kunder, G; Martin, P; Saab, S1
Barg-Hock, H; Becker, T; Bleck, JS; Bock, CT; Böker, KH; Flemming, P; Klempnauer, J; Manns, MP; Rosenau, J; Tillmann, HL; Trautwein, C1
Berg, T; Hopf, U; Schernick, A; Van Bömmel, F1
de Man, RA; Janssen, HL; Kwekkeboom, J; Niesters, HG; Schalm, SW; Sprengers, D1
Adams, P1
Akuta, N; Arase, Y; Hosaka, T; Ikeda, K; Kobayashi, M; Kumada, H; Saitoh, S; Someya, T; Suzuki, F; Suzuki, Y; Tsubota, A1
Fan, ST; Lai, CL; Liu, CL; Lo, CM; Wong, J1
Chan, HW; Tong, KL; Tsang, WK1
Burroughs, AK; Papatheodoridis, GV; Sevastianos, V1
Bar-Nathan, N; Ben-Ari, Z; Mor, E; Shaharabani, E; Shapira, Z; Tur-Kaspa, R1
Bernardos, A; Cañas, E; Díaz, C; García, I; Gómez, MA; Hinojosa, R; Martín, C; Pareja, F; Pascasio, JM; Pérez-Bernal, JB; Sayago, M; Serrano, J; Sousa, JM; Tamayo, MJ1
Yan, J; Zhang, LS; Zhao, XK1
Bartholomeusz, A; Bowden, S; Locarnini, S1
Cevreska, L; Efremov, DG; Georgievski, B; Panovska, I; Pivkova, A1
Chen, M; Deng, W; Li, X; Ruan, L; Wang, Y; Zhou, G; Zhou, S; Zhou, Z1
Boyer, N; Castelnau, C; Marcellin, P1
Färkkilä, M1
Bohane, TD; Connor, FL; Kennedy, SE; Rosenberg, AR1
Feber, J; Filler, G; Le Saux, N; Weiler, G1
Cirocco, R; Kato, T; Levi, DM; Madariaga, J; Nery, JR; Nery-Avila, C; Nishida, S; Reddy, KR; Ruiz, P; Schiff, E; Tzakis, AG; Weppler, D1
Schwarz, KB1
Brandwein, J; Gupta, V; Kamel-Reid, S; Lipton, JH; Messner, HA; Minden, MD1
Buti, M; Casafont, F; Cruz de Castro, E; García-Rey, C; González, A; Herrero, JI; Jardí, R; Mas, A; Miras, M; Prieto, M1
Zoulim, F3
Kessler, HH; Marth, E; Stauber, RE; Stelzl, E1
Allwinn, R; Caspary, WF; Faust, D; Rabenau, HF; Zeuzem, S1
Hidaka, S; Horiike, N; Iuchi, H; Konishi, I; Michitaka, K; Miyake, T; Nakanishi, S; Onji, M; Yoshino, I1
Castellví, JM; del Río, N; Diloy, R; Hernández, JA; Martínez, X; Salat, D1
Rossi, G1
Ohmoto, K; Tsuduki, M; Yamamoto, S1
Ben-Ari, Z; Melzer, E; Schmilovitz-Weiss, H; Tur-Kaspa, R1
Ahmed, A; Ahmed, AM; Garcia, G; Keeffe, EB; Nguyen, MH; Simpson, ND; Simpson, PW1
de Man, RA; Janssen, HL; Niesters, HG; Schalm, SW; van Nunen, AB; van Zonneveld, M1
Kimura, T; Kiyosawa, K; Maki, N; Matsumoto, A; Orii, K; Rokuhara, A; Sun, X; Tanaka, E; Yagi, S; Yamaura, T1
Boucher, CA; Haverkamp, M; Hoepelman, AI; Smit, M; Weersink, A1
Bock, CT; Dienes, HP; Klein, C; Kubicka, S; Locarnini, S; Manns, MP; Trautwein, C; Wedemeyer, H; Wüstefeld, T1
Maeda, Y; Okamoto, R; Sasaki, T1
Ayres, A; Bartholomeusz, A; Cooley, L; Crowe, S; Lewin, S; Locarnini, S; Mijch, A; Sasadeusz, J1
Hou, HY; Li, AM; Li, XM; Shen, HM; Shi, MF; Shi, ZJ; Teng, BQ; Yang, YB; Zou, L1
Berger, F; Boillot, O; Chevallier, P; Dumortier, J; Scoazec, JY1
Hou, JL; Luo, KX; Sun, J; Wang, ZH; Xiao, L; Zhang, L1
Chen, YM; Lei, Y; Xiang, GQ; Zhang, HH; Zhang, WY1
Cai, C; Chen, G; He, X; Huang, J; Lu, M; Wang, G; Yang, Y; Zhu, X2
Disel, U; Paydas, S; Sahin, B; Yavuz, S1
Chiba, T; Fukai, K; Goto, S; Imazeki, F; Narita, M; Saisho, H; Shishido, H; Yokosuka, O1
Andreone, P; Bernardi, M; Biselli, M; Cursaro, C; Gramenzi, A; Lorenzini, S1
Albeniz Arbizu, E; Barcena Marugan, R; de Vicente Lopez, E; Garcia Gonzalez, M; Mateo Lindeman, M; Moraleda Garcia, G; Oton Nieto, E1
Albeniz Arbizu, E; Barcena Marugan, R; Carrera Alonso, E; de Vicente Lopez, E; Garcia Gonzalez, M; Martin Davila, P; Moreno Garcia, J; Nuño Vazquez-Garza, J; Oton Nieto, E1
Ahn, SH; Chang, HY; Han, KH; Kim, KH; Kim, SI; Lee, KH; Seong, BL; Tong, S; Yoon, YJ1
Ali, HY1
Maier, KP1
Asari, S; Deguchi, M; Ichigo, K; Iwatani, Y; Kagita, M; Kanakura, Y; Nakano, T; Sasahara, Y; Tahara, K1
Sablon, E; Shapiro, F; Zoulim, F1
Cheng, VC; Lau, GK; Lo, CM1
Elefsiniotis, IS; Kafiri, G; Ketikoglou, I; Mavrogiannis, C; Moulakakis, A; Pantazis, KD1
Bai, YJ; Lv, GT; Wang, Y; Yan, XJ; Zhang, WH; Zhao, JR1
Chan, AO; Fan, ST; Kato, T; Lai, CL; Mizokami, M; Ng, IO; Sum, SM; Wong, DK; Yuan, HJ; Yuen, JC; Yuen, MF1
Beckebaum, S; Broelsch, CE; Cicinnati, VR; Gerken, G1
Cao, YJ; Huang, JS; Lin, LY; Wang, H; Zhou, DY1
Huang, DS; Liang, TB; Wang, WL; Wu, J; Xu, X; Zheng, SS1
Ciancia, R; De Divitiis, B; De Renzo, A; Del Giudice, A; Pane, F; Persico, M; Picardi, M; Quintarelli, C; Rotoli, B; Salvatore, F1
Fan, J; Liang, WF; Xie, YJ; Yang, DH; Zhao, NF1
Pai, RB; Pai, SB; Schinazi, RF1
Berenberg, JL; Mills, SJ; Ramos, F1
Buster, EH; Schalm, SW; van der Eijk, AA1
De Diego, L; Martín, E; Martín, L; Martínez, MC; Rendón, P; Soria, MJ1
Balistreri, WF; Hochman, JA1
Bertoletti, A; Gilson, RJ; Lascar, RM; Lopes, AR; Maini, MK1
Gong, Q; Liu, C; Lu, Z; Wang, Y; Zhang, D; Zhang, S; Zhang, X1
Kang, YK; Kim, E; Kim, SB; Kim, SW; Kim, WK; Lee, GW; Lee, JH; Lee, JL; Lee, JS; Lee, KH; Oh, S; Ryu, MH; Suh, C1
Arinaga, T; Hisamochi, A; Ide, T; Koga, Y; Kumashiro, R; Kuwahara, R; Ogata, K; Sata, M; Tanaka, K1
Lee, HC; Suh, DJ1
Lai, CL; Poynard, T; Ratziu, V; Yuen, MF1
Heathcote, J1
Perrillo, RP3
Berenguer, M; Wright, TL1
Altmeyer, P; Boms, S; Gambichler, T; Paech, V; Rotterdam, S; Stücker, M1
Au, WY; Cheng, HC; Cheung, M; Fong, DY; Lai, LS; Lau, GK; Liang, R; Lie, A; Ngan, R; Yiu, HH; Zhang, HY1
Kirchner, JT; Lin, KW1
Chan, AO; Hui, CK; Lai, CL; Sablon, E; Sum, SM; Wang, BC; Wong, DK; Yuan, HJ; Yuen, MF1
Dussaix, E; Férey, MP; Fki, L; Mackiewicz, V; Roque-Afonso, AM1
Brown, NA1
Kobayashi, S1
Benhamou, Y1
Chan, AT; Chan, PK; Ho, WM; Johnson, PJ; Lam, KC; Lee, JJ; Lei, KI; Leung, TW; Mok, TS; Yeo, W; Zee, B; Zhong, S1
Lavanchy, D1
Akan, H; Akbulut, H; Arat, M; Arslan, O; Beksaç, M; Bozdayi, M; Idilman, R; Karayalçin, S; Ozcan, M; Ozden, A; Soydan, E; Soykan, I; Törüner, M; Türkyilmaz, AR; Van Thiel, DH1
Mauss, S1
Ganem, D; Prince, AM1
Bilici, A; Ozguroglu, M; Serdengecti, S; Turna, H1
Blockmans, D; De Backer, AI; Deeren, DH; Malbrain, ML; Verbraeken, H1
Bonino, F; Brunetto, MR; Casazza, G; Favre, C; Macchia, P; Menconi, MC; Nardi, M; Oliveri, F1
Cheung, ST; Fan, ST; Lai, CL; Liu, CL; Lo, CM; Ng, IO1
Chen, HY; Song, PH; Tian, DY; Xu, D; Zhang, ZG1
Chao, TY; Dai, MS; Lu, JJ; Shyu, RY; Wu, PF2
Chen, TY; Lee, YC; Su, WC; Tsao, CJ; Young, KC1
Bunnapradist, S; Dixit, V; Dulai, G; Fabrizi, F; Martin, P1
Hino, T; Ide, T; Inoue, H; Koga, Y; Kumashiro, R; Kuwahara, R; Sata, M; Tanabe, R; Tanaka, E1
Maggiolo, F; Ripamonti, D; Suter, F1
Attili, A; Berloco, P; Callejon, V; Ferretti, G; Ferretti, S; Ginanni Corradini, S; Iappelli, M; Lilli, D; Mancini, C; Masini, A; Merli, M; Rivanera, D; Rossi, M; Tanzilli, P1
Angelico, M; Di Paolo, D; Lenci, I; Piccolo, P; Tisone, G; Zazza, S1
Abbas, Z; Jafri, W; Khokhar, N; Shah, SH; Zuberi, SJ1
Angus, P; Locarnini, S1
Chien, RN; Liaw, YF; Yeh, CT1
Elefsiniotis, IS; Mpotsi, C; Pantazis, KD; Paparizos, V1
Chan, FK; Chan, HL; Chui, AK; Hui, AY; Lai, EC; Lau, WY; Rao, AR; Sung, JJ; Wong, J1
Black, A; Dixon, JS; el-Sayed, MH; el-Tawil, A; Karim, AM; Shanab, G1
Asaka, M; Imamura, M; Kanamori, H; Kawamura, T; Masauzi, N; Miura, T; Obara, S; Saitoh, S; Tanaka, J; Tsutsumi, Y; Yamada, M1
Bielefeld, P; Cohen, P; Guillevin, L; Hausfater, P; Imbert, B; Larroche, C; Loustaud-Ratti, V; Mahr, A; Petitjean, P; Queyrel, V; Roudier, J; Smadja, D1
Perelson, AS; Ribeiro, RM1
Bunnapradist, S; Fabrizi, F; Martin, P1
Chan, TM; Ho, SK; Lai, KN; Tang, CS; Tse, KC1
Drake, A; Mijch, A; Sasadeusz, J1
Cooksley, WG1
Janssen, HL; Schalm, SW; van Zonneveld, M1
Buti, M; Esteban, R; Guardia, J; Jardi, R; Martinez, M; Rodriguez-Frias, F; Schaper, M; Valdes, A1
Huh, W; Joh, JW; Kim, DJ; Kim, JA; Kim, SJ; Kim, YG; Lee, KW; Oh, HY1
Murphy, MJ; Wilcox, RD1
Benhamou, Y; Cahour, A; Katlama, C; Lada, O; Poynard, T; Thibault, V1
Ayaz, C; Değertekin, H; Kokoğlu, OF; Yalçin, K1
Avci, IY; Bozdayi, AM; Eyigun, CP; Pahsa, A; Turkyilmaz, AR; Yurdaydin, C1
Ayres, A; Bartholomeusz, A; Bowden, S; Lau, D; Lewin, SR; Locarnini, S; Walters, T; Wightman, F1
Borlenghi, E; Cariani, E; Motta, M; Pelizzari, AM; Rossi, G; Turconi, P1
Cote, PJ; Delaney, WE; Gerin, JL; Jacob, JR; Korba, BE; Tennant, BC; Toshkov, I1
Enomoto, M; Hino, M; Nishiguchi, S; Seki, S; Yamane, T1
Lim, YS; Suh, DJ1
Cho, M; Heo, J; Jang, HJ; Kang, DH; Kim, CM; Kim, GH; Kim, HH; Park, HK; Shin, YM; Song, GA; Yang, US1
Angus, P; Ayres, A; Bartholomeusz, A; Colonno, RJ; Discotto, L; Levine, SM; Locarnini, S; Plym, M; Pokornowski, K; Rose, RE; Sievert, W; Tenney, DJ; Thompson, G; Walsh, AW; Warner, N; Weinheimer, SP; Yu, CF1
Chao, TY; Dai, MS; Kao, WY; Liu, TM; Shyu, RY1
Kondili, LA; Mutimer, D; Osman, H1
Andreone, P; Bernardi, M; Biselli, M; Cammà, C; Cursaro, C; Gramenzi, A; Trevisani, F1
Chan, AO; Lai, CL; Sablon, E; Wong, BC; Wong, DK; Yuan, HJ; Yuen, MF1
Cho, B; Cho, M; Heo, J; Jang, H; Jun, H; Kim, C; Kim, H; Park, H; Shin, W1
Antonio, G; Federica, S; Giuseppe, L; Luca, L; Michela, T; Nicola, P; Paola, P; Patrizia, C; Simona, S1
Käser, L; Kolyvanos Naumann, U; Vetter, W1
Asahina, Y; Izumi, N1
Matsumura, M1
Fujiwara, K; Mochida, S1
Yoshiba, M1
Makuuchi, M; Sugawara, Y1
Albert, J; Lindström, A; Odeberg, J1
Bani-Sadr, F; Molina, JM; Palmer, P; Scieux, C1
Curry, MP1
De Medina, M; Madariaga, J; Montalbano, M; Neff, GW; Nery, C; Nery, J; O'brien, CB; Ruiz, P; Safdar, K; Schiff, ER; Shire, N; Tzakis, AG1
Basso, M; Campo, N; Delfino, A; Martelli, A; Mattioli, F; Pelli, N; Picciotto, A; Torre, F1
Duncan, R; Lau, DT; Madariaga, JR; Montalbano, M; Muslu, H; Neff, GW; Nery, C; Nery, J; O'Brien, CB; Ruiz, P; Safdar, K; Schiff, ER; Shire, NJ; Tzakis, AG1
Ambu, S; Ancarani, F; Bonasso, M; Bruno, R; Cozzi-Lepri, A; d'Arminio Monforte, A; Ferraro, T; Puoti, M; Santantonio, T; Toti, M; Tundo, P1
Da Costa, M; Dan, YY; Isaac, J; Lee, HL; Lee, KH; Lee, YM; Lim, SG; Mak, K; Prabhakaran, K; Sutedja, DS; Wai, CT; Wee, A1
Chen, YS; Chi, NH; Chou, NK; Hsu, RB; Huang, SC; Ko, WJ; Lai, MY; Lee, YT; Liau, CS; Tsao, CI; Wang, SS; Yu, HY1
Akuta, N; Arase, Y; Hosaka, T; Ikeda, K; Kobayashi, M; Kumada, H; Saitoh, S; Sezaki, H; Someya, T; Suzuki, F; Suzuki, Y; Tsubota, A1
Ackerman, Z; Ben-Ari, Z; Lurie, Y; Reshef, R; Rosner, G; Safadi, R; Sbeit, W; Schmilovitz-Weiss, H; Sikuler, E; Tur-Kaspa, R; Zuckerman, E1
Liu, C; Lu, Y; Pan, CE; Wang, B; Wu, Z; Yu, L1
Akiyoshi, J; Itano, S; Koga, H; Kumashiro, R; Kurogi, J; Matsugaki, S; Nagamatsu, H; Nagaoka, S; Sata, M; Tajiri, N; Torimura, T; Yamasaki, S1
Telegdy, L1
Däumer, M; Kaiser, R; Matz, B; Rockstroh, JK; Schewe, CK; Schildgen, O; Vogel, M; Weitner, L1
Akuta, N; Arase, Y; Hosaka, T; Ikeda, K; Kobayashi, M; Kumada, H; Matsuda, M; Ooga, H; Saitoh, S; Satoh, J; Sezaki, H; Someya, T; Suzuki, F; Suzuki, Y; Tsubota, A1
D'Onofrio, M; Marrone, A; Ricciotti, R; Ruggiero, G; Utili, R; Zampino, R1
Christian, CL1
Cotler, SJ; Mohanty, SR1
Ali, H; Egawa, H; Kasahara, M; Marusawa, H; Nabeshima, M; Ogawa, K; Tanaka, K; Ueda, M; Uryuhara, K1
Akay, S; Akyildiz, M; Karasu, Z; Tokat, Y1
Duan, XZ; Li, HW; Wang, FS; Wang, M; Xu, D; Zhuang, H1
Akarca, U; Akyildiz, M; Arikan, C; Batur, Y; Demirbas, T; Ersoz, G; Gunsar, F; Karasu, Z; Kilic, M; Kobat, A; Ozacar, T; Tokat, Y1
Ando, K; Fukuno, K; Hara, T; Imawari, M; Kasahara, S; Moriwaki, H; Onishi, H; Oyama, M; Sawada, M; Takahashi, T; Takai, S; Takami, T; Tomita, E; Tsurumi, H; Yamada, T1
Enjoji, M; Kotoh, K; Nakamuta, M; Nawata, H; Noguchi, K; Sugimoto, R; Tsuruta, S1
Caccamo, L; Colombo, M; Fassati, LR; Lunghi, G; Maggioni, M; Radice, F; Romeo, R; Rossi, G1
Abbadessa, V; Ammatuna, E; Calvaruso, G; Craxí, A; Di Stefano, R; Di Trapani, R; Ferraro, D; Iannitto, E; Minardi, V; Mulè, A; Stefano, RD; Trapani, RD1
Adani, GL; Baccarani, U; Bresadola, F; Della Rocca, G; Risaliti, A; Viale, P1
Bo, P; Burra, P; Cillo, U; Loreno, M; Naoumov, N; Senzolo, M1
Chen, LY; Huang, J; Li, ZG; Qiao, P; Qiu, JM; Wang, SQ1
Alessandria, C; Carenzi, S; Debernardi-Venon, W; Franchello, A; Gaia, S; Ghisetti, V; Marzano, A; Premoli, A; Rizzetto, M; Salizzoni, M1
Akuta, N; Arfase, Y; Hosaka, T; Ikeda, K; Kobayashi, M; Kumada, H; Matsuda, M; Miyakawa, Y; Saitoh, S; Sato, J; Someya, T; Suzuki, F; Suzuki, Y; Watabiki, S1
Cho, YS; Chon, CY; Han, KH; Lee, CK; Moon, YM; Park, IS; Suh, JH; Won, SY1
Gehri, M; Gerner, P; Laubscher, B; Roulet, M; Wirth, S1
Bunnapradist, S; Fabrizi, F; Martin, P; Messa, PG; Rusconi, E; Villa, M1
Choi, BC; Lei, XY; Li, D; Men, K; Xu, DZ; Yan, YP; Zhang, JX1
Joh, JW; Kim, SJ; Lee, DH; Lee, HH; Lee, KW; Park, JW; Yoo, BC1
Idilman, R2
Ceballos, M; Diaz, F; Garcia, A; Garcia, T; González, P; Mazuecos, A; Rivero, M1
Barrios Peinado, C; Cuervas-Mons Martínez, V; Herreros de Tejada Echanojáuregui, A; López Monclús, J; Lucena de la Poza, JL; Moreno Planas, JM; Portero Azorin, F; Revilla Negro, J; Rubio González, E; Sánchez Turrión, V1
Hiraoka, A; Hirooka, M; Horiike, N; Iuchi, H; Kubo, Y; Kumagi, T; Kurose, K; Michitaka, K; Miyaoka, H; Ohmoto, M; Okada, S; Onji, M; Uehara, T; Yamamoto, K; Yamashita, Y1
Feucht, HH; Laufs, R; Petersen, J; Schröter, M; Sterneck, M; Wursthorn, K; Zöllner, B1
Akalin, E; Ames, S; Bromberg, JS; Murphy, B; Sehgal, V1
Chen, PM; Chiou, TJ; Hsiao, LT; Lee, MY; Lin, PC; Poh, SB1
Colombo, M; Donato, MF1
Alaimo, G; Almasio, PL; Bonura, C; Cappello, M; Craxì, A; Di Marco, V; Di Stefano, R; Ferraro, D; Giglio, M; Parisi, P1
Asaka, M; Imamura, M; Kanamori, H; Masauzi, N; Mori, A; Tanaka, J; Tsutsumi, Y1
Lei, XY; Li, D; Men, K; Xu, DZ; Yan, YP; Zhang, JX1
Chen, H; Cheng, SQ; Cong, WM; Shen, F; Wang, PJ; Wu, MC; Yang, JH; Zhao, YX1
Cañas, C; Casais, LA; Casanova, A; Chahri, N; Figueras, J; Gornals, J; Lopez, C; Taltavull, TC; Verdura, B1
Gao, ZL; Gu, L; Huang, YS; Li, G; Ma, HH; Peng, XM; Xie, QF1
Hou, W; Li, MW; Liu, KZ; Wo, JE1
Choi, MS; Koh, KC; Lee, JH; Moon, W; Moon, YM; Paik, SW; Rhee, JC; Shim, SG; Yoo, BC1
Chao, TY; Dai, MS1
Bellido, D; Casado, JL; Chamorro, AJ; Moreno, S1
Au, WY; Cheung, WW; Hui, CK; Kwong, YL; Lau, GK; Leung, N; Liang, R; Lie, AK; Wong, BC; Yueng, YH; Zhang, HY1
Chen, HS; Feng, LL; Guo, XB; He, JY; Yang, RY; Zhang, FX; Zhu, YT1
Chiba, T; Fukai, K; Imamura, T; Imazeki, F; Kanda, T; Kojima, H; Nishimura, M; Saisho, H; Saito, Y; Yokosuka, O1
Erb, SR; Ho, JK; Hoskins, PJ; Law, JK; Steinbrecher, UP; Yoshida, EM1
Chen, Y; Liu, XX; Wei, L; Yu, YX1
Chan, AT; Chan, PK; Ho, WM; Hui, EP; Johnson, PJ; Lam, KC; Lee, JJ; Mo, FK; Mok, TS; Yeo, W1
Yatsuhashi, H1
Liu, F; Ma, ZM; Wang, YX; Wen, YM; Weng, XH; Yao, X; Zhang, JM1
Husa, P1
de Silva, HJ; Herath, CA; Sheriff, MH1
Ahn, BM; Bae, SH; Cho, SH; Choi, JY; Chung, KW; Han, NI; Jang, JW; Sun, HS; Yang, JM; Yoon, SK1
Cao, Y; Geng, H; Hua, B; Sun, Y; Wang, H; Yu, A1
Choi, WB; Chung, YH; Kim, KM; Lee, HC; Lee, YS; Lim, YS; Suh, DJ1
Garipidou, V; Giouleme, O; Perifanis, V; Tziomalos, K; Vakalopoulou, S; Vassiliadis, T1
Colby, TJ; Erion, MD; Fujitaki, JM; Reddy, KR; van Poelje, PD1
Chayama, K; Fujimoto, Y; Hiraga, N; Imamura, M; Iwao, E; Noguchi, C; Ochi, H; Oga, H; Takahashi, S; Takaishi, H; Tateno, C; Tsuge, M; Yoshizato, K1
Chen, CJ; Cheng, G; He, YS; Liu, N; Ou, ZY1
Shen, ZY; Wang, ZF; Zhu, ZJ1
Berg, T; Seehofer, D1
Araki, Y; Fujio, K; Fujioka, S; Hashimoto, K; Iwasaki, Y; Kaneyoshi, T; Kobashi, H; Nishida, T; Piao, CY; Sakaguchi, K; Senoh, T; Shiratori, Y; Terada, R1
Bester, R; Cotton, MF; de Waal, N; Rabie, H1
Colombo, M; Cortelezzi, A; Deliliers, GL; Fantini, NN; Lampertico, P; Pasquini, MC; Viganò, M; Zilioli, VR1
Colombo, M; Iavarone, M; Lampertico, P; Lunghi, G; Manenti, E; Viganò, M1
Chen, DS; Kao, JH; Liu, CJ2
Hashimoto, K; Kishikawa, K; Kuwano, H; Maehara, Y; Mochida, Y; Shimada, M; Shimura, T; Soejima, Y; Suehiro, T; Yoshizumi, T1
Lai, MY; Lee, SD; Ng, YY; Yang, WC1
Aguilar-Benavides, S; Alvarado-Esquivel, C; Conde-González, CJ; de la Ascensión Carrera-Gracia, M; Juárez-Figueroa, L; Ruiz-Maya, L; Sablon, E; Torres-Valenzuela, A1
Bradarić, N1
Beld, MG; Lange, JM; Pogány, K; Prins, JM; Wit, FW; Zaaijer, HL1
Avilés, JF; Bárcena, R; Barrios, C; Buti, M; Casanovas, T; Cuervas, V; De la Mata, M; Del Campo, S; Delgado, M; Dieguez, ML; Fraga, E; Gonzalez, A; Herrero, JI; Loinaz, C; Mas, A; Moraleda, G; Moreno, JM; Muñoz, R; Otero, A; Prieto, M; Rueda, M; Sousa, JM1
Barcena, R; Blesa, C; Foruny, JR; Garcia-Garzon, S; Garcia-Gonzalez, M; Moreno, A; Moreno-Zamora, A; Oton, E; Ruiz, P1
Chiang, YJ; Chu, SH; Fang, JT; Huang, CC; Huang, JY; Lin, HH; Tian, YC; Wu, MS; Yang, CW; Yen, TH; Yu, CC1
Shah, SR1
Chao, TC; Chen, PM; Chiou, TJ; Chu, CJ; Hsiao, LT; Lin, YC; Liu, JH; Tzeng, CH; Wang, WS; Yang, MH; Yen, CC1
de Man, RA; de Vries-Sluijs, TE; Hansen, BE; Osterhaus, AD; van der Eijk, AA; van der Ende, ME1
Akuta, N; Arase, Y; Hosaka, T; Ikeda, K; Kobayashi, M; Kumada, H; Matsuda, M; Saitoh, S; Satoh, J; Sezaki, H; Someya, T; Suzuki, F; Suzuki, Y; Watahiki, S1
Chayama, K; Iino, S; Imamura, M; Kawata, S; Kimura, T; Kiyosawa, K; Kobayashi, M; Maki, N; Matsumoto, A; Minami, M; Mizokami, M; Nagaoka, S; Okanoue, T; Suzuki, F; Tanaka, E; Tanaka, Y; Yatsuhashi, H; Yotsuyanagi, H1
Arai, S; Hasumi, M; Hatori, M; Makino, T; Okugi, H; Shibata, Y; Suzuki, K1
Fouillard, L; Gozlan, J; Serfaty, L1
Guan, ZZ; He, YF; He, YJ; Huang, HQ; Jiang, WQ; Li, YH; Lin, TY; Lin, XB; Sun, XF; Wang, FH; Xia, ZJ; Zhang, L1
Zhang, FK1
Cai, HD; Liu, M; Wang, L1
Gu, HX; Hattori, T; Li, D; Zhang, SY; Zhong, ZH; Zhuang, M1
Benhamou, Y; Fleury, H; Katlama, C; Le Teuff, G; Pellegrin, I; Piketty, C; Rozenbaum, W; Trimoulet, P; Trylesinski, A; Urbinelli, R1
Enomoto, M; Nishiguchi, S; Tamori, A1
Eguchi, K; Fukushima, T; Gotoh, T; Hayashi, T; Ichikawa, T; Ida, H; Kawakami, A; Nakamura, H; Takeshita, S; Toriyama, K; Tsujino, A1
Lee, ST; Ng, YY; Yang, WC1
Colak, T; Dalgiç, A; Emiroğlu, R; Filik, L; Gür, G; Haberal, M; Karakayali, H; Moray, G; Ozdemir, N; Yilmaz, U1
Akan, M; Akarsu, M; Astarcioğlu, H; Astarcioğlu, I; Karademir, S; Ozkardesler, S; Ozzeybek, D; Sayiner, A; Tankurt, E1
Ayres, A; Bartholomeusz, A; Cooper, DA; Dore, GJ; Lewin, S; Locarnini, S; Matthews, GV; Sasaduesz, J; Seaberg, E; Thio, CL1
Goffin, E; Horsmans, Y; Kanaan, N1
Boninsegna, S; Caroli, D; Fagiuoli, S; Floreani, A; Lobello, S1
Schiff, ER; Schreibman, IR1
Abelli, LA; Aloisi, A; Casula, F; Chezzi, C; Dettori, G; Martinelli, M; Medici, MC; Valcavi, P1
Canbay, A; Dalekos, GN; Eisenbach, C; Encke, J; Gerken, G; Graziadei, I; Hadem, J; Leifeld, L; Manns, MP; Schmidt, H; Schneider, A; Spengler, U; Tillmann, HL; Vogel, W; Wedemeyer, H; Zachou, K1
Aranda-Michel, J; Bonatti, H; Dickson, RC; Mendez, J; Satyanarayana, R; Yen, RD1
Dan, YY; Lim, SG; Wai, CT; Yeoh, KG1
Bakal, I; Ben Ari, Z; Kramer, MR; Morali, G; Shitrit, AB; Shitrit, D1
Bizzarri, R; Bonino, F; Brunetto, MR; Choudhury, S; Civitano, L; Colombatto, P; Gieschke, R; Oliveri, F1
Gong, ZJ; Jiang, XL; Mizokami, M; Xu, LM; Yuan, J; Zhou, BP1
Hasegawa, H; Miyagi, T; Nagasaki, A; Nakachi, S; Shinzato, O; Taira, N; Takasu, N; Tomoyose, T1
Tillmann, HL1
Kumada, H; Nakamura, H; Suzuki, F1
Planas, R; Ribera, JM; Sancho, JM; Vives, S1
Cai, CJ; Chen, GH; Lu, MQ; Yang, Y; Zhao, H1
Abate, ML; Ciancio, A; Gaia, S; Olivero, A; Rizzetto, M; Smedile, A1
Chau, TN; Chiu, MC; Lai, ST; Ng, TK; Tam, CM; Yu, WC1
Berg, T; Feucht, HH; Hüppe, D; Möller, B; Sarrazin, C; Spengler, U; van Bömmel, F; Wiedenmann, B; Zöllner, B1
Hollinger, FB; Lau, DT1
Ayli, D; Dede, F1
Lai, KN; Tang, S1
Chen, YB; Li, B; Li, ZH; Wang, WT; Wen, TF; Xu, MQ; Yan, LN; Yan, ML; Yang, JY; Zeng, Y1
Angelico, M; Carbone, M; Di Paolo, D; Lenci, I; Longhi, C; Tisone, G; Trinito, MO1
Chen, CH; Chen, DS; Hsieh, SC; Sheu, JC; Tsai, FC1
Grant, RM; Levy, V1
Abut, E; Akbayir, N; Bolukbas, C; Bolukbas, FF; Dalay, AR; Horoz, M; Ince, AT; Kendir, T; Ovunc, O; Sokmen, MH1
Akcam, M; Artan, R; Gelen, T; Yilmaz, A1
Barbaria, F; De Lisi, S; Di Marco, V; Li Vecchi, M; Maringhini, S1
Schiff, ER2
Arici, C; Castagna, A; Cozzi-Lepri, A; Dabis, F; De Luca, A; Garrido, M; Gervais, A; Gill, J; Ledergerber, B; Lundgren, JD; Milazzo, L; Moller, NF; Monforte, Ad; Mussini, C; Ourishi, N; Paraninfo, G; Puoti, M; Raffi, F; Rickenbach, M; Rockstroh, J; Suarez-Lozano, I; Winnock, M1
Acar, K; Aki, Z; Bozdayi, G; Haznedar, R; Sucak, GT; Yağci, M1
Han, YS; Joh, JW; Kim, DJ; Kim, SJ; Kwon, CH; Lee, SK; Park, JB; Park, JW1
Chen, YS; Chi, NH; Chou, NK; Chu, SH; Hsu, RB; Huang, SC; Ko, WJ; Lai, MY; Tsao, CI; Wang, SS; Yu, HY1
Huang, GT; Lee, CZ; Lee, HS; Sheu, JC; Yang, PM1
Han, B; Jin, LJ; Shi, M; Wang, RS; Xu, YP; Yang, ZJ; Zhang, H; Zhang, Y; Zhu, YF1
Trautwein, C1
Ciancia, R; Martinelli, V; Montante, B; Orlando, R; Piazza, M; Portella, G; Rotoli, B; Tiseo, D; Tosone, G1
Chiba, T; Egawa, H; Marusawa, H; Takada, Y; Ueda, M; Uemoto, S; Umeda, M1
Huang, YW; Kao, JH; Lai, MK; Lai, MY; Lee, PH; Liu, CJ; Tsai, MK; Wang, SS1
Devereux, S; Ho, AY; Lim, ZY; Moses, SE; Mufti, GJ; Pagliuca, A; Sudhanva, M; Zuckerman, M1
Arabe, J; Gomes, SA; Mello, FC; Niel, C; Rolla, VC; Santos, EA; Sucupira, MV1
Pol, S2
Cetin, M; Demir, H; Kasem, M; Kuşkonmaz, B; Tavil, B; Uçkan, D1
Colonno, R; De Clercq, E; Neyts, J; Ying, C1
Dassanayake, AS; de Silva, AP; de Silva, HJ; Manamperi, A1
Chen, HC; Hung, CC; Hwang, SJ; Kuo, MC; Tsai, JC; Wang, YC1
Cakir, N; Midilli, K; Pamuk, ON; Umit, H1
Baldick, CJ; Colonno, RJ; Eggers, B; Fang, J; Hsu, M; Levine, SM; Mazzucco, CE; Plym, MJ; Pokornowski, KA; Poundstone, P; Rose, RE; Tenney, DJ; Walsh, AW; Yang, J; Yu, CF; Zhang, S1
Das, K; Hissar, S; Kumar, M; Monga, R; Pande, C; Sarin, SK; Satapathy, S; Sharma, BC1
Choi, KH; Hong, SP; Hwang, SG; Kim, S; Ko, KH; Kwon, CI; Lee, JH; Oh, D; Park, PW; Rim, KS1
Hester, J; Jain, MK; Lee, WM; Parekh, NK1
Dumas, L; Mieli-Vergani, G; Vergani, D1
Chen, CL; Cheng, YF; Concejero, A; Eng, HL; Jawan, B; Lin, CC; Lin, TS; Liu, YW; Wang, CC; Wang, SH; Yang, CH; Yong, CC1
Cho, YS; Kim, DH; Kim, DY; Kim, HJ; Lee, CK; Park, BK; Park, IS; Suh, JH; Won, SY1
Angelousi, AG; Charatsis, GG; Falagas, ME; Lampropoulos, KM; Panos, GZ1
Baskin, E; Bilezikçi, B; Canan, O; Melek, E; Ozçay, F; Surmali Onay, O1
Iwasaki, Y; Kobashi, H; Matsuda, H; Matsukawa, H; Miyake, Y; Sadamori, H; Sakaguchi, K; Shinoura, S; Shiratori, Y; Takaki, A; Tanaka, N; Terada, R; Umeda, Y; Yagi, T1
Attar, N; Comanor, L; Elkin, C; Jain, MK; Keiser, P; Kipnis, P; Lee, WM; Leung, K; Ocampo, A; White, C1
Goto, H; Hayashi, K; Hirooka, Y; Honda, T; Ishigami, M; Itoh, A; Katano, Y; Kumada, T; Nakano, I; Takeda, Y; Toyoda, H; Yano, M; Yoshioka, K1
Cho, JY; Joh, JW; Kim, SI; Kwon, CH; Lee, KU; Lee, KW; Lee, SK; Suh, KS; Yi, NJ1
Lok, AS; Tan, J1
Arterburn, S; Borroto-Esoda, K; Brosgart, C; Chuck, S; Colombo, M; Hadziyannis, S; Lai, CL; Neuhaus, P; Samuel, D; Schiff, E; Terrault, N; Tillmann, H; Villeneuve, JP; Zeuzem, S1
Cheong, JW; Hahn, JS; Kim, JS; Kim, Y; Lee, CK; Lee, ST; Min, YH; Park, IH; Park, SY1
Li, Q; Wen, H1
Ishikawa, S; Iwasaki, Y; Kato, J; Kobashi, H; Miyake, Y; Nawa, T; Sakaguchi, K; Shiratori, Y; Takaki, A; Tatsukawa, M1
Chen, XG; Li, W; Liu, Y; Niu, YJ; Shen, ZY; Wang, Y; Wei, ZY; Zang, YJ; Zhang, ZT; Zhu, XD1
Iino, S; Itoh, F; Koike, K; Moriya, K; Nagase, Y; Okuse, C; Suzuki, M; Suzuki, Y; Takahashi, H; Yotsuyanagi, H1
Bendenoun, M; Mazeron, MC; Sanson-le Pors, MJ; Schnepf, N; Sellier, P; Zini, JM1
Chheda, MG; Doherty, LM; Drappatz, J; Gigas, DC; Greenberger, NJ; Kesari, S; Weiss, SE; Wen, PY1
Sobhonslidsuk, A; Ungkanont, A1
Ahn, JS; Hong, YS; Hwang, IG; Jung, CW; Kang, WK; Kim, K; Kim, WS; Koh, KC; Lee, MH; Lee, SC; Lim, TK; Park, BB; Park, S; Uhm, JE1
Angus, PW; Crawford, DH; Gane, EJ; Jeffrey, GP; McCaughan, GW; Ring, J; Strasser, S1
Alonzo, M; Buell, J; Kaiser, TE; Kemmer, N; Neff, GW; Thomas, M; Zacharias, VC1
Rimland, D; Rouphael, NG; Talati, NJ1
Dore, GJ; Matthews, GV1
Hannoun, C; Lindh, M; Malmström, S1
Iino, S1
Koike, K; Yotsuyanagi, H2
Ding, XR; Lou, SK; Sun, DC; Wang, SQ; Yang, J1
Deng, WW; Gu, HX; Li, D; Li, GQ; Wang, JX; Xu, WZ1
Bastens, B; Delforge, M; Demoulin, JC; Dupont, P; Fontaine, F; Michels, V; Plomteux, O; Sente, JM1
Argentini, C; Canitano, A; Catone, S; D'Ugo, E; Gallinella, B; Giuseppetti, R; Glück, R; Kondili, LA; Orobello, S; Palmieri, G; Rapicetta, M1
Yao, G1
Bonino, F; Brunetto, MR; Ciccorossi, P; Coco, B; Colombatto, P; Flichman, D; Maina, AM; Moriconi, F; Oliveri, F; Sacco, R1
Boehm, S; Hahn, J; Holler, E; Jilg, W; Knöll, A1
Celebi Kobak, A; Ersoz, G; Gunsar, F; Karasu, Z; Kilic, M; Ozacar, T; Tekin, F; Tokat, Y; Yuzer, Y1
Chang, HR; Lian, JD; Lin, CC1
Jiao, Z; Jiao, ZY1
Bhat, S; Brennan, TP; Chong, CR; Hale, B; Hegarty, R; Jilek, BL; Liu, JO; McMahon, MA; Shen, L; Siliciano, RF; Thio, CL; Wind-Rotolo, M; Xing, S; Zhou, Y1
Kloudová, A; Mrázek, J; Orságová, I; Roznovský, L1
Dedek, V; Kabieszová, L; Kloudová, A; Orságová, I; Roznovský, L; Zjevíková, A1
Fei, G; Lee, LH; Lim, LC; Lim, ST; Loong, S; Quek, R; Tao, M; Yap, SP1
Huang, XT; Lin, F; Zeng, AP1
Bader, TF; Fazili, J; Tierney, W1
Dong, MH; Joseph, TA; Saab, S; Tong, MJ1
Harada, N; Ikegami, T; Maehara, Y; Soejima, Y; Taketomi, A; Uchiyama, H; Yamashita, Y; Yoshizumi, T1
Banu, NA; Khan, MA; Khatoon, S; Quadir, E; Rahman, MM1
Ayliffe, U; Dervisevic, S; Garcia-Diaz, A; Geretti, AM; Gilson, R; Johnson, M; Nebbia, G; Smith, C; Tedder, R1
Esteve, M; González-Huix, F; Loras, C1
Brechmann, T; Kohlhaas, K; Vorgerd, M1
Gao, SX; Gui, YP; Kong, LH; Liu, WH1
Makuuchi, M; Sugawara, Y; Takemura, N; Tamura, S1
Cai, CJ; Chen, GH; Jiang, H; Jiang, N; Li, H; Li, X; Lu, MQ; Wang, GS; Xu, C; Yang, Y; Yi, HM; Yi, SH; Zhang, J; Zhang, JF; Zhang, Q; Zhang, YC1
Ahn, HJ; Ahn, SH; Han, KH; Huh, KH; Ju, MK; Kim, MS; Kim, SI; Kim, YS1
Hayashi, T; Iyama, S; Kato, J; Kawano, Y; Kobune, M; Matsunaga, T; Miyanishi, K; Niitsu, Y; Okuda, T; Ono, K; Sagawa, T; Sato, T; Sato, Y; Takada, K; Takimoto, R1
Buti, M; Casafont, F; Esteban, R; González, A; Herrero, JI; Jardi, R; Mas, A; Miras, M; Prieto, M1
Niederau, C2
Dai, J; Gu, M; Jin, SJ; Lai, W; Li, B; Lu, SC; Tao, CM; Wen, TF; Yan, LN; Zeng, Y; Zhang, XH; Zhao, J; Zhao, JC1
Clayton, MM; Feitelson, MA; Schinazi, RF; Sun, B1
Kiss, A; Rudin, D; Shah, SM; Sottile, VM; Wetz, RV1
Abe, H; Chayama, K; Fujimoto, Y; Hatakeyama, T; Hiraga, N; Imamura, M; Kumada, H; Maekawa, T; Mori, N; Ochi, H; Suzuki, F; Takahashi, S; Tsuge, M; Yatsuji, H1
Martyak, LA; Saab, S; Taqavi, E1
Coterell, A; Fisher, RA; Luketic, VA; Maluf, D; Posner, MP; Sanyal, AJ; Shiffman, ML; Sterling, RK; Todd Stravitz, R; Yilmaz, N1
Colombo, M; Iavarone, M; Lampertico, P; Manenti, E; Sablon, E; Viganò, M1
Easley, KA; Lennox, JL; Lu, C; Ofotokun, I; Smithson, SE1
Cho, EH; Cho, JY; Cho, YB; Kwon, CH; Lee, HW; Lee, KU; Suh, KS; Yang, SH; Yi, NJ1
Akuta, N; Arase, Y; Chihara, N; Hosaka, T; Ikeda, K; Kawamura, Y; Kobayashi, M; Kumada, H; Sezaki, H; Suzuki, F; Suzuki, Y; Watahiki, S; Yatsuji, H1
Akyildiz, M; Aydin, U; Karasu, Z; Kilic, M; Ozacar, T; Zeytunlu, M1
Chayama, K; Takahashi, S1
Harada, S; Kaku, M; Koike, K; Mizokami, M; Oka, S1
Chen, ZY; Jiao, ZY; Li, B; Li, ZH; Lu, SC; Ma, YK; Wang, WT; Wen, TF; Xu, MQ; Yan, LN; Yang, JY; Zeng, Y; Zhang, ZW; Zhao, JC1
Chen, XY; Dong, JL; Huang, CY; Ma, LN; Sun, GZ1
Bahr, MJ; Cornberg, M; Deterding, K; Hadem, J; Manns, MP; Metzler, F; Pothakamuri, SV; Schlaphoff, V; Wedemeyer, H1
Choi, MS; Gwak, GY; Huh, W; Joh, JW; Kim, SJ; Koh, KC; Lee, DH; Lee, JH; Oh, HY1
Busuttil, RW; Cameron, AM; Ghobrial, RM; Hiatt, JR; Tong, MJ; Zimmerman, MA1
Fraser, A; Gafter-Gvili, A; Katz, LH; Leibovici, L; Tur-Kaspa, R1
Janssen, HL; Reijnders, JG1
Kaczmarski, M; Lebensztejn, DM; Skiba, E; Sobaniec-Łotowska, ME1
Adler, G; Dikopoulos, N; Hasel, C; Seufferlein, T; Zizer, E1
Foroncewicz, B; Górnicka, B; Krawczyk, M; Mucha, K; Nyckowski, P; Ołdakowska-Jedynak, U; Paczek, L; Paczkowska, A; Patkowski, W; Pilecki, T; Ziarkiewicz-Wróblewska, B; Zieniewicz, K; Ziółkowski, J1
Bao, SP; Guan, ZZ; He, YF; He, YJ; Huang, HQ; Jiang, WQ; Li, YH; Lin, TY; Sun, XF; Wang, FH; Xia, ZJ; Xu, RH; Zhang, L1
Gao, LL; Li, Y; Lin, JS; Wang, XY; Zhang, YH1
Chen, XY; Chen, Y; Han, ZH; Li, J; Lu, HY; Si, CW; Yu, YY; Zeng, Z; Zhang, JJ; Zhuang, LW1
Chang, MC; Chao, TY; Chen, PJ; Cheng, AL; Hsiao, HH; Hsiung, CA; Hsu, C; Hwang, WS; Li, CC; Liao, YM; Lin, SF; Lin, TH; Liu, TW; Su, IJ; Tien, HF; Wang, MC; Wu, HB; Young, JH1
Brosgart, CL; Chow, WC; Gardner, SD; Gray, DF; Heathcote, EJ; Lai, JY; Perrillo, RP; Scott, SA; Sung, JJ; Woessner, MA; Zeuzem, S1
Barraud, L; Billioud, G; Durantel, S; Pichoud, C; Trépo, C; Villet, S; Zoulim, F1
Armignacco, O; Barbarini, G; Barbaro, G; Barlattani, A; Camporiondo, MP; Ferri, F; Francavilla, R; Mazzoni, E; Mecenate, F; Nauri, L; Nosotti, L; Paffetti, A; Pellicelli, AM; Romano, M; Soccorsi, F; Struglia, C; Villani, R1
Baldick, CJ; Colonno, RJ; Eggers, BJ; Fang, J; Levine, SM; Pokornowski, KA; Rose, RE; Tenney, DJ; Yu, CF1
Kajiwara, E; Kinjo, M; Mizokami, M; Ohashi, T; Sadoshima, S; Tanaka, Y; Uchimura, K1
Akdogan, M; Cicek, B; Kilic, ZM; Kuran, S; Odemis, B; Oguz, D; Sasmaz, N1
Akin, H; Mert, A; Ozaras, R; Ozturk, R; Senturk, H; Tabak, F; Tahan, V1
Shen, ZY; Song, HL; Wang, J; Wang, ZL; Zheng, WP1
Brechot, C; Castaing, D; Dussaix, E; Fallot, G; Faria, LC; Ferrari, TC; Gigou, M; Guettier, C; Roche, B; Roque-Afonso, AM; Samuel, D; Sebagh, M1
Cane, P; Dudley, T; Freshwater, DA; Mutimer, DJ1
Al-Soud, WA; Bielawski, KP; Charmuszko, U; Stalke, P; Wadstrom, T1
Alves-Filho, G; Lorena, SL; Mazzali, M; Sevá-Pereira, T; Soares, EC; Urbini Dos Santos, C1
Csako, G; Liang, TJ; Loomba, R; Pucino, F; Rowley, AK; Smith, KG; Wesley, R1
Altintas, A; Bayan, K; Cil, T; Isikdogan, A; Ozekinci, T; Pasa, S1
Girke, J; Manns, MP; Tillmann, HL; Wedemeyer, H; Wiegand, J1
Hasenclever, D; Tillmann, HL; Wiegand, J1
de Man, RA; Heijtink, RA; Honkoop, P; Schalm, SW1
Bartholomew, M; Dienstag, JL; Perrillo, RP; Rubin, M; Schiff, ER; Vicary, C1
Merigan, TC1
de Man, RA; Heijtink, RA; Niesters, HG; Schalm, SW2
Benhamou, Y; Dohin, E; Gentilini, M; Huraux, JM; Katlama, C; Lunel-Fabiani, F; Opolon, P; Poynard, T1
Boehme, R; Bonhoeffer, S; Hill, AM; McDade, H; Nowak, MA; Thomas, HC1
Grimm, I1
Korba, BE1
Bain, VG; Fischer, KP; Kneteman, NM; Ma, MM; Tipples, GA; Tyrrell, DL1
Pierce, PF; Schnittman, SM1
Ahmed, M; Beranek, P; Brown, D; Burroughs, AK; Dusheiko, G; Elias, E; Grellier, L; Kennedy, F; Kibbler, H; McMaster, P; McPhillips, P; Mutimer, D; Rolles, K1
Marinos, G; Naoumov, NV; Williams, R1
Benhamou, Y; Coutellier, A; Dohin, E; Hamm, N; Herson, S; Katlama, C; Lunel, F; Opolon, P; Poynard, T; Tubiana, R1
Bain, VG; Fischer, K; Gutfreund, K; Jewell, LD; Kneteman, NM; Lee, H; Ma, MM; Shapiro, JA; Tipples, G; Tyrrell, DL1
Ching, CK; Dent, J; Hill, A; Lai, CL; Li, E; Tung, AK; Wong, BC; Wu, PC; Young, J1
Schalm, SW1
Bartholomew, MM; Brown, NA; Bunzendahl, H; Condreay, LD; Jansen, RW; Jeffers, LJ; Johnson, LC; Reddy, KR; Schiff, ER; Tzakis, AG1
Ben-Ari, Z; Mor, E; Shapira, Z; Shmueli, D; Tur-Kaspa, R1
Jung, MC; Sackmann, M; Zachoval, R1
de Man, RA; Honkoop, P; Schalm, SW; Zondervan, PE1
Terrault, NA; Wright, TL1
de Man, RA; Honkoop, P; Niesters, HG; Osterhaus, AD; Schalm, SW1
de Man, RA; Honkoop, P; Rademakers, LH; Schalm, SW; Scholte, HR; Van Den Berg, JW; Zondervan, PE1
Eggers, HJ1
Cattral, MS; Greig, PD; Hemming, AW; Levy, G; Lilly, LB; Philosophe, B; Superina, RA1
Bar-Nathan, N; Ben-Ari, Z; Mor, E; Shaharabani, E; Shapira, Z; Shmueli, D; Tur-Kaspa, R1
Ahmed, A; Cohn, G; Ehrenpreis, ED; Lissoos, TW; Schiano, TD; Siano, C; Zaitman, D1
Barber, J; De Man, RA; Fevery, J; Honkoop, P; Main, J; Nevens, F; Sullivan, MT; Thomas, HC; Tyrrell, DL1
Al Faraidy, K; Anderson, FH; Davis, JE; Steinbrecher, UP; Vartanian, RK; Yoshida, EM1
Hino, O; Kajino, K; Kamiya, N; Sakurai, J; Takahara, T; Yamamura, Ki; Yuasa, S1
Cisterne, JM; Duffaut, M; Durand, D; Henry, S; Icart, J; Rostaing, L1
Beuers, U; Mühlhöfer, A; Samtleben, W; Thoenes, GH; von Appen, K; Weiss, M1
de Man, RA; Honkoop, P; Niesters, HG1
Bain, VG; Davis, JE; Erb, SR; Fischer, KP; Kneteman, NM; Ma, MM; Tyrrell, DL; Yoshida, EM1
Arnold, JC; Golling, M; Herfarth, C; Otto, G; Rudek, B; Theilmann, L1
de Man, RA; Haagsma, EB; Honkoop, P; Niesters, HG; Osterhaus, AD; Schalm, SW1
Allen, MI; Andrews, CW; Brown, N; Condreay, LD; Deslauriers, M; Tipples, GA; Tyrrell, DL; Walters, KA1
Arase, Y; Chayama, K; Hashimoto, M; Ikeda, K; Kobayashi, M; Koida, I; Koike, H; Kumada, H; Miyano, Y; Murashima, N; Saitoh, S; Suzuki, Y; Tsubota, A1
Herrero, JI; Pardo, F; Prieto, J; Quiroga, J; Riezu-Boj, JI; Sangro, B; Sola, I1
Chambers, S; Chapman, BA; Clark, FL; Drummond, MW; Patton, WN1
Condreay, L; Debernardi-Venon, W; Marzano, A; Rizzetto, M1
Chan, TM; Cheng, IK; Lai, CL; Lai, KN; Li, FK; Wu, PC1
Nery, JR; Rodriguez, M; Ruiz, P; Schiff, ER; Tzakis, AG; Weppler, D1
De Rosa, G; Pezzullo, L; Picardi, M; Raiola, A; Rotoli, B; Selleri, C1
Artinian, L; Busuttil, RW; Conrad, AJ; Goldstein, LI; Goss, JA; Holt, C; Imagawa, DK; Markmann, JF; Markowitz, JS; Martin, P; Murray, NG; Pakrasi, A; Schmidt, P; Seu, P; Stribling, R; Yersiz, H1
Cornu, C; Goffin, E; Horsmans, Y; Pirson, Y; Squifflet, JP1
Addo, M; Altfeld, M; Kupfer, B; Pult, I; Rockstroh, JK; Spengler, U; Will, H1
Bertoletti, A; Boehme, R; Boni, C; Cavalli, A; Ferrari, C; Fiaccadori, F; Panebianco, R; Penna, A; Pilli, M; Scognamiglio, P; Urbani, S1
Chamuleau, RA; de Man, RA; Jones, EA; Rietbroek, RC; Smorenburg, S; ter Borg, F1
Fujita, R; Handa, K; Inoue, K; Sekiyama, K; Takahashi, Y; Yoshiba, M1
Bartholomeusz, AI; de Man, RA; Locarnini, SA; Niesters, HG; Zondervan, PE1
Josefson, D1
Andreone, P; Belli, L; Bernardi, M; Caraceni, P; Cavallari, A; D'Errico, A; Dal Monte, PR; Ercolani, G; Forti, D; Grazi, GL; Ideo, G; Jovine, E; Mazziotti, A; Milandri, GL1
Arazi, J; Ben-Moshe, O; Berr, S; Burakova, T; Dagan, S; Eid, A; Eren, R; Galun, E; Gillard, J; Ilan, E; Jurim, O; Lubin, I; Mansour, TS; Neville, L; Nussbaum, O; Reisner, Y; Shouval, D; Yuen, L1
Ahmed, A; Keeffe, EB1
Bye, A; Johnson, MA; Moore, KH; Pakes, GE; Yuen, GJ1
Ben-Ari, Z; Fraser, G; Kazetsker, A; Tur-Kaspa, R; Zemel, R1
Mazzola, M; Pastore, G; Santantonio, T1
Ahmed, M; Barmat, S; Boxall, E; Buchan, S; Burroughs, N; Cane, P; Dragon, E; Elias, E; Gutekunst, K; Martin, B; McMaster, P; Mutimer, D; O'Donnell, K; Pillay, D; Rand, D; Shaw, J; Tang, H1
Anschuetz, G; Brown, N; Caldwell, S; Crowther, L; Dienstag, J; Farr, G; Gish, R; Levy, G; Martin, P; Perrillo, R; Rakela, J; Schiff, E; Villeneuve, JP; Wright, T1
Chen, WN; Koh, S; Leong, AL; Lim, GK; Lim, N; Oon, CJ; Tan, GS1
Kumashiro, R; Sata, M1
Dulai, G; Higa, L; Kobashigawa, J; Martin, P1
Chizzolini, C; Dayer, JM; Guillevin, L; Olivieri, J; Pizzolato, G; Sarasin, F; Wicki, J1
Esquivel, CO; Garcia, G; Imperial, JC; Keeffe, EB; Monge, H; So, SK1
Bock, T; Böker, KH; Bruns, I; Condreay, LD; Gauthier, J; Glowienka, M; Jäckel, E; Manns, MP; Oldhafer, K; Raab, HR; Tillmann, HL; Trautwein, C1
Al-Taie, OH; Gassel, AM; Mörk, H; Scheurlen, M; Weissbrich, B; Wilhelm, M1
Chien, RN; Chu, CM; Liaw, YF; Tsai, SL; Yeh, CT1
Aldrich, CE; Condreay, LD; Deslauriers, M; Mason, WS; Saputelli, J; Zhou, T1
Atkins, M; Barrett, C; Cooper, DA; Dore, GJ; Goh, LE; Thakrar, B1
Ben-Ari, Z; Mor, E; Pappo, O; Tur-Kaspa, R; Zemel, R1
Adams, O; Braunstein, S; Horneff, G; Niehues, T; Wahn, V1
Cane, PA; Mutimer, D; Pillay, D1
Agut, H; Benhamou, Y; Bochet, M; Bricaire, F; Katlama, C; Opolon, P; Poynard, T; Seguret, C; Thibault, V1
Fiddian, AP1
Bárcena, R; del Campo, S; Domínguez-Antonaya, M; López-Sanromán, A; Martínez-Turnes, A; Moreno, N; Urman, J1
Bonham, CA; Cacciarelli, TV; Dodson, SF; Fung, JJ; Geller, DA; Rakela, J1
Benhamou, Y; Bochet, M; Bricaire, F; Caumes, E; Di Martino, V; Katlama, C; Opolon, P; Poynard, T; Thibault, V1
Briceno, MN; Garcia-Kennedy, R; Gish, RR; Osorio, RW; Poordad, FF; Roberts, JP; Yao, FY1
Angus, PW; Bartholomeusz, A; Bowden, S; Chui, AK; Jones, RM; Koorey, D; Littlejohn, M; Locarnini, SA; McCaughan, GW; Sheil, AG; Spencer, J; Verran, D1
Bortolotti, F; Sokal, EM1
Imazeki, F; Saisho, H; Seta, T; Tagawa, M; Yokosuka, O1
Castellano, G; Fernández, I; Jiménez, C; Solís Herruzo, JA1
Buti, M; Costa, X; Cotrina, M; Esteban, R; Guardia, J; Jardi, R; Pascual, C; Rodriguez-Frias, F1
Boxall, L; Buchan, S; Cane, P; Elias, E; Hübscher, S; Martin, B; Mutimer, D; O'Donnell, K; Pillay, D; Ratcliffe, D; Shaw, J; Shields, P1
Locarnini, SA; Shaw, T1
Gibbs, CS; Howard, T; Jacobsmeyer, S; Lamy, P; Murray, A; Peters, MG; Singer, G; Xiong, X1
Chan, JY; Chan, PK; Johnson, PJ; Leung, NW; Steinberg, JL; Tam, JS; Yeo, W; Zhong, S1
Battegay, M; Jacob, AL; Maclachlan, D; Tyndall, A1
Cane, PA; Cook, P; Dowling, D; Elias, E; Mutimer, D; O'Donnell, K; Pillay, D; Ratcliffe, D; Shaw, J1
Renner, EL1
De Mautort, E; Fritsch, S; Kempf-Durepaire, G; Krantz, V; Lang, JM; Nicolle, M; Partisani, M; Rey, D; Schmitt, C; Stoll-Keller, F1
Beards, G; Cane, PA; Cook, P; Elias, E; Mutimer, D; Pillay, D; Ratcliffe, D1
Baccarani, M; Damiani, D; Ermacora, A; Fanin, R; Patriarca, F; Silvestri, F; Sperotto, A; Zaja, F1
Baccarani, M; Damiani, D; Ermacora, A; Fanin, R; Silvestri, F; Sperotto, A1
Korba, BE; Morrey, JD; Sidwell, RW1
Al Asghar, H; Cattral, MS; Greig, PD; Hemming, AW; Humar, A; Levy, GA; Lilly, LB; Malkan, G1
Bordin, V; Catalano, C; Di Landro, D; Fabbian, F; Manani, SM; Vogel, W1
Bechstein, WO; Berg, T; Hopf, U; Müller, AR; Neuhaus, P; Neuhaus, R; Rayes, N; Seehofer, D2
Bréchot, C; Chrétien, Y; Fontaine, H; Kreis, H; Legendre, C; Pol, S; Poupon, RE; Thiers, V; Zylberberg, H1
Sherlock, CH; Yoshida, EM1
Ben-Ari, Z; Fainguelernt, H; Kitay-Cohen, Y; Lishner, M; Tur-Kaspa, R1
Deres, K; Rübsamen-Waigmann, H1
Schalm, SW; van Wijngaarden, JK1
Hopf, U1
Atkins, M; Cane, PA; Cooper, D; Pillay, D; Ratcliffe, D1
Belle, SH; Colquhoun, SD; Pruett, TL; Samuel, D; Teperman, LW1
Kruger, M; Lake, JR; Perrillo, RP; Sievers, T1
Barnes, E; Burroughs, A; Dusheiko, G; Webster, G1
Angus, PW; Crawford, DH; Gane, EJ; Harley, H; McCaughan, GW1
Bonham, CA; de Vera, ME; Dodson, SF; Fung, JJ; Geller, DA; Rakela, J1
De Man, RA; Fries, E; Niesters, HG; Osterhaus, AD; Pas, SD1
Carey, WD1
Main, J; Thomas, HC; Wright, M1
Bye, C; Jenkins, JM; Johnson, MA1
McGory, R; Pruett, TL1
Dodson, SF1
Ahmed, M; Anschuetz, G; Barrett, C; Burroughs, A; Dhillon, AP; Dusheiko, G; Elias, E; Grellier, L; Hubscher, S; Mutimer, D; Rolles, K1
Bain, VG; Fischer, KP; George, R; Gutfreund, KS; Ma, MM; Tyrrel, DL; Villeneuve, JP; Williams, M; Yoshida, EM1
Adams, O; Häussinger, D; Petry, W1
Zuckerman, AJ; Zuckerman, JN1
Reshef, R; Sbeit, W; Tur-Kaspa, R1
Andorno, E; Brizzolara, R; Campo, N; Picciotto, A; Sinelli, N; Torre, F; Valente, U1
Chan, PK; Ho, WM; Hui, P; Johnson, PJ; Leung, NW; Steinberg, JL; Tam, JS; Yeo, W; Zee, B; Zhong, S1
Erhardt, A; Guillevin, L; Häussinger, D; Neuen-Jacob, E; Sagir, A1
Fujii, S; Fujiwara, T; Fukuda, S; Sezaki, T; Sunami, K; Yoshida, C1
Busuttil, RW; Chen, P; Dawson, S; Farmer, DG; Ghobrial, RM; Goldstein, L; Han, SH; Holt, C; King, K; Kunder, G; Martin, P; Ofman, J; Yersiz, H1
Marzano, A; Rizzetto, M1
Demetriou, D; Ferenci, P; Kletzmayr, J; Kovarik, J; Müller, C; Puchhammer-Stöckl, E; Watschinger, B1
Chiwakata, CB; Dietrich, M; Günther, S; Hannoun, C; Manegold, C; Polywka, S; Wywiol, A1
Hu, RH; Lai, MY; Lee, CJ; Lee, PH; Tsai, MK1
Fischer, L; Rogiers, X; Sterneck, M; Zöllner, B1
Ho, MC; Hu, RH; Lai, HS; Lai, MY; Lee, PH; Tsai, MK; Yang, PM1
Choi, IS; Choi, SH; Heo, JS; Joh, JW; Kim, SJ; Kim, SM; Kim, YI; Koh, KC; Lee, BB; Lee, JH; Lee, SK; Lee, WY; Paik, SW; Park, JH; Peck, KR; Sohn, TS; Song, JH1
Beleza, M; Gomes, A; Macedo, G; Maia, JC; Ribeiro, A; Teixeira, A1
Gondo, H; Himeji, D; Kaji, Y; Niho, Y; Sata, M; Uchida, N1
Ben-Ari, Z; Mor, E; Shapira, Z; Tur-Kaspa, R1
Cheung, ST; Fan, ST; Lai, CL; Liu, CL; Lo, CM; Ng, IO; Wong, J; Yuen, MF1
Martin, P; Rosen, HR1
Bechstein, WO; Hopf, U; Naumann, U; Neuhaus, P; Neuhaus, R; Rayes, N; Seehofer, D1
Maddrey, WC1
Doo, E; Liang, TJ1
Han, DJ; Jung, JG; Kim, SB; Kim, SC; Kim, TH; Lee, SK; Park, JS; Park, SK; Yang, WS; Yu, ES1
Jia, Y; Liu, G; Ren, H; Wang, H; Xiong, Y; Zhang, D; Zhuo, Z1
Vargas, HE1
Grande Santamaría, L; Romero Gómez, M; Suárez García, E1
Forns, X; Sánchez-Tapias, JM1
Brown, D; Dusheiko, GM; Saunders, NA; Teo, CG; Whalley, SA1
Bastian, H; Batallan, A; Benifla, JL; Faucher, P; Madelenat, P; Matheron, S; Morau, G1
Endo, T; Fujimoto, K; Haseyama, Y; Koike, T; Koizumi, K; Nishio, M; Sakai, T; Sawada, K; Takashima, H; Yamamoto, S1
Boeker, KH; Manns, MP; Rosenau, J; Tillmann, HL; Trautwein, C1
Fujii, N; Harada, M; Kiura, K; Matsuo, K; Shimomura, H; Shinagawa, K; Takenaka, K1
Prescott, LM1
Rubin, M1
Gupta, S; Jaffe, M; Piraka, C1
Cainelli, F; Concia, E; Longhi, MS; Vento, S1
Heathcote, EJ; Hoofnagle, JH; Lok, AS1
Albayrak, D; Dagdemir, A; Dilber, C; Kalayci, AG1
Cahlin, C; Friman, S; Olausson, M2
Han, SH; Jensen, D; Keeffe, EB; Lok, AS; Luketic, V; Teo, EK; Terrault, N1
Gładysz, A; Inglot, M; Jander, A; Jobs, K; Latoszyńska, J; Makulska, I; Pietrzyk, J; Rajkowski, T; Szczepańska, M; Szprynger, K; Zachwieja, J; Zachwieja, K; Zurowska, A; Zwolińska, D1
Delaney, WE; Locarnini, S; Shaw, T1
Arnaout, WS; Chan, CK; Colquhoun, SD; Fong, TL; Geller, SA; Khanafshar, E; Nichols, WS; Vierling, JM; Yu, AS1
Chang, TT; Cheng, PN; Jen, CM; Kao, AW; Young, KC1
Bahr, MJ; Klempnauer, J; Manns, MP; Rosenau, J; Tillmann, HL; Trautwein, C1
Anschuetz, G; Atkins, M; Barrett, CA; Bassendine, M; Burra, P; Caccamo, L; de Man, RA; Iemmolo, RM; Lopes, AR; Naoumov, NV; O'Grady, JG; Portmann, BC; Williams, R1
Barbui, AM; Ciancio, A; David, E; Debernardi-Venon, W; Franchello, A; Gentilcore, E; Marzano, A; Negro, F; Piantino, P; Rizzetto, M; Salizzoni, M; Smedile, A1
Kuchimanchi, U; Rooney, G1
Ciancio, A; Marzano, A; Negro, F; Rizzetto, M; Salizzoni, M1
Aydogdu, S; Selimoglu, MA; Unal, F; Yagci, RV; Yüce, G1
Tanikawa, K1
Bass, NM; Freise, C; Maslow, L; Terrault, NA; Yao, FY1
Borrás-Cuesta, F; Condreay, L; Cullen, JM; Hervás-Stubbs, S; Lasarte, JJ; Prieto, J; Sarobe, P; Vivas, I1
Chon, CY; Chung, HY; Han, KH; Kim, JH; Lee, CK; Lee, JS; Lee, KS; Moon, YM; Paik, YH; Ryu, WS1
Raj, V1
Armstrong, DR; Chu, CJ; Fontana, RJ; Lok, AS; Magee, JC; Merion, RM; Moore, C; Punch, JD; Su, GL1
Aaron, L; Carnot, F; Pialoux, G1
Chizzolini, C; Deléaval, P; Descombes, E; Hecker, E; Nicole, A; Pugin, P; Regamey, C; Schrago, G; Stadler, P1
Chen, RW; Koskela, P; Lappalainen, M; Piiparinen, H; Sarna, S; Seppänen, M1
Baruch, Y; Gelman, R; Green, J; Khankin, E; Nakhoul, F1
Benhamou, Y; Bochet, M; Brosgart, C; Calvez, V; Fievet, MH; Fry, J; Gibbs, CS; Katlama, C; Namini, H; Poynard, T; Thibault, V; Vig, P1
Hata, M; Ikegaya, S; Imamura, S; Kawahito, M; Kawai, Y; Tsutani, H; Ueda, T; Yoshida, A1
Boyle, BA1
Hasegawa, K; Hashimoto, E; Hayashi, N; Kanai, N; Naritomi, T; Ogawa, M; Takasaki, K; Taniai, M1
Chung, RT; Kim, AY; Polsky, B1
Leung, N1
Chen, DS; Chen, PJ; Chou, NK; Chu, SH; Jen, YM; Kao, JH; Lai, MY; Lee, PH; Liu, CJ1
Buffello-Le Guillou, D; Duclos-Vallée, JC; Dussaix, E; Féray, C; Petit, MA; Roche, B; Samuel, D1
Alba, L; Antinori, A; Grisetti, S; Liuzzi, G; Sette, P; Zaccarelli, M1
Bowden, S; Lau, GK; Lewin, SR; Locarnini, S; Perelson, AS; Ribeiro, RM; Walters, T1
Chen, CH; Cheng, CH; Lee, WC; Lian, JD; Shu, KH; Wu, MJ1
Bechstein, WO; Berg, T; Müller, AR; Naumann, U; Neuhaus, P; Neuhaus, R; Rayes, N; Seehofer, D; Steinmüller, T; Tullius, SG1
Fabrizi, F; Lunghi, G; Martin, P1
Cane, P; Gazzard, B; Matthews, GV; Nelson, M; Pillay, D; Ratcliffe, D1
Berg, T; Hopf, U; Müller, AR; Neuhaus, P; Neuhaus, R; Radke, C; Rayes, N; Seehofer, D; Settmacher, U; Steinmüller, T1
Motta, M; Pelizzari, A; Puoti, M; Rossi, G1
Merle, P; Trépo, C; Zoulim, F1
Balducci, M; Clementi, M; Manzin, A; Petrelli, E; Pieretti, C; Rocchi, MB1
Agut, H; Aubron-Olivier, C; Katlama, C; Thibault, V1
Hamaki, T; Kami, M; Kusumi, E; Miyakoshi, S; Morinaga, S; Mutou, Y; Ueyama, J1
Aubron-Olivier, C; Benhamou, Y; Bernard, B; Di Martino, V; Poynard, T; Thabut, D; Thibault, V1
Angelico, M; Araco, A; Casciani, CU; Di Paolo, D; Lionetti, R; Petrolati, A; Tisone, G; Trinito, MO; Zazza, S1
Haran, M; Klepfish, A; Lurie, Y; Malnick, S; Shtalrid, M1
Chan, TM; Ho, SK; Lai, KN; Moniri, K; Tang, S1
Ayres, A; Bonacini, M; Gibbs, C; Kurz, A; Locarnini, S1
Fontaine, H; Pol, S1
Ramrakhiani, S; Sponseller, CA1
de Man, RA; Niesters, HG; Pas, SD; van der Eijk, AA1
Bock, CT; Klempnauer, J; Locarnini, S; Manns, MP; Tillmann, HL; Torresi, J; Trautwein, C1
Haznedar, R; Yağci, M1
Abensur, H; Araújo, MR; Haiashi, AR; Noronha, IL; Romão Junior, JE; Santos, FR1
Huang, D; Liang, T; Liao Sy, SY; Lu Aw, AW; Shen, Y; Wang, W; Wu, J; Xu, X; Zhang, M; Zheng, S1
Duan, Y; Liang, S; Wang, F; Yuan, G; Zhu, L1
Lu, Z; Xu, X1
Asaka, M; Chiba, K; Hashino, S; Hige, S; Izumiyama, K; Nozawa, A; Suzuki, S; Takahata, M1
Buti, M; Cotrina, M; Esteban, R; Jardi, R; Rodriguez-Frias, F; Valdes, A1
Grob, PJ; Reichen, J1
Asaka, M; Chiba, K; Hashino, S; Hige, S; Izumiyama, K; Kondo, T; Nozawa, A; Suzuki, S; Yonezumi, M1
Blazek, J; Dick, D; Eason, JD; Guo, L; Lipscomb, J; Loss, GE; Mason, AL; Perrillo, RP1
Ben-Ari, Z; Daudi, N; Dinari, G; Klein, A; Mor, E; Shapira, R; Shouval, D; Tur-Kaspa, R1
Andreani, T; Calmus, Y; Chazouillères, O; Poupon, R1
Boyer, N; Castelneau, C; Marcellin, P1
Nguyen, MH; Wright, TL1
Cooper, DA; Dore, GJ1
Brems, JJ; Holt, D; Thomas, R; Van Thiel, D1
Chung, YH; Han, JM; Jung, S; Kwon, Y; Lee, HC; Lee, YJ; Lee, YS; Suh, DJ; Yu, E1
Chan, WM; Fung, TT; Hui, PK; Lam, KM; Lau, CF; Loo, CK; Tung, YM; Yip, WC1
Hasnain, SE; Kazim, SN; Khan, LA; Sarin, SK; Wakil, SM1
Nakagawa, M; Sato, B; Simizu, Y; Suemura, M1
Pramoolsinsup, C1
Mancuso, A; Pagliaro, L1
Araya, VR; Manzarbeitia, C; Munoz, SJ; Ortiz, JA; Reich, DJ; Rothstein, KD1
Chesky, A; Demetris, AJ; Dodson, FS; Dvorchik, I; Fung, JJ; Gray, E; Joya-Vazquez, PP; Shakil, O; Vargas, HE1
Choi, MS; Joh, JW; Kim, SJ; Koh, KC; Lee, JH; Lee, SK; Paik, SW; Park, SJ1
Julander, JG; Morrey, JD; Sidwell, RW1
Jurriaans, S; Lange, JM; Weel, J; Weverling, GJ; Wit, FW1
Gillis, S; Hubert, A; Ilan, Y; Safadi, R; Shibolet, O; Shouval, D1
Aulitzky, WE; Einsele, H; Henkes, M; Martin, S1
Chang, CN; Cheng, YC; Skalski, V; Zhou, JH1

Reviews

203 review(s) available for lamivudine and Hepatitis B Virus Infection

ArticleYear
A review of non-nucleoside anti-hepatitis B virus agents.
    European journal of medicinal chemistry, 2014, Mar-21, Volume: 75

    Topics: Animals; Antiviral Agents; Biological Products; Hepatitis B; Hepatitis B virus; Humans; Small Molecule Libraries

2014
Hepatitis B virus genetic multiplicity and the associated HBV lamivudine resistance mutations in HBV/HIV co-infection in Western Kenya: A review article.
    Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2022, Volume: 98

    Topics: Anti-Retroviral Agents; Coinfection; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Kenya; Lamivudine; Mutation

2022
Adefovir for lamivudine-resistant hepatitis B.
    Antiviral therapy, 2022, Volume: 27, Issue:2

    Topics: Adenine; Drug Resistance, Viral; Hepatitis B; Humans; Lamivudine; Organophosphonates

2022
Lamivudine vs placebo or no treatment in preventing the transmission of hepatitis B virus during pregnancy: a systematic review and meta-analysis.
    Transactions of the Royal Society of Tropical Medicine and Hygiene, 2020, 02-07, Volume: 114, Issue:2

    Topics: Antiviral Agents; Female; Hepatitis B; Hepatitis B virus; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic

2020
Combination of Entecavir or Tenofovir with Pegylated Interferon-α for Long-Term Reduction in Hepatitis B Surface Antigen Levels: Simultaneous, Sequential, or Add-on Combination Therapy.
    International journal of molecular sciences, 2021, Feb-01, Volume: 22, Issue:3

    Topics: Adenine; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Genotype; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Interferon-alpha; Lamivudine; Organophosphonates; Randomized Controlled Trials as Topic; Reproducibility of Results; Tenofovir; Treatment Outcome; Viral Load

2021
Pharmacological interventions for acute hepatitis B infection: an attempted network meta-analysis.
    The Cochrane database of systematic reviews, 2017, Mar-21, Volume: 3

    Topics: Acute Disease; Antiviral Agents; Disease Progression; Guanine; Hepatic Encephalopathy; Hepatitis B; Hepatitis C, Chronic; Humans; Immunization, Passive; Interferons; Lamivudine; Network Meta-Analysis; Odds Ratio; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors

2017
Antiretroviral therapy for pregnant women living with HIV or hepatitis B: a systematic review and meta-analysis.
    BMJ open, 2017, Sep-11, Volume: 7, Issue:9

    Topics: Adult; Anti-Retroviral Agents; Drug Combinations; Emtricitabine; Female; Hepatitis B; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Lopinavir; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Ritonavir; Tenofovir; Young Adult; Zidovudine

2017
Prophylactic effect of lamivudine on chemotherapy-induced hepatitis B virus reactivation in patients with solid tumour: A meta-analysis.
    European journal of cancer care, 2018, Volume: 27, Issue:2

    Topics: Anti-HIV Agents; Antiviral Agents; Hepatitis B; Humans; Lamivudine; Neoplasms; Retrospective Studies; Virus Activation

2018
Management of HBV reactivation in non-oncological patients.
    Expert review of anti-infective therapy, 2018, Volume: 16, Issue:8

    Topics: Antiviral Agents; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunosuppressive Agents; Lamivudine; Virus Activation

2018
Lamivudine plus tenofovir combination therapy versus lamivudine monotherapy for HBV/HIV coinfection: a meta-analysis.
    Virology journal, 2018, 09-10, Volume: 15, Issue:1

    Topics: Alanine Transaminase; Antiviral Agents; Coinfection; Drug Therapy, Combination; Hepatitis B; Hepatitis B e Antigens; HIV Infections; Humans; Lamivudine; RNA, Viral; Tenofovir; Treatment Outcome

2018
Comparative effectiveness of anti-viral drugs with dual activity for treating hepatitis B and HIV co-infected patients: a network meta-analysis.
    BMC infectious diseases, 2018, Nov-14, Volume: 18, Issue:1

    Topics: Adenine; Adult; Aged; Antiviral Agents; Coinfection; Emtricitabine; Female; Hepatitis B; Hepatitis B virus; HIV; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Network Meta-Analysis; Organophosphonates; Tenofovir; Treatment Outcome; Young Adult

2018
HIV/HBV coinfection in children and antiviral therapy.
    Expert review of anti-infective therapy, 2013, Volume: 11, Issue:3

    Topics: Adolescent; Adult; Antiviral Agents; Child; Child, Preschool; Coinfection; Female; Hepatitis B; HIV Infections; Humans; Lamivudine; Male; Young Adult

2013
Prevention of recurrent hepatitis B infection after liver transplantation.
    Hepatobiliary & pancreatic diseases international : HBPD INT, 2013, Volume: 12, Issue:5

    Topics: Adaptive Immunity; Administration, Oral; Adoptive Transfer; Antiviral Agents; Drug Administration Schedule; Drug Resistance, Viral; Hepatitis B; Hepatitis B Vaccines; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Secondary Prevention; Treatment Outcome; Virus Activation

2013
Effects of entecavir and lamivudine for hepatitis B decompensated cirrhosis: meta-analysis.
    World journal of gastroenterology, 2013, Oct-21, Volume: 19, Issue:39

    Topics: Adult; Aged; Antiviral Agents; Bilirubin; Biomarkers; Chi-Square Distribution; DNA, Viral; Drug Resistance, Viral; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Middle Aged; Odds Ratio; Prothrombin Time; Serum Albumin; Serum Albumin, Human; Treatment Outcome; Viral Load

2013
Regression of fibrosis after HBV antiviral therapy. Is cirrhosis reversible?
    Liver international : official journal of the International Association for the Study of the Liver, 2014, Volume: 34 Suppl 1

    Topics: Adenine; Administration, Oral; Antiviral Agents; Carcinoma, Hepatocellular; Fibrosis; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Nucleosides; Organophosphonates; Telbivudine; Tenofovir; Thymidine

2014
Postoperative therapy options for hepatocellular carcinoma.
    Scandinavian journal of gastroenterology, 2014, Volume: 49, Issue:6

    Topics: Antineoplastic Agents; Antiviral Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chemotherapy, Adjuvant; Disease-Free Survival; Hepatitis B; Hepatitis C; Humans; Interferon-alpha; Lamivudine; Liver Neoplasms; Neoplasm Recurrence, Local; Postoperative Care; Radiotherapy, Adjuvant; Survival Rate

2014
HBIG Remains Significant in the Era of New Potent Nucleoside Analogues for Prophylaxis Against Hepatitis B Recurrence After Liver Transplantation.
    International reviews of immunology, 2016, 07-03, Volume: 35, Issue:4

    Topics: Animals; Combined Modality Therapy; Hepatitis B; Hepatitis B Vaccines; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Postoperative Complications

2016
Prophylactic lamivudine to improve the outcome of HBsAg-positive lymphoma patients during chemotherapy: a systematic review and meta-analysis.
    Clinics and research in hepatology and gastroenterology, 2015, Volume: 39, Issue:1

    Topics: Antineoplastic Agents; Hepatitis B; Hepatitis B Surface Antigens; Humans; Lamivudine; Lymphoma; Treatment Outcome

2015
Breastfeeding while taking lamivudine or tenofovir disoproxil fumarate: a review of the evidence.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015, Jan-15, Volume: 60, Issue:2

    Topics: Adenine; Anti-HIV Agents; Breast Feeding; Disease Transmission, Infectious; Female; Hepatitis B; Humans; Infant, Newborn; Lamivudine; Organophosphonates; Pregnancy; Tenofovir

2015
The efficacy of lamivudine prophylaxis against hepatitis B reactivation in breast cancer patients undergoing chemotherapy: a meta-analysis.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 2015, Volume: 114, Issue:2

    Topics: Antiviral Agents; Breast Neoplasms; Drug Therapy; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Treatment Outcome; Virus Activation

2015
Anti-viral therapy in hepatitis B virus reactivation with acute-on-chronic liver failure.
    Hepatology international, 2015, Volume: 9, Issue:3

    Topics: Acute-On-Chronic Liver Failure; Antiviral Agents; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Prognosis

2015
Prophylactic Effect of Lamivudine for Chemotherapy-Induced Hepatitis B Reactivation in Breast Cancer: A Meta-Analysis.
    PloS one, 2015, Volume: 10, Issue:6

    Topics: Antineoplastic Agents; Breast Neoplasms; Chemical and Drug Induced Liver Injury; Female; Hepatitis B; Humans; Lamivudine; Reverse Transcriptase Inhibitors

2015
Active vaccination to prevent de novo hepatitis B virus infection in liver transplantation.
    World journal of gastroenterology, 2015, Oct-21, Volume: 21, Issue:39

    Topics: Antiviral Agents; Donor Selection; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Vaccines; Humans; Immunoglobulins; Immunosuppressive Agents; Lamivudine; Liver Transplantation; Risk Factors; Tissue Donors; Treatment Outcome; Vaccination; Waiting Lists

2015
Prophylactic managements of hepatitis B viral infection in liver transplantation.
    World journal of gastroenterology, 2016, Jan-07, Volume: 22, Issue:1

    Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis B; Hepatitis B Vaccines; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Recurrence; Risk Factors; Secondary Prevention; Tissue Donors

2016
Systematic review with network meta-analysis: Comparative efficacy of oral nucleos(t)ide analogues for the prevention of chemotherapy-induced hepatitis B virus reactivation.
    Oncotarget, 2016, May-24, Volume: 7, Issue:21

    Topics: Adenine; Antineoplastic Agents; Antiviral Agents; Controlled Clinical Trials as Topic; Guanine; Hepatitis B; Hepatitis B virus; Host-Pathogen Interactions; Humans; Lamivudine; Organophosphonates; Telbivudine; Thymidine; Virus Activation

2016
Comparison of entecavir and lamivudine in preventing HBV reactivation in lymphoma patients undergoing chemotherapy: a meta-analysis.
    International journal of clinical pharmacy, 2016, Volume: 38, Issue:5

    Topics: Antineoplastic Agents; Antiviral Agents; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma; Treatment Outcome

2016
Coexistence of acquired hemophilia A and epidermolysis bullosa acquisita: Two case reports and published work review.
    The Journal of dermatology, 2017, Volume: 44, Issue:1

    Topics: Adult; Autoantibodies; Autoimmune Diseases; Biopsy; China; Collagen Type VII; Cyclosporine; Epidermolysis Bullosa Acquisita; Esophageal Diseases; Factor VIII; Gastrointestinal Hemorrhage; Glucocorticoids; Hematemesis; Hemophilia A; Hepatitis B; Humans; Immunosuppressive Agents; Lamivudine; Male; Middle Aged; Prednisone; Reverse Transcriptase Inhibitors; Skin

2017
Liver grafts from hepatitis B surface antigen-positive donors: A review of the literature.
    World journal of gastroenterology, 2016, Sep-21, Volume: 22, Issue:35

    Topics: Antiviral Agents; Graft Survival; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver; Liver Failure; Liver Transplantation; Risk; Tissue Donors

2016
Update on occult hepatitis B virus infection.
    World journal of gastroenterology, 2016, Oct-21, Volume: 22, Issue:39

    Topics: Antiviral Agents; Coinfection; DNA, Viral; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; Humans; Interferons; Lamivudine; Liver Cirrhosis; Liver Transplantation; Mutation; Occupational Exposure; Prevalence; Renal Dialysis; RNA Splicing; Viral Load

2016
Antiviral therapies for managing viral hepatitis in lymphoma patients.
    Expert opinion on pharmacotherapy, 2017, Volume: 18, Issue:4

    Topics: Antiviral Agents; Guanine; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis C; Humans; Lamivudine; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Rituximab; Tenofovir; Virus Activation

2017
Hepatitis B core-related antigen assay is useful for monitoring the antiviral effects of nucleoside analogue therapy.
    Intervirology, 2008, Volume: 51 Suppl 1

    Topics: Antiviral Agents; Biomarkers; Drug Resistance, Viral; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B virus; Humans; Lamivudine; Treatment Outcome

2008
[Management of hepatitis B virus reactivation during chemotherapy or immunosuppressive therapy].
    Presse medicale (Paris, France : 1983), 2008, Volume: 37, Issue:11

    Topics: Antineoplastic Agents; Antiviral Agents; Diagnosis, Differential; Hepatitis B; Hepatitis B Vaccines; Hepatitis B virus; Humans; Immunosuppressive Agents; Lamivudine; Risk Factors; Virus Activation

2008
Hepatitis B and liver transplantation: 2008 update.
    Reviews in medical virology, 2009, Volume: 19, Issue:1

    Topics: Adenine; Antiviral Agents; Drug Therapy, Combination; Guanine; Hepatitis B; Hepatitis B Vaccines; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Nucleosides; Organophosphonates; Pyrimidinones; Telbivudine; Tenofovir; Thymidine

2009
Liver transplantation for hepatitis B: what is the best hepatitis B immune globulin/antiviral regimen?
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2008, Volume: 14 Suppl 2

    Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis B; Humans; Immunoglobulins, Intravenous; Injections, Intramuscular; Lamivudine; Liver Transplantation

2008
Hepatitis B immune globulin and HBV-related liver transplantation.
    Expert opinion on biological therapy, 2008, Volume: 8, Issue:11

    Topics: Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Immunoglobulins; Immunotherapy; Lamivudine; Liver Transplantation; Recurrence; Treatment Outcome; Virology

2008
Lamivudine or lamivudine combined with hepatitis B immunoglobulin in prophylaxis of hepatitis B recurrence after liver transplantation: a meta-analysis.
    Transplant international : official journal of the European Society for Organ Transplantation, 2009, Volume: 22, Issue:4

    Topics: Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Mutation; Research Design; Reverse Transcriptase Inhibitors; Secondary Prevention; Treatment Outcome

2009
[Interferon in hepatitis B].
    Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 7

    Topics: Adenine; Antiviral Agents; Clinical Trials as Topic; Drug Therapy, Combination; Genotype; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Multicenter Studies as Topic; Nucleosides; Organophosphonates; Polyethylene Glycols; Pyrimidinones; Randomized Controlled Trials as Topic; Recombinant Proteins; Telbivudine; Thymidine; Treatment Outcome

2008
[Hepatitis B in patients with HIV infection].
    Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 7

    Topics: Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; Comorbidity; Deoxycytidine; Drug Resistance, Viral; Drug Therapy, Combination; Emtricitabine; Guanine; Hepatitis B; Hepatitis B Vaccines; Hepatitis B virus; HIV; HIV Infections; Humans; Interferon-alpha; Lamivudine; Nucleosides; Organophosphonates; Practice Guidelines as Topic; Pyrimidinones; Reverse Transcriptase Inhibitors; Telbivudine; Tenofovir; Thymidine; Virus Replication

2008
Hepatitis B virus associated focal and segmental glomerular sclerosis: report of two cases and review of literature.
    Clinical and experimental nephrology, 2009, Volume: 13, Issue:4

    Topics: Adolescent; Biopsy; DNA, Viral; Glomerulosclerosis, Focal Segmental; Hepatitis B; Hepatitis B Antigens; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunohistochemistry; Kidney; Lamivudine; Male; Nephrotic Syndrome; Proteinuria; Treatment Outcome

2009
Hepatitis B therapy in children.
    Expert review of gastroenterology & hepatology, 2009, Volume: 3, Issue:1

    Topics: Adenine; Adolescent; Antiviral Agents; Child; Child, Preschool; Drug Therapy, Combination; Hepatitis B; Humans; Infant; Infant, Newborn; Interferon-alpha; Lamivudine; Organophosphonates; Treatment Outcome

2009
Post-liver transplant hepatitis B prophylaxis: the role of oral nucleos(t)ide analogues.
    Current opinion in organ transplantation, 2009, Volume: 14, Issue:3

    Topics: Adenine; Administration, Oral; Antiviral Agents; Drug Administration Schedule; Drug Therapy, Combination; Graft Survival; Guanine; Hepatitis B; Humans; Immunoglobulins; Injections, Intramuscular; Lamivudine; Liver Transplantation; Nucleosides; Nucleotides; Organophosphonates; Secondary Prevention; Tenofovir; Treatment Outcome

2009
Use of tumor necrosis factor-alpha-blocking agents in hepatitis B virus-positive patients: reports of 3 cases and review of the literature.
    The Journal of rheumatology, 2009, Volume: 36, Issue:6

    Topics: Aged; Antirheumatic Agents; Biological Products; Chronic Disease; Contraindications; Female; Hepatitis B; Hepatitis B virus; Humans; Immunocompromised Host; Immunosuppressive Agents; Lamivudine; Male; Middle Aged; Premedication; Reverse Transcriptase Inhibitors; Rheumatic Diseases; Tumor Necrosis Factor-alpha; Virus Activation; Virus Replication

2009
Effect of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in lymphoma: a meta-analysis of published clinical trials and a decision tree addressing prolonged prophylaxis and maintenance.
    Haematologica, 2009, Volume: 94, Issue:7

    Topics: Antiviral Agents; Clinical Trials as Topic; Decision Support Techniques; Hepatitis B; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Lamivudine; Lymphoma; Models, Biological; Reverse Transcriptase Inhibitors; Treatment Outcome

2009
The option of liver transplantation for hepatitis B: where are we?
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2009, Volume: 41 Suppl 2

    Topics: Adenine; Antiviral Agents; Drug Therapy, Combination; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Organophosphonates; Postoperative Complications; Practice Guidelines as Topic; Secondary Prevention; Viral Load

2009
Liver transplantation for hepatitis B virus. Pre-emptive and peri-operative prophylaxis.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2009, Volume: 41 Suppl 2

    Topics: Adenine; Antiviral Agents; DNA, Viral; Drug Administration Schedule; Drug Therapy, Combination; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Organophosphonates; Perioperative Care; Postoperative Complications; Secondary Prevention; Treatment Outcome

2009
[Reactivation of hepatitis B virus in patients with hematological neoplasms].
    Nederlands tijdschrift voor geneeskunde, 2009, May-09, Volume: 153, Issue:19

    Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Antineoplastic Agents; Antiviral Agents; Female; Graft vs Host Disease; Hematologic Neoplasms; Hepatitis B; Hepatitis B virus; Humans; Immunosuppression Therapy; Lamivudine; Male; Risk Factors; Sex Factors; Transplants; Virus Activation

2009
Prevention of recurrent hepatitis B virus infection after liver transplantation: hepatitis B immunoglobulin, antiviral drugs, or both? Systematic review and meta-analysis.
    Transplant infectious disease : an official journal of the Transplantation Society, 2010, Aug-01, Volume: 12, Issue:4

    Topics: Adenine; Adult; Antiviral Agents; Cohort Studies; Controlled Clinical Trials as Topic; Drug Therapy, Combination; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Middle Aged; Organophosphonates; Randomized Controlled Trials as Topic; Secondary Prevention; Treatment Outcome

2010
Liver grafts from anti-hepatitis B core positive donors: a systematic review.
    Journal of hepatology, 2010, Volume: 52, Issue:2

    Topics: Algorithms; Antiviral Agents; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Humans; Lamivudine; Liver Transplantation; Recurrence; Risk Factors; Tissue Donors; Treatment Outcome

2010
[Management and treatment of pregnant women with hepatitis B].
    Nederlands tijdschrift voor geneeskunde, 2009, Volume: 153

    Topics: Antiviral Agents; Female; Hepatitis B; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Viral Load

2009
[Anti-viral treatment for liver cirrhosis].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2010, Volume: 107, Issue:1

    Topics: Hepatitis B; Hepatitis C; Humans; Interferons; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Reverse Transcriptase Inhibitors

2010
[Advance in clinical studies of the kinetics of hepatitis B virus].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2010, Volume: 18, Issue:1

    Topics: Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Interferon-alpha; Kinetics; Lamivudine; Models, Statistical; Viral Load

2010
Treatment of hepatitis B virus-associated glomerulonephritis: a meta-analysis.
    World journal of gastroenterology, 2010, Feb-14, Volume: 16, Issue:6

    Topics: Adrenal Cortex Hormones; Antiviral Agents; Glomerulonephritis; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Interferons; Lamivudine; Proteinuria; Treatment Outcome

2010
Is response to antiviral treatment influenced by hepatitis B virus genotype?
    Journal of hepatology, 2010, Volume: 52, Issue:3

    Topics: Antiviral Agents; Genotype; Hepatitis B; Hepatitis B virus; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Polyethylene Glycols; Recombinant Proteins; Treatment Outcome

2010
Comparison of different immunoprophylaxis regimens after liver transplantation with hepatitis B core antibody-positive donors: a systematic review.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2010, Volume: 16, Issue:3

    Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation

2010
Current therapeutic strategies for recurrent hepatitis B virus infection after liver transplantation.
    World journal of gastroenterology, 2010, May-28, Volume: 16, Issue:20

    Topics: Adenine; Antiviral Agents; Asia; Guanine; Hepatitis B; Hepatitis B virus; Humans; Interferons; Lamivudine; Liver Transplantation; Organophosphonates; Recurrence; Reverse Transcriptase Inhibitors; Tenofovir

2010
HIV-HBV coinfection among South African patients receiving antiretroviral therapy.
    Antiviral therapy, 2010, Volume: 15, Issue:3 Pt B

    Topics: Anti-HIV Agents; Drug Therapy, Combination; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Prevalence; Reverse Transcriptase Inhibitors; South Africa

2010
Hepatitis B immunoglobulins and/or lamivudine for preventing hepatitis B recurrence after liver transplantation: a systematic review.
    Journal of gastroenterology and hepatology, 2010, Volume: 25, Issue:5

    Topics: Antiviral Agents; Drug Administration Schedule; Drug Therapy, Combination; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Risk Assessment; Risk Factors; Secondary Prevention; Time Factors; Treatment Outcome

2010
[Hepatitis B virus (HBV) infection and hepatocarcinogenesis].
    Orvosi hetilap, 2010, Jun-27, Volume: 151, Issue:26

    Topics: Antiviral Agents; Carcinoma, Hepatocellular; Epigenesis, Genetic; Hepatitis B; Hepatitis B Surface Antigens; Humans; Interferons; Lamivudine; Liver Neoplasms; Oncogenes; Population Surveillance; Primary Prevention; Protein Precursors; Secondary Prevention; Trans-Activators; Viral Regulatory and Accessory Proteins

2010
Lamivudine in late pregnancy to interrupt in utero transmission of hepatitis B virus: a systematic review and meta-analysis.
    Obstetrics and gynecology, 2010, Volume: 116, Issue:1

    Topics: Carrier State; DNA, Viral; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Models, Theoretical; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors

2010
Impact of immunosuppression and chemotherapy on reactivation of viral hepatitis.
    Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2010, Volume: 21, Issue:4

    Topics: Antiviral Agents; Hepacivirus; Hepatitis A; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis C; Hepatitis Delta Virus; Humans; Immunosuppression Therapy; Lamivudine; Recurrence; Virus Activation

2010
Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation.
    The Cochrane database of systematic reviews, 2010, Jul-07, Issue:7

    Topics: Adenine; Antiviral Agents; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Organophosphonates; Randomized Controlled Trials as Topic; Secondary Prevention

2010
Review of the use of hepatitis B core antibody-positive kidney donors.
    Transplantation reviews (Orlando, Fla.), 2010, Volume: 24, Issue:4

    Topics: Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Humans; Kidney Transplantation; Lamivudine; Liver; Patient Selection; Reverse Transcriptase Inhibitors; Risk Assessment; Tissue Donors; Transaminases; Viral Load

2010
Therapy with nucleos(t)ide analogues: current role in dialysis patients.
    The International journal of artificial organs, 2010, Volume: 33, Issue:6

    Topics: Antiviral Agents; Hepatitis B; Humans; Interferons; Kidney Failure, Chronic; Lamivudine; Nucleosides; Nucleotides; Renal Dialysis; Reverse Transcriptase Inhibitors

2010
Mutation pattern of lamivudine resistance in relation to hepatitis B genotypes: hepatitis B genotypes differ in their lamivudine resistance associated mutation pattern.
    Journal of medical virology, 2010, Volume: 82, Issue:11

    Topics: Antiviral Agents; Australia; DNA Mutational Analysis; Drug Resistance, Viral; Genotype; Germany; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutation

2010
Interferon and lamivudine combination therapy versus lamivudine monotherapy for hepatitis B e antigen-negative hepatitis B treatment: a meta-analysis of randomized controlled trials.
    Hepatobiliary & pancreatic diseases international : HBPD INT, 2010, Volume: 9, Issue:5

    Topics: Antiviral Agents; Drug Carriers; Drug Therapy, Combination; Hepatitis B; Hepatitis B e Antigens; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Polyethylene Glycols; Randomized Controlled Trials as Topic; Recombinant Proteins; Reverse Transcriptase Inhibitors

2010
Inflammatory bowel disease and hepatitis B and C in Western Balkans: a referral centre study and review of the literature.
    Journal of Crohn's & colitis, 2010, Volume: 4, Issue:4

    Topics: Adenine; Adolescent; Adult; Aged; Antiviral Agents; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Female; Greece; Hepatitis B; Hepatitis C; Humans; Inflammatory Bowel Diseases; Interferon-alpha; Lamivudine; Male; Middle Aged; Organophosphonates; Prevalence; Retrospective Studies; Ribavirin; Tenofovir; Treatment Outcome

2010
The difficulties of managing severe hepatitis B virus reactivation.
    Liver international : official journal of the International Association for the Study of the Liver, 2011, Volume: 31 Suppl 1

    Topics: Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Recurrence; Virus Activation

2011
The impact of human immunodeficiency virus on viral hepatitis.
    Liver international : official journal of the International Association for the Study of the Liver, 2011, Volume: 31 Suppl 1

    Topics: Adenine; Antiviral Agents; Deoxycytidine; Disease Progression; Drug Therapy, Combination; Emtricitabine; Guanine; Hepatitis B; Hepatitis C; Hepatitis Viruses; HIV Infections; Humans; Interferon-alpha; Lamivudine; Nucleosides; Organophosphonates; Pyrimidinones; Telbivudine; Tenofovir; Thymidine

2011
An overview of treatment response rates to various anti-viral drugs in Pakistani hepatitis B virus infected patients.
    Virology journal, 2011, Jan-15, Volume: 8

    Topics: Antiviral Agents; Genetic Variation; Hepatitis B; Hepatitis B virus; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Pakistan; Polyethylene Glycols; Recombinant Proteins

2011
Hepatitis B immunoglobulin and/or nucleos(t)ide analogues for prophylaxis against hepatitis b virus recurrence after liver transplantation: a systematic review.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2011, Volume: 17, Issue:10

    Topics: Adenine; Antiviral Agents; Chi-Square Distribution; Drug Therapy, Combination; Evidence-Based Medicine; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Organophosphonates; Risk Assessment; Risk Factors; Secondary Prevention; Time Factors; Treatment Outcome

2011
Antiviral therapy for hepatitis B infection during pregnancy and breastfeeding.
    Antiviral therapy, 2011, Volume: 16, Issue:5

    Topics: Adenine; Antiviral Agents; Breast Feeding; Female; Guanine; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Nucleosides; Organophosphonates; Placenta; Pregnancy; Pregnancy Complications, Infectious; Pyrimidinones; Telbivudine; Tenofovir; Thymidine

2011
Evaluation and management of hepatitis B virus infection in hematopoietic stem cell transplantation: before and after transplantation.
    Expert review of anti-infective therapy, 2011, Volume: 9, Issue:8

    Topics: Antibiotic Prophylaxis; Antiviral Agents; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Risk Factors; Virus Activation

2011
Hepatitis B virus infection: pathogenesis, reactivation and management in hematopoietic stem cell transplant recipients.
    Expert review of anti-infective therapy, 2011, Volume: 9, Issue:10

    Topics: Antiviral Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Disease Management; DNA, Viral; Drug Administration Schedule; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunity, Cellular; Immunosuppression Therapy; Lamivudine; Opportunistic Infections; Transplantation Conditioning; Virus Activation; Virus Replication

2011
Cost-effectiveness analysis of prophylactic lamivudine use in preventing vertical transmission of hepatitis B virus infection.
    PharmacoEconomics, 2011, Volume: 29, Issue:12

    Topics: Antiviral Agents; Cost of Illness; Cost-Benefit Analysis; Health Care Costs; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Primary Prevention; Quality-Adjusted Life Years; Taiwan

2011
A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus.
    World journal of gastroenterology, 2011, Oct-14, Volume: 17, Issue:38

    Topics: Antiviral Agents; Databases, Factual; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Treatment Outcome; Viral Load

2011
Management of severe acute to fulminant hepatitis B: to treat or not to treat or when to treat?
    Liver international : official journal of the International Association for the Study of the Liver, 2012, Volume: 32, Issue:4

    Topics: Adenine; Antiviral Agents; Guanine; Hepatitis B; Humans; Interferons; Lamivudine; Liver Failure, Acute; Organophosphonates; Tenofovir

2012
[Pharmacological treatment of acute hepatitis B].
    Medicina clinica, 2012, May-19, Volume: 138, Issue:14

    Topics: Acute Disease; Adenine; Antiviral Agents; Guanine; Hepatitis B; Humans; Lamivudine; Nucleosides; Organophosphonates; Practice Guidelines as Topic; Pyrimidinones; Spain; Telbivudine; Tenofovir; Thymidine; Treatment Outcome

2012
Meta-analysis: oral anti-viral agents in adults with decompensated hepatitis B virus cirrhosis.
    Alimentary pharmacology & therapeutics, 2012, Volume: 35, Issue:6

    Topics: Adenine; Administration, Oral; Adult; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Guanine; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Nucleosides; Organophosphonates; Pyrimidinones; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Telbivudine; Tenofovir; Thymidine; Time Factors; Treatment Outcome; Viral Load

2012
Influence of anti-HBc positive organ donor in lung donor selection.
    Archivos de bronconeumologia, 2012, Volume: 48, Issue:9

    Topics: Antiviral Agents; Donor Selection; Follow-Up Studies; gamma-Globulins; Health Care Surveys; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Humans; Informed Consent; Lamivudine; Lung Transplantation; Organizational Policy; Practice Patterns, Physicians'; Preoperative Care; Spain; Tissue Donors; Vaccination

2012
A meta-analysis of nucleos(t)ide analogues in patients with decompensated cirrhosis due to hepatitis B.
    Digestive diseases and sciences, 2013, Volume: 58, Issue:3

    Topics: Antiviral Agents; Hepatitis B; Humans; Lamivudine; Liver Cirrhosis; Nucleosides; Nucleotides; Reverse Transcriptase Inhibitors; Telbivudine; Thymidine

2013
Hepatitis B virus infection in hemodialysis patients.
    Seminars in nephrology, 2002, Volume: 22, Issue:4

    Topics: Antiviral Agents; Hepatitis B; Hepatitis B Vaccines; Humans; Interferon-alpha; Kidney Failure, Chronic; Lamivudine; Prognosis; Renal Dialysis; Risk Factors

2002
Prevention of recurrent hepatitis B post-liver transplantation.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2002, Volume: 8, Issue:10 Suppl 1

    Topics: Adenine; Antiviral Agents; Guanine; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Organophosphonates; Postoperative Complications; Reverse Transcriptase Inhibitors; Secondary Prevention; Viral Hepatitis Vaccines

2002
Use of hepatitis B core antibody-positive donors for liver transplantation.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2002, Volume: 8, Issue:10 Suppl 1

    Topics: Hepatitis B; Hepatitis B Antibodies; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Reverse Transcriptase Inhibitors; Tissue Donors

2002
The virological and clinical significance of mutations in the overlapping envelope and polymerase genes of hepatitis B virus.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2002, Volume: 25, Issue:2

    Topics: DNA-Directed DNA Polymerase; Drug Resistance, Viral; Genes, Viral; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Humans; Lamivudine; Mutation; Reverse Transcriptase Inhibitors

2002
Prophylaxis and treatment of recurrent hepatitis B after liver transplantation.
    Transplantation, 2003, Feb-15, Volume: 75, Issue:3 Suppl

    Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis B; Humans; Immunization; Immunoglobulins; Lamivudine; Liver Transplantation; Preventive Medicine; Reverse Transcriptase Inhibitors; Secondary Prevention

2003
Prevention of and treatment for hepatitis B virus infection after liver transplantation in the nucleoside analogues era.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2003, Volume: 3, Issue:3

    Topics: Adenine; Antiviral Agents; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Nucleosides; Organophosphonates; Postoperative Complications; Recurrence; Time Factors; Transplantation Immunology

2003
Management of patients with decompensated HBV cirrhosis.
    Seminars in liver disease, 2003, Volume: 23, Issue:1

    Topics: Adenine; Antiviral Agents; Carcinoma, Hepatocellular; Disease Progression; Drug Resistance; Hepatitis B; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Organophosphonates; Prognosis; Reverse Transcriptase Inhibitors; Risk Factors

2003
Lamivudine resistant occult HBV: implications for public health?
    Journal of hepatology, 2003, Volume: 38, Issue:4

    Topics: Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Public Health; Reverse Transcriptase Inhibitors

2003
[Treatment of hepatitis B].
    La Revue de medecine interne, 2002, Volume: 23 Suppl 5

    Topics: Adenine; Antiviral Agents; Clinical Trials, Phase III as Topic; Drug Therapy, Combination; Hepatitis B; Humans; Interferon-alpha; Lamivudine; Organophosphonates; Treatment Outcome

2002
[Drug therapy of hepatitis B and C].
    Duodecim; laaketieteellinen aikakauskirja, 2003, Volume: 119, Issue:6

    Topics: Antiviral Agents; Clinical Trials as Topic; Drug Therapy, Combination; Hepatitis B; Hepatitis B Vaccines; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Polyethylene Glycols; Recombinant Proteins; Reverse Transcriptase Inhibitors; Ribavirin

2003
Pediatric issues in new therapies for hepatitis B and C.
    Current gastroenterology reports, 2003, Volume: 5, Issue:3

    Topics: Adolescent; Adult; Age Factors; Antiviral Agents; Child; Child, Preschool; Hepatitis B; Hepatitis C; Humans; Interferon-alpha; Lamivudine; Reverse Transcriptase Inhibitors

2003
Towards an improved and cost-saving prophylaxis of hepatitis B virus recurrence after liver transplantation?
    Journal of hepatology, 2003, Volume: 38, Issue:6

    Topics: Cost Control; Drug Costs; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Postoperative Care; Preventive Medicine; Reverse Transcriptase Inhibitors; Secondary Prevention

2003
Prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with hemato-oncological neoplasias treated with chemotherapy.
    Leukemia & lymphoma, 2003, Volume: 44, Issue:5

    Topics: Antineoplastic Agents; Chronic Disease; Hematologic Neoplasms; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Virus Activation

2003
[Hepatotoxicity of chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2003, Volume: 30, Issue:6

    Topics: Antineoplastic Agents; Antiviral Agents; Chemical and Drug Induced Liver Injury; Hematologic Neoplasms; Hepatitis B; Hepatitis C; Humans; Interferon-alpha; Lamivudine; Liver Diseases; Neoplasms; Reverse Transcriptase Inhibitors

2003
[Hepatitis: associated diseases. Risk groups -- prevention -- treatment].
    Praxis, 2003, Aug-13, Volume: 92, Issue:33

    Topics: Adenine; Adult; Antiviral Agents; Child; DNA, Viral; Female; Hepacivirus; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C; Hepatitis C, Chronic; Humans; Infant; Infant, Newborn; Interferons; Lamivudine; Liver Cirrhosis; Male; Mutation; Organophosphonates; Recurrence; Ribavirin; Risk Factors; RNA, Viral; Time Factors

2003
Early detection of hepatitis B drug resistance: implications for patient management.
    Expert review of molecular diagnostics, 2003, Volume: 3, Issue:5

    Topics: Adenine; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Genotype; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Organophosphonates; Reverse Transcriptase Inhibitors

2003
Current issues and treatment of fulminant hepatic failure including transplantation in Hong Kong and the Far East.
    Seminars in liver disease, 2003, Volume: 23, Issue:3

    Topics: Asia, Eastern; Hepatitis B; Hong Kong; Humans; Immunotherapy, Adoptive; Lamivudine; Liver Failure; Liver Transplantation; Reverse Transcriptase Inhibitors

2003
Treatment of hepatitis B reinfection after liver transplantation.
    Minerva chirurgica, 2003, Volume: 58, Issue:5

    Topics: Drug Therapy, Combination; Hepatitis B; Humans; Immunization, Passive; Immunoglobulins; Interferon-alpha; Lamivudine; Liver Transplantation; Recurrence; Reverse Transcriptase Inhibitors

2003
Treatment modalities for hepatitis B viral infection and resistance to antiviral therapy.
    Panminerva medica, 2003, Volume: 45, Issue:3

    Topics: Antiviral Agents; Drug Design; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutation

2003
Lamivudine prophylaxis for chemotherapy induced reactivation hepatitis B: a case report and review.
    Hawaii medical journal, 2003, Volume: 62, Issue:10

    Topics: Adult; Antineoplastic Protocols; Female; Hepatitis B; Humans; Lamivudine; Leukemia, Myeloid, Acute; Reverse Transcriptase Inhibitors

2003
Doctor to patient transmission of hepatitis B virus: implications of HBV DNA levels and potential new solutions.
    Antiviral research, 2003, Volume: 60, Issue:2

    Topics: Adenine; Antiviral Agents; DNA, Viral; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Infectious Disease Transmission, Professional-to-Patient; Interferon-alpha; Lamivudine; Organophosphonates; Organophosphorus Compounds; Physicians; Risk Factors; Risk Management; Tenofovir; Viral Load

2003
Chronic viral hepatitis: always be current!
    Pediatrics in review, 2003, Volume: 24, Issue:12

    Topics: Adenine; Adolescent; Adult; Antiviral Agents; Child; Female; Hepacivirus; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C; Humans; Immunization Schedule; Infant, Newborn; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Prevalence; Risk Factors; Serologic Tests; Treatment Outcome; United States; Viral Hepatitis Vaccines

2003
Viral hepatitis B.
    Lancet (London, England), 2003, Dec-20, Volume: 362, Issue:9401

    Topics: Adenine; Antiviral Agents; Comorbidity; Drug Therapy, Combination; Genotype; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; HIV Infections; Humans; Interferon-alpha; Lamivudine; Organophosphonates; Reverse Transcriptase Inhibitors; Viral Load

2003
Results of lamivudine therapy for HBe antigen positive hepatitis (in the West).
    Journal of hepatology, 2003, Volume: 39 Suppl 1

    Topics: Hepatitis B; Hepatitis B e Antigens; Humans; Lamivudine; North America; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Treatment Outcome

2003
Hepatitis B virus resistance to antivirals: clinical implications and management.
    Journal of hepatology, 2003, Volume: 39 Suppl 1

    Topics: Antiviral Agents; Drug Resistance, Microbial; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Prognosis; Reverse Transcriptase Inhibitors

2003
Management of the patient with hepatitis B virus-related cirrhosis.
    Journal of hepatology, 2003, Volume: 39 Suppl 1

    Topics: Adenine; Antiviral Agents; Hepatitis B; Humans; Interferons; Lamivudine; Liver Cirrhosis; Nucleosides; Organophosphonates; Reverse Transcriptase Inhibitors

2003
Treatment of recurrence of hepatitis B in transplant patients.
    Journal of hepatology, 2003, Volume: 39 Suppl 1

    Topics: 2-Aminopurine; Antiviral Agents; Drug Resistance, Microbial; Famciclovir; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Postoperative Care; Reverse Transcriptase Inhibitors; Secondary Prevention

2003
Hepatitis B.
    American family physician, 2004, Jan-01, Volume: 69, Issue:1

    Topics: Acute Disease; Antiviral Agents; Carcinoma, Hepatocellular; Chronic Disease; Disease Progression; Hepatitis B; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Mass Screening; Patient Selection; Recombinant Proteins; Reverse Transcriptase Inhibitors; Risk Factors; Sexually Transmitted Diseases; Substance Abuse, Intravenous; United States; Vaccination

2004
Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures.
    Journal of viral hepatitis, 2004, Volume: 11, Issue:2

    Topics: Antiviral Agents; Carcinoma, Hepatocellular; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Vaccines; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Cirrhosis; Polyethylene Glycols; Recombinant Proteins

2004
Hepatitis B virus infection--natural history and clinical consequences.
    The New England journal of medicine, 2004, Mar-11, Volume: 350, Issue:11

    Topics: Antiviral Agents; Biomarkers; Carcinoma, Hepatocellular; DNA, Viral; Hepatitis B; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferons; Lamivudine; Liver Neoplasms; Viremia; Virus Replication

2004
Lamivudine for the treatment of hepatitis B virus-related liver disease after renal transplantation: meta-analysis of clinical trials.
    Transplantation, 2004, Mar-27, Volume: 77, Issue:6

    Topics: DNA, Viral; Hepatitis B; Humans; Kidney Transplantation; Lamivudine; MEDLINE; Postoperative Complications

2004
PGS consensus statement on management of hepatitis B virus infection--2003.
    JPMA. The Journal of the Pakistan Medical Association, 2004, Volume: 54, Issue:3

    Topics: Antiviral Agents; Carrier State; Disease Transmission, Infectious; Hepatitis B; Hepatitis B Antigens; Hepatitis B Vaccines; Humans; Interferon-alpha; Lamivudine; Pakistan; Prevalence; Reverse Transcriptase Inhibitors

2004
Molecular virology of hepatitis B virus.
    Seminars in liver disease, 2004, Volume: 24 Suppl 1

    Topics: Adenine; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Genotype; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Mutation; Organophosphonates; Reverse Transcriptase Inhibitors; Transcription, Genetic; Viral Proteins; Virus Replication

2004
Hepatitis B virus kinetics and mathematical modeling.
    Seminars in liver disease, 2004, Volume: 24 Suppl 1

    Topics: Adenine; Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B virus; Hepatocytes; Lamivudine; Models, Biological; Organophosphonates; Reverse Transcriptase Inhibitors; Viral Load; Virion

2004
HBV infection in patients with end-stage renal disease.
    Seminars in liver disease, 2004, Volume: 24 Suppl 1

    Topics: Antiviral Agents; Comorbidity; Cross Infection; Glomerulonephritis; Hepatitis B; Humans; Interferon-alpha; Kidney Failure, Chronic; Kidney Transplantation; Lamivudine; Renal Dialysis; Universal Precautions; Vaccination

2004
The role of interferon therapy in hepatitis B.
    MedGenMed : Medscape general medicine, 2004, Mar-18, Volume: 6, Issue:1

    Topics: Adenine; Antiviral Agents; Clinical Trials as Topic; Hepatitis B; Humans; Interferon-alpha; Lamivudine; Organophosphonates; Patient Selection; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prognosis; Risk Assessment; Risk Factors; Treatment Outcome

2004
Current antiviral therapy for chronic hepatitis B.
    Journal of Korean medical science, 2004, Volume: 19, Issue:4

    Topics: Adenine; Antiviral Agents; Hepatitis B; Humans; Interferon-alpha; Lamivudine; Organophosphonates; Reverse Transcriptase Inhibitors

2004
Evolving strategies to prevent HBV recurrence.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2004, Volume: 10, Issue:10 Suppl 2

    Topics: Antiviral Agents; Drug Administration Schedule; Drug Therapy, Combination; Hepatitis Antibodies; Hepatitis B; Hepatitis B Core Antigens; Hepatitis D; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Cirrhosis; Liver Transplantation; Preoperative Care; Reverse Transcriptase Inhibitors; Secondary Prevention; Survival Analysis; Tissue Donors

2004
[Hepatitis B (acute and chronic)].
    Praxis, 2004, Jul-28, Volume: 93, Issue:31-32

    Topics: Acute Disease; Adenine; Adolescent; Adult; Antiviral Agents; Child; Diagnosis, Differential; Drug Therapy, Combination; Follow-Up Studies; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Male; Organophosphonates; Prognosis; Reverse Transcriptase Inhibitors; Risk Factors; Time Factors

2004
[Hepatitis B viral mutation and its clinical significance].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 8

    Topics: Antiviral Agents; Genotype; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Mutation; Polymerase Chain Reaction; Treatment Outcome

2004
[Detection of lamivudine-resistant hepatitis B virus].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 8

    Topics: Antiviral Agents; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Nucleic Acid Amplification Techniques; Plasmids; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Reverse Transcriptase Inhibitors

2004
[Advances in the treatment of acute hepatitis B].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 8

    Topics: Acute Disease; Anticoagulants; Antiviral Agents; Carrier State; Clinical Trials as Topic; Diagnosis, Differential; Disseminated Intravascular Coagulation; Drug Therapy, Combination; Guanine; Hepatitis B; Humans; Interferons; Lamivudine

2004
[Recent advances in the treatment of fulminant hepatitis B].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 8

    Topics: Acute Disease; Antiviral Agents; Carrier State; Cyclosporine; Drug Therapy, Combination; Guanine; Hemodiafiltration; Hepatitis B; Humans; Immunosuppressive Agents; Lamivudine; Liver Failure, Acute; Liver Transplantation; Methylprednisolone; Plasma Exchange; Prognosis; Pulse Therapy, Drug

2004
[Current status of treatment for HBV-related cirrhosis].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 8

    Topics: Alanine Transaminase; Antiviral Agents; Biomarkers; DNA, Viral; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Interferon-alpha; Interferon-beta; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Risk; Treatment Outcome

2004
[Liver transplantation for hepatitis B virus cirrhosis].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 8

    Topics: Biomarkers; Brain Death; Combined Modality Therapy; DNA, Viral; Hepatitis B; Hepatitis B Vaccines; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Cirrhosis; Liver Transplantation; Living Donors; Preoperative Care; Reverse Transcriptase Inhibitors; Secondary Prevention

2004
Hepatitis B and hepatitis C viruses in liver transplantation.
    Transplantation, 2004, Oct-15, Volume: 78, Issue:7

    Topics: Hepatitis B; Hepatitis C; Humans; Immunoglobulins; Immunosuppression Therapy; Lamivudine; Liver Transplantation; Reoperation; Vaccination

2004
[Treatment of hepatitis B].
    Orvosi hetilap, 2004, Nov-07, Volume: 145, Issue:45

    Topics: Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferons; Lamivudine; Liver Transplantation; Nucleosides; Viral Load

2004
Management of hepatitis B in liver transplant patients.
    Journal of clinical gastroenterology, 2005, Volume: 39, Issue:1

    Topics: Antiviral Agents; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Postoperative Complications; Recurrence; Risk Factors

2005
Lamivudine in the treatment of HBV-related liver disease after renal transplantation: an update.
    The International journal of artificial organs, 2005, Volume: 28, Issue:3

    Topics: Antiviral Agents; Graft Survival; Hepatitis B; Humans; Interferons; Kidney Failure, Chronic; Kidney Transplantation; Lamivudine; Survival Analysis

2005
[Prevention and treatment of hepatitis B virus infection after liver transplantation].
    Gastroenterologie clinique et biologique, 2005, Volume: 29, Issue:4

    Topics: Antiviral Agents; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Survival

2005
Prevention of hepatocellular carcinoma.
    Seminars in liver disease, 2005, Volume: 25, Issue:2

    Topics: Carcinoma, Hepatocellular; Chemoprevention; Disease Progression; Disease Susceptibility; Hepatitis B; Humans; Interferons; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Reverse Transcriptase Inhibitors; Secondary Prevention; Vaccination

2005
Reactivation of hepatitis B virus with rituximab.
    Expert opinion on drug safety, 2005, Volume: 4, Issue:3

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antibodies, Viral; Antineoplastic Agents; Antiviral Agents; Autoimmune Diseases; Hepatitis B; Hepatitis B virus; Humans; Kinetics; Lamivudine; Lymphoma, Non-Hodgkin; Rituximab

2005
Adefovir-lamivudine combination therapy and hepatitis B viral kinetics.
    Journal of hepatology, 2005, Volume: 43, Issue:2

    Topics: Adenine; Antiviral Agents; Drug Therapy, Combination; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Organophosphonates; Reverse Transcriptase Inhibitors; Treatment Outcome; Virulence

2005
[Diagnostic tests: HBV-DNA].
    Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 7

    Topics: Antiviral Agents; Biomarkers; DNA, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Monitoring, Physiologic; Nucleic Acid Amplification Techniques

2005
Advances in prophylaxis and treatment of recurrent hepatitis B after liver transplantation.
    Hepatobiliary & pancreatic diseases international : HBPD INT, 2005, Volume: 4, Issue:4

    Topics: Antibiotic Prophylaxis; Antiviral Agents; Hepatitis B; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Lamivudine; Liver Transplantation; Recurrence

2005
Prevention of hepatitis B recurrence after liver transplantation.
    Transplantation, 2005, Sep-27, Volume: 80, Issue:1 Suppl

    Topics: Antiviral Agents; Hepatitis B; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Recurrence

2005
Therapeutic implications of hepatitis B virus genotypes.
    Liver international : official journal of the International Association for the Study of the Liver, 2005, Volume: 25, Issue:6

    Topics: Antiviral Agents; Carcinoma, Hepatocellular; Genes, Viral; Genotype; Hepatitis B; Hepatitis B virus; Humans; Interferon-alpha; Lamivudine; Liver Neoplasms

2005
[Prophylaxis and therapy of hepatitis B after liver transplantation].
    Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti, 2005, Volume: 59, Issue:5

    Topics: Hepatitis B; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Recurrence

2005
Understanding hepatitis B.
    The Journal of the Association of Physicians of India, 2005, Volume: 53

    Topics: Acute Disease; Adenine; Algorithms; Antiviral Agents; Hepatitis B; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Organophosphonates; Recombinant Proteins

2005
Lamivudine treatment of decompensated hepatitis B virus-related cirrhosis.
    Hepatobiliary & pancreatic diseases international : HBPD INT, 2006, Volume: 5, Issue:1

    Topics: Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Reverse Transcriptase Inhibitors; Severity of Illness Index; Treatment Outcome; Virus Replication

2006
Hepatitis B virus genotypes and response to antiviral therapy.
    Clinical laboratory, 2006, Volume: 52, Issue:1-2

    Topics: Adenine; Antiviral Agents; Genotype; Hepatitis B; Hepatitis B virus; Humans; Interferon-alpha; Lamivudine; Organophosphonates

2006
Prevention and treatment of recurrent Hepatitis B after liver transplantation: the current role of nucleoside and nucleotide analogues.
    Annals of clinical microbiology and antimicrobials, 2006, Apr-06, Volume: 5

    Topics: Adenine; Antiviral Agents; Drug Therapy, Combination; Guanine; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Nucleosides; Nucleotides; Organophosphonates; Recurrence; Tenofovir

2006
Hepatitis B: the pathway to recovery through treatment.
    Gastroenterology clinics of North America, 2006, Volume: 35, Issue:2

    Topics: Adenine; Antiviral Agents; Drug Resistance, Viral; Guanine; Hepatitis B; Hepatitis C, Chronic; Humans; Interferon-alpha; Lamivudine; Organophosphonates; Reverse Transcriptase Inhibitors

2006
Antiretroviral therapy for hepatitis B virus-HIV-coinfected patients: promises and pitfalls.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Oct-01, Volume: 43, Issue:7

    Topics: Adenine; Antiretroviral Therapy, Highly Active; Antiviral Agents; Deoxycytidine; Drug Combinations; Emtricitabine; Guanine; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Organophosphonates; Preventive Medicine; Tenofovir

2006
[Therapy of hepatitis B virus infection].
    Praxis, 2006, Sep-06, Volume: 95, Issue:36

    Topics: Adenine; Antiviral Agents; Drug Antagonism; Drug Resistance, Viral; Drug Synergism; Drug Therapy, Combination; Forecasting; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Cirrhosis; Organophosphonates; Polyethylene Glycols; Prognosis; Recombinant Proteins; Reverse Transcriptase Inhibitors; Time Factors

2006
[Managing lamivudine resistance in liver transplantation for hepatitis B liver disease].
    Gastroenterologie clinique et biologique, 2006, Volume: 30, Issue:10 Pt 2

    Topics: Adenine; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B Vaccines; Hepatitis B, Chronic; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Organophosphonates; Practice Guidelines as Topic; Reverse Transcriptase Inhibitors; Secondary Prevention; Treatment Outcome

2006
[Impact of resistance to analogue antivirals and therapeutic strategies in situations of dialysis, kidney transplantation, vasculitis, and preemptive treatments in immunosuppressed patients].
    Gastroenterologie clinique et biologique, 2006, Volume: 30, Issue:10 Pt 2

    Topics: Adenine; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B Vaccines; Humans; Immunocompromised Host; Kidney Failure, Chronic; Kidney Transplantation; Lamivudine; Organophosphonates; Renal Dialysis; Reverse Transcriptase Inhibitors; Treatment Outcome; Vasculitis

2006
Hepatitis B virus: something old, something new.
    Journal of pediatric gastroenterology and nutrition, 2007, Volume: 44, Issue:1

    Topics: Adolescent; Adult; Antiviral Agents; Carrier State; Child; Child, Preschool; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infant; Interferon-alpha; Lamivudine

2007
Hepatitis B reverse seroconversion in HIV-positive patients: case series and review of the literature.
    AIDS (London, England), 2007, Mar-30, Volume: 21, Issue:6

    Topics: Adenine; Adult; Aged; Aged, 80 and over; Anti-HIV Agents; CD4 Lymphocyte Count; DNA, Viral; Hepatitis B; Hepatitis B Surface Antigens; HIV Seropositivity; Humans; Lamivudine; Middle Aged; Organophosphonates; Tenofovir

2007
[Drugs for hepatitis B and C infection].
    Nihon rinsho. Japanese journal of clinical medicine, 2007, Feb-28, Volume: 65 Suppl 2 Pt. 1

    Topics: Adenine; Antiviral Agents; Drug Therapy, Combination; Guanine; Hepatitis B; Hepatitis B virus; Hepatitis C; Humans; Lamivudine; Mutation; Oligopeptides; Organophosphonates; Proline; Ribavirin; Serine Proteinase Inhibitors

2007
[Mechanisms of drug resistance in hepatitis viruses B and C].
    Nihon rinsho. Japanese journal of clinical medicine, 2007, Feb-28, Volume: 65 Suppl 2 Pt. 1

    Topics: Adenine; Antiviral Agents; Drug Resistance, Viral; Gene Products, pol; Guanine; Hepacivirus; Hepatitis B; Hepatitis B virus; Hepatitis C; Humans; Interferons; Lamivudine; Mutation; Organophosphonates; Ribavirin; Viral Nonstructural Proteins

2007
Drug resistance in antiviral treatment for infections with hepatitis B and C viruses.
    Journal of gastroenterology, 2007, Volume: 42, Issue:5

    Topics: Adenine; Antiviral Agents; Drug Resistance, Viral; Guanine; Hepacivirus; Hepatitis B; Hepatitis B virus; Hepatitis C; Humans; Lamivudine; Organophosphonates

2007
Entecavir is a potent anti-HBV drug superior to lamivudine: experience from clinical trials in China.
    The Journal of antimicrobial chemotherapy, 2007, Volume: 60, Issue:2

    Topics: Antiviral Agents; China; Drug Resistance, Viral; Guanine; Hepatitis B; Humans; Lamivudine; Randomized Controlled Trials as Topic

2007
Liver transplantation using hepatitis B core antibody-positive grafts: review and university of Tokyo experience.
    Digestive diseases and sciences, 2007, Volume: 52, Issue:10

    Topics: Disease Transmission, Infectious; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Japan; Lamivudine; Liver Transplantation; Reverse Transcriptase Inhibitors; Risk Factors; Tissue Donors; Universities

2007
Interferon and lamivudine vs. interferon for hepatitis B e antigen-positive hepatitis B treatment: meta-analysis of randomized controlled trials.
    Liver international : official journal of the International Association for the Study of the Liver, 2007, Volume: 27, Issue:9

    Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Hepatitis B; Hepatitis B e Antigens; Humans; Interferon-alpha; Lamivudine; Polyethylene Glycols; Randomized Controlled Trials as Topic

2007
Lamivudine prophylaxis is effective in reducing hepatitis B reactivation and reactivation-related mortality in chemotherapy patients: a meta-analysis.
    Liver international : official journal of the International Association for the Study of the Liver, 2008, Volume: 28, Issue:1

    Topics: Databases, Bibliographic; Drug Therapy; Hepatitis B; Humans; Lamivudine; Secondary Prevention

2008
[Attention-getting sexually transmitted diseases: Hepatitis B].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2007, Nov-10, Volume: 96, Issue:11

    Topics: Adenine; Adenosine; Antiviral Agents; Comorbidity; Drug Therapy, Combination; Genotype; Guanine; Guanosine; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Organophosphonates; Reverse Transcriptase Inhibitors; Sexually Transmitted Diseases, Viral

2007
Lamivudine prevents reactivation of hepatitis B and reduces mortality in immunosuppressed patients: systematic review and meta-analysis.
    Journal of viral hepatitis, 2008, Volume: 15, Issue:2

    Topics: Antiviral Agents; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunocompromised Host; Lamivudine; Randomized Controlled Trials as Topic; Treatment Outcome

2008
Hepatitis B immunoglobulin and Lamivudine improve hepatitis B-related outcomes after liver transplantation: meta-analysis.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2008, Volume: 6, Issue:6

    Topics: Adult; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Orthohepadnavirus; Secondary Prevention; Treatment Outcome

2008
New nucleoside analogues for chronic hepatitis B.
    Journal of hepatology, 1995, Volume: 22, Issue:1 Suppl

    Topics: 2-Aminopurine; Antiviral Agents; Arabinofuranosyluracil; Chronic Disease; Drug Evaluation, Preclinical; Famciclovir; Hepatitis B; Humans; Lamivudine; Nucleosides; Zalcitabine

1995
New developments in antiviral therapy for chronic hepatitis B infection.
    Scandinavian journal of gastroenterology. Supplement, 1995, Volume: 212

    Topics: 2-Aminopurine; Antiviral Agents; Arabinofuranosyluracil; Clinical Trials as Topic; Famciclovir; Hepatitis B; Hepatitis, Chronic; Humans; Interferon-alpha; Lamivudine; Treatment Outcome; Zalcitabine

1995
Treatment of posttransplantation hepatitis B.
    Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 1997, Volume: 3, Issue:5 Suppl 1

    Topics: 2-Aminopurine; Antiviral Agents; Famciclovir; Ganciclovir; Hepatitis B; Humans; Lamivudine; Liver Transplantation

1997
Clinical pharmacokinetics of lamivudine.
    Clinical pharmacokinetics, 1999, Volume: 36, Issue:1

    Topics: Absorption; Age Factors; Anti-HIV Agents; Child; Clinical Trials as Topic; Drug Interactions; Female; Hepatitis B; Humans; Infant, Newborn; Lamivudine; Maternal-Fetal Exchange; Pregnancy; Renal Insufficiency; Reverse Transcriptase Inhibitors

1999
[New management of hepatitis B virus].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1999, Apr-10, Volume: 88, Issue:4

    Topics: 2-Aminopurine; Adrenal Cortex Hormones; Antiviral Agents; Famciclovir; Germanium; Hepatitis B; Humans; Immunologic Factors; Interferons; Interleukin-12; Lamivudine; Organometallic Compounds; Propionates; Reverse Transcriptase Inhibitors; Thymosin

1999
Prevention of hepatitis B flare-up during chemotherapy using lamivudine: case report and review of the literature.
    Annals of hematology, 1999, Volume: 78, Issue:5

    Topics: Female; Hepatitis B; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Middle Aged; Reverse Transcriptase Inhibitors

1999
Lamivudine therapy for hepatitis B infection.
    Scandinavian journal of gastroenterology. Supplement, 1999, Volume: 230

    Topics: DNA, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Reverse Transcriptase Inhibitors; Secondary Prevention; Transaminases; Treatment Outcome; Virus Replication

1999
Update on prevention and treatment of viral hepatitis in children.
    Current opinion in pediatrics, 1999, Volume: 11, Issue:5

    Topics: Child; Female; Hepatitis A; Hepatitis B; Hepatitis C; Humans; Infectious Disease Transmission, Vertical; Interferons; Lamivudine; Male; Viral Hepatitis Vaccines

1999
Preclinical aspects of lamivudine and famciclovir against hepatitis B virus.
    Journal of viral hepatitis, 1999, Volume: 6, Issue:2

    Topics: 2-Aminopurine; Antiviral Agents; Famciclovir; Hepatitis B; Hepatitis B virus; Humans; Lamivudine

1999
[Hepatitis B: when to use lamivudine?].
    Schweizerische medizinische Wochenschrift, 2000, Jan-11, Volume: 130, Issue:1-2

    Topics: Antiviral Agents; Hepatitis B; Humans; Interferon-alpha; Lamivudine

2000
Transgenic mice as a chemotherapeutic model for hepatitis B virus infection.
    Antiviral therapy, 1998, Volume: 3, Issue:Suppl 3

    Topics: Administration, Oral; Animals; Disease Models, Animal; DNA, Viral; Dose-Response Relationship, Drug; Genome, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B Virus, Woodchuck; Humans; Interferon-alpha; Lamivudine; Mice; Mice, Transgenic; Polymerase Chain Reaction; Sex Factors; Time Factors; Viral Load; Virus Replication; Zidovudine

1998
Lamivudine for treating active hepatitis B in renal transplant recipients: a case report.
    Clinical nephrology, 2000, Volume: 53, Issue:4

    Topics: Hepatitis B; Humans; Kidney Transplantation; Lamivudine; Male; Middle Aged; Postoperative Complications; Reverse Transcriptase Inhibitors

2000
Lamivudine for hepatitis B in clinical practice.
    Journal of medical virology, 2000, Volume: 61, Issue:3

    Topics: Antiviral Agents; Controlled Clinical Trials as Topic; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver; Treatment Outcome; Virus Replication

2000
Development of resistance and perspectives for future therapies against hepatitis B infections: lessons to be learned from HIV.
    Infection, 1999, Volume: 27 Suppl 2

    Topics: Drug Resistance, Microbial; Drug Therapy, Combination; Hepatitis B; HIV Infections; Humans; Lamivudine; Microbial Sensitivity Tests; Prognosis; Reverse Transcriptase Inhibitors; Treatment Outcome

1999
Doctor-to-patient transmission of viral hepatitis B: is it a problem, is there a solution?
    Journal of viral hepatitis, 2000, Volume: 7, Issue:4

    Topics: Antiviral Agents; DNA, Viral; General Surgery; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Humans; Infectious Disease Transmission, Professional-to-Patient; Lamivudine; Practice Guidelines as Topic; Risk Factors

2000
[Therapy of problem cases in hepatitis B].
    Praxis, 2000, May-31, Volume: 89, Issue:22

    Topics: Antiviral Agents; Hepatitis B; Humans; Interferon-alpha; Lamivudine; Liver; Liver Function Tests; Liver Transplantation

2000
Transplantation in the hepatitis B patient and current therapies to prevent recurrence.
    Seminars in liver disease, 2000, Volume: 20 Suppl 1

    Topics: Adult; Female; Hepatitis B; Hepatitis B Vaccines; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Reverse Transcriptase Inhibitors; Risk Factors; Secondary Prevention; Survival Analysis

2000
Posttransplantation: emerging and future therapies.
    Seminars in liver disease, 2000, Volume: 20 Suppl 1

    Topics: 2-Aminopurine; Antiviral Agents; Drug Therapy, Combination; Famciclovir; Ganciclovir; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Nucleosides; Postoperative Care; Risk Factors; Secondary Prevention; Survival Analysis

2000
Drug-resistant viral hepatitis.
    The Journal of infection, 2000, Volume: 41, Issue:1

    Topics: Amantadine; Antiviral Agents; Drug Resistance, Microbial; Hepacivirus; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis C; Humans; Interferon-alpha; Lamivudine; Mutation; Reverse Transcriptase Inhibitors; Ribavirin

2000
Hepatitis B immune globulin: the US experience.
    Clinical transplantation, 2000, Volume: 14 Suppl 2

    Topics: Antiviral Agents; Graft Survival; Hepatitis B; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Immunosuppressive Agents; Incidence; Lamivudine; Liver Cirrhosis; Liver Transplantation; Mutation; Patient Selection; Time Factors; Transplantation, Homologous; Treatment Failure; Treatment Outcome; United States; Virus Replication

2000
Antiviral therapy to prevent and treat hepatitis B virus infection in hepatic allografts.
    Clinical transplantation, 2000, Volume: 14 Suppl 2

    Topics: 2-Aminopurine; Antiviral Agents; Drug Combinations; Drug Resistance, Microbial; Famciclovir; Ganciclovir; Hepatitis B; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Survival Rate; Transplantation, Homologous

2000
Current topics in hepatitis B.
    The Journal of infection, 2000, Volume: 41, Issue:2

    Topics: Antiviral Agents; Blood Donors; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Humans; Interferon-alpha; Lamivudine; Mutation; Reverse Transcriptase Inhibitors

2000
Posttransplantation prevention and treatment of recurrent hepatitis B.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2000, Volume: 6, Issue:6 Suppl 2

    Topics: Antiviral Agents; Drug Resistance; Hepatitis B; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Recurrence

2000
Hepatitis B and C in the liver transplant recipient.
    Seminars in liver disease, 2000, Volume: 20, Issue:4

    Topics: Graft Enhancement, Immunologic; Hepatitis B; Hepatitis C; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Recurrence; Reverse Transcriptase Inhibitors; Risk Factors

2000
Hepatitis B--an important public health issue.
    Clinical laboratory, 2001, Volume: 47, Issue:1-2

    Topics: Antiviral Agents; Carrier State; Endemic Diseases; Hepatitis B; Hepatitis B Vaccines; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Liver Diseases; Public Health

2001
Molecular anatomy and pathophysiologic implications of drug resistance in hepatitis B virus infection.
    Gastroenterology, 2001, Volume: 120, Issue:4

    Topics: Drug Resistance, Microbial; Gene Products, pol; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutation; Reverse Transcriptase Inhibitors; Virus Replication

2001
Management of hepatitis B: 2000--summary of a workshop.
    Gastroenterology, 2001, Volume: 120, Issue:7

    Topics: Animals; Disease Models, Animal; DNA, Viral; Drug Resistance, Microbial; Drug Therapy, Combination; Hepatitis B; Hepatitis B Vaccines; Humans; Interferon-alpha; Lamivudine; Liver Transplantation; Recurrence

2001
Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.
    Antiviral chemistry & chemotherapy, 2001, Volume: 12, Issue:1

    Topics: 2-Aminopurine; Adenine; Amino Acid Sequence; Animals; Anti-HIV Agents; Antimetabolites; Antiviral Agents; Biological Availability; Cell Line; Clinical Trials as Topic; DNA Replication; DNA-Directed DNA Polymerase; DNA, Viral; Drug Design; Drug Evaluation, Preclinical; Drug Resistance, Multiple; Drug Resistance, Viral; Drug Therapy, Combination; Enzyme Inhibitors; Famciclovir; Gene Products, pol; Hepatitis B; Hepatitis B virus; Hepatitis Viruses; Hepatitis, Animal; HIV; Humans; Lamivudine; Models, Animal; Molecular Sequence Data; Molecular Structure; Nucleosides; Organophosphonates; Sequence Alignment; Sequence Homology, Amino Acid; Species Specificity; Virus Replication

2001
Transmission of hepatitis B infection from hepatitis B core antibody--positive livers: background and prevention.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2001, Volume: 7, Issue:6

    Topics: Antiviral Agents; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Humans; Lamivudine; Liver Transplantation; Tissue Donors

2001
Liver transplantation and hepatitis B virus infection: the situation seems to be under control, but the virus is still there.
    Journal of hepatology, 2001, Volume: 34, Issue:6

    Topics: Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Recurrence; Risk Factors

2001
Treatment of hepatitis B.
    Clinical cornerstone, 2001, Volume: 3, Issue:6

    Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis B; Hepatitis B Vaccines; Hepatitis B virus; Humans; Interferon-alpha; Lamivudine; Liver Transplantation; Reverse Transcriptase Inhibitors; Treatment Outcome

2001
Lamivudine therapy for severe acute hepatitis B virus infection after renal transplantation: case report and literature review.
    Transplantation proceedings, 2001, Volume: 33, Issue:6

    Topics: Hepatitis B; Humans; Kidney Failure, Chronic; Kidney Transplantation; Lamivudine; Male; Middle Aged; Postoperative Complications; Reverse Transcriptase Inhibitors

2001
Successful lamivudine therapy for post-chemotherapeutic fulminant hepatitis B in a hepatitis B virus carrier with non-Hodgkin's lymphoma: case report and review of the literature.
    Annals of hematology, 2001, Volume: 80, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carrier State; Cyclophosphamide; Doxorubicin; Hepatitis B; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Reverse Transcriptase Inhibitors

2001
Treatment of HBV-related liver disease in the dialysis population: reality and promises.
    The International journal of artificial organs, 2001, Volume: 24, Issue:9

    Topics: Antiviral Agents; Genome, Viral; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunocompetence; Interferon-alpha; Kidney Diseases; Lamivudine; Renal Dialysis; Virus Replication

2001
[HVB and HVC infections in nephrology].
    Nephrologie, 2001, Volume: 22, Issue:6

    Topics: Antiviral Agents; Comorbidity; Contraindications; Graft Rejection; Hepatitis B; Hepatitis C; Humans; Immunosuppression Therapy; Interferon-alpha; Kidney Diseases; Kidney Transplantation; Lamivudine; Liver Cirrhosis; Postoperative Complications; Renal Dialysis; Ribavirin; Vaccination; Viral Hepatitis Vaccines; Viremia

2001
Current management strategies for hepatitis B in the elderly.
    Drugs & aging, 2001, Volume: 18, Issue:10

    Topics: Aged; Antiviral Agents; Hepatitis B; Humans; Interferon-alpha; Lamivudine

2001
[Prevention and treatment of viral hepatitis in renal insufficiency conditions].
    Nephrologie, 2001, Volume: 22, Issue:7

    Topics: Antiviral Agents; Biopsy; Comorbidity; Contraindications; Cryoglobulinemia; Female; Graft Rejection; Hepatitis B; Hepatitis B Vaccines; Hepatitis C; Humans; Immunosuppressive Agents; Interferon-alpha; Kidney Failure, Chronic; Kidney Transplantation; Lamivudine; Liver; Male; Renal Dialysis; Ribavirin; Severity of Illness Index

2001
Treatment of hepatitis B and C following liver transplantation.
    Current gastroenterology reports, 2002, Volume: 4, Issue:1

    Topics: Adenine; Antiviral Agents; Clinical Trials as Topic; Disease Progression; Drug Resistance; Drug Therapy, Combination; Hepatitis B; Hepatitis C; Humans; Immunoglobulins; Interferon-alpha; Lamivudine; Liver Transplantation; Organophosphonates; Prognosis; Ribavirin; Secondary Prevention; Survival Rate

2002
[Hepatic transplantation and HBV reinfection].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2002, Volume: 10, Issue:1

    Topics: Antiviral Agents; Chemoprevention; Hepatitis B; Hepatitis C; Humans; Interferon-alpha; Lamivudine; Liver Transplantation; Ribavirin; Secondary Prevention

2002
[Risks and precautions for the use of lamivudine in patients with chronic hepatitis B virus infection].
    Gastroenterologie clinique et biologique, 2002, Volume: 26, Issue:1

    Topics: DNA, Viral; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferons; Lamivudine

2002
[New management strategies for hepatitis B].
    Gastroenterologie clinique et biologique, 2002, Volume: 26, Issue:2

    Topics: Adenine; Antiviral Agents; Arabinofuranosyluracil; Deoxycytidine; Emtricitabine; Guanine; Hepatitis B; Humans; Lamivudine; Organophosphonates

2002
Therapeutic advances in the management of hepatitis B and hepatitis C.
    Current opinion in infectious diseases, 2001, Volume: 14, Issue:5

    Topics: 2-Aminopurine; Antiviral Agents; Drug Therapy, Combination; Famciclovir; Hepatitis B; Hepatitis C; Humans; Interferon-alpha; Lamivudine; Ribavirin

2001
The impact of HIV therapy on co-infection with hepatitis B and hepatitis C viruses.
    Current opinion in infectious diseases, 2001, Volume: 14, Issue:6

    Topics: Antiretroviral Therapy, Highly Active; Drug Therapy, Combination; Hepatitis B; Hepatitis C; HIV Infections; Humans; Lamivudine; Liver; Ribavirin; Viremia

2001
Management of viral hepatitis B.
    Journal of gastroenterology and hepatology, 2002, Volume: 17 Suppl

    Topics: Adjuvants, Immunologic; Antiviral Agents; Forecasting; Genetic Variation; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferons; Lamivudine; Nucleosides; Reverse Transcriptase Inhibitors

2002

Trials

137 trial(s) available for lamivudine and Hepatitis B Virus Infection

ArticleYear
Randomized Controlled Study of Tenofovir versus Lamivudine Followed by Tenofovir in Severe Exacerbation of Hepatitis B.
    Antimicrobial agents and chemotherapy, 2022, 02-15, Volume: 66, Issue:2

    Topics: Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Tenofovir; Treatment Outcome

2022
New Insights on Long-Term Hepatitis B Virus Responses in HIV-Hepatitis B virus Co-infected Patients: Implications for Antiretroviral Management in Hepatitis B virus-Endemic Settings.
    Journal of acquired immune deficiency syndromes (1999), 2021, 01-01, Volume: 86, Issue:1

    Topics: Adult; Alanine Transaminase; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; Cohort Studies; Coinfection; DNA, Viral; Drug Resistance, Viral; Emtricitabine; Female; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Retrospective Studies; Uganda; Zimbabwe

2021
Active immunization for prevention of De novo hepatitis B virus infection after adult living donor liver transplantation with a hepatitis B core antigen-positive graft.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2017, Volume: 23, Issue:10

    Topics: Adult; Allografts; Antibiotic Prophylaxis; Antiviral Agents; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Humans; Incidence; Lamivudine; Liver; Liver Transplantation; Living Donors; Male; Middle Aged; Postoperative Complications; Serologic Tests; Treatment Outcome; Vaccination

2017
Clinical effect of lamivudine in treating liver function lesion caused by hepatitis B combined with Anti-TB drugs.
    Pakistan journal of pharmaceutical sciences, 2018, Volume: 31, Issue:4(Special)

    Topics: Adult; Aged; Antitubercular Agents; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis B; Humans; Isoniazid; Lamivudine; Liver; Liver Function Tests; Male; Middle Aged; Rifampin; Treatment Outcome; Tuberculosis; Withholding Treatment; Young Adult

2018
Combination of lamivudine and adefovir without hepatitis B immune globulin is safe and effective prophylaxis against hepatitis B virus recurrence in hepatitis B surface antigen-positive liver transplant candidates.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2013, Volume: 19, Issue:3

    Topics: Adenine; Adult; Aged; Antiviral Agents; Biomarkers; Disease-Free Survival; DNA, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Kaplan-Meier Estimate; Lamivudine; Liver Transplantation; Male; Middle Aged; New South Wales; New Zealand; Organophosphonates; Prospective Studies; Risk Factors; Secondary Prevention; Time Factors; Treatment Outcome; Victoria; Viral Load; Young Adult

2013
Prevalence, clinical and virologic outcomes of hepatitis B virus co-infection in HIV-1 positive Kenyan women on antiretroviral therapy.
    PloS one, 2013, Volume: 8, Issue:3

    Topics: Adult; Alanine Transaminase; Anti-Retroviral Agents; CD4-Positive T-Lymphocytes; Cohort Studies; Coinfection; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B; HIV Infections; HIV-1; Humans; Kaplan-Meier Estimate; Kenya; Lamivudine; Logistic Models; Prevalence; Proportional Hazards Models; Prospective Studies; Sex Workers; Treatment Outcome

2013
Efficacy of combined therapy in patients with hepatitis B virus-related decompensated cirrhosis.
    World journal of gastroenterology, 2013, Jun-14, Volume: 19, Issue:22

    Topics: Adenine; Adult; Alanine Transaminase; Antiviral Agents; Biomarkers; Chi-Square Distribution; China; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; Humans; Kaplan-Meier Estimate; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Organophosphonates; Time Factors; Treatment Outcome; Viral Load

2013
De novo combined lamivudine and adefovir dipivoxil therapy vs entecavir monotherapy for hepatitis B virus-related decompensated cirrhosis.
    World journal of gastroenterology, 2013, Oct-07, Volume: 19, Issue:37

    Topics: Adenine; Adult; Alanine Transaminase; Analysis of Variance; Antiviral Agents; Biomarkers; Chi-Square Distribution; China; DNA, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Organophosphonates; Prospective Studies; Time Factors; Treatment Outcome

2013
Treatment of severe, nonfulminant acute hepatitis B with lamivudine vs placebo: a prospective randomized double-blinded multicentre trial.
    Journal of viral hepatitis, 2014, Volume: 21, Issue:10

    Topics: Adult; Alanine Transaminase; Antiviral Agents; Bilirubin; DNA, Viral; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Middle Aged; Placebos; Prospective Studies; Treatment Outcome

2014
Maintaining remission in lamivudine-resistant patients with a virological response to adefovir add-on lamivudine after stopping lamivudine therapy.
    Liver international : official journal of the International Association for the Study of the Liver, 2014, Volume: 34, Issue:10

    Topics: Adenine; Alanine Transaminase; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Organophosphonates; Polymerase Chain Reaction; Treatment Outcome; Ultrasonography; Viral Load

2014
Hepatitis B virus reactivation in hepatitis B surface antigen seropositive patients with metastatic non-small cell lung cancer receiving cytotoxic chemotherapy: the efficacy of preemptive lamivudine and identification of risk factors.
    Medical oncology (Northwood, London, England), 2014, Volume: 31, Issue:8

    Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome; Virus Activation

2014
Entecavir vs lamivudine for prevention of hepatitis B virus reactivation among patients with untreated diffuse large B-cell lymphoma receiving R-CHOP chemotherapy: a randomized clinical trial.
    JAMA, 2014, Dec-17, Volume: 312, Issue:23

    Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cyclophosphamide; Doxorubicin; Female; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Rituximab; Vincristine; Young Adult

2014
Covalently closed-circular hepatitis B virus DNA reduction with entecavir or lamivudine.
    World journal of gastroenterology, 2015, Apr-21, Volume: 21, Issue:15

    Topics: Adolescent; Adult; Aged; Antiviral Agents; Biomarkers; Biopsy; DNA, Circular; DNA, Viral; Double-Blind Method; Down-Regulation; Female; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Linear Models; Liver; Male; Middle Aged; Time Factors; Treatment Outcome; Viral Load; Young Adult

2015
Emergence of Lamivudine-Resistant HBV during Antiretroviral Therapy Including Lamivudine for Patients Coinfected with HIV and HBV in China.
    PloS one, 2015, Volume: 10, Issue:8

    Topics: Adolescent; Adult; Anti-Retroviral Agents; China; Coinfection; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Virus Replication; Young Adult

2015
A comparison of lamivudine vs entecavir for prophylaxis of hepatitis B virus reactivation in allogeneic hematopoietic stem cell transplantation recipients: a single-institutional experience.
    Bone marrow transplantation, 2016, Volume: 51, Issue:4

    Topics: Adolescent; Adult; Allografts; Female; Follow-Up Studies; Guanine; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Virus Activation

2016
Proportion and factors associated with Hepatitis B viremia in antiretroviral treatment naïve and experienced HIV co-infected Ghanaian patients.
    BMC infectious diseases, 2016, Jan-13, Volume: 16

    Topics: Adolescent; Adult; Anti-HIV Agents; Antiviral Agents; Coinfection; Cross-Sectional Studies; Female; Ghana; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Tenofovir; Viral Load; Viremia; Young Adult

2016
Evidence of long-term suppression of hepatitis B virus DNA by tenofovir as rescue treatment in patients coinfected by HIV.
    Antiviral therapy, 2008, Volume: 13, Issue:3

    Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; DNA Mutational Analysis; DNA, Viral; Drug Resistance, Viral; Female; Genotype; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Mutation; Organophosphonates; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Tenofovir; Time Factors; Treatment Outcome; Virus Replication

2008
[Lamivudine and adefovir dipivoxil combination treatment for liver cirrhosis patients with CHB].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2008, Volume: 16, Issue:6

    Topics: Adenine; Adult; Aged; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Organophosphonates

2008
A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in Thailand.
    Hepatology (Baltimore, Md.), 2008, Volume: 48, Issue:4

    Topics: Adenine; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; DNA, Viral; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Prospective Studies; Tenofovir; Thailand; Treatment Outcome; Zidovudine

2008
A randomized study of adefovir dipivoxil in place of HBIG in combination with lamivudine as post-liver transplantation hepatitis B prophylaxis.
    Hepatology (Baltimore, Md.), 2008, Volume: 48, Issue:5

    Topics: Adenine; Adult; Aged; Antiviral Agents; DNA, Viral; Female; Hepatitis B; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Patient Selection; Postoperative Complications; Viral Load

2008
[Effect of high viral hepatitis B virus DNA loads on vertical transmission of hepatitis B virus in late-pregnant women].
    Zhonghua fu chan ke za zhi, 2008, Volume: 43, Issue:5

    Topics: Administration, Oral; Adult; Antiviral Agents; DNA, Viral; Double-Blind Method; Female; Follow-Up Studies; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Viral Load

2008
Chemotherapy-induced Hepatitis B virus reactivation in HbsAg positive cancer patients: a single center experience.
    Medical oncology (Northwood, London, England), 2009, Volume: 26, Issue:4

    Topics: Anti-HIV Agents; Antineoplastic Agents; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Neoplasms; Retrospective Studies; Treatment Outcome; Virus Activation

2009
Efficacy and safety of adefovir dipivoxil plus pegylated interferon-alpha2a for the treatment of lamivudine-resistant hepatitis B virus infection in HIV-infected patients.
    Antiviral therapy, 2008, Volume: 13, Issue:7

    Topics: Adenine; Adult; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Male; Organophosphonates; Polyethylene Glycols; Recombinant Proteins; Reverse Transcriptase Inhibitors; Treatment Outcome

2008
Viral dynamics of hepatitis B virus DNA in human immunodeficiency virus-1-hepatitis B virus coinfected individuals: similar effectiveness of lamivudine, tenofovir, or combination therapy.
    Hepatology (Baltimore, Md.), 2009, Volume: 49, Issue:4

    Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Biopsy; DNA, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Immunosuppression Therapy; Lamivudine; Liver; Male; Middle Aged; Models, Biological; Organophosphonates; Prospective Studies; Tenofovir; Viral Load; Young Adult

2009
Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study.
    Journal of viral hepatitis, 2009, Volume: 16, Issue:2

    Topics: Adult; Antibodies, Viral; Antiviral Agents; Chemoprevention; Double-Blind Method; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Placebos; Pregnancy; Pregnancy Complications, Infectious; Treatment Outcome

2009
Early changes of hepatitis B virus quasispecies during lamivudine treatment and the correlation with antiviral efficacy.
    Journal of hepatology, 2009, Volume: 50, Issue:5

    Topics: Adult; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Phylogeny; RNA-Directed DNA Polymerase; Treatment Outcome

2009
Combination HBV therapy is linked to greater HBV DNA suppression in a cohort of lamivudine-experienced HIV/HBV coinfected individuals.
    AIDS (London, England), 2009, Aug-24, Volume: 23, Issue:13

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cross-Sectional Studies; DNA, Viral; Female; Genotype; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Mutation; Viral Load

2009
Lamivudine for the prevention of hepatitis B virus reactivation after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with advanced or relapsed non-Hodgkin's lymphoma single institution experience.
    Expert opinion on pharmacotherapy, 2009, Volume: 10, Issue:15

    Topics: Adult; Antineoplastic Agents; Combined Modality Therapy; Female; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Incidence; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prospective Studies; Reverse Transcriptase Inhibitors; Severity of Illness Index; Transplantation, Autologous; Young Adult

2009
Adefovir plus lamivudine are more effective than adefovir alone in lamivudine-resistant HBeAg- chronic hepatitis B patients: a 4-year study.
    Journal of gastroenterology and hepatology, 2010, Volume: 25, Issue:1

    Topics: Adenine; Adult; Aged; Alanine Transaminase; Antiviral Agents; Biomarkers; DNA, Viral; Drug Resistance, Multiple, Viral; Drug Therapy, Combination; Female; Genotype; Hepatitis B; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Time Factors; Treatment Outcome; Viral Load; Young Adult

2010
The study of efficacy of lamivudine in patients with severe acute hepatitis B.
    Digestive diseases and sciences, 2010, Volume: 55, Issue:3

    Topics: Acute Disease; Adult; Aged; Anti-HIV Agents; Bilirubin; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Failure; Male; Middle Aged; Proportional Hazards Models

2010
Hepatitis B virus reactivation and efficacy of prophylaxis with lamivudine in patients undergoing allogeneic stem cell transplantation.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2010, Volume: 16, Issue:6

    Topics: Adult; Aged; Blood Donors; DNA, Viral; Female; Graft vs Host Disease; Hematologic Neoplasms; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Stem Cell Transplantation; Survival Analysis; Transplantation, Homologous; Treatment Outcome; Virus Activation; Young Adult

2010
Hepatitus B virus reactivation in HBV-DNA negative and positive patients with hematological malignancies.
    Hematology (Amsterdam, Netherlands), 2010, Volume: 15, Issue:4

    Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antiviral Agents; DNA, Viral; Female; Hematologic Neoplasms; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Reverse Transcriptase Inhibitors; Risk Factors; Rituximab; Virus Activation

2010
[Analysis of the prophylactic effect of nucleosides against reactivation of HBV in HBsAg-positive patients with non-hepatic tumors after chemotherapy].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2010, Volume: 32, Issue:6

    Topics: Adult; Antineoplastic Agents; Antiviral Agents; Breast Neoplasms; Female; Follow-Up Studies; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Lung Neoplasms; Lymphoma; Male; Middle Aged; Nucleosides; Pyrimidinones; Retrospective Studies; Telbivudine; Thymidine; Virus Activation

2010
Preventing chemotherapy-induced hepatitis B reactivation in breast cancer patients: a prospective comparison of prophylactic versus deferred preemptive lamivudine.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2011, Volume: 19, Issue:11

    Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Chemotherapy, Adjuvant; Cohort Studies; DNA, Viral; Drug Administration Schedule; Feasibility Studies; Female; Hematologic Neoplasms; Hepatitis B; Hepatitis B Surface Antigens; Humans; Lamivudine; Male; Middle Aged; Prospective Studies; Retrospective Studies; Reverse Transcriptase Inhibitors; Time Factors; Virus Activation

2011
Comparison of entecavir and lamivudine in preventing hepatitis B reactivation in lymphoma patients during chemotherapy.
    Journal of viral hepatitis, 2011, Volume: 18, Issue:12

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antiviral Agents; Chemoprevention; China; Female; Guanine; Hepatitis B; Humans; Lamivudine; Lymphoma; Male; Middle Aged; Treatment Outcome; Virus Activation; Young Adult

2011
Partially randomized, non-blinded trial of DNA and MVA therapeutic vaccines based on hepatitis B virus surface protein for chronic HBV infection.
    PloS one, 2011, Feb-15, Volume: 6, Issue:2

    Topics: Adolescent; Adult; Antigens, Surface; Chronic Disease; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Immunity, Cellular; Interferon-gamma; Lamivudine; Male; Medication Adherence; Safety; Serologic Tests; Vaccination; Vaccines, DNA; Vaccinia virus; Viral Load; Viral Proteins; Young Adult

2011
A single-center, prospective and randomized controlled study: Can the prophylactic use of lamivudine prevent hepatitis B virus reactivation in hepatitis B s-antigen seropositive breast cancer patients during chemotherapy?
    Breast cancer research and treatment, 2011, Volume: 127, Issue:3

    Topics: Adult; Antineoplastic Agents; Antiviral Agents; Breast Neoplasms; Female; Hepatitis Antigens; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Function Tests; Middle Aged; Prospective Studies; Secondary Prevention; Treatment Outcome; Virus Activation

2011
Efficacy of peripartum antiviral treatment for hepatic failure due to hepatitis B virus.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2011, Volume: 114, Issue:1

    Topics: Adult; Antiviral Agents; DNA, Viral; Female; Guanine; Hepatitis B; Hepatitis B e Antigens; Humans; Infant, Newborn; Lamivudine; Liver Failure; Maternal Mortality; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Time Factors; Treatment Outcome; Uterine Diseases; Virus Replication; Young Adult

2011
HBV lamivudine resistance among hepatitis B and HIV coinfected patients starting lamivudine, stavudine and nevirapine in Kenya.
    Journal of viral hepatitis, 2011, Volume: 18, Issue:10

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; Humans; Kenya; Lamivudine; Male; Nevirapine; Stavudine; Treatment Outcome; Viral Load

2011
Long-term adefovir plus lamivudine therapy does not decrease creatinine clearance in HBeAg-negative chronic hepatitis B patients.
    Liver international : official journal of the International Association for the Study of the Liver, 2011, Volume: 31, Issue:10

    Topics: Adenine; Adult; Age Factors; Aged; Creatine; Drug Resistance, Viral; Drug Therapy, Combination; Female; Greece; Hepatitis B; Hepatitis B e Antigens; Humans; Kidney; Lamivudine; Linear Models; Male; Middle Aged; Organophosphonates

2011
Comparison of the efficacies of lamivudine versus entecavir in patients with hepatitis B virus-related decompensated cirrhosis.
    Liver international : official journal of the International Association for the Study of the Liver, 2012, Volume: 32, Issue:4

    Topics: Adult; Aged; Antiviral Agents; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Middle Aged; Multivariate Analysis; Republic of Korea; Viremia

2012
The efficacy and safety of antiviral therapy with lamivudine to stop the vertical transmission of hepatitis B virus.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2012, Volume: 31, Issue:9

    Topics: Adult; Alanine Transaminase; Antiviral Agents; Chemoprevention; Cohort Studies; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Humans; Immunotherapy; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies

2012
Treatment response and evolution of HBV resistance during lamivudine plus adefovir or entecavir therapy in patients with adefovir-resistant mutants.
    Antiviral therapy, 2012, Volume: 17, Issue:4

    Topics: Adenine; Adult; Aged; Antiviral Agents; Base Sequence; Cloning, Molecular; DNA, Viral; Drug Administration Schedule; Drug Resistance, Viral; Drug Therapy, Combination; Female; Genotype; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates

2012
Safety and efficacy of subcutaneous hepatitis B immunoglobulin after liver transplantation: an open single-arm prospective study.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2013, Volume: 13, Issue:2

    Topics: Adult; Aged; Antiviral Agents; Cohort Studies; Female; Hepatitis B; Humans; Immunoglobulins; Injections, Subcutaneous; Lamivudine; Liver Transplantation; Male; Middle Aged; Prospective Studies; Quality of Life; Self Administration; Treatment Outcome

2013
Adding adefovir vs. switching to entecavir for lamivudine-resistant chronic hepatitis B (ACE study): a 2-year follow-up randomized controlled trial.
    Liver international : official journal of the International Association for the Study of the Liver, 2013, Volume: 33, Issue:2

    Topics: Adenine; Adult; Analysis of Variance; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Follow-Up Studies; Guanine; Hepatitis B; Hepatitis B, Chronic; Humans; Immunoassay; Lamivudine; Male; Middle Aged; Oligonucleotides; Organophosphonates; Prospective Studies; Republic of Korea; Reverse Transcriptase Inhibitors; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Treatment Outcome

2013
[Lamivudine as prophylaxis against hepatitis B virus reinfection following orthotopic liver transplantation].
    Zhonghua yi xue za zhi, 2002, Apr-10, Volume: 82, Issue:7

    Topics: Adult; Antiviral Agents; Chemoprevention; DNA, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Male; Postoperative Complications

2002
Lamivudine and famciclovir combination therapy with or without addition of interferon-alpha-2b for HBeAg-positive chronic hepatitis B: a pilot study.
    Scandinavian journal of infectious diseases, 2002, Volume: 34, Issue:7

    Topics: 2-Aminopurine; Adult; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Famciclovir; Female; Hepatitis B; Hepatitis B e Antigens; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Male; Middle Aged; Pilot Projects; Recombinant Proteins

2002
Oral ganciclovir for treatment of lamivudine-resistant hepatitis B virus infection: a pilot study.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, Oct-15, Volume: 35, Issue:8

    Topics: Administration, Oral; Adult; Anti-HIV Agents; Antiviral Agents; Drug Resistance, Viral; Female; Ganciclovir; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Pilot Projects

2002
Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients.
    Hepatology (Baltimore, Md.), 2002, Volume: 36, Issue:5

    Topics: Adult; DNA, Viral; Drug Resistance, Viral; Female; Graft Survival; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Kidney Transplantation; Lamivudine; Male; Middle Aged; Postoperative Complications; Prospective Studies; Recurrence; Reverse Transcriptase Inhibitors; Transplantation, Homologous; Treatment Outcome; Virus Replication

2002
Efficacy of lamivudine therapy for advanced liver disease in patients with precore mutant hepatitis B virus infection awaiting liver transplantation.
    Transplantation, 2002, Oct-27, Volume: 74, Issue:8

    Topics: Alanine Transaminase; Cohort Studies; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Mutation; Preoperative Care; Reverse Transcriptase Inhibitors; Severity of Illness Index; Virus Replication; Waiting Lists

2002
[Therapeutic efficacy of lamivudine in patients with hepatitis B virus-related decompensated cirrhosis in Korea].
    Taehan Kan Hakhoe chi = The Korean journal of hepatology, 2002, Volume: 8, Issue:4

    Topics: Adult; Antiviral Agents; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged

2002
Lamivudine therapy in renal allograft recipients with hepatitis B virus infection.
    Transplantation proceedings, 2003, Volume: 35, Issue:1

    Topics: Adult; Antiviral Agents; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunosuppressive Agents; Kidney Transplantation; Lamivudine; Male; Postoperative Complications; Recurrence; Retrospective Studies; Reverse Transcriptase Inhibitors; Virus Activation

2003
[Effect of single-using or combined-using lamivudine/interferon-alpha 1b on serum markers in patients with hepatitis B].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2003, Volume: 11, Issue:2

    Topics: Adolescent; Adult; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B e Antigens; Humans; Interferon-alpha; Lamivudine; Male; Middle Aged

2003
A randomized study comparing lamivudine monotherapy after a short course of hepatitis B immune globulin (HBIg) and lamivudine with long-term lamivudine plus HBIg in the prevention of hepatitis B virus recurrence after liver transplantation.
    Journal of hepatology, 2003, Volume: 38, Issue:6

    Topics: Adolescent; Adult; Aged; Drug Administration Schedule; Drug Costs; Drug Therapy, Combination; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Middle Aged; Postoperative Care; Reverse Transcriptase Inhibitors; Secondary Prevention; Treatment Outcome; Virus Replication

2003
Interruption of HBV intrauterine transmission: a clinical study.
    World journal of gastroenterology, 2003, Volume: 9, Issue:7

    Topics: Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Humans; Immunoglobulins; Incidence; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy

2003
Trial of lamivudine in hepatitis B surface antigen carriers with persistent hepatitis B core IgM antibody.
    Saudi medical journal, 2003, Volume: 24, Issue:9

    Topics: Adult; Carrier State; Enzyme-Linked Immunosorbent Assay; Female; Headache; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulin M; Iraq; Lamivudine; Male; Middle Aged; Nausea; Reverse Transcriptase Inhibitors; Treatment Outcome

2003
Reconstitution of hepatitis B virus (HBV)-specific T cell responses with treatment of human immunodeficiency virus/HBV coinfection.
    The Journal of infectious diseases, 2003, Dec-15, Volume: 188, Issue:12

    Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; CD4 Lymphocyte Count; CD4-CD8 Ratio; Hepatitis B; Hepatitis B virus; HIV Seropositivity; HIV-1; Humans; Lamivudine; Species Specificity; T-Lymphocytes; Viral Load

2003
Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy.
    Gastroenterology, 2003, Volume: 125, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; DNA, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Time Factors; Virus Activation

2003
Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004, Mar-01, Volume: 22, Issue:5

    Topics: Adult; Age Distribution; Aged; Carrier State; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Incidence; Lamivudine; Male; Middle Aged; Neoplasm Staging; Neoplasms; Primary Prevention; Probability; Prognosis; Reference Values; Risk Assessment; Secondary Prevention; Serologic Tests; Sex Distribution; Survival Analysis; Treatment Outcome

2004
Lamivudine prophylaxis for prevention of chemotherapy-induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies.
    Journal of viral hepatitis, 2004, Volume: 11, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Carrier State; DNA, Viral; Female; Hematologic Neoplasms; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged

2004
No benefit to continue lamivudine therapy after emergence of YMDD mutations.
    Antiviral therapy, 2004, Volume: 9, Issue:2

    Topics: Adolescent; Adult; Amino Acid Motifs; Antiviral Agents; Drug Administration Schedule; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Treatment Outcome

2004
Lamivudine facilitates optimal chemotherapy in hepatitis B virus-infected children with hematological malignancies: a preliminary report.
    Pediatric hematology and oncology, 2004, Volume: 21, Issue:2

    Topics: Adolescent; Antineoplastic Agents; Antiviral Agents; Child; Child, Preschool; Drug Synergism; Female; Hematologic Neoplasms; Hepatitis B; Humans; Immunosuppression Therapy; Lamivudine; Male; Remission Induction; Treatment Outcome; Virus Activation

2004
Short-term corticosteroids then lamivudine and plasma exchanges to treat hepatitis B virus-related polyarteritis nodosa.
    Arthritis and rheumatism, 2004, Jun-15, Volume: 51, Issue:3

    Topics: Administration, Oral; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Drug Administration Schedule; Female; Hepatitis B; Humans; Lamivudine; Male; Methylprednisolone; Plasma Exchange; Polyarteritis Nodosa; Prednisone; Reverse Transcriptase Inhibitors; Treatment Outcome

2004
A three-month course of lamivudine therapy in HBeAg-positive hepatitis B patients with normal aminotransferase levels.
    The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2004, Volume: 15, Issue:1

    Topics: Adolescent; Adult; DNA, Viral; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Function Tests; Male; Polymerase Chain Reaction; Probability; Prospective Studies; Severity of Illness Index; Statistics, Nonparametric; Transaminases; Treatment Outcome; Viral Load

2004
High risk of hepatocellular carcinoma in anti-HBe positive liver cirrhosis patients developing lamivudine resistance.
    Journal of viral hepatitis, 2004, Volume: 11, Issue:5

    Topics: Adult; Carcinoma, Hepatocellular; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Mutation; Reverse Transcriptase Inhibitors; Risk Assessment

2004
Ninety-six-week efficacy of combination therapy with lamivudine and tenofovir in patients coinfected with HIV-1 and wild-type hepatitis B virus.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Oct-01, Volume: 39, Issue:7

    Topics: Adenine; Adult; Anti-HIV Agents; Drug Therapy, Combination; Female; Hepatitis B; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Tenofovir

2004
The management of hepatitis B virus/HIV-1 co-infected patients starting their first HAART regimen. Treating two infections for the price of one drug?
    Antiviral therapy, 2004, Volume: 9, Issue:5

    Topics: Adult; Alanine Transaminase; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Aspartate Aminotransferases; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Liver; Male; Prospective Studies; Reverse Transcriptase Inhibitors; Treatment Outcome

2004
Lamivudine treatment for acute severe hepatitis B: a pilot study.
    Liver international : official journal of the International Association for the Study of the Liver, 2004, Volume: 24, Issue:6

    Topics: Acute Disease; Adult; DNA, Viral; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Hepatitis B; Humans; Immunocompromised Host; Lamivudine; Male; Pilot Projects; Polymerase Chain Reaction; Risk Assessment; Severity of Illness Index; Treatment Outcome

2004
Lamivudine in prevention and treatment of recurrent HBV after liver transplantation.
    Hepatobiliary & pancreatic diseases international : HBPD INT, 2004, Volume: 3, Issue:4

    Topics: Adult; Female; Follow-Up Studies; Hepatitis B; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Reverse Transcriptase Inhibitors; Secondary Prevention; Treatment Outcome

2004
Efficacy of lamivudine treatment in Japanese patients with hepatitis B virus-related cirrhosis.
    Journal of gastroenterology, 2004, Volume: 39, Issue:11

    Topics: Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Mutation; Time Factors

2004
Low-dose hepatitis B immune globulin and higher-dose lamivudine combination to prevent hepatitis B virus recurrence after liver transplantation.
    Antiviral therapy, 2004, Volume: 9, Issue:6

    Topics: Adolescent; Adult; Combined Modality Therapy; DNA, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Immunoglobulins, Intravenous; Lamivudine; Liver Transplantation; Male; Middle Aged; Reverse Transcriptase Inhibitors; Secondary Prevention; Treatment Outcome

2004
Genotypic resistance of hepatitis B virus to lamivudine in renal transplant recipients.
    Transplantation proceedings, 2005, Volume: 37, Issue:2

    Topics: Adult; Base Sequence; DNA Primers; DNA, Viral; Drug Resistance, Viral; Female; Genotype; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Kidney Transplantation; Lamivudine; Male; Mutation

2005
[Anti-viral therapy using lamivudine and thymosin is helpful to prevent recurrence in hepatocellular carcinoma with coexisting active hepatitis B].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2005, Volume: 27, Issue:2

    Topics: Adult; Aged; Carcinoma, Hepatocellular; DNA, Viral; Female; Hepatectomy; Hepatitis B; Humans; Lamivudine; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Postoperative Period; Reverse Transcriptase Inhibitors; Survival Rate; Thymalfasin; Thymosin

2005
Character of HBV (hepatitis B virus) polymerase gene rtM204V/I and rtL180M mutation in patients with lamivudine resistance.
    Journal of Zhejiang University. Science. B, 2005, Volume: 6, Issue:7

    Topics: China; DNA Mutational Analysis; DNA, Viral; Drug Resistance, Viral; Gene Products, pol; Genetic Predisposition to Disease; Genetic Testing; Hepatitis B; Hepatitis B virus; Humans; Incidence; Lamivudine; Polymorphism, Genetic; Risk Assessment; Risk Factors

2005
Prevention of hepatitis B virus reactivation in patients with nasopharyngeal carcinoma with lamivudine.
    American journal of clinical oncology, 2005, Volume: 28, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Carrier State; Cisplatin; Female; Hepatitis B; Hepatitis B virus; Humans; Incidence; Lamivudine; Male; Middle Aged; Nasopharyngeal Neoplasms; Radiotherapy, Adjuvant; Virus Activation

2005
Timing of lamivudine administration according to Child class in patients with decompensated cirrhosis.
    Journal of gastroenterology and hepatology, 2005, Volume: 20, Issue:10

    Topics: Adult; DNA, Viral; Drug Administration Schedule; Female; Follow-Up Studies; Genetic Variation; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Reverse Transcriptase Inhibitors; Severity of Illness Index; Treatment Outcome

2005
Adefovir dipivoxil alone or in combination with ongoing lamivudine in patients with decompensated liver disease and lamivudine-resistant hepatitis B virus.
    Journal of Korean medical science, 2005, Volume: 20, Issue:5

    Topics: Adenine; Adolescent; Adult; Anti-HIV Agents; Antiviral Agents; Drug Combinations; Drug Resistance, Viral; Female; Hepatitis B; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Organophosphonates; Treatment Outcome

2005
Prevention of hepatitis B reactivation with lamivudine in hepatitis B virus carriers with hematologic malignancies treated with chemotherapy--a prospective case series.
    American journal of hematology, 2005, Volume: 80, Issue:3

    Topics: Adrenal Cortex Hormones; Adult; Aged; Antineoplastic Agents; DNA, Viral; Drug Therapy, Combination; Female; Hematologic Neoplasms; Hepatitis B; Hepatitis B virus; Humans; Immunosuppressive Agents; Lamivudine; Male; Middle Aged; Premedication; Prospective Studies; Serologic Tests; Treatment Outcome; Virus Activation

2005
Lamivudine treatment in patients with HBV-related hepatocellular carcinoma--using an untreated, matched control cohort.
    Acta medica Okayama, 2005, Volume: 59, Issue:5

    Topics: Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; Female; Hepatitis B; Humans; Lamivudine; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local

2005
Pegylated interferon and ribavirin for the recurrence of chronic hepatitis C genotype 1 in transplant patients.
    Transplantation proceedings, 2005, Volume: 37, Issue:9

    Topics: Adult; Antiviral Agents; Biopsy; Female; Hepatitis B; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Transplantation; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Recurrence; Ribavirin; Treatment Outcome

2005
Extended lamivudine therapy against hepatitis B virus infection in hematopoietic stem cell transplant recipients.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2006, Volume: 12, Issue:1

    Topics: Adult; Antiviral Agents; Drug Resistance; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Premedication; Viral Load; Virus Activation

2006
Lamivudine prophylaxis reduces the incidence and severity of hepatitis in hepatitis B virus carriers who receive chemotherapy for lymphoma.
    Cancer, 2006, Mar-15, Volume: 106, Issue:6

    Topics: Administration, Oral; Adolescent; Adult; Aged; Anthracyclines; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Dose-Response Relationship, Drug; Female; Hepatitis B; Hepatitis B virus; Hodgkin Disease; Humans; Incidence; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Primary Prevention; Prognosis; Survival Rate; Treatment Outcome

2006
Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience.
    Journal of viral hepatitis, 2006, Volume: 13, Issue:4

    Topics: Adult; Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; Bilirubin; DNA, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Failure, Acute; Male; Middle Aged; Prothrombin Time

2006
A multiphase model of the dynamics of HBV infection in HBeAg-negative patients during pegylated interferon-alpha2a, lamivudine and combination therapy.
    Antiviral therapy, 2006, Volume: 11, Issue:2

    Topics: Antiviral Agents; DNA, Viral; Double-Blind Method; Drug Therapy, Combination; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Models, Biological; Polyethylene Glycols; Recombinant Proteins; Time Factors; Viral Load

2006
Changes in viral loads of lamivudine-resistant mutants and evolution of HBV sequences during adefovir dipivoxil therapy.
    Journal of medical virology, 2006, Volume: 78, Issue:8

    Topics: Adenine; Adult; Antiviral Agents; Drug Administration Schedule; Drug Resistance, Viral; Evolution, Molecular; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Viral; Hepatitis B; Hepatitis B virus; Humans; Interferons; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; RNA-Directed DNA Polymerase; Viral Load

2006
The effectiveness of lamivudine treatment in cirrhotic patients with HBV precore mutations: a prospective, open-label study.
    Digestive diseases and sciences, 2006, Volume: 51, Issue:7

    Topics: Adult; Aged; Antiviral Agents; Biomarkers; DNA, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Mutation; Prospective Studies; Reverse Transcriptase Inhibitors; Severity of Illness Index; Survival Analysis; Treatment Outcome; Virus Replication

2006
Lamivudine and high-dose interferon alpha 2a combination treatment in naïve HBeAg-positive immunoactive chronic hepatitis B in children: an East Mediterranean center's experience.
    European journal of pediatrics, 2007, Volume: 166, Issue:3

    Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B e Antigens; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Male; Recombinant Proteins; Reverse Transcriptase Inhibitors; Treatment Outcome; Turkey

2007
A prospective study on chemotherapy-induced hepatitis B virus reactivation in chronic HBs Ag carriers with hematologic malignancies and pre-emptive therapy with nucleoside analogues.
    Leukemia & lymphoma, 2006, Volume: 47, Issue:8

    Topics: 2-Aminopurine; Adult; Aged; Antineoplastic Agents; Antiviral Agents; Chronic Disease; Famciclovir; Female; Hematologic Neoplasms; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Nucleosides; Pilot Projects; Prospective Studies; Virus Activation

2006
Sequential treatment with lamivudine and interferon-alpha monotherapies in hepatitis B e antigen-negative Chinese patients and its suppression of lamivudine-resistant mutations.
    The Journal of antimicrobial chemotherapy, 2006, Volume: 58, Issue:5

    Topics: Adult; Antiviral Agents; China; Drug Administration Schedule; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Male; Middle Aged; Recombinant Proteins; Reverse Transcriptase Inhibitors

2006
Two-year assessment of entecavir resistance in Lamivudine-refractory hepatitis B virus patients reveals different clinical outcomes depending on the resistance substitutions present.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:3

    Topics: Antiviral Agents; Cells, Cultured; DNA-Directed DNA Polymerase; DNA, Viral; Double-Blind Method; Drug Resistance, Viral; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutation; Plasmids; Treatment Outcome; Virus Replication

2007
A randomized controlled trial of lamivudine to treat acute hepatitis B.
    Hepatology (Baltimore, Md.), 2007, Volume: 45, Issue:1

    Topics: Acute Disease; Adolescent; Adult; Aged; Bilirubin; Child; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Immunocompetence; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; Treatment Outcome

2007
Active immunization to prevent de novo hepatitis B virus infection in pediatric live donor liver recipients.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2007, Volume: 7, Issue:1

    Topics: Child; Child, Preschool; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Vaccines; Humans; Infant; Lamivudine; Liver Transplantation; Living Donors; Male; Treatment Outcome; Vaccination

2007
Efficacy of adefovir dipivoxil in the treatment of lamivudine-resistant hepatitis B virus genotype C infection.
    Liver international : official journal of the International Association for the Study of the Liver, 2007, Volume: 27, Issue:1

    Topics: Adenine; Adult; Aged; Antiviral Agents; Drug Administration Schedule; Drug Resistance, Viral; Female; Genotype; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Organophosphonates

2007
Short-term high-dose followed by long-term low-dose hepatitis B immunoglobulin and lamivudine therapy prevented recurrent hepatitis B after liver transplantation.
    Transplantation, 2007, Jan-27, Volume: 83, Issue:2

    Topics: Dose-Response Relationship, Drug; Follow-Up Studies; Hepatitis B; Hepatitis B Antigens; Hepatitis B virus; Humans; Immunoglobulins; Immunotherapy; Lamivudine; Liver Transplantation; Secondary Prevention; Time Factors

2007
Treatment of hepatitis B with lamivudine and tenofovir in HIV/HBV-coinfected patients: factors associated with response.
    Journal of viral hepatitis, 2007, Volume: 14, Issue:3

    Topics: Adenine; Adult; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Genotype; Hepatitis B; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Tenofovir; Viral Load

2007
Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: final long-term results.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2007, Volume: 13, Issue:3

    Topics: Adenine; Adult; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; Humans; Kidney Diseases; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Prospective Studies; Secondary Prevention; Waiting Lists

2007
[The study of the different medicating ways and the formula for intravenous loading dosage of hepatitis B immunoglobulin in liver transplantation].
    Zhonghua wai ke za zhi [Chinese journal of surgery], 2006, Nov-01, Volume: 44, Issue:21

    Topics: Alanine Transaminase; Antiviral Agents; Combined Modality Therapy; Drug Therapy, Combination; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Linear Models; Liver Transplantation; Secondary Prevention; Treatment Outcome

2006
[Lamivudine therapy in patients with severe acute hepatitis B].
    Klinicka mikrobiologie a infekcni lekarstvi, 2007, Volume: 13, Issue:2

    Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Female; Hepatitis B; Humans; Lamivudine; Male; Middle Aged

2007
Hepatitis B vaccination after living donor liver transplantation.
    Liver international : official journal of the International Association for the Study of the Liver, 2007, Volume: 27, Issue:7

    Topics: Adult; Antiviral Agents; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Vaccines; Humans; Immunization Schedule; Immunization, Passive; Immunoglobulins; Lamivudine; Liver; Liver Transplantation; Living Donors; Male; Prospective Studies; Time Factors; Treatment Outcome

2007
Adherence to Lamivudine after an early withdrawal of hepatitis B immune globulin plays an important role in the long-term prevention of hepatitis B virus recurrence.
    Transplantation, 2007, Sep-15, Volume: 84, Issue:5

    Topics: Disease-Free Survival; Female; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Secondary Prevention; Time Factors

2007
Low resistance to adefovir combined with lamivudine: a 3-year study of 145 lamivudine-resistant hepatitis B patients.
    Gastroenterology, 2007, Volume: 133, Issue:5

    Topics: Adenine; Adult; Aged; Antiviral Agents; Disease Progression; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Longitudinal Studies; Male; Middle Aged; Organophosphonates; Risk Factors; Survival Analysis; Treatment Outcome

2007
[Liver transplantation for chronic hepatitis B patients with lamivudine monotherapy or lamivudine combined with individualized low-dose hepatitis B immunoglobulin treatment].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2007, Volume: 15, Issue:11

    Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Secondary Prevention

2007
[A clinical analysis of HBV reactivation in patients with malignant tumors].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2007, Volume: 15, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Carrier State; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Neoplasms; Virus Activation

2007
Effects of antiviral agents and HBV genotypes on intrahepatic covalently closed circular DNA in HBeAg-positive chronic hepatitis B patients.
    World journal of gastroenterology, 2008, Feb-28, Volume: 14, Issue:8

    Topics: Adult; Antiviral Agents; DNA, Circular; Female; Gene Expression Regulation; Genotype; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Male; Middle Aged; Recombinant Proteins; Time Factors

2008
A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: a randomized trial.
    Hepatology (Baltimore, Md.), 2008, Volume: 47, Issue:3

    Topics: Adult; Aged; Antiviral Agents; Female; Hepatitis B; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Secondary Prevention; Survival Analysis; Treatment Outcome

2008
Lamivudine compared with lamivudine and adefovir dipivoxil for the treatment of HBeAg-positive chronic hepatitis B.
    Journal of hepatology, 2008, Volume: 48, Issue:5

    Topics: Adenine; Adolescent; Adult; Aged; Alanine Transaminase; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Female; Genotype; Hepatitis B; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates

2008
The long-term effects of lamivudine treatment in patients with HBeAg-negative liver cirrhosis.
    Advances in therapy, 2008, Volume: 25, Issue:3

    Topics: Adult; Aged; Anti-HIV Agents; Female; Hepatitis B; Hepatitis B e Antigens; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged

2008
Correlation of quantitative assay of HBsAg and HBV DNA levels during chronic HBV treatment.
    Digestive diseases and sciences, 2008, Volume: 53, Issue:11

    Topics: Adult; Antiviral Agents; Biomarkers; DNA, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoassay; Interferon alpha-2; Interferon-alpha; Lamivudine; Male; Polyethylene Glycols; Recombinant Proteins; Viral Load

2008
Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation.
    Gastroenterology, 2008, Volume: 134, Issue:7

    Topics: Adenine; Adolescent; Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; DNA, Circular; DNA, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Immunohistochemistry; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Organophosphonates; Polymerase Chain Reaction; Risk Assessment; Risk Factors; Secondary Prevention; Sequence Analysis, DNA; Time Factors; Treatment Outcome; Viral Load; Virus Replication

2008
Hepatitis B immunoglobulin and Lamivudine improve hepatitis B-related outcomes after liver transplantation: meta-analysis.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2008, Volume: 6, Issue:6

    Topics: Adult; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Orthohepadnavirus; Secondary Prevention; Treatment Outcome

2008
Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis-B surface antigen (HBSAG) seropositive cancer patients undergoing cytotoxic chemotherapy.
    Leukemia & lymphoma, 2008, Volume: 49, Issue:5

    Topics: Adult; Antineoplastic Agents; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Neoplasms; Prevalence; Treatment Outcome; Virus Activation

2008
A preliminary trial of lamivudine for chronic hepatitis B infection.
    The New England journal of medicine, 1995, Dec-21, Volume: 333, Issue:25

    Topics: Adolescent; Adult; Aged; Alanine Transaminase; Antiviral Agents; Chronic Disease; DNA, Viral; Double-Blind Method; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; Zalcitabine

1995
Efficacy of lamivudine on replication of hepatitis B virus in HIV-infected patients.
    Lancet (London, England), 1995, Feb-11, Volume: 345, Issue:8946

    Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Virus Replication; Zalcitabine

1995
Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis.
    Lancet (London, England), 1996, Nov-02, Volume: 348, Issue:9036

    Topics: DNA, Viral; Fibrosis; Hepatitis B; Hepatitis B Surface Antigens; Humans; Lamivudine; Liver Failure; Liver Transplantation; Recurrence

1996
Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: a placebo-controlled trial.
    Hepatology (Baltimore, Md.), 1997, Volume: 25, Issue:1

    Topics: Adolescent; Adult; Antiviral Agents; Carrier State; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Single-Blind Method

1997
[Therapy of chronic hepatitis B virus infection with the nucleoside analog lamivudine].
    Zeitschrift fur Gastroenterologie, 1996, Volume: 34, Issue:12

    Topics: Administration, Oral; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Hepatitis B; Hepatitis, Chronic; Humans; Lamivudine; Reverse Transcriptase Inhibitors

1996
Histological improvement in patients with chronic hepatitis B virus infection treated with lamivudine.
    Liver, 1997, Volume: 17, Issue:2

    Topics: Adolescent; Adult; Antiviral Agents; Chronic Disease; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver; Male; Middle Aged

1997
Effect of lamivudine on morphology and function of mitochondria in patients with chronic hepatitis B.
    Hepatology (Baltimore, Md.), 1997, Volume: 26, Issue:1

    Topics: Adult; Biopsy; Breath Tests; Chronic Disease; Female; Hepatitis B; Humans; Lamivudine; Liver; Liver Diseases, Alcoholic; Male; Microscopy, Electron; Middle Aged; Mitochondria, Liver

1997
Lamivudine therapy for chronic hepatitis B: a six-month randomized dose-ranging study.
    Gastroenterology, 1997, Volume: 113, Issue:4

    Topics: Adult; Alanine Transaminase; Antiviral Agents; Asia; DNA, Viral; Dose-Response Relationship, Drug; Ethnicity; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Reverse Transcriptase Inhibitors; Time Factors

1997
Efficacy and safety of lamivudine on replication of recurrent hepatitis B after cadaveric renal transplantation.
    Transplantation, 1997, Dec-15, Volume: 64, Issue:11

    Topics: Antiviral Agents; Cyclosporine; Female; Hepatitis B; Hepatitis B virus; Humans; Immunosuppressive Agents; Kidney Transplantation; Lamivudine; Liver Function Tests; Male; Middle Aged; Pilot Projects; Virus Replication

1997
Quantitative assessment of hepatitis B virus DNA during a 24-week course of lamivudine therapy.
    Annals of internal medicine, 1998, Apr-15, Volume: 128, Issue:8

    Topics: Antiviral Agents; DNA, Viral; Drug Administration Schedule; Hepatitis B; Humans; Lamivudine; Polymerase Chain Reaction

1998
Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B.
    The Journal of clinical investigation, 1998, Sep-01, Volume: 102, Issue:5

    Topics: Adult; Antiviral Agents; CD4-Positive T-Lymphocytes; Cell Division; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis, Chronic; Humans; Lamivudine; Male

1998
High pre-treatment serum hepatitis B virus titre predicts failure of lamivudine prophylaxis and graft re-infection after liver transplantation.
    Journal of hepatology, 1999, Volume: 30, Issue:4

    Topics: Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Polymerase Chain Reaction; Prognosis; Recurrence; Treatment Failure; Virus Replication

1999
Multicenter study of lamivudine therapy for hepatitis B after liver transplantation. Lamivudine Transplant Group.
    Hepatology (Baltimore, Md.), 1999, Volume: 29, Issue:5

    Topics: Adult; Aged; Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver; Liver Transplantation; Male; Middle Aged; Postoperative Complications

1999
Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy.
    Hepatology (Baltimore, Md.), 1999, Volume: 30, Issue:2

    Topics: Adolescent; Adult; Alanine Transaminase; Antiviral Agents; Conserved Sequence; DNA, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation

1999
Dual efficacy of lamivudine treatment in human immunodeficiency virus/hepatitis B virus-coinfected persons in a randomized, controlled study (CAESAR). The CAESAR Coordinating Committee.
    The Journal of infectious diseases, 1999, Volume: 180, Issue:3

    Topics: Acetamides; Acetophenones; Adult; Aged; Anti-HIV Agents; Antiviral Agents; Disease Progression; Disease-Free Survival; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Placebos; Retrospective Studies; Time Factors

1999
A study of the pharmacokinetic interaction between lamivudine and alpha interferon.
    European journal of clinical pharmacology, 2000, Volume: 56, Issue:4

    Topics: Adult; Anti-HIV Agents; Antiviral Agents; Area Under Curve; Drug Combinations; Half-Life; Hepatitis B; Humans; Interferon-alpha; Lamivudine; Male; Metabolic Clearance Rate

2000
Lamivudine as first- and second-line treatment of hepatitis B infection after liver transplantation.
    Transplant international : official journal of the European Society for Organ Transplantation, 2000, Volume: 13, Issue:4

    Topics: 2-Aminopurine; Anti-HIV Agents; Antiviral Agents; Famciclovir; Hepatitis B; Hepatitis B virus; HIV; Humans; Lamivudine; Liver; Liver Transplantation; Prospective Studies; Reverse Transcriptase Inhibitors

2000
Twelve months of lamivudine treatment for chronic hepatitis B virus infection in renal transplant recipients.
    Transplantation, 2000, Nov-15, Volume: 70, Issue:9

    Topics: Adult; Anti-HIV Agents; Chronic Disease; DNA, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Kidney Transplantation; Lamivudine; Liver; Male; Middle Aged; Prospective Studies; Reverse Transcriptase Inhibitors; Time Factors

2000
Results on preemptive or prophylactic treatment of lamivudine in HBsAg (+) renal allograft recipients: comparison with salvage treatment after hepatic dysfunction with HBV recurrence.
    Transplantation, 2001, Feb-15, Volume: 71, Issue:3

    Topics: DNA, Viral; Female; Graft Rejection; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Kidney Transplantation; Lamivudine; Liver Diseases; Male; Recurrence; Reverse Transcriptase Inhibitors; Salvage Therapy

2001
Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantation.
    Journal of hepatology, 2001, Volume: 34, Issue:6

    Topics: Adult; Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver; Liver Transplantation; Male; Middle Aged; Mutation; Recurrence

2001
Lamivudine is effective for the treatment of reactivation of hepatitis B virus and fulminant hepatic failure in renal transplant recipients.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2001, Volume: 38, Issue:5

    Topics: Adolescent; Adult; Alanine Transaminase; Anti-Inflammatory Agents; Antilymphocyte Serum; Bilirubin; DNA, Viral; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Kidney Transplantation; Lamivudine; Liver Failure; Male; Methylprednisolone; Middle Aged; Prothrombin Time; Treatment Outcome; Virus Activation

2001
Failure of a reinforced triple course of hepatitis B vaccination in patients transplanted for HBV-related cirrhosis.
    Hepatology (Baltimore, Md.), 2002, Volume: 35, Issue:1

    Topics: Adult; DNA, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Polymerase Chain Reaction; Treatment Failure; Vaccines, Synthetic

2002
Hepatitis B viral genotypes and lamivudine resistance.
    Journal of hepatology, 2002, Volume: 36, Issue:2

    Topics: Adult; Drug Resistance, Viral; Female; Genotype; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Reverse Transcriptase Inhibitors

2002
[Prevention and treatment of HBV reinfection following liver transplantation].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2002, Volume: 10, Issue:1

    Topics: 2-Aminopurine; Adult; Antiviral Agents; Biopsy; DNA, Viral; Drug Combinations; Famciclovir; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Postoperative Care; Preoperative Care; Recurrence

2002
Is lamivudine with 1-week HBlg as effective as long-term high-dose HBlg in HBV prophylaxis after liver transplantation?
    Transplantation proceedings, 2002, Volume: 34, Issue:4

    Topics: Adult; Disease-Free Survival; Drug Administration Schedule; Female; Follow-Up Studies; Hepatitis B; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Prospective Studies; Recurrence; Retrospective Studies; Reverse Transcriptase Inhibitors; Survival Rate; Time Factors

2002
Lamivudine therapy for prevention of immunosuppressive-induced hepatitis B virus reactivation in hepatitis B surface antigen carriers.
    Blood, 2002, Jul-15, Volume: 100, Issue:2

    Topics: Adolescent; Adult; Aged; Antiviral Agents; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunocompromised Host; Immunosuppressive Agents; Lamivudine; Liver Function Tests; Male; Middle Aged; Opportunistic Infections; Treatment Outcome; Virus Activation

2002

Other Studies

832 other study(ies) available for lamivudine and Hepatitis B Virus Infection

ArticleYear
Isolation and biological evaluation of filiformin, plakortide F, and plakortone G from the Caribbean sponge Plakortis sp.
    Journal of natural products, 2001, Volume: 64, Issue:11

    Topics: Animals; Antimalarials; Bromobenzenes; Chromatography, High Pressure Liquid; Colonic Neoplasms; Dioxanes; Gas Chromatography-Mass Spectrometry; Hepatitis B; HIV; Humans; Jamaica; Lactones; Leukemia P388; Lung Neoplasms; Mice; Molecular Structure; Mycobacterium tuberculosis; Neoplasms, Unknown Primary; Nuclear Magnetic Resonance, Biomolecular; Plasmodium berghei; Plasmodium falciparum; Porifera; Spectrometry, Mass, Electrospray Ionization; Tumor Cells, Cultured

2001
Synthesis and in vitro anti-hepatitis B and C virus activities of ring-expanded ('fat') nucleobase analogues containing the imidazo[4,5-e][1,3]diazepine-4,8-dione ring system.
    Bioorganic & medicinal chemistry letters, 2005, Dec-15, Volume: 15, Issue:24

    Topics: Antiviral Agents; Benzazepines; Hepacivirus; Hepatitis B; Hepatitis B virus; Hepatitis C; Humans; Imidazoles; Nucleosides; Virion

2005
Synthesis and in vitro anti-hepatitis B virus activities of 4-aryl-6-chloro-quinolin-2-one and 5-aryl-7-chloro-1,4-benzodiazepine derivatives.
    Bioorganic & medicinal chemistry letters, 2008, Jul-01, Volume: 18, Issue:13

    Topics: Antiviral Agents; Benzodiazepines; Cell Line, Tumor; Chemistry, Pharmaceutical; Chlorine; Drug Design; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; In Vitro Techniques; Inhibitory Concentration 50; Models, Chemical; Molecular Conformation; Molecular Structure; Structure-Activity Relationship

2008
Synthesis and the biological evaluation of arylnaphthalene lignans as anti-hepatitis B virus agents.
    Bioorganic & medicinal chemistry, 2010, Volume: 18, Issue:3

    Topics: Cell Line, Tumor; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lignans; Promoter Regions, Genetic; Structure-Activity Relationship; Viral Core Proteins; Virus Replication

2010
Orally bioavailable anti-HBV dinucleotide acyloxyalkyl prodrugs.
    Bioorganic & medicinal chemistry letters, 2010, Mar-01, Volume: 20, Issue:5

    Topics: Administration, Oral; Animals; Antiviral Agents; Cell Line; Female; Hepatitis B; Hepatitis B virus; Humans; Male; Mice; Mice, Transgenic; Mutation; Nucleotides; Prodrugs; Rats; Rats, Sprague-Dawley

2010
Heat stress cognate 70 host protein as a potential drug target against drug resistance in hepatitis B virus.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5

    Topics: 3' Untranslated Regions; Alkaloids; Antiviral Agents; Down-Regulation; Drug Design; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; Hepatocytes; HSC70 Heat-Shock Proteins; Humans; In Vitro Techniques; Quinolizines; RNA, Small Interfering; Virus Replication

2010
Design and synthesis of novel benzimidazole derivatives as inhibitors of hepatitis B virus.
    Bioorganic & medicinal chemistry, 2010, Jul-15, Volume: 18, Issue:14

    Topics: Antiviral Agents; Benzimidazoles; Cell Line, Tumor; Cell Survival; Hepatitis B; Hepatitis B virus; Humans; Structure-Activity Relationship

2010
Tryptamine derivatives as novel non-nucleosidic inhibitors against hepatitis B virus.
    Bioorganic & medicinal chemistry, 2011, May-15, Volume: 19, Issue:10

    Topics: Antiviral Agents; Cell Survival; DNA, Viral; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Humans; Structure-Activity Relationship; Tryptamines

2011
Synthesis and biological evaluation of novel homochiral carbocyclic nucleosides from 1-amino-2-indanols.
    Bioorganic & medicinal chemistry, 2012, Oct-01, Volume: 20, Issue:19

    Topics: Animals; Antiviral Agents; Bovine Virus Diarrhea-Mucosal Disease; Cattle; Cell Line; Chlorocebus aethiops; Diarrhea Viruses, Bovine Viral; Dogs; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Herpes Simplex; Herpesvirus 1, Human; Humans; Indans; Nucleosides; Stereoisomerism; Vero Cells

2012
A new class of pyrimidine nucleosides: inhibitors of hepatitis B and C viruses.
    Bioorganic & medicinal chemistry letters, 2012, Oct-15, Volume: 22, Issue:20

    Topics: Antiviral Agents; Cell Line, Tumor; Hepacivirus; Hepatitis B; Hepatitis B virus; Hepatitis C; Humans; Liver; Pyrimidine Nucleosides

2012
Synthesis and biological evaluation of nucleoside analogues than contain silatrane on the basis of the structure of acyclovir (ACV) as novel inhibitors of hepatitis B virus (HBV).
    Bioorganic & medicinal chemistry letters, 2013, Mar-01, Volume: 23, Issue:5

    Topics: Acyclovir; Animals; Antiviral Agents; Bridged Bicyclo Compounds, Heterocyclic; Female; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Organosilicon Compounds; Purine Nucleosides; Random Allocation

2013
Synthesis and anti-hepatitis B virus activity of C4 amide-substituted isosteviol derivatives.
    Bioorganic & medicinal chemistry, 2015, Feb-15, Volume: 23, Issue:4

    Topics: Amides; Antiviral Agents; Cell Line; Diterpenes, Kaurane; DNA Replication; DNA, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; NF-kappa B

2015
Synthesis and biological evaluation of 4-substituted fluoronucleoside analogs for the treatment of hepatitis B virus infection.
    Journal of medicinal chemistry, 2015, May-14, Volume: 58, Issue:9

    Topics: Animals; Antiviral Agents; Cell Line, Tumor; Cytidine; DNA Replication; DNA, Viral; Ducks; Hepatitis B; Hepatitis B virus; Humans; Leukocyte Count; Mice; Models, Molecular; Mutagenicity Tests; Nucleosides; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship; Toxicity Tests, Acute

2015
Design, synthesis, and biological evaluation of new 1,2,3-triazolo-2'-deoxy-2'-fluoro- 4'-azido nucleoside derivatives as potent anti-HBV agents.
    European journal of medicinal chemistry, 2018, Jan-01, Volume: 143

    Topics: Animals; Antiviral Agents; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Design; Ducks; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Hepatitis B Virus, Duck; Humans; Models, Molecular; Molecular Structure; Monosaccharides; Nucleosides; Structure-Activity Relationship; Triazoles; Virus Replication

2018
Junceellolide B, a novel inhibitor of Hepatitis B virus.
    Bioorganic & medicinal chemistry, 2020, 08-15, Volume: 28, Issue:16

    Topics: Antiviral Agents; Cell Line; Diterpenes; DNA Replication; DNA, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans

2020
Synthesis and evaluation of new phenyl acrylamide derivatives as potent non-nucleoside anti-HBV agents.
    Bioorganic & medicinal chemistry, 2021, 01-01, Volume: 29

    Topics: Acrylamide; Antiviral Agents; Drug Design; Drug Resistance; Gene Expression Regulation; Guanine; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Humans; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Lamivudine; Molecular Docking Simulation; Mutation; Protein Binding; Protein Conformation; Structure-Activity Relationship; Virus Replication

2021
Effectiveness of prophylactic antiviral therapy in reducing HBV reactivation for HBsAg-positive recipients following allogeneic hematopoietic stem cell transplantation: a multi-institutional experience from an HBV endemic area.
    Annals of hematology, 2022, Volume: 101, Issue:3

    Topics: Adult; Antiviral Agents; Female; Guanine; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Retrospective Studies; Transplantation, Homologous; Virus Activation; Young Adult

2022
Hepatitis B surface antigen and hepatitis B RNA changes in HIV/hepatitis B virus co-infected participants receiving hepatitis B virus-active antiretroviral therapy.
    AIDS (London, England), 2022, 06-01, Volume: 36, Issue:7

    Topics: Adult; Coinfection; Emtricitabine; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; HIV Infections; Humans; Lamivudine; Male; Retrospective Studies; RNA

2022
A small molecule targeting hepatitis B surface antigen inhibits clinically relevant drug-resistant hepatitis B virus.
    The Journal of antimicrobial chemotherapy, 2022, 07-28, Volume: 77, Issue:8

    Topics: Antiviral Agents; Drug Resistance, Viral; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Mutation; RNA-Directed DNA Polymerase

2022
Association of Pre-S/S and Polymerase Mutations with Acute and Chronic Hepatitis B Virus Infections in Patients from Rio de Janeiro, Brazil.
    Viruses, 2022, 06-24, Volume: 14, Issue:7

    Topics: Brazil; DNA, Viral; Drug Resistance, Viral; Genotype; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Mutation; Nucleotides; Phylogeny; Protein S

2022
Antenatal hepatitis B virus sero-prevalence, risk factors, pregnancy outcomes and vertical transmission rate within 24 months after birth in a high HIV prevalence setting.
    BMC infectious diseases, 2023, Oct-27, Volume: 23, Issue:1

    Topics: Child; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Mothers; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prevalence; Risk Factors; Seroepidemiologic Studies; Tenofovir

2023
Long-term observation on hepatitis B surface antigen seroclearance in therapy experienced HIV/HBV co-infected Chinese.
    Journal of viral hepatitis, 2020, Volume: 27, Issue:2

    Topics: Adult; Anti-HIV Agents; Antiviral Agents; Asian People; China; Coinfection; DNA, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B Surface Antigens; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Retrospective Studies; Tenofovir; Time Factors; Young Adult

2020
Hepatitis B virus seroprevalence among HIV-infected patients receiving combination antiretroviral therapy three decades after universal neonatal hepatitis B immunization program in Taiwan.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2021, Volume: 54, Issue:2

    Topics: Adult; Anti-Retroviral Agents; Biomarkers; CD4 Lymphocyte Count; Coinfection; Female; Hemochromatosis; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Immunization Programs; Lamivudine; Male; Retrospective Studies; Seroepidemiologic Studies; Syphilis; Taiwan; Tenofovir; Young Adult

2021
Hepatitis B virus among hematopoietic stem cell transplant recipients: Antiviral impact in seroconversion, engraftment, and mortality in a Latin American center.
    Transplant infectious disease : an official journal of the Transplantation Society, 2020, Volume: 22, Issue:2

    Topics: Adult; Aged; Antiviral Agents; Female; Guanine; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B virus; Humans; Immunocompromised Host; Lamivudine; Latin America; Male; Middle Aged; Retrospective Studies; Rituximab; Seroconversion; Transplant Recipients; Virus Activation

2020
Case reports of latent HBV hepatitis in patients after neurosurgical treatment for hypothalamic and pituitary tumors.
    BMC infectious diseases, 2020, Mar-18, Volume: 20, Issue:1

    Topics: Aged; Antiviral Agents; DNA, Viral; Female; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Hypothalamic Neoplasms; Immunosuppression Therapy; Lamivudine; Male; Middle Aged; Pituitary Neoplasms; Retrospective Studies; Steroids; Virus Activation

2020
Efficacy and Safety of Lamivudine or Telbivudine in Preventing Mother-to-Child Transmission of Hepatitis B Virus: A Real-World Study.
    BioMed research international, 2020, Volume: 2020

    Topics: Adult; Female; Hepatitis B; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Telbivudine

2020
A Telomerase-Derived Peptide Exerts an Anti-Hepatitis B Virus Effect
    Frontiers in immunology, 2020, Volume: 11

    Topics: Animals; Antiviral Agents; DNA Damage; DNA, Mitochondrial; Drug Synergism; Guanine; Heme Oxygenase-1; Hep G2 Cells; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Interferon Regulatory Factor-3; Interferon Type I; Lamivudine; Membrane Proteins; Mice; Mice, Transgenic; Peptide Fragments; Phagosomes; Signal Transduction; Telomerase; Virus Replication

2020
Nanopore sequencing from extraction-free direct PCR of dried serum spots for portable hepatitis B virus drug-resistance typing.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2020, Volume: 129

    Topics: Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Mutation; Nanopore Sequencing; Pharmaceutical Preparations; Polymerase Chain Reaction

2020
Impact of Lamivudine-Based Antiretroviral Treatment on Hepatitis B Viremia in HIV-Coinfected South Africans.
    Viruses, 2020, 06-11, Volume: 12, Issue:6

    Topics: Adult; Anti-HIV Agents; Antiviral Agents; Coinfection; Female; Follow-Up Studies; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Prospective Studies; Tenofovir; Viral Load; Viremia; Young Adult

2020
Trends in Liver Transplantation for Chronic Hepatitis B in an Era of Highly Potent Antiviral Therapies.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2021, Volume: 27, Issue:1

    Topics: Antiviral Agents; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Transplantation; Treatment Outcome

2021
Assessing the association between platelets and immune recovery in HIV/HBV co-infected patients: A long-term cohort in Asia.
    Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2020, Volume: 84

    Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Blood Platelets; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Cohort Studies; Cyclopropanes; Female; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Immune Reconstitution; Lamivudine; Longitudinal Studies; Male; Platelet Count; Retrospective Studies; Tenofovir

2020
Prevalence and molecular characterization of hepatitis B virus infection in HIV-infected children in Senegal.
    Clinics and research in hepatology and gastroenterology, 2021, Volume: 45, Issue:2

    Topics: Adolescent; Coinfection; Diagnostic Tests, Routine; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Persistent Infection; Phylogeny; Prevalence; Retrospective Studies; Senegal; Viremia

2021
Complex genetic encoding of the hepatitis B virus on-drug persistence.
    Scientific reports, 2020, 09-23, Volume: 10, Issue:1

    Topics: Antiviral Agents; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Tenofovir

2020
Efficacy of Nucleotide/Nucleoside Analogues and Hepatitis B Immunoglobulin Therapy in Blocking Mother-to-Child Transmission of Hepatitis B in an Eastern Chinese Group.
    Infectious diseases in obstetrics and gynecology, 2020, Volume: 2020

    Topics: Antiviral Agents; Case-Control Studies; China; DNA, Viral; Drug Administration Schedule; Female; Gestational Age; Hepatitis B; Hepatitis B Antigens; Hepatitis B virus; Humans; Immunoglobulins; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Telbivudine; Tenofovir; Treatment Outcome

2020
Management of Hepatitis-B Virus Infection in Immunocompromised Children: A Single Center Experience.
    Journal of pediatric gastroenterology and nutrition, 2021, 04-01, Volume: 72, Issue:4

    Topics: Antiviral Agents; Child; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Herpesviridae Infections; Humans; Lamivudine; Retrospective Studies; Symptom Flare Up; Virus Activation

2021
Heart Retransplantation From an Hepatitis B Core Antibody (Anti-HBcore)-Positive Donor: A Case Report.
    Transplantation proceedings, 2021, Volume: 53, Issue:4

    Topics: Antiviral Agents; Graft Rejection; Heart Failure; Heart Transplantation; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Humans; Immunosuppressive Agents; Lamivudine; Male; Middle Aged; Reoperation; Risk Factors; Tissue Donors

2021
Hepatitis B immunoglobulin (HBIG) combined with long-term entecavir prophylaxis for hepatitis B virus infection in allogeneic hematopoietic stem cell transplantation with hepatitis B surface antigen-positive donors.
    Leukemia & lymphoma, 2021, Volume: 62, Issue:9

    Topics: Antiviral Agents; Guanine; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Treatment Outcome

2021
Understanding Hepatitis B Virus Dynamics and the Antiviral Effect of Interferon Alpha Treatment in Humanized Chimeric Mice.
    Journal of virology, 2021, 06-24, Volume: 95, Issue:14

    Topics: Animals; Antiviral Agents; Child, Preschool; Disease Models, Animal; DNA, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Infant; Interferon-alpha; Kinetics; Lamivudine; Liver Transplantation; Male; Mice, SCID; Models, Theoretical; Polyethylene Glycols; Recombinant Proteins; Serum Albumin; Transplantation Chimera

2021
Predominance of Hepatitis B Virus Genotype A Among Treated HIV Infected Patients Experiencing High Hepatitis B Virus Drug Resistance in Nairobi, Kenya.
    AIDS research and human retroviruses, 2017, Volume: 33, Issue:9

    Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Child, Preschool; Cross-Sectional Studies; DNA, Viral; Drug Resistance, Viral; Emtricitabine; Female; Genes, pol; Genotype; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Kenya; Lamivudine; Male; Middle Aged; Tenofovir; Viral Load; Young Adult

2017
Impacts of HBV rtH55R polymerase substitution on viral replication and rtM204I/V resistance to nucleoside/nucleotide antiviral drugs.
    Antiviral therapy, 2018, Volume: 23, Issue:1

    Topics: Amino Acid Substitution; Antiviral Agents; Biomarkers; Cell Line; Drug Resistance, Viral; Genotype; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Microbial Sensitivity Tests; Mutation; RNA-Directed DNA Polymerase; Virus Replication

2018
Post-transplant withdrawal of lamivudine results in fatal hepatitis flares in kidney transplant recipients, under immune suppression, with inactive hepatitis B infection.
    African health sciences, 2016, Volume: 16, Issue:4

    Topics: Adult; Antiviral Agents; Hepatitis B; Hepatitis B Surface Antigens; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Lamivudine; Male; Retrospective Studies

2016
Is hepatitis B immune globulin still needed after liver transplantation for chronic hepatitis B?
    Hepatology (Baltimore, Md.), 2017, Volume: 66, Issue:4

    Topics: Antiviral Agents; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Recurrence

2017
Hepatitis B testing and treatment in HIV patients in The Gambia-Compliance with international guidelines and clinical outcomes.
    PloS one, 2017, Volume: 12, Issue:6

    Topics: Adult; Antiretroviral Therapy, Highly Active; Antiviral Agents; Coinfection; Cross-Sectional Studies; Female; Gambia; Hepatitis B; HIV Infections; Humans; Lamivudine; Male; Mass Screening; Middle Aged; Practice Guidelines as Topic; Tenofovir; Treatment Outcome; Young Adult

2017
Letter: role of tenofovir to prevent mother-to-child transmission of hepatitis B virus.
    Alimentary pharmacology & therapeutics, 2017, Volume: 46, Issue:5

    Topics: Child; Hepatitis B; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy Complications, Infectious; Tenofovir

2017
Hepatitis B reactivation characterized by HBsAg negativity and anti-HbsAg antibodies persistence in haematopoietic stem cell transplanted patient after lamivudine withdrawal.
    BMC infectious diseases, 2017, 08-15, Volume: 17, Issue:1

    Topics: Antibiotic Prophylaxis; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunocompromised Host; Lamivudine; Male; Middle Aged; Virus Activation

2017
Development of a digital droplet PCR assay to measure HBV DNA in patients receiving long-term TDF treatment.
    Journal of virological methods, 2017, Volume: 249

    Topics: Antiviral Agents; Clinical Trials, Phase III as Topic; DNA, Viral; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Limit of Detection; Polymerase Chain Reaction; Sensitivity and Specificity; Seroconversion; Tenofovir; Viral Load; Virus Replication

2017
Lamivudine versus entecavir in the rescue of chemotherapy-induced hepatitis B flare-up.
    Journal of the Chinese Medical Association : JCMA, 2017, Volume: 80, Issue:12

    Topics: Aged; Antineoplastic Agents; Antiviral Agents; Female; Guanine; Hepatitis B; Humans; Lamivudine; Male; Middle Aged; Prognosis; Retrospective Studies

2017
Eighteen-month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy.
    Journal of viral hepatitis, 2018, Volume: 25, Issue:2

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antiviral Agents; DNA, Viral; Female; Hematologic Neoplasms; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunosuppressive Agents; Lamivudine; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell; Male; Middle Aged; Virus Activation; Young Adult

2018
Single-virion sequencing of lamivudine-treated HBV populations reveal population evolution dynamics and demographic history.
    BMC genomics, 2017, Oct-27, Volume: 18, Issue:1

    Topics: Alleles; Amino Acid Substitution; Computational Biology; DNA Barcoding, Taxonomic; Drug Resistance, Viral; Evolution, Molecular; Gene Frequency; Genome, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutation; Virion

2017
Comparing Efficacy of Lamivudine, Adefovir Dipivoxil, Telbivudine, and Entecavir in Treating Nucleoside Analogues Naïve for HBeAg-Negative Hepatitis B with Medium Hepatitis B Virus (HBV) DNA Levels.
    Medical science monitor : international medical journal of experimental and clinical research, 2017, Nov-02, Volume: 23

    Topics: Adenine; Adult; Alanine Transaminase; DNA, Viral; Female; Follow-Up Studies; Guanine; Hepatitis B; Hepatitis B e Antigens; Humans; Lamivudine; Male; Multivariate Analysis; Nucleosides; Organophosphonates; Proportional Hazards Models; Telbivudine; Thymidine

2017
Antiviral therapy for hepatitis B virus during second pregnancies.
    The journal of obstetrics and gynaecology research, 2018, Volume: 44, Issue:3

    Topics: Adult; Antiviral Agents; Female; Gravidity; Hepatitis B; Hepatitis B virus; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Tenofovir

2018
Early Combination Therapy with Corticosteroid and Nucleoside Analogue Induces Rapid Resolution of Inflammation in Acute Liver Failure due to Transient Hepatitis B Virus Infection.
    Internal medicine (Tokyo, Japan), 2018, Jun-01, Volume: 57, Issue:11

    Topics: Adult; Alanine Transaminase; Antiviral Agents; Drug Therapy, Combination; Female; Glucocorticoids; Guanine; Hepatitis B; Hepatitis B virus; Humans; Inflammation; Lamivudine; Liver Failure, Acute; Male; Methylprednisolone; Middle Aged; Prednisolone; Retrospective Studies; Survival Rate; Time-to-Treatment

2018
Utilization of hepatitis B core antibody positive grafts in living donor liver transplantation.
    Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 2018, Volume: 37, Issue:1

    Topics: Adolescent; Adult; Antiviral Agents; Female; Guanine; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B virus; Humans; Immunosuppressive Agents; Lamivudine; Liver Transplantation; Living Donors; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Risk; Tenofovir; Transplants; Virus Activation; Young Adult

2018
Involvement of multidrug resistance protein 4 in the hepatocyte efflux of lamivudine and entecavir.
    Molecular medicine reports, 2018, Volume: 17, Issue:5

    Topics: Antiviral Agents; Biological Transport; Guanine; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Hepatocytes; Humans; Lamivudine; Multidrug Resistance-Associated Proteins

2018
Successful Treatment of a South African Pediatric Case of Acute Liver Failure Caused by Perinatal Transmission of Hepatitis B.
    The Pediatric infectious disease journal, 2019, Volume: 38, Issue:3

    Topics: Antiviral Agents; Female; Hepatitis B; Hepatitis B virus; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Liver Failure, Acute; Male; Mothers; Perinatal Care; South Africa; Treatment Outcome

2019
Precore G1896A mutation is associated with reduced rates of HBsAg seroclearance in treated HIV hepatitis B virus co-infected patients from Western Africa.
    Journal of viral hepatitis, 2018, Volume: 25, Issue:10

    Topics: Adult; Africa, Western; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antiviral Agents; DNA, Viral; Female; Genotype; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Mutation; Promoter Regions, Genetic; Prospective Studies; Tenofovir

2018
Hepatitis B Virus Serum DNA andRNA Levels in Nucleos(t)ide Analog-Treated or Untreated Patients During Chronic and Acute Infection.
    Hepatology (Baltimore, Md.), 2018, Volume: 68, Issue:6

    Topics: Biomarkers; DNA, Viral; Hepatitis B; Humans; Lamivudine; Nucleosides; RNA, Viral; Viral Load

2018
Changes in Liver Tissue Trace Element Concentrations During Hepatitis B Viral Infection Treatment.
    Biological trace element research, 2019, Volume: 188, Issue:2

    Topics: Adult; Antiviral Agents; Biopsy; Female; Fibrosis; Guanine; Hepatitis B; Humans; Lamivudine; Liver; Liver Function Tests; Male; Middle Aged; Telbivudine; Tenofovir; Trace Elements; Young Adult

2019
Efficacy of lamivudine prophylaxis in preventing hepatitis B virus reactivation in patients with resolved infection undergoing allogeneic SCT and receiving rituximab.
    Infection, 2019, Volume: 47, Issue:1

    Topics: Adult; Aged; Antibiotic Prophylaxis; Antiviral Agents; Female; Hematologic Neoplasms; Hepatitis B; Hepatitis B virus; Humans; Italy; Lamivudine; Male; Middle Aged; Rituximab; Stem Cell Transplantation; Virus Activation; Young Adult

2019
Lamivudine prophylaxis prevents hepatitis B virus reactivation in anti-HBc positive patients under rituximab for non-Hodgkin lymphoma.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2019, Volume: 51, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; DNA, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunosuppressive Agents; Italy; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Rituximab; Treatment Outcome; Virus Activation

2019
High Prevalence of HBV Lamivudine-Resistant Mutations in HBV/HIV Co-Infected Patients on Antiretroviral Therapy in the Area with the Highest Prevalence of HIV/HBV Co-Infection in China.
    Intervirology, 2018, Volume: 61, Issue:3

    Topics: Adult; Anti-HIV Agents; China; Coinfection; DNA-Directed DNA Polymerase; Drug Resistance, Multiple, Viral; Female; Hepatitis B; Hepatitis B virus; HIV; HIV Infections; Humans; Lamivudine; Male; Multivariate Analysis; Mutation; Prevalence; Tenofovir; Viral Load

2018
Response of hepatitis B virus to antiretroviral treatment containing lamivudine in HBsAg-positive and HBsAg-negative HIV-positive South African adults.
    Journal of medical virology, 2019, Volume: 91, Issue:5

    Topics: Adolescent; Adult; Anti-Retroviral Agents; Child; Cohort Studies; Coinfection; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Middle Aged; South Africa; Treatment Outcome; Viral Load; Young Adult

2019
Rates of HBV, HCV, HDV and HIV type 1 among pregnant women and HIV type 1 drug resistance-associated mutations in breastfeeding women on antiretroviral therapy.
    BMC pregnancy and childbirth, 2018, Dec-22, Volume: 18, Issue:1

    Topics: Adolescent; Adult; Anti-HIV Agents; Breast Feeding; Cameroon; Coinfection; Drug Resistance, Viral; Female; Health Knowledge, Attitudes, Practice; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Vaccines; Hepatitis C; Hepatitis C Antibodies; Hepatitis D; HIV Seroprevalence; HIV-1; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Mutation; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Vaccination; Young Adult; Zidovudine

2018
Lamivudine use in pregnant HBsAg-females effectively reduces maternal viremia.
    Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology, 2019, Volume: 20, Issue:1

    Topics: Adult; DNA, Viral; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Humans; Immunoglobulins; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Reverse Transcriptase Inhibitors; Vaccination; Viral Load; Viremia; Young Adult

2019
Role of
    Bioscience reports, 2019, 03-29, Volume: 39, Issue:3

    Topics: Adult; Asian People; China; Female; Genetic Predisposition to Disease; Genotype; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Outcome Assessment, Health Care; Peptide Termination Factors; Polymorphism, Single Nucleotide; Reverse Transcriptase Inhibitors

2019
Entecavir and Low Genetic Barrier Antiviral Agents for Hepatocellular Carcinoma in Hepatitis B Viral Cirrhosis: Propensity Score Matching.
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2019, Volume: 29, Issue:4

    Topics: Adenine; Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; China; Female; Guanine; Hepatitis B; Hepatitis B virus; Humans; Incidence; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Organophosphonates; Retrospective Studies; Risk Factors; Telbivudine

2019
Early initiation of antiviral therapy contributes to a rapid and significant loss of serum HBsAg in infantile-onset hepatitis B.
    Journal of hepatology, 2019, Volume: 71, Issue:5

    Topics: Alanine Transaminase; Antiviral Agents; Child, Preschool; DNA, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Infant; Interferon-alpha; Lamivudine; Male; Prospective Studies; Time-to-Treatment; Treatment Outcome; Viral Load

2019
High frequency of complex mutational patterns in lamivudine resistant hepatitis B virus isolates.
    Journal of medical virology, 2013, Volume: 85, Issue:5

    Topics: Adenine; Antiviral Agents; Codon, Nonsense; Drug Resistance, Viral; Genotype; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Mutation, Missense; Organophosphonates; RNA-Directed DNA Polymerase

2013
Hepatitis B therapy, hepatocellular carcinoma and HBsAg mutants.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2013, Volume: 45, Issue:6

    Topics: Adenine; Antiviral Agents; Carcinoma, Hepatocellular; DNA, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B Surface Antigens; Humans; Immunohistochemistry; Lamivudine; Liver Neoplasms; Male; Middle Aged; Organophosphonates; Real-Time Polymerase Chain Reaction; Tomography, X-Ray Computed

2013
Forty-eight-week retrospective study of telbivudine and lamivudine treatment in patients with hepatitis B-related cirrhosis.
    Journal of viral hepatitis, 2013, Volume: 20 Suppl 1

    Topics: Adolescent; Adult; Aged; Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Retrospective Studies; Telbivudine; Thymidine; Treatment Outcome; Young Adult

2013
Towards complete eradication of hepatitis B infection from perinatal transmission: review of the mechanisms of in utero infection and the use of antiviral treatment during pregnancy.
    European journal of obstetrics, gynecology, and reproductive biology, 2013, Volume: 169, Issue:1

    Topics: Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Humans; Immunization; Infectious Disease Transmission, Vertical; Lamivudine; Male; Pregnancy; Pregnancy Complications, Infectious; Spermatozoa; Viral Load

2013
Prophylactic effect of antiretroviral therapy on hepatitis B virus infection.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 56, Issue:12

    Topics: Adenine; Adult; Alanine Transaminase; Anti-Retroviral Agents; Antibiotic Prophylaxis; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; HIV Infections; Humans; Kaplan-Meier Estimate; Lamivudine; Male; Organophosphonates; Retrospective Studies; Tenofovir

2013
Adefovir is effective to promote development of immunity to donor origin hepatitis B virus in an allogeneic transplant recipient: a case report.
    Transplantation proceedings, 2013, Volume: 45, Issue:2

    Topics: Adenine; Adult; Alanine Transaminase; Anemia, Aplastic; Antiviral Agents; Aspartate Aminotransferases; Biomarkers; DNA, Viral; Donor Selection; Drug Resistance, Viral; Drug Therapy, Combination; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunosuppressive Agents; Lamivudine; Living Donors; Male; Organophosphonates; Time Factors; Transplantation, Homologous; Treatment Outcome

2013
Liver transplantation in hepatitis B core-negative recipients using livers from hepatitis B core-positive donors: a 13-year experience.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2013, Volume: 19, Issue:6

    Topics: Adult; Aged; DNA, Viral; Female; Follow-Up Studies; Graft Survival; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Humans; Immunoglobulins; Immunosuppressive Agents; Lamivudine; Liver; Liver Failure; Liver Transplantation; Male; Middle Aged; Time Factors; Tissue Donors; Treatment Outcome

2013
Prevention of de novo hepatitis B in recipients of core antibody-positive livers with lamivudine and other nucleos(t)ides: a 12-year experience.
    Transplantation, 2013, Apr-15, Volume: 95, Issue:7

    Topics: Adenine; Adult; Aged; Analysis of Variance; Antiviral Agents; Biomarkers; Chi-Square Distribution; DNA, Viral; Donor Selection; Female; Guanine; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunosuppressive Agents; Lamivudine; Liver Transplantation; Logistic Models; Male; Middle Aged; Organophosphonates; Retrospective Studies; Risk Factors; Tenofovir; Time Factors; Tissue Donors; Treatment Outcome; Viral Load

2013
HBV recurrence lowered by lamivudine/HBIG combination therapy in liver transplant patients: ten-year experience.
    Hepatobiliary & pancreatic diseases international : HBPD INT, 2013, Volume: 12, Issue:2

    Topics: Adult; Aged; Antiviral Agents; Biomarkers; Carcinoma, Hepatocellular; DNA, Viral; End Stage Liver Disease; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Secondary Prevention; Survival Analysis; Time Factors; Treatment Outcome

2013
Access to treatment for HBV infection and its consistency with 2008 European guidelines in a multicentre cross-sectional study of HIV/HBV co-infected patients in Italy.
    BMC research notes, 2013, Apr-17, Volume: 6

    Topics: Adenine; Adult; Anti-Retroviral Agents; Coinfection; Cross-Sectional Studies; Deoxycytidine; Emtricitabine; Europe; Female; Guideline Adherence; Health Services Accessibility; Hepatitis B; HIV Infections; Humans; Infectious Disease Medicine; Italy; Lamivudine; Male; Multivariate Analysis; Organophosphonates; Practice Guidelines as Topic; Regression Analysis; Tenofovir; Treatment Outcome

2013
Prognosis of 153 patients with decompensated hepatitis B virus-related cirrhosis is improved after 3-year continuous lamivudine treatment.
    Chinese medical journal, 2013, Volume: 126, Issue:8

    Topics: Adult; Aged; Antiviral Agents; Cohort Studies; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Mutation; Prognosis; Retrospective Studies

2013
Long-term effects of prophylactic and therapeutic lamivudine treatments in hepatitis B surface antigen-positive renal allograft recipients.
    Clinical and experimental nephrology, 2014, Volume: 18, Issue:1

    Topics: Adult; Allografts; Antiviral Agents; Biomarkers; Carcinoma, Hepatocellular; Disease-Free Survival; Drug Administration Schedule; Drug Resistance, Viral; Female; Graft Rejection; Graft Survival; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunosuppressive Agents; Incidence; Kaplan-Meier Estimate; Kidney Transplantation; Lamivudine; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Risk Factors; Taiwan; Time Factors; Transplant Recipients; Treatment Outcome; Virus Activation

2014
Very late onset hepatitis-B virus reactivation following rituximab despite lamivudine prophylaxis: the need for continued vigilance.
    Leukemia & lymphoma, 2014, Volume: 55, Issue:4

    Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antiviral Agents; Chemoprevention; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Rituximab; Virus Activation; Waldenstrom Macroglobulinemia

2014
Living related liver transplantation for hepatitis B-related liver disease without hepatitis B immune globulin prophylaxis.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2013, Volume: 19, Issue:9

    Topics: Adenine; Adolescent; Adult; Aged; Antiviral Agents; DNA, Viral; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Immunosuppression Therapy; Immunosuppressive Agents; Lamivudine; Liver Transplantation; Living Donors; Male; Middle Aged; Organophosphonates; Prospective Studies; Recurrence; Tenofovir; Treatment Outcome

2013
Lamivudine-resistant HBV strain rtM204V/I in acute hepatitis B.
    The Journal of infection, 2013, Volume: 67, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Italy; Lamivudine; Male; Middle Aged; Mutation, Missense; Polymerase Chain Reaction; RNA-Directed DNA Polymerase; Sequence Analysis, DNA; Viral Load; Young Adult

2013
HIV-HBV coinfection in Southern Africa and the effect of lamivudine- versus tenofovir-containing cART on HBV outcomes.
    Journal of acquired immune deficiency syndromes (1999), 2013, Oct-01, Volume: 64, Issue:2

    Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cohort Studies; Coinfection; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Prospective Studies; Reverse Transcriptase Inhibitors; South Africa; Tenofovir; Treatment Outcome; Zambia

2013
Risk factors for long-term persistence of serum hepatitis B surface antigen following acute hepatitis B virus infection in Japanese adults.
    Hepatology (Baltimore, Md.), 2014, Volume: 59, Issue:1

    Topics: Adult; Antiviral Agents; Cohort Studies; Disease Progression; Female; Genotype; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Japan; Lamivudine; Male; Middle Aged; Risk Factors; Time Factors; Young Adult

2014
Prophylactic effect of lamivudine-based antiretroviral therapy on incident hepatitis B virus infection among HIV-infected patients.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 57, Issue:10

    Topics: Anti-Retroviral Agents; Antibiotic Prophylaxis; Hepatitis B; HIV Infections; Humans; Incidence; Kaplan-Meier Estimate; Lamivudine

2013
Clinical-pathological analysis of hepatitis B virus recurrence after liver transplantation in Chinese patients.
    Journal of gastroenterology and hepatology, 2014, Volume: 29, Issue:3

    Topics: Adult; Age Factors; Antiviral Agents; Aspartic Acid; Carcinoma, Hepatocellular; China; DNA, Viral; Drug Therapy, Combination; End Stage Liver Disease; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Neoplasms; Liver Transplantation; Male; Methionine; Middle Aged; Mutation; Retrospective Studies; Risk Factors; Secondary Prevention; Sex Factors; Tyrosine

2014
Liver transplantation for HBsAg-positive recipients using grafts from HBsAg-positive deceased donors.
    Transplant international : official journal of the European Society for Organ Transplantation, 2013, Volume: 26, Issue:12

    Topics: Adult; Aged; Antiviral Agents; Female; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Tissue Donors

2013
Pre-emptive treatment of hepatitis B infection by lamivudine in two Tunisian renal transplant recipients.
    Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2013, Volume: 24, Issue:6

    Topics: Adult; Disease Progression; Female; Hepatitis B; Hepatitis B Surface Antigens; Humans; Kidney Transplantation; Lamivudine; Male; Reverse Transcriptase Inhibitors; Tunisia

2013
Short duration of lamivudine for the prevention of hepatitis B virus transmission in pregnancy: lack of potency and selection of resistance mutations.
    Journal of viral hepatitis, 2014, Volume: 21, Issue:11

    Topics: Antiviral Agents; Blood; DNA, Viral; Drug Resistance, Viral; Female; Genetic Variation; Hepatitis B; Hepatitis B virus; High-Throughput Nucleotide Sequencing; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Mutation; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Selection, Genetic; Treatment Outcome; Viral Load

2014
Higher adherence with 3-year entecavir treatment than lamivudine or telbivudine in treatment-naïve Taiwanese patients with chronic hepatitis B.
    Journal of gastroenterology and hepatology, 2014, Volume: 29, Issue:1

    Topics: Administration, Oral; Adolescent; Adult; Antiviral Agents; Cohort Studies; Dihydropyridines; Female; Follow-Up Studies; Guanine; Hepatitis B; Humans; Lamivudine; Male; Middle Aged; Patient Compliance; Prospective Studies; Taiwan; Time Factors; Young Adult

2014
Pretreatment HBsAg level and an early decrease in MELD score predict prognosis to lamivudine treatment for HBeAg-negative acute-on-chronic liver failure.
    Clinics and research in hepatology and gastroenterology, 2014, Volume: 38, Issue:3

    Topics: Acute-On-Chronic Liver Failure; Adult; DNA, Viral; Female; Hepatitis B; Hepatitis B Surface Antigens; Humans; Lamivudine; Male; Middle Aged; Prognosis; Retrospective Studies; Reverse Transcriptase Inhibitors; Severity of Illness Index

2014
Lamivudine compared with newer antivirals for prophylaxis of hepatitis B core antibody positive livers: a cost-effectiveness analysis.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2014, Volume: 14, Issue:3

    Topics: Adenine; Antiviral Agents; Cohort Studies; Cost-Benefit Analysis; Decision Trees; Follow-Up Studies; Graft Survival; Guanine; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Markov Chains; Organophosphonates; Prognosis; Quality-Adjusted Life Years; Survival Rate; Tenofovir

2014
Mathematical models of the interrelated dynamics of hepatitis D and B.
    Mathematical biosciences, 2014, Volume: 247

    Topics: Cell Proliferation; Coinfection; Computer Simulation; Hepatitis B; Hepatitis B virus; Hepatitis D; Hepatitis Delta Virus; Hepatocytes; Humans; Lamivudine; Models, Immunological; Virus Replication

2014
Hepatitis B and C co-infection among HIV-infected adults while on antiretroviral treatment: long-term survival, CD4 cell count recovery and antiretroviral toxicity in Cambodia.
    PloS one, 2014, Volume: 9, Issue:2

    Topics: Adult; Alkynes; Anti-Retroviral Agents; Benzoxazines; Cambodia; CD4 Lymphocyte Count; Coinfection; Cyclopropanes; Female; Hepatitis B; Hepatitis C; HIV Infections; Humans; Kaplan-Meier Estimate; Lamivudine; Liver; Logistic Models; Male; Middle Aged; Nevirapine; Proportional Hazards Models; Retrospective Studies; Stavudine; Treatment Outcome; Zidovudine

2014
Management of the HBV reactivation in isolated HBcAb positive patients affected with Non Hodgkin Lymphoma.
    BMC gastroenterology, 2014, Feb-17, Volume: 14

    Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cost-Benefit Analysis; Cyclophosphamide; DNA, Viral; Doxorubicin; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Retrospective Studies; Rituximab; Vincristine; Virus Activation

2014
Case report: passive transfer of hepatitis B antibodies from intravenous immunoglobulin.
    BMC infectious diseases, 2014, Feb-22, Volume: 14

    Topics: Antiviral Agents; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Lamivudine; Lymphoma, Follicular; Male; Medical Errors; Middle Aged; Serologic Tests

2014
[Relationship between effect of lamivudine in the treatment of cirrhotic patients with uncompensated hepatitis B with HBV genotypes and cytotoxic T lymphocyte].
    Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology, 2013, Volume: 27, Issue:4

    Topics: Adult; Aged; Alanine Transaminase; Antiviral Agents; Female; Genotype; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; T-Lymphocytes, Cytotoxic

2013
Incidence and risk factors for incomplete HBV DNA suppression in HIV/HBV-co-infected patients initiating tenofovir-based therapy.
    Journal of viral hepatitis, 2014, Volume: 21, Issue:4

    Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cohort Studies; Coinfection; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Incidence; Lamivudine; Male; Middle Aged; Organophosphonates; Retrospective Studies; Risk Factors; Tenofovir; Viral Load; Viremia

2014
Hepatitis B and C seroprevalence in solid tumors - necessity for screening during chemotherapy.
    Asian Pacific journal of cancer prevention : APJCP, 2014, Volume: 15, Issue:3

    Topics: DNA, Viral; Female; Hepacivirus; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis C; Humans; Lamivudine; Liver Function Tests; Male; Middle Aged; Neoplasms; Retrospective Studies; RNA, Viral; Seroepidemiologic Studies

2014
Virologic and serologic outcomes of mono versus dual HBV therapy and characterization of HIV/HBV coinfection in a US cohort.
    Journal of acquired immune deficiency syndromes (1999), 2014, Jun-01, Volume: 66, Issue:2

    Topics: Adenine; Adult; Antibodies, Viral; Antiretroviral Therapy, Highly Active; Antiviral Agents; CD4 Lymphocyte Count; Coinfection; Deoxycytidine; DNA, Viral; Emtricitabine; Female; Follow-Up Studies; Hepatitis B; Hepatitis B e Antigens; HIV Infections; Humans; Lamivudine; Logistic Models; Male; Middle Aged; Organophosphonates; Randomized Controlled Trials as Topic; Retrospective Studies; Tenofovir; United States

2014
Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus.
    Journal of hepatology, 2014, Volume: 61, Issue:3

    Topics: Adenine; Adult; Antiviral Agents; Cohort Studies; Female; Gastrointestinal Diseases; Hepatitis B; Hepatitis B virus; Humans; Incidence; Lamivudine; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prospective Studies; Tenofovir; Time Factors; Treatment Outcome; Viral Load

2014
Safe use of liver grafts from hepatitis B surface antigen positive donors in liver transplantation.
    Journal of hepatology, 2014, Volume: 61, Issue:4

    Topics: Adult; Antiviral Agents; China; Donor Selection; End Stage Liver Disease; Female; Graft Survival; Hepatitis B; Hepatitis B Surface Antigens; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver; Liver Transplantation; Male; Middle Aged; Patient Safety; Retrospective Studies; Seroepidemiologic Studies; Tissue Donors; Transplants; Treatment Outcome

2014
Virological characteristics of occult hepatitis B virus in a North American cohort of human immunodeficiency virus type 1-positive patients on dual active anti-HBV/HIV therapy.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2014, Volume: 60, Issue:4

    Topics: Adult; Anti-HIV Agents; Asymptomatic Diseases; Base Sequence; DNA, Viral; Female; Gene Products, pol; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Leukocytes, Mononuclear; Male; Middle Aged; North America; Sequence Analysis, DNA; Viral Load

2014
Entecavir treatment in kidney transplant recipients infected with hepatitis B.
    Clinical transplantation, 2014, Volume: 28, Issue:9

    Topics: Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Follow-Up Studies; Glomerular Filtration Rate; Guanine; Hepatitis B; Hepatitis B virus; Humans; Kidney Function Tests; Kidney Transplantation; Lamivudine; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; Transplant Recipients

2014
The impact of oral antiviral therapy on long-term survival of hepatitis B surface antigen-positive patients on haemodialysis.
    The New Zealand medical journal, 2014, Jun-20, Volume: 127, Issue:1396

    Topics: Administration, Oral; Aged; Female; Hepatitis B; Hepatitis B Surface Antigens; Humans; Kaplan-Meier Estimate; Kidney Failure, Chronic; Kidney Transplantation; Lamivudine; Male; Middle Aged; Proportional Hazards Models; Renal Dialysis; Retrospective Studies; Reverse Transcriptase Inhibitors; Survivors

2014
HBsAg clearance by Peg-interferon addition to a long-term nucleos(t)ide analogue therapy.
    World journal of gastroenterology, 2014, Jul-14, Volume: 20, Issue:26

    Topics: Adenine; Adult; Antiviral Agents; Biomarkers; DNA, Viral; Drug Administration Schedule; Drug Therapy, Combination; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Interferon-alpha; Lamivudine; Male; Organophosphonates; Polyethylene Glycols; Recombinant Proteins; Time Factors; Treatment Outcome; Viral Load

2014
Rescue therapy with adefovir in decompensated liver cirrhosis patients with lamivudine-resistant hepatitis B virus.
    Clinical and molecular hepatology, 2014, Volume: 20, Issue:2

    Topics: Adenine; Adult; Aged; Antiviral Agents; Cohort Studies; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Odds Ratio; Organophosphonates; Retrospective Studies; Severity of Illness Index; Survival Rate

2014
Therapy of acute and fulminant hepatitis B.
    Intervirology, 2014, Volume: 57, Issue:3-4

    Topics: Antiviral Agents; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Humans; Interferon-alpha; Lamivudine; Liver; Liver Failure, Acute; Liver Transplantation; Polyethylene Glycols; Recombinant Proteins; Reverse Transcriptase Inhibitors; Telbivudine; Thymidine

2014
Hepatitis B virus sub-genotype A1 infection is characterized by high replication levels and rapid emergence of drug resistance in HIV-positive adults receiving first-line antiretroviral therapy in Malawi.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014, Dec-01, Volume: 59, Issue:11

    Topics: Adult; Anti-HIV Agents; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Malawi; Male; Nevirapine; Phylogeny; Retrospective Studies; Sequence Analysis, DNA; Stavudine; Viral Load; Virus Replication

2014
Clinicopathological features of hepatitis B virus recurrence after liver transplantation: eleven-year experience.
    International journal of clinical and experimental pathology, 2014, Volume: 7, Issue:7

    Topics: Adult; Antiviral Agents; Female; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence

2014
Hepatitis B virus mother-to-child transmission among HIV-infected women receiving lamivudine-containing antiretroviral regimens during pregnancy and breastfeeding.
    Journal of viral hepatitis, 2015, Volume: 22, Issue:3

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Breast Feeding; Child; Coinfection; Female; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Male; Pregnancy; Risk Factors; Young Adult

2015
Lamivudine/telbivudine-associated neuromyopathy: neurogenic damage, mitochondrial dysfunction and mitochondrial DNA depletion.
    Journal of clinical pathology, 2014, Volume: 67, Issue:11

    Topics: Adult; Aged, 80 and over; Antiviral Agents; Biopsy; DNA, Mitochondrial; Female; Hepatitis B; Humans; Lamivudine; Male; Microscopy, Electron; Middle Aged; Mitochondria, Muscle; Muscle, Skeletal; Muscular Diseases; Peripheral Nerves; Peripheral Nervous System Diseases; Predictive Value of Tests; Real-Time Polymerase Chain Reaction; Retrospective Studies; Telbivudine; Thymidine; Young Adult

2014
[Retrospective analysis of the efficacy and safety of anti-hepatitis B virus drugs taken during pregnancy in women from the Guangdong Province].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2014, Volume: 22, Issue:7

    Topics: Adenine; Antiviral Agents; Female; Guanine; Hepatitis B; Hepatitis B virus; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Male; Mothers; Organophosphonates; Pregnancy; Retrospective Studies; Telbivudine; Thymidine; Time Factors

2014
Different mechanism of selection of adefovir-resistant mutant viruses during adefovir monotherapy in patients with lamivudine-resistant chronic hepatitis B.
    Antiviral research, 2014, Volume: 112

    Topics: Adenine; Adult; Aged; Antiviral Agents; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Mutation Rate; Mutation, Missense; Organophosphonates; Point Mutation; Retrospective Studies; RNA-Directed DNA Polymerase; Selection, Genetic; Young Adult

2014
Editorial commentary: the conundrum of Lamivudine and tenofovir disoproxil fumarate for hepatitis B: fetus versus infant.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015, Jan-15, Volume: 60, Issue:2

    Topics: Adenine; Anti-HIV Agents; Breast Feeding; Disease Transmission, Infectious; Female; Hepatitis B; Humans; Lamivudine; Organophosphonates; Pregnancy

2015
[Clinical pathology of recurrent hepatitis B after liver transplantation].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2014, Volume: 22, Issue:9

    Topics: Adenine; Antiviral Agents; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Organophosphonates; Recurrence

2014
The outcomes of kidney transplantation in hepatitis B surface antigen (HBsAg)-negative recipients receiving graft from HBsAg-positive donors: a retrospective, propensity score-matched study.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2014, Volume: 14, Issue:12

    Topics: Adult; Antiviral Agents; Female; Follow-Up Studies; Glomerular Filtration Rate; Graft Rejection; Graft Survival; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Incidence; Kidney Failure, Chronic; Kidney Function Tests; Kidney Transplantation; Lamivudine; Longitudinal Studies; Male; Middle Aged; Postoperative Complications; Prognosis; Propensity Score; Retrospective Studies; Risk Factors; Thailand; Tissue Donors

2014
Prediction of prognosis to lamivudine in patients with spontaneous reactivation of hepatitis B virus-related acute-on-chronic liver failure: using virologic response at week 4.
    European journal of internal medicine, 2014, Volume: 25, Issue:9

    Topics: Acute-On-Chronic Liver Failure; Adult; Antiviral Agents; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Prognosis; Survival Analysis; Time Factors; Treatment Outcome

2014
Postexposure prophylactic effect of hepatitis B virus (HBV)-active antiretroviral therapy against HBV infection.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:2

    Topics: Adenine; Animals; Antiviral Agents; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mice; Organophosphonates; Retrospective Studies; Tenofovir

2015
Optimal antiviral prophylaxis against hepatitis B reactivation in patients receiving rituximab-based chemotherapy for lymphoma.
    JAMA, 2014, Dec-17, Volume: 312, Issue:23

    Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Female; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Lymphoma, Large B-Cell, Diffuse; Male

2014
Combining age and HBsAg level predicts post-treatment durability of nucleos(t)ide analogue-induced HBeAg seroconversion.
    Journal of gastroenterology and hepatology, 2015, Volume: 30, Issue:5

    Topics: Adult; Aging; Antiviral Agents; Consolidation Chemotherapy; Female; Follow-Up Studies; Forecasting; Hepatitis B; Hepatitis B e Antigens; Humans; Lamivudine; Male; Middle Aged; Molecular Sequence Data; Nucleotides; Recurrence; Retrospective Studies; Risk; Seroconversion; Time Factors; Young Adult

2015
Entecavir allows an unexpectedly high residual replication of HBV mutants resistant to lamivudine.
    Antiviral therapy, 2015, Volume: 20, Issue:8

    Topics: Antiviral Agents; Cell Line, Tumor; Cells, Cultured; DNA, Viral; Drug Resistance, Viral; Guanine; Hepatitis B; Hepatitis B virus; Humans; Inhibitory Concentration 50; Lamivudine; Microbial Sensitivity Tests; Mutation; Virus Replication

2015
De novo hepatitis B virus infection after pediatric liver transplantations with hepatitis B core antibody-positive donors: a single-center 20-yr experience.
    Pediatric transplantation, 2015, Volume: 19, Issue:3

    Topics: Adolescent; Child; Child, Preschool; Female; Graft Survival; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Incidence; Lamivudine; Liver Failure; Liver Transplantation; Living Donors; Male; Proportional Hazards Models; Republic of Korea; Retrospective Studies; Risk Factors

2015
Low-dose short-term hepatitis B immunoglobulin with high genetic barrier antivirals: the ideal post-transplant hepatitis B virus prophylaxis?
    Transplant infectious disease : an official journal of the Transplantation Society, 2015, Volume: 17, Issue:3

    Topics: Adenine; Adult; Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Drug Resistance, Viral; Drug Therapy, Combination; Female; Follow-Up Studies; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Prospective Studies; Recurrence; Tenofovir

2015
Hepatitis B-related serological events in hematopoietic stem cell transplant patients and efficacy of lamivudine prophylaxis against reactivation.
    Hematological oncology, 2016, Volume: 34, Issue:3

    Topics: Adolescent; Adult; Allografts; Autografts; Child; Child, Preschool; Female; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B virus; Humans; Infant; Lamivudine; Male; Middle Aged; Neoplasms; Virus Activation

2016
Solid organ transplantation from hepatitis B virus-positive donors: consensus guidelines for recipient management.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2015, Volume: 15, Issue:5

    Topics: Antiviral Agents; Cost-Benefit Analysis; Heart Transplantation; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B virus; Humans; Kidney Transplantation; Lamivudine; Liver Transplantation; Societies, Medical; Tissue and Organ Procurement; Tissue Donors; United States

2015
Analysis of HBV genotype, drug resistant mutations, and pre-core/basal core promoter mutations in Korean patients with acute hepatitis B.
    Journal of medical virology, 2015, Volume: 87, Issue:6

    Topics: Adenine; Adult; Aged; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Genotype; Guanine; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Promoter Regions, Genetic; Prospective Studies; Republic of Korea; Viral Core Proteins; Virus Replication

2015
Relationship Between Serum DNA Replication, Clinicopathological Characteristics and Prognosis of Hepatitis B Virus-associated Glomerulonephritis with Severe Proteinuria by Lamivudine Plus Adefovir Dipivoxil Combination Therapy.
    Biomedical and environmental sciences : BES, 2015, Volume: 28, Issue:3

    Topics: Adenine; Adult; Aged; Antiviral Agents; DNA Replication; DNA, Viral; Drug Therapy, Combination; Female; Glomerulonephritis; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Prognosis; Proteinuria; Young Adult

2015
Telbivudine in liver transplant recipients: Renal protection does not overcome the risk of polyneuropathy and myopathy.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2015, Volume: 21, Issue:8

    Topics: Aged; Antiviral Agents; Diabetes Mellitus; Drug Substitution; End Stage Liver Disease; Female; Glomerular Filtration Rate; Hepatitis B; Humans; Incidence; Kaplan-Meier Estimate; Kidney; Lamivudine; Liver Transplantation; Male; Middle Aged; Muscular Diseases; Polyneuropathies; Proportional Hazards Models; Prospective Studies; Recovery of Function; Recurrence; Renal Insufficiency, Chronic; Risk Factors; Telbivudine; Thymidine; Time Factors; Treatment Outcome; Turkey

2015
The impact of hepatitis B virus (HBV) infection on clinical outcomes of patients with diffuse large B-cell lymphoma.
    European journal of cancer care, 2015, Volume: 24, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-HIV Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; Rituximab; Survival Analysis; Treatment Outcome; Young Adult

2015
Efficacy and safety of lamivudine or tenofovir plus intramuscular hepatitis B immunoglobulin in prevention of hepatitis B virus reinfection after liver transplant.
    Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2015, Volume: 13 Suppl 1

    Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Injections, Intramuscular; Lamivudine; Liver Failure; Liver Transplantation; Male; Middle Aged; Prospective Studies; Recurrence; Tenofovir; Time Factors; Treatment Outcome; Virus Activation; Young Adult

2015
Nucleoside-Nucleotide Analog Combination Therapy Is Effective in Preventing Recurrent Hepatitis B After Liver Transplantation.
    Digestive diseases and sciences, 2015, Volume: 60, Issue:9

    Topics: Adenine; Adult; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Prospective Studies; Recurrence; Tenofovir

2015
Prevalence and types of drug-resistant variants in Chinese patients with acute hepatitis B.
    Journal of medical virology, 2015, Volume: 87, Issue:9

    Topics: Adenine; Adult; Antiviral Agents; China; DNA, Viral; Drug Resistance, Viral; Female; Genetic Variation; Guanine; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Mutation, Missense; Organophosphonates; Prevalence; RNA-Directed DNA Polymerase; Telbivudine; Thymidine; Time Factors; Young Adult

2015
Hepatitis B and HIV co-infection is still treated using lamivudine-only antiretroviral therapy combination in Uganda.
    African health sciences, 2015, Volume: 15, Issue:2

    Topics: Adult; Alanine Transaminase; Anti-Retroviral Agents; CD4 Lymphocyte Count; Coinfection; Cross-Sectional Studies; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Reverse Transcriptase Polymerase Chain Reaction; Treatment Outcome; Uganda; Viral Load

2015
HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons.
    BMC gastroenterology, 2015, Jul-08, Volume: 15

    Topics: Adult; Aged; Antiviral Agents; Coinfection; Drug Resistance, Viral; Female; Genotype; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Retrospective Studies; Switzerland; Tenofovir; Viral Load; Young Adult

2015
Efficacy of tenofovir disoproxil fumarate to prevent vertical transmission in mothers with lamivudine-resistant HBV.
    Antiviral therapy, 2015, Volume: 20, Issue:7

    Topics: Adult; Antiviral Agents; Biomarkers; Drug Resistance, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Male; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Treatment Outcome; Viral Load; Virus Replication

2015
Hepatitis B surface antigen quantification as a predictor of seroclearance during treatment in HIV-hepatitis B virus coinfected patients from Sub-Saharan Africa.
    Journal of gastroenterology and hepatology, 2016, Volume: 31, Issue:3

    Topics: Africa; Antiviral Agents; Biomarkers; Cohort Studies; Coinfection; Drug Therapy, Combination; Emtricitabine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; HIV Infections; Humans; Lamivudine; Predictive Value of Tests; Prospective Studies; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Tenofovir; Time Factors

2016
Circulating FoxP3+ Regulatory T and Interleukin17-Producing Th17 Cells Actively Influence HBV Clearance in De Novo Hepatitis B Virus Infected Patients after Orthotopic Liver Transplantation.
    PloS one, 2015, Volume: 10, Issue:9

    Topics: Adult; Case-Control Studies; Female; Forkhead Transcription Factors; Hepatitis B; Hepatitis B virus; Humans; Interleukin-17; Lamivudine; Liver Transplantation; Male; Middle Aged; Prognosis; T-Lymphocytes, Regulatory; Th17 Cells; Transplantation, Homologous; Treatment Outcome

2015
Adefovir- or Lamivudine-Induced Renal Tubular Dysfunction after Liver Transplantation.
    Medicine, 2015, Volume: 94, Issue:38

    Topics: Adenine; Female; Hepatitis B; Humans; Incidence; Kidney Diseases; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Postoperative Complications; Recurrence; Republic of Korea; Retrospective Studies; Reverse Transcriptase Inhibitors; Risk Factors

2015
Discrete virus infection model of hepatitis B virus.
    Bio-medical materials and engineering, 2015, Volume: 26 Suppl 1

    Topics: Antiviral Agents; Computer Simulation; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Models, Biological; Virus Replication

2015
Long-term efficacy of Peg-Interferon/Ribavirin with and without Lamivudine therapy for HBeAg-positive hepatitis B and C dual infection.
    Journal of gastroenterology and hepatology, 2016, Volume: 31, Issue:4

    Topics: Adult; Antiviral Agents; Biomarkers; Coinfection; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis B; Hepatitis B e Antigens; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Time Factors; Treatment Outcome; Young Adult

2016
Effects of hepatitis B surface antigen (HBsAg) positivity of donors in HBsAg(+) renal transplant recipients: comparison of outcomes with HBsAg(+) and HBsAg(-) donors.
    Transplant infectious disease : an official journal of the Transplantation Society, 2016, Volume: 18, Issue:1

    Topics: Adult; Antiviral Agents; Female; Glomerular Filtration Rate; Graft Rejection; Graft Survival; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Kidney Transplantation; Lamivudine; Liver; Male; Middle Aged; Postoperative Complications; Tenofovir; Tissue Donors; Transplant Recipients

2016
De novo hepatitis b prophylaxis with hepatitis B virus vaccine and hepatitis B immunoglobulin in pediatric recipients of core antibody-positive livers.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2016, Volume: 22, Issue:2

    Topics: Adolescent; Child; Child, Preschool; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Humans; Immunoglobulins; Infant; Injections, Intramuscular; Lamivudine; Liver; Liver Transplantation; Living Donors; Male; Retrospective Studies; Treatment Outcome

2016
A novel method for nucleos(t)ide analogues susceptibility assay of hepatitis B virus by viral polymerase transcomplementation.
    Antiviral research, 2016, Volume: 126

    Topics: Antiviral Agents; Cell Line; DNA, Viral; Drug Resistance, Viral; Gene Products, pol; Genetic Complementation Test; Genetic Predisposition to Disease; Guanine; HEK293 Cells; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Inhibitory Concentration 50; Lamivudine; Lentivirus; Mutation; Nucleotides; Real-Time Polymerase Chain Reaction; RNA Viruses; Transduction, Genetic; Virus Replication

2016
Lamivudine Monotherapy-Based cART Is Efficacious for HBV Treatment in HIV/HBV Coinfection When Baseline HBV DNA <20,000 IU/mL.
    Journal of acquired immune deficiency syndromes (1999), 2016, May-01, Volume: 72, Issue:1

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; China; Cohort Studies; Coinfection; DNA, Viral; Drug Therapy, Combination; Emtricitabine; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Prospective Studies; Tenofovir

2016
Prophylaxis for hepatitis B reactivation during and after chemotherapy: many questions, some answers.
    Leukemia & lymphoma, 2016, Volume: 57, Issue:6

    Topics: Antineoplastic Agents; Antiviral Agents; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Virus Activation

2016
Hepatitis B immune reconstitution syndrome in a patient with HIV infection.
    International journal of STD & AIDS, 2016, Volume: 27, Issue:12

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Coinfection; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Immune Reconstitution Inflammatory Syndrome; Lamivudine; Treatment Outcome

2016
Development and validation of an oligonucleotide ligation assay to detect lamivudine resistance in hepatitis B virus.
    Journal of virological methods, 2016, Volume: 233

    Topics: Antiviral Agents; Cloning, Molecular; Drug Resistance, Viral; Genes, Viral; Genotype; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Microbial Sensitivity Tests; Mutation; Oligonucleotides

2016
Hepatitis B virus related cryoglobulinemic vasculitis: A multicentre open label study from the Gruppo Italiano di Studio delle Crioglobulinemie - GISC.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2016, Volume: 48, Issue:7

    Topics: Adenine; Aged; Antiviral Agents; Cryoglobulinemia; Female; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Italy; Lamivudine; Male; Middle Aged; Organophosphonates; Treatment Outcome; Vasculitis

2016
Betaine Inhibits Hepatitis B Virus with an Advantage of Decreasing Resistance to Lamivudine and Interferon α.
    Journal of agricultural and food chemistry, 2016, May-25, Volume: 64, Issue:20

    Topics: Antiviral Agents; Betaine; Drug Resistance, Viral; Endoplasmic Reticulum Chaperone BiP; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Humans; Interferon-alpha; Lamivudine; Viral Proteins; Virus Replication

2016
HBV genotypes and drug resistance mutations in antiretroviral treatment-naive and treatment-experienced HBV-HIV-coinfected patients.
    Antiviral therapy, 2017, Volume: 22, Issue:1

    Topics: Anti-HIV Agents; Antiviral Agents; Coinfection; Cross-Sectional Studies; DNA, Viral; Drug Resistance, Viral; Genotype; Ghana; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Mutation; Viral Load

2017
Dually Active HIV/HBV Antiretrovirals as Protection Against Incident Hepatitis B Infections: Potential for Prophylaxis.
    The Journal of infectious diseases, 2016, Aug-15, Volume: 214, Issue:4

    Topics: Adult; Antiviral Agents; Chemoprevention; Emtricitabine; Female; Follow-Up Studies; Hepatitis B; HIV Infections; Humans; Lamivudine; Male; Prospective Studies; Tenofovir

2016
Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2016, Volume: 22, Issue:11

    Topics: Adult; Carrier State; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Transplantation, Autologous; Transplantation, Homologous; Virus Activation

2016
Delayed, Uncommon Recurrence of Hepatocellular Carcinoma After Liver Transplantation: A Case Report.
    Transplantation proceedings, 2016, Volume: 48, Issue:5

    Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Hepatitis B; Hepatitis B virus; Humans; Immunosuppressive Agents; Lamivudine; Liver Neoplasms; Liver Transplantation; Male; Neoplasm Recurrence, Local; Recurrence; Tacrolimus; Tissue Donors; Treatment Outcome

2016
Lamivudine and fingolimod co-administration in two patients with multiple sclerosis and occult hepatitis B virus infection.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2017, Volume: 38, Issue:3

    Topics: Adult; Female; Fingolimod Hydrochloride; Hepatitis B; Humans; Immunosuppressive Agents; Lamivudine; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Reverse Transcriptase Inhibitors

2017
Long-term nucleos(t)ide analog(s) monoprophylaxis in Delta coinfected liver transplant recipients.
    Transplant infectious disease : an official journal of the Transplantation Society, 2017, Volume: 19, Issue:1

    Topics: Antiviral Agents; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Transplantation

2017
Reactivation of hepatitis B virus in cancer patients treated with chemotherapy for solid tumors. Is the prophylaxis really required?
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2017, Volume: 49, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Alanine Transaminase; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Italy; Lamivudine; Male; Middle Aged; Neoplasms; Virus Activation

2017
Risks and treatment strategies for de novo hepatitis B virus infection from anti-HBc-positive donors in pediatric living donor liver transplantation.
    Pediatric transplantation, 2017, Volume: 21, Issue:2

    Topics: Adolescent; Adult; Allografts; Child; Child, Preschool; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Immunoglobulins; Infant; Lamivudine; Liver Failure; Liver Transplantation; Living Donors; Male; Middle Aged; Retrospective Studies; Risk Factors; Tissue Donors; Young Adult

2017
Response to Tenofovir Among Lamivudine-experienced Hepatitis B and HIV-coinfected Adolescents.
    The Pediatric infectious disease journal, 2017, Volume: 36, Issue:4

    Topics: Adolescent; Adult; Antiviral Agents; Child; Coinfection; DNA, Viral; Hepatitis B; HIV Infections; Humans; Lamivudine; Longitudinal Studies; Prospective Studies; Tenofovir; Young Adult

2017
Virological Response to Tenofovir Disoproxil Fumarate in HIV-Positive Patients with Lamivudine-Resistant Hepatitis B Virus Coinfection in an Area Hyperendemic for Hepatitis B Virus Infection.
    PloS one, 2016, Volume: 11, Issue:12

    Topics: Adult; Coinfection; Drug Combinations; Drug Resistance, Viral; Endemic Diseases; Female; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Tenofovir; Treatment Outcome

2016
Potential effect of lamivudine-induced S gene mutations on liver-related pathogenesis in hepatitis D virus infection.
    Hepatology (Baltimore, Md.), 2017, Volume: 65, Issue:4

    Topics: Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis D; Hepatitis Delta Virus; Humans; Lamivudine; Liver Transplantation; Mutation

2017
Characterization of occult hepatitis B virus infection among HIV positive patients in Cameroon.
    AIDS research and therapy, 2017, Mar-08, Volume: 14, Issue:1

    Topics: Adolescent; Adult; Base Sequence; Cameroon; Child, Preschool; Coinfection; Cross-Sectional Studies; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; HIV; HIV Infections; HIV Seropositivity; Humans; Lamivudine; Male; Middle Aged; Mutation; Phylogeny; Prevalence; Prospective Studies; Risk Factors; Sequence Analysis; Young Adult

2017
[Application of serum hepatitis B virus large surface protein determination in lamivudine anti-viral therapy for patients with hepatitis B].
    Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology, 2008, Volume: 22, Issue:2

    Topics: Adult; Antiviral Agents; DNA, Viral; Enzyme-Linked Immunosorbent Assay; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Polymerase Chain Reaction; Treatment Outcome; Viral Envelope Proteins; Young Adult

2008
Early hepatitis B virus DNA suppression can predict virologic response to peginterferon and lamivudine treatment.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2008, Volume: 6, Issue:9

    Topics: Adult; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Male; Polyethylene Glycols; Predictive Value of Tests; Prognosis; Recombinant Proteins; ROC Curve; Sensitivity and Specificity; Time Factors; Treatment Outcome

2008
Interaction of hepatitis B and C viruses in patients infected with HIV.
    Journal of acquired immune deficiency syndromes (1999), 2008, Aug-01, Volume: 48, Issue:4

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; DNA, Viral; Female; Hepacivirus; Hepatitis B; Hepatitis B virus; Hepatitis C; HIV Infections; Humans; Lamivudine; Male; RNA, Viral

2008
Predictive factors associated with the progression to hepatic failure caused by lamivudine-resistant HBV.
    Digestive diseases and sciences, 2008, Volume: 53, Issue:11

    Topics: Adenine; Adult; Antiviral Agents; Bilirubin; Disease Progression; Drug Resistance, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Failure; Male; Middle Aged; Multivariate Analysis; Organophosphonates; Patient Selection; Predictive Value of Tests; Prognosis; Prothrombin Time; Retrospective Studies; Treatment Outcome

2008
Lamivudine treatment improves the prognosis of fulminant hepatitis B.
    Internal medicine (Tokyo, Japan), 2008, Volume: 47, Issue:14

    Topics: Adult; Aged; Antiviral Agents; Cohort Studies; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Failure, Acute; Male; Middle Aged; Retrospective Studies; Survival Analysis; Systemic Inflammatory Response Syndrome

2008
Pretreatment alanine transaminase level may not be the most important predictor of HBeAg loss in the older patient.
    Liver international : official journal of the International Association for the Study of the Liver, 2009, Volume: 29, Issue:2

    Topics: Adult; Age Factors; Alanine Transaminase; Hepatitis B; Hepatitis B e Antigens; Humans; Korea; Lamivudine; Middle Aged; Models, Biological

2009
[Prevention and treatment of hepatitis B recurrence after liver transplantation].
    Zhonghua yi xue za zhi, 2008, Mar-04, Volume: 88, Issue:9

    Topics: Adult; Antiviral Agents; Female; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Secondary Prevention

2008
Subacute cutaneous lupus erythematosus and interstitial myositis occurring with hepatitis B infection: response to antiviral therapy with lamivudine.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2008, Volume: 14, Issue:6

    Topics: Aged; Antiviral Agents; Female; Hepatitis B; Humans; Lamivudine; Lupus Erythematosus, Cutaneous; Mitochondria; Myositis; Skin; Treatment Outcome

2008
A decline in hepatitis B virus surface antigen (hbsag) predicts clearance, but does not correlate with quantitative hbeag or HBV DNA levels.
    Antiviral therapy, 2008, Volume: 13, Issue:4

    Topics: 2-Aminopurine; Antiviral Agents; DNA, Viral; Famciclovir; Female; Heart Transplantation; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Male; Predictive Value of Tests; Treatment Outcome

2008
Reevaluation of the effect of lamivudine therapy preoperative to prevent HBV recurrence after liver transplantation.
    Hepatobiliary & pancreatic diseases international : HBPD INT, 2008, Volume: 7, Issue:4

    Topics: DNA, Viral; Drug Administration Schedule; Drug Therapy, Combination; Glucocorticoids; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Immunoglobulins; Immunosuppressive Agents; Lamivudine; Liver Transplantation; Mutation; Mycophenolic Acid; Odds Ratio; Retrospective Studies; Reverse Transcriptase Inhibitors; Risk Assessment; Secondary Prevention; Time Factors; Treatment Outcome

2008
Immediate allergy, drug-induced eruption, by entecavir.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2009, Volume: 23, Issue:4

    Topics: Adult; Antiviral Agents; Drug Eruptions; Drug Hypersensitivity; Guanine; Hepatitis B; Humans; Lamivudine; Male

2009
Liver enzyme elevation after lamivudine withdrawal in HIV-hepatitis B virus co-infected patients: the Swiss HIV Cohort Study.
    HIV medicine, 2009, Volume: 10, Issue:1

    Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Epidemiologic Methods; Female; Hepatitis B; Hepatitis B e Antigens; HIV-1; Humans; Lamivudine; Liver Diseases; Male; Middle Aged; Recurrence; Switzerland; Viral Load

2009
Hepatitis B virus reactivation after a resolutive acute hepatitis leading to a diagnosis of T cell lymphoma.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2009, Volume: 41, Issue:7

    Topics: Aged; Antiviral Agents; DNA, Viral; Fatal Outcome; Female; Hepatitis B; Hepatitis B e Antigens; Humans; Lamivudine; Lymphoma, T-Cell; Neoplasm Recurrence, Local; Recurrence; Remission, Spontaneous

2009
Alanine aminotransferase levels are not significantly elevated in patients with HIV/HBV co-infection and lamivudine resistance.
    International journal of STD & AIDS, 2008, Volume: 19, Issue:11

    Topics: Adult; AIDS-Related Opportunistic Infections; Alanine Transaminase; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Clinical Audit; DNA, Viral; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Middle Aged

2008
[Post-transplant prophylaxis of the recurrence of lamivudine-resistant YMDD mutant hepatitis B virus in liver recipients].
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2008, Volume: 28, Issue:10

    Topics: Adult; Aged; Amino Acid Motifs; Antiviral Agents; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Mutation; Recurrence

2008
Lamivudine treatment for severe acute HBV hepatitis.
    International journal of medical sciences, 2008, Volume: 5, Issue:6

    Topics: Acute Disease; Adult; Antiviral Agents; Female; Hepatitis B; Humans; Lamivudine; Male; Middle Aged

2008
Hepatitis B reactivation prophylaxis in immune-suppressed patients.
    Haematologica, 2008, Volume: 93, Issue:11

    Topics: Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B virus; Humans; Immunocompromised Host; Lamivudine; Virus Activation

2008
Sensitivity and accuracy of an updated line probe assay (HBV DR v.3) in detecting mutations associated with hepatitis B antiviral resistance.
    Journal of hepatology, 2009, Volume: 50, Issue:1

    Topics: Adenine; Adult; Antiviral Agents; DNA Probes; DNA, Viral; Drug Resistance, Viral; Female; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Sensitivity and Specificity

2009
Occult hepatitis B virus infection in immunocompromised patients.
    The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, 2008, Volume: 12, Issue:4

    Topics: Adult; Aged; Case-Control Studies; CD4 Lymphocyte Count; DNA, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; Humans; Immunocompromised Host; Lamivudine; Male; Middle Aged; Prevalence; Renal Dialysis; Viral Load

2008
Hepatitis B reactivation in allogeneic hemopoietic stem cell transplantation setting: a pediatric experience.
    Pediatric transplantation, 2009, Volume: 13, Issue:7

    Topics: Adolescent; Antiviral Agents; Child; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Humans; Immunosuppressive Agents; Lamivudine; Liver Diseases; Male; Transplantation, Homologous; Treatment Outcome; Virus Activation

2009
Prophylactic use of lamivudine with chronic immunosuppressive therapy for rheumatologic disorders.
    Rheumatology international, 2009, Volume: 29, Issue:7

    Topics: Adult; Aged; Biomarkers; DNA, Viral; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; Humans; Immunocompromised Host; Immunosuppressive Agents; Lamivudine; Liver Function Tests; Male; Middle Aged; Opportunistic Infections; Retrospective Studies; Reverse Transcriptase Inhibitors; Rheumatic Diseases; Treatment Outcome; Viral Load

2009
Erythema nodosum migrans in a male patient with hepatitis B infection.
    Clinical and experimental dermatology, 2009, Volume: 34, Issue:4

    Topics: Adult; Anti-Bacterial Agents; Antiviral Agents; Erythema Nodosum; Hepatitis B; Humans; Lamivudine; Leg; Male; Potassium Iodide; Treatment Outcome

2009
Pharmacology, clinical efficacy and safety of lamivudine in hepatitis B virus infection.
    Expert review of gastroenterology & hepatology, 2008, Volume: 2, Issue:4

    Topics: Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Secondary Prevention

2008
What is the optimal regimen for preventing hepatitis B recurrence after liver transplantation?
    Nature clinical practice. Gastroenterology & hepatology, 2009, Volume: 6, Issue:2

    Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis B; Hepatitis B Antibodies; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Recurrence; Treatment Outcome

2009
Costs and efficacy of "on demand" low-dose immunoprophylaxis in HBV transplanted patients: experience in the Romanian program of liver transplantation.
    Journal of gastrointestinal and liver diseases : JGLD, 2008, Volume: 17, Issue:4

    Topics: Adult; Comorbidity; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis D; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunotherapy; Lamivudine; Liver Failure; Liver Transplantation; Male; Middle Aged; Program Evaluation; Recurrence; Retrospective Studies; Reverse Transcriptase Inhibitors; Romania; Survival Analysis; Treatment Outcome

2008
Hepatitis B: a "GLOBAL" health challenge.
    Gastroenterology, 2009, Volume: 136, Issue:2

    Topics: Antiviral Agents; DNA, Viral; Global Health; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Nucleosides; Patient Selection; Pyrimidinones; Randomized Controlled Trials as Topic; Telbivudine; Thymidine; Virus Replication

2009
Management of hepatitis B reactivation in patients with lupus nephritis.
    Rheumatology international, 2009, Volume: 29, Issue:11

    Topics: Adult; Alanine Transaminase; Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B Surface Antigens; Humans; Lamivudine; Lupus Nephritis; Male; Middle Aged; Retrospective Studies; Virus Activation

2009
Hepatitis B virus prevention strategies for antibody to hepatitis B core antigen-positive liver donation: a survey of North American, European, and Asian-Pacific transplant programs.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2009, Volume: 15, Issue:2

    Topics: Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Humans; Lamivudine; Male; Reverse Transcriptase Inhibitors; Surveys and Questionnaires; Time Factors; Treatment Outcome

2009
Prolonged use of tenofovir in HIV/hepatitis B virus (HBV)-coinfected individuals does not lead to HBV polymerase mutations and is associated with persistence of lamivudine HBV polymerase mutations.
    HIV medicine, 2009, Volume: 10, Issue:4

    Topics: Adenine; Adult; Aged; Antiretroviral Therapy, Highly Active; Antiviral Agents; Cross-Sectional Studies; Drug Resistance, Viral; Female; Gene Products, pol; Genotype; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Polymerase Chain Reaction; Retrospective Studies; Tenofovir; Viral Load; Viremia

2009
Emergence of adefovir-resistant mutants after reversion to YMDD wild-type in lamivudine-resistant patients receiving adefovir monotherapy.
    Journal of gastroenterology and hepatology, 2009, Volume: 24, Issue:1

    Topics: Adenine; Adult; Antiviral Agents; DNA, Viral; Drug Resistance, Multiple, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Polymorphism, Restriction Fragment Length; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Time Factors; Treatment Outcome; Viral Load

2009
Long-term outcome of tenofovir disoproxil fumarate use against hepatitis B in an HIV-coinfected cohort.
    HIV medicine, 2009, Volume: 10, Issue:5

    Topics: Adenine; Adult; Antiviral Agents; Deoxycytidine; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Emtricitabine; Female; Hepatitis B; Hepatitis B Antigens; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Organophosphonates; Retrospective Studies; Reverse Transcriptase Inhibitors; Tenofovir; Time Factors; Treatment Outcome; Virus Replication

2009
Hepatitis B virus mutations potentially conferring adefovir/tenofovir resistance in treatment-naive patients.
    World journal of gastroenterology, 2009, Feb-14, Volume: 15, Issue:6

    Topics: Adenine; Adult; Amino Acid Substitution; Antiviral Agents; Drug Resistance, Viral; Genetic Variation; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Tenofovir; Viral Proteins

2009
The rtA194T polymerase mutation impacts viral replication and susceptibility to tenofovir in hepatitis B e antigen-positive and hepatitis B e antigen-negative hepatitis B virus strains.
    Hepatology (Baltimore, Md.), 2009, Volume: 49, Issue:4

    Topics: Adenine; Anti-HIV Agents; Cell Line, Tumor; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Mutation; Nucleosides; Organophosphonates; Pyrimidinones; Telbivudine; Tenofovir; Thymidine; Viral Proteins; Virus Replication

2009
Lamivudine combined with hepatitis B immunoglobulin in for prophylaxis of hepatitis B recurrence after liver transplantation: time for a change?
    Transplant international : official journal of the European Society for Organ Transplantation, 2009, Volume: 22, Issue:4

    Topics: Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Reverse Transcriptase Inhibitors; Secondary Prevention

2009
Ultra-deep pyrosequencing of hepatitis B virus quasispecies from nucleoside and nucleotide reverse-transcriptase inhibitor (NRTI)-treated patients and NRTI-naive patients.
    The Journal of infectious diseases, 2009, May-01, Volume: 199, Issue:9

    Topics: Adenine; Antiviral Agents; Base Sequence; DNA Primers; DNA, Viral; Drug Resistance, Viral; Genetic Variation; Genotype; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Mutation; Organophosphonates; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase

2009
Hepatitis B reactivation in a hepatitis B surface antigen-negative patient after allogeneic bone marrow transplant: successful treatment with lamivudine and seroconversion.
    Diagnostic microbiology and infectious disease, 2009, Volume: 64, Issue:1

    Topics: Adult; Antiviral Agents; Bone Marrow Transplantation; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Humans; Immunosuppressive Agents; Lamivudine

2009
[Evaluation of the effect of living donor liver transplantation on the treatment of severe hepatitis].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2009, Volume: 17, Issue:3

    Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Female; Follow-Up Studies; Hepatitis B; Humans; Immunoglobulins; Immunosuppressive Agents; Kidney Function Tests; Lamivudine; Liver Cirrhosis; Liver Function Tests; Liver Transplantation; Living Donors; Male; Middle Aged; Postoperative Complications; Postoperative Period; Treatment Outcome; Young Adult

2009
Treatment of subacute hepatitis B with lamivudine: a pilot study in Serbia.
    Vojnosanitetski pregled, 2009, Volume: 66, Issue:3

    Topics: Acute Disease; Adult; Aged; Antiviral Agents; Female; Hepatitis B; Humans; Lamivudine; Liver Failure, Acute; Male; Middle Aged

2009
Effective treatment for de novo hepatitis B with nucleotide analogue in patients with hematological malignancies.
    American journal of hematology, 2009, Volume: 84, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cervix Uteri; Cyclophosphamide; Doxorubicin; Etoposide; Female; Guanine; Hematopoietic Stem Cell Transplantation; Hepatitis B; Humans; Lamivudine; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Recurrence; Remission Induction; Stomach; Transplantation, Autologous; Vincristine

2009
[Hepatitis B viral infection treated with lamivudine during pregnancy].
    Gastroenterologie clinique et biologique, 2009, Volume: 33, Issue:5

    Topics: Acute Disease; Adult; Female; Hepatitis B; Humans; Lamivudine; Pregnancy; Pregnancy Complications, Infectious

2009
Frequent detection of hepatitis B virus variants associated with lamivudine resistance in treated South African patients infected chronically with different HBV genotypes.
    Journal of medical virology, 2009, Volume: 81, Issue:6

    Topics: Adult; Aged; Antiviral Agents; Drug Resistance, Viral; Female; Genotype; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation, Missense; Point Mutation; Polymorphism, Genetic; Retrospective Studies; RNA-Directed DNA Polymerase; Sequence Analysis, DNA; South Africa; Viral Proteins; Young Adult

2009
Emergency transplantation for acute reactivation of chronic hepatitis B with high viral load: role of antiviral therapy.
    Liver international : official journal of the International Association for the Study of the Liver, 2009, Volume: 29, Issue:5

    Topics: Adenine; Blood Chemical Analysis; DNA, Viral; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Reverse Transcriptase Inhibitors; Secondary Prevention; Tenofovir; Ultrasonography; Viral Load

2009
The controversial role of lamivudine prophylaxis in occult HBV carriers treated with chemo-immune therapy.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2009, Volume: 41, Issue:11

    Topics: Antiviral Agents; Carrier State; Chemoprevention; Drug-Related Side Effects and Adverse Reactions; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Humans; Lamivudine; Lymphoma; Retrospective Studies

2009
[Prophylaxsis against recurrance of hepatitis B virus after liver transplantation].
    Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology, 2008, Volume: 22, Issue:5

    Topics: Adolescent; Adult; Aged; Antibiotic Prophylaxis; Antiviral Agents; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence; Young Adult

2008
Liver transplantation and management of the hepatitis B virus. Preface.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2009, Volume: 41 Suppl 2

    Topics: Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Postoperative Complications; Secondary Prevention

2009
High risk of hepatitis B-virus reactivation after hematopoietic cell transplantation in hepatitis B core antibody-positive patients.
    European journal of haematology, 2009, Volume: 83, Issue:4

    Topics: Adolescent; Adult; Aged; Female; Guanine; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B virus; Humans; Incidence; Lamivudine; Male; Middle Aged; Plasma Exchange; Risk; Virus Activation; Young Adult

2009
Lamivudine prophylaxis and hepatitis B vaccination for prevention of hepatitis B virus reverse seroconversion in long-term survivors after allogeneic stem cell transplantation.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2009, Volume: 15, Issue:7

    Topics: Aged; Anti-HIV Agents; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B Vaccines; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Retrospective Studies; Risk Factors; Time Factors; Transplantation, Homologous; Vaccination; Virus Activation

2009
Prophylaxis of hepatitis B virus recurrence after liver transplantation.
    Journal of gastrointestinal and liver diseases : JGLD, 2009, Volume: 18, Issue:2

    Topics: Antiviral Agents; Cost-Benefit Analysis; DNA, Viral; Drug Costs; Drug Therapy, Combination; Female; Health Care Costs; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins, Intravenous; Lamivudine; Liver Transplantation; Male; Middle Aged; Patient Selection; Secondary Prevention; Viral Load

2009
[Nucleos(t)ides as prophylaxis for the reactivation of hepatitis B virus in immunosuppressed patients].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2009, Volume: 17, Issue:6

    Topics: Adult; Antineoplastic Agents; Antiviral Agents; Carrier State; DNA, Viral; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunosuppressive Agents; Lamivudine; Liver Function Tests; Male; Middle Aged; Nucleosides; Retrospective Studies; Virus Activation

2009
Successful treatment of fulminant hepatitis B during pregnancy.
    Zeitschrift fur Gastroenterologie, 2009, Volume: 47, Issue:7

    Topics: Anti-HIV Agents; Female; Hepatitis B; Humans; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Treatment Outcome; Young Adult

2009
Early hepatitis B virological rebound on entecavir through selection of lamivudine-associated mutations.
    The Journal of antimicrobial chemotherapy, 2009, Volume: 64, Issue:4

    Topics: Adult; Amino Acid Sequence; Antiviral Agents; Drug Resistance, Viral; Guanine; Hepatitis B; Humans; Lamivudine; Male; Molecular Sequence Data; Mutation, Missense; Selection, Genetic; Treatment Outcome

2009
Add-on combination therapy with adefovir dipivoxil induces renal impairment in patients with lamivudine-refractory hepatitis B virus.
    Journal of viral hepatitis, 2010, Feb-01, Volume: 17, Issue:2

    Topics: Adenine; Adult; Aged; Alanine Transaminase; Antiviral Agents; Creatinine; DNA, Viral; Drug Resistance, Viral; Fanconi Syndrome; Female; Hepatitis B; Hepatitis B virus; Humans; Kidney; Lamivudine; Male; Middle Aged; Organophosphonates; Phosphates; Renal Insufficiency; Serum; Treatment Outcome; Viral Load

2010
Reactivation of hepatitis B virus following rituximab-based regimens: a serious complication in both HBsAg-positive and HBsAg-negative patients.
    Annals of hematology, 2010, Volume: 89, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Incidence; Lamivudine; Lymphoma, B-Cell; Male; Middle Aged; Premedication; Retrospective Studies; Rituximab; Virus Activation

2010
A case of acute rejection shortly after initiation of lamivudine therapy in a simultaneous pancreas and kidney recipient with viral hepatitis type B.
    Transplant infectious disease : an official journal of the Transplantation Society, 2009, Volume: 11, Issue:6

    Topics: Adult; Antiviral Agents; Graft Rejection; Hepatitis B; Hepatitis B virus; Humans; Kidney Transplantation; Lamivudine; Male; Pancreas Transplantation

2009
Favorable outcome of de novo hepatitis B infection after liver transplantation with lamivudine and adefovir therapy.
    Transplant infectious disease : an official journal of the Transplantation Society, 2009, Volume: 11, Issue:6

    Topics: Adenine; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis, Biliary; Liver Transplantation; Middle Aged; Organophosphonates; Treatment Outcome

2009
The significance of enzyme immunoassay for the assessment of hepatitis B virus core-related antigen following liver transplantation.
    Internal medicine (Tokyo, Japan), 2009, Volume: 48, Issue:18

    Topics: Adenine; Adult; Aged; Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoenzyme Techniques; Lamivudine; Liver Transplantation; Living Donors; Male; Middle Aged; Organophosphonates; Time Factors; Virus Replication

2009
[Prevention and management of hepatitis B virus reinfection after liver transplantation].
    Zhonghua wai ke za zhi [Chinese journal of surgery], 2009, Aug-15, Volume: 47, Issue:16

    Topics: Adolescent; Adult; Aged; Female; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Postoperative Period; Retrospective Studies; Secondary Prevention; Young Adult

2009
The management of cirrhotic ascites.
    Hepatology (Baltimore, Md.), 2009, Volume: 50, Issue:4

    Topics: Antiviral Agents; Ascites; Carcinoma, Hepatocellular; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Neoplasms; Liver Transplantation; Practice Guidelines as Topic

2009
[Investigation of oxidative stress and antioxidant defense in patients with hepatitis B virus infection and the effect of interferon-alpha plus lamivudine combination therapy on oxidative stress].
    Mikrobiyoloji bulteni, 2009, Volume: 43, Issue:3

    Topics: Acute Disease; Adult; Alanine Transaminase; Antioxidants; Antiviral Agents; Aspartate Aminotransferases; Carrier State; Case-Control Studies; Drug Therapy, Combination; Female; Glutathione Peroxidase; Hepatitis B; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Liver; Male; Malondialdehyde; Oxidative Stress; Superoxide Dismutase

2009
The course of inactive hepatitis B in hepatitis-C-coinfected patients treated with interferon and ribavirin.
    Antiviral therapy, 2009, Volume: 14, Issue:6

    Topics: Adult; Aged; Antiviral Agents; Drug Administration Schedule; Female; Hepatitis B; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin

2009
Occult hepatitis B virus infection and lamivudine-resistant mutations in isolates from renal patients undergoing hemodialysis.
    Journal of gastroenterology and hepatology, 2010, Volume: 25, Issue:1

    Topics: Adult; Aged; Antiviral Agents; Brazil; Cross Infection; DNA, Viral; Drug Resistance, Viral; Female; Gene Products, pol; Genotype; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis C Antibodies; Humans; Lamivudine; Male; Middle Aged; Molecular Sequence Data; Mutation; Polymerase Chain Reaction; Prevalence; Renal Dialysis; Viral Envelope Proteins

2010
Serial knife stabbings with HIV exposure--implications for post-exposure prophylaxis.
    The Journal of infection, 2010, Volume: 60, Issue:1

    Topics: Anti-HIV Agents; Crime Victims; Disease Transmission, Infectious; Drug Combinations; Hepatitis B; Hepatitis C; HIV Infections; Humans; Lamivudine; Lopinavir; Post-Exposure Prophylaxis; Pyrimidinones; Viral Load; Wounds, Stab; Zidovudine

2010
Description of liver disease in a cohort of HIV/HBV coinfected patients.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2010, Volume: 47, Issue:1

    Topics: Adult; Alanine Transaminase; Analysis of Variance; Anti-HIV Agents; Aspartate Aminotransferases; Cohort Studies; DNA, Viral; Female; Hepatitis B; HIV; HIV Infections; Humans; Lamivudine; Male; Predictive Value of Tests; Proportional Hazards Models; Risk Factors; Statistics, Nonparametric

2010
Hepatitis B virus reactivation and role of antiviral prophylaxis in lymphoma patients with past hepatitis B virus infection who are receiving chemoimmunotherapy.
    Cancer, 2010, Jan-01, Volume: 116, Issue:1

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antiviral Agents; Female; Hepatitis B; Hepatitis B virus; Humans; Immunologic Factors; Lamivudine; Lymphoma; Male; Middle Aged; Prevalence; Rituximab; Virus Activation; Virus Latency; Virus Replication

2010
[Lamivudine, interferon-alpha and oxymatrine treatment for the surviving hepatic failure patients with hepatitis B].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2009, Volume: 17, Issue:7

    Topics: Adolescent; Adult; Alkaloids; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Interferon-alpha; Lamivudine; Liver Failure; Liver Function Tests; Male; Matrines; Middle Aged; Quinolizines; Treatment Outcome; Young Adult

2009
Mechanism of entecavir resistance of hepatitis B virus with viral breakthrough as determined by long-term clinical assessment and molecular docking simulation.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:2

    Topics: Adult; Antiviral Agents; Computer Simulation; Cross-Sectional Studies; DNA, Viral; Drug Resistance, Viral; Female; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Polymerase Chain Reaction; RNA-Directed DNA Polymerase; Viral Proteins

2010
Co-infection of Toxoplasma gondii with HBV in HIV-infected and uninfected pregnant women in Burkina Faso.
    Pakistan journal of biological sciences : PJBS, 2009, Sep-01, Volume: 12, Issue:17

    Topics: Adult; Anti-HIV Agents; Burkina Faso; Female; Hepatitis B; Hepatitis B Antigens; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Complications, Parasitic; Surveys and Questionnaires; Toxoplasma; Toxoplasmosis; Young Adult

2009
Inhibitory effect of emodin and Astragalus polysaccharide on the replication of HBV.
    World journal of gastroenterology, 2009, Dec-07, Volume: 15, Issue:45

    Topics: Animals; Astragalus Plant; Body Weight; Emodin; Female; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatocytes; Humans; Lamivudine; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Plant Extracts; Polysaccharides; Protein Kinase Inhibitors; Random Allocation; Virus Replication

2009
Influential factors of prognosis in lamivudine treatment for patients with acute-on-chronic hepatitis B liver failure.
    Journal of gastroenterology and hepatology, 2010, Volume: 25, Issue:3

    Topics: Acute Disease; Adult; Antiviral Agents; China; Cohort Studies; DNA, Viral; Female; Genotype; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Prognosis; Retrospective Studies; Survival Rate; Treatment Outcome; Viral Load

2010
Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analogues.
    Hepatology (Baltimore, Md.), 2010, Volume: 51, Issue:1

    Topics: Adenine; Adolescent; Adult; Cohort Studies; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Retrospective Studies; Tenofovir; Treatment Outcome

2010
[Protocol for the antiviral therapy of hepatitis B and D].
    Orvosi hetilap, 2010, Jan-03, Volume: 151, Issue:1

    Topics: Adenine; Antiviral Agents; Biopsy; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis D; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Lamivudine; Liver Cirrhosis; Nucleotides; Organophosphonates; Polyethylene Glycols; Recombinant Proteins; Tenofovir

2010
[Hepatitis B virus reactivation after cessation of prophylactic lamivudine therapy in B-cell lymphoma patients treated with rituximab combined CHOP therapy].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2009, Volume: 50, Issue:12

    Topics: Adult; Aged; Anti-HIV Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carrier State; Cyclophosphamide; Doxorubicin; Female; Hepatitis B; Hepatitis B virus; Humans; Immunocompromised Host; Lamivudine; Lymphoma, B-Cell; Male; Middle Aged; Prednisolone; Rituximab; Vincristine; Virus Activation

2009
Prevalence and clinical characterization of patients with acute hepatitis B induced by lamivudine-resistant strains.
    Journal of gastroenterology and hepatology, 2010, Volume: 25, Issue:4

    Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; DNA Mutational Analysis; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Female; Genotype; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Japan; Lamivudine; Male; Middle Aged; Mutation; Phenotype; Prevalence; Severity of Illness Index; Young Adult

2010
[The antiviral treatment impacts on clinical outcomes of renal transplantation recipients with hepatitis B virus infection].
    Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology, 2009, Volume: 23, Issue:3

    Topics: Adenine; Adult; Aged; Antiviral Agents; Case-Control Studies; Female; Hepatitis B; Hepatitis B virus; Humans; Kidney Transplantation; Lamivudine; Male; Middle Aged; Organophosphonates; Treatment Outcome

2009
[Construction and application of a genechip method for detection of hepatitis B virus lamivudine-resistant mutants and basal core promotor/Pre-C mutants].
    Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology, 2009, Volume: 23, Issue:4

    Topics: Antiviral Agents; Base Sequence; Drug Resistance, Viral; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B virus; Humans; Lamivudine; Molecular Sequence Data; Mutation; Oligonucleotide Array Sequence Analysis; Promoter Regions, Genetic

2009
Prevention of de novo hepatitis B virus infections: more seems no better.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2010, Volume: 16, Issue:3

    Topics: Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver; Liver Transplantation

2010
Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipients.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2010, Volume: 10, Issue:5

    Topics: Adult; Aged; Antiviral Agents; Graft Survival; Hepatitis; Hepatitis B; Hepatitis B virus; HIV; HIV Infections; Humans; Immunoglobulins; Immunologic Deficiency Syndromes; Infections; Lamivudine; Liver Cirrhosis; Liver Failure; Liver Transplantation; Longitudinal Studies; Male; Middle Aged; Secondary Prevention; Treatment Outcome; Virus Diseases; Viruses

2010
Hepatitis B virus drug resistance in HIV-1-infected patients taking lamivudine-containing antiretroviral therapy.
    AIDS patient care and STDs, 2010, Volume: 24, Issue:4

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; CD4 Lymphocyte Count; Cross-Sectional Studies; DNA, Viral; Drug Resistance, Viral; Female; Genotype; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Prevalence; Risk Factors; Treatment Outcome

2010
Hepatitis B virus-associated nephropathy: an International Data Analysis.
    Iranian journal of kidney diseases, 2010, Volume: 4, Issue:2

    Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Female; Glomerulonephritis; Hepatitis B; Humans; Infant; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; Young Adult

2010
Molecular characterization of hepatitis B virus and a 9-year clinical profile in a patient infected with genotype I.
    Journal of medical virology, 2010, Volume: 82, Issue:6

    Topics: Amino Acid Substitution; Antiviral Agents; Canada; Cluster Analysis; DNA, Viral; Genotype; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B virus; Humans; Lamivudine; Longitudinal Studies; Male; Middle Aged; Molecular Sequence Data; Phylogeny; Polymorphism, Genetic; Sequence Analysis, DNA; Sequence Homology; Vietnam

2010
Viral resistance in hepatitis B: prevalence and management.
    Current gastroenterology reports, 2010, Volume: 12, Issue:1

    Topics: Adenine; Antiviral Agents; Drug Resistance, Viral; Genetic Testing; Genotype; Guanine; Hepatitis B; Humans; Lamivudine; Nucleosides; Organophosphonates; Phenotype; Pyrimidinones; Telbivudine; Tenofovir; Thymidine

2010
Inhibitory effect on hepatitis B virus in vitro by a peroxisome proliferator-activated receptor-gamma ligand, rosiglitazone.
    Biochemical and biophysical research communications, 2010, May-28, Volume: 396, Issue:2

    Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis B; Hepatitis B virus; Humans; Interferon-alpha; Lamivudine; Ligands; PPAR gamma; Rosiglitazone; Thiazolidinediones; Virus Replication

2010
Transmission of antiviral drug resistant hepatitis B virus: implications for public health and patient management.
    Journal of gastroenterology and hepatology, 2010, Volume: 25, Issue:4

    Topics: Acute Disease; Antiviral Agents; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Genotype; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Mutation; Phenotype; Prevalence; Public Health; Severity of Illness Index; Treatment Outcome

2010
Education and imaging. Hepatobiliary and pancreatic: multiple sexually transmitted infections.
    Journal of gastroenterology and hepatology, 2010, Volume: 25, Issue:4

    Topics: Acute Disease; Anti-Infective Agents; Antiprotozoal Agents; Antiviral Agents; Colonoscopy; Entamoebiasis; Gastrointestinal Hemorrhage; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Homosexuality, Male; Humans; Immunoglobulin M; Jaundice; Lamivudine; Male; Metronidazole; Middle Aged; Penicillins; Rectum; Syphilis Serodiagnosis; Syphilis, Cutaneous; Unsafe Sex

2010
[Therapeutic recommendations for year 2010: antiviral treatment of chronic HBV infection].
    Przeglad epidemiologiczny, 2010, Volume: 64, Issue:1

    Topics: Antiviral Agents; Disease Management; Health Services Accessibility; Hepatitis B; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Poland; Practice Guidelines as Topic; Practice Patterns, Physicians'; Primary Health Care; Recombinant Proteins

2010
Peptide nucleic acid array for detection of point mutations in hepatitis B virus associated with antiviral resistance.
    Journal of clinical microbiology, 2010, Volume: 48, Issue:9

    Topics: Adenine; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Microbial Sensitivity Tests; Mutation, Missense; Oligonucleotide Array Sequence Analysis; Organophosphonates; Peptide Nucleic Acids; Point Mutation; Sensitivity and Specificity

2010
Acute hepatitis B infection associated with drug-resistant hepatitis B virus.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2010, Volume: 48, Issue:4

    Topics: Adenine; Adult; Amino Acid Substitution; Antiviral Agents; China; DNA, Viral; Drug Resistance, Viral; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Molecular Sequence Data; Mutation, Missense; Organophosphonates; Polymerase Chain Reaction; RNA-Directed DNA Polymerase; Sequence Analysis, DNA; Viral Proteins

2010
Escape hepatitis B virus mutations in recipients of antibody to hepatitis B core antigen-positive liver grafts receiving hepatitis B immunoglobulins.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2010, Volume: 16, Issue:7

    Topics: Adolescent; Adult; Aged; Antiviral Agents; Hepatitis B; Hepatitis B Surface Antigens; Humans; Immunoglobulins; Incidence; Lamivudine; Liver Transplantation; Longitudinal Studies; Middle Aged; Mutation; Nucleosides; Retrospective Studies; Risk Factors; Transplantation; Treatment Outcome; Viral Envelope Proteins; Young Adult

2010
[Evolution of hepatitis B virus quasispecies during lamivudine-entecavir sequential therapy].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2010, Volume: 18, Issue:6

    Topics: Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Evolution, Molecular; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine

2010
[Genotypic resistance to entecavir in chronic hepatitis B patients].
    The Korean journal of hepatology, 2010, Volume: 16, Issue:2

    Topics: Adult; Antiviral Agents; Drug Resistance, Viral; Female; Genotype; Guanine; Hepatitis B; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Mutation; Polymorphism, Restriction Fragment Length; Retrospective Studies; RNA-Directed DNA Polymerase

2010
Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy.
    Journal of viral hepatitis, 2011, Volume: 18, Issue:6

    Topics: Adenine; Adult; Aged; Antiviral Agents; Asian People; DNA, Circular; DNA, Viral; Drug Resistance; Female; Gene Products, pol; Genetic Variation; Genome, Viral; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver; Liver Transplantation; Male; Middle Aged; Organophosphonates; Phylogeny; Tenofovir; Trans-Activators; Viral Envelope Proteins; Viral Regulatory and Accessory Proteins; Virus Replication

2011
High viremia, prolonged Lamivudine therapy and recurrent hepatocellular carcinoma predict posttransplant hepatitis B recurrence.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2010, Volume: 10, Issue:7

    Topics: Adult; DNA, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Mutation; Predictive Value of Tests; Recurrence; Retrospective Studies; Reverse Transcriptase Inhibitors

2010
High frequency of lamivudine resistance mutations in Brazilian patients co-infected with HIV and hepatitis B.
    Journal of medical virology, 2010, Volume: 82, Issue:9

    Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Brazil; Comorbidity; Cross-Sectional Studies; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Mutation; Organophosphonates; Tenofovir; Viral Core Proteins; Viral Load; Viral Proteins

2010
Posttransplant prophylaxis strategies for hepatitis B.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2010, Volume: 10, Issue:8

    Topics: Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Secondary Prevention

2010
Prophylaxis against hepatitis B recurrence posttransplantation using lamivudine and individualized low-dose hepatitis B immunoglobulin.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2010, Volume: 10, Issue:8

    Topics: Adult; Aged; Costs and Cost Analysis; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Immunoglobulins; Injections, Intramuscular; Lamivudine; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Secondary Prevention; Viral Load

2010
[Resistance mutation patterns of hepatitis B virus in patients with suboptimal response to adefovir dipivoxil therapy after lamivudine resistance].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2010, Volume: 18, Issue:7

    Topics: Adenine; Adult; Antiviral Agents; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates

2010
Hepatitis B virus (HBV) subgenotypes C2 and B2 differ in lamivudine- and adefovir-resistance-associated mutational patterns in HBV-infected Chinese patients.
    Journal of clinical microbiology, 2010, Volume: 48, Issue:12

    Topics: Adenine; Adolescent; Adult; Antiviral Agents; Asian People; China; Drug Resistance, Viral; Female; Genotype; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation, Missense; Organophosphonates; Prevalence; Young Adult

2010
Short Communication: Hepatitis B Virus Harboring Nucleotide Deletions in the Basal Core Promoter in HBe-Positive HIV-Coinfected Patients Under Lamivudine Therapy.
    AIDS research and human retroviruses, 2011, Volume: 27, Issue:5

    Topics: Anti-HIV Agents; DNA, Viral; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Longitudinal Studies; Promoter Regions, Genetic; Sequence Analysis, DNA; Sequence Deletion

2011
Sensitive assay for quantification of hepatitis B virus mutants by use of a minor groove binder probe and peptide nucleic acids.
    Journal of clinical microbiology, 2010, Volume: 48, Issue:12

    Topics: Adult; Antiviral Agents; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Microbial Sensitivity Tests; Mutation; Oligonucleotide Probes; Peptide Nucleic Acids; Sensitivity and Specificity

2010
Anti-hepatitis B virus activities of cinobufacini and its active components bufalin and cinobufagin in HepG2.2.15 cells.
    Biological & pharmaceutical bulletin, 2010, Volume: 33, Issue:10

    Topics: Animals; Antiviral Agents; Bufanolides; Bufonidae; Drugs, Chinese Herbal; Hep G2 Cells; Hepatitis B; Hepatitis B Antigens; Hepatitis B virus; Humans; Lamivudine; RNA, Messenger; Transfection

2010
Hepatitis B genotype G and high frequency of lamivudine-resistance mutations among human immunodeficiency virus/hepatitis B virus co-infected patients in Brazil.
    Memorias do Instituto Oswaldo Cruz, 2010, Volume: 105, Issue:6

    Topics: Adult; Antiviral Agents; Brazil; DNA, Viral; Drug Resistance, Viral; Female; Genotype; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Mutation; Polymerase Chain Reaction; Viral Load

2010
Rapid detection of drug-resistant mutations in hepatitis B virus by the PCR-Invader assay.
    Journal of virological methods, 2011, Volume: 171, Issue:1

    Topics: Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Microbial Sensitivity Tests; Mutation, Missense; Polymerase Chain Reaction; RNA-Directed DNA Polymerase; Sensitivity and Specificity; Viral Proteins

2011
Lamivudine treatment in infantile fulminant hepatitis B.
    Pediatrics international : official journal of the Japan Pediatric Society, 2010, Volume: 52, Issue:4

    Topics: Antiviral Agents; Hepatitis B; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Liver Failure, Acute; Male; Reverse Transcriptase Inhibitors

2010
Hepatitis B after transplantation: competition between the recipient virus and the donor virus.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2010, Volume: 16, Issue:11

    Topics: DNA, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Nucleotides; Polymerase Chain Reaction; Specimen Handling; Tissue Donors; Transplants

2010
Occult hepatitis B virus infection of donor and recipient origin after liver transplantation despite nucleoside analogue prophylaxis.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2010, Volume: 16, Issue:11

    Topics: Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Immunohistochemistry; Lamivudine; Liver Transplantation; Male; Middle Aged; Nucleosides; Tissue Donors

2010
HBsAg-negative mono-infection with hepatitis B virus genotype G.
    Journal of viral hepatitis, 2011, Volume: 18, Issue:11

    Topics: Antiviral Agents; Blood Donors; DNA, Viral; Drug Resistance, Viral; Genotype; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Phylogeny; Serotyping

2011
Fatal hepatitis B virus reactivation due to a lamivudine mutant despite undetectable initial viral load.
    European journal of gastroenterology & hepatology, 2011, Volume: 23, Issue:1

    Topics: Drug Resistance, Viral; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B virus; Humans; Immunosuppression Therapy; Lamivudine; Lymphoma; Male; Middle Aged; Splenic Neoplasms; Viral Load; Virus Activation

2011
Immune and viral profile from tolerance to hepatitis B surface antigen clearance: a longitudinal study of vertically hepatitis B virus-infected children on combined therapy.
    Journal of virology, 2011, Volume: 85, Issue:5

    Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immune Tolerance; Infectious Disease Transmission, Vertical; Interferon-alpha; Lamivudine; Longitudinal Studies; Male; Mutation; T-Lymphocytes

2011
Prevention of lamivudine-resistant hepatitis B recurrence after liver transplantation with entecavir plus tenofovir combination therapy and perioperative hepatitis B immunoglobulin only.
    Transplant infectious disease : an official journal of the Transplantation Society, 2011, Volume: 13, Issue:3

    Topics: Adenine; Antiviral Agents; Combined Modality Therapy; Drug Resistance, Viral; Guanine; Hepatitis B; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Perioperative Care; Secondary Prevention; Tenofovir; Treatment Outcome

2011
Pharmacokinetics and efficacy of intravenous or intramuscular hepatitis B immunoglobulins in prophylaxis of hepatitis B after liver transplantation.
    Minerva medica, 2010, Volume: 101, Issue:6

    Topics: Adenine; Adult; Aged; Antiviral Agents; Drug Administration Schedule; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Injections, Intramuscular; Injections, Intravenous; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Organophosphonates; Prohibitins; Prospective Studies; Reverse Transcriptase Inhibitors; Secondary Prevention

2010
Prophylactic use of lamivudine for hepatitis B exacerbation in post-operative breast cancer patients receiving anthracycline-based adjuvant chemotherapy.
    British journal of cancer, 2011, Feb-15, Volume: 104, Issue:4

    Topics: Adult; Aged; Algorithms; Anthracyclines; Antibiotic Prophylaxis; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Breast Neoplasms; Carcinoma; Case-Control Studies; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease Progression; Female; Hepatitis B; Humans; Incidence; Lamivudine; Middle Aged; Postoperative Complications; Retrospective Studies

2011
Lamivudine treatment is associated with improved survival in fulminant hepatitis B.
    Liver international : official journal of the International Association for the Study of the Liver, 2011, Volume: 31, Issue:4

    Topics: Biomarkers; China; Cohort Studies; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Failure, Acute; Male; Retrospective Studies; Survival Analysis; Treatment Outcome

2011
Prophylaxis against de novo hepatitis B for liver transplantation utilizing hep B core (+) donors: does hepatitis B immunoglobulin provide a survival advantage?
    Transplant international : official journal of the European Society for Organ Transplantation, 2011, Volume: 24, Issue:6

    Topics: Adult; Antiviral Agents; Female; Graft Survival; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Proportional Hazards Models; Tissue Donors

2011
Low liver stiffness among cirrhotic patients with hepatitis B after prolonged treatment with nucleoside analogs.
    Scandinavian journal of gastroenterology, 2011, Volume: 46, Issue:6

    Topics: Adenine; Adult; Elasticity Imaging Techniques; Female; Hepatitis B; Humans; Lamivudine; Liver; Liver Cirrhosis; Male; Middle Aged; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Time Factors

2011
Long-term results of hepatitis B immunoglobulin and lamuvidine for hepatitis B prophylaxis after liver transplantation.
    Transplantation proceedings, 2011, Volume: 43, Issue:2

    Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Female; Hepatitis B; Hepatitis B Surface Antigens; Humans; Immunoglobulins; Lamivudine; Liver Failure; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Reverse Transcriptase Inhibitors; Risk Factors

2011
Regression of indolent B-cell lymphoma after Lamivudine prophylaxis of hepatitis B virus infection.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Jun-20, Volume: 29, Issue:18

    Topics: Antiviral Agents; Asymptomatic Diseases; Bone Marrow; Carrier State; Cell Transformation, Viral; Disease Progression; Female; Genes, bcl-2; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma, B-Cell; Lymphoma, Follicular; Middle Aged; Neoplasm, Residual; Remission Induction; Splenic Neoplasms

2011
Risk of hepatitis B reactivation and the role of novel agents and stem-cell transplantation in multiple myeloma patients with hepatitis B virus (HBV) infection.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antiviral Agents; Boronic Acids; Bortezomib; Comorbidity; Endemic Diseases; Female; Hepatitis B; Humans; Immunologic Factors; Incidence; Lamivudine; Male; Middle Aged; Multiple Myeloma; Prevalence; Prospective Studies; Pyrazines; Retrospective Studies; Risk Factors; Secondary Prevention; Stem Cell Transplantation; Transplantation, Autologous; Virus Activation

2012
The effect of prophylactic lamivudine on hepatitis B virus reactivation in HBsAg-positive patients with diffuse large B-cell lymphoma undergoing prolonged rituximab therapy.
    Medical oncology (Northwood, London, England), 2012, Volume: 29, Issue:2

    Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Retrospective Studies; Reverse Transcriptase Inhibitors; Rituximab; Survival Rate; Treatment Outcome; Virus Activation; Young Adult

2012
Interference of replication between hepatitis B and C viruses in patients infected with HIV.
    Journal of medical virology, 2011, Volume: 83, Issue:7

    Topics: Adult; Antibodies, Viral; CD4 Lymphocyte Count; Cell Line, Tumor; China; DNA, Viral; Female; Hepacivirus; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis C; HIV; HIV Infections; Humans; Lamivudine; Longitudinal Studies; Male; Mutation; Plasmids; Risk Factors; RNA, Viral; Transfection; Virus Replication

2011
Successful treatment of hepatitis B virus associated nephrotic syndrome with oral Lamivudine in a Nigerian child: a case report.
    Journal of tropical pediatrics, 2012, Volume: 58, Issue:2

    Topics: Antiviral Agents; Child; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Nephrotic Syndrome; Nigeria; Remission Induction

2012
A patient with rheumatoid arthritis treated with tocilizumab together with lamivudine prophylaxis after remission of infliximab-reactivated hepatitis B.
    Modern rheumatology, 2011, Volume: 21, Issue:6

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Hepatitis B; Humans; Infliximab; Lamivudine; Middle Aged; Recurrence; Reverse Transcriptase Inhibitors; Treatment Outcome

2011
Detection of hepatitis B virus variants in HBV monoinfected and HBV/HIV coinfected Iranian patients under lamivudine treatment.
    Current HIV research, 2011, Volume: 9, Issue:4

    Topics: Adult; Anti-HIV Agents; Cohort Studies; DNA Mutational Analysis; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Female; Gene Frequency; Genotype; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Iran; Lamivudine; Male; Mutation; Phylogeny

2011
HBV primary drug resistance in newly diagnosed HIV-HBV-coinfected individuals in Spain.
    Antiviral therapy, 2011, Volume: 16, Issue:4

    Topics: Adult; Cohort Studies; Drug Resistance, Viral; Female; Gene Products, pol; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Reverse Transcriptase Inhibitors; Spain

2011
Risk of liver-associated morbidity and mortality in a cohort of HIV and HBV coinfected Han Chinese.
    Infection, 2011, Volume: 39, Issue:5

    Topics: Adult; Alanine Transaminase; Anti-HIV Agents; CD4 Lymphocyte Count; China; Cohort Studies; Coinfection; DNA, Viral; Female; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; HIV; HIV Infections; Humans; Lamivudine; Liver; Male; Middle Aged; Retrospective Studies; Risk Factors; RNA, Viral; Young Adult

2011
Design, synthesis, and biological evaluation of triazolo-pyrimidine derivatives as novel inhibitors of hepatitis B virus surface antigen (HBsAg) secretion.
    Journal of medicinal chemistry, 2011, Aug-25, Volume: 54, Issue:16

    Topics: Adenine; Animals; Antiviral Agents; Biological Availability; Drug Design; Drug Resistance, Viral; Guanine; Hep G2 Cells; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Mice; Models, Chemical; Molecular Structure; Mutation; Organophosphonates; Pyrimidines; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Tenofovir; Tetrazoles

2011
Cost-effectiveness of maternal treatment to prevent perinatal hepatitis B virus transmission.
    Obstetrics and gynecology, 2011, Volume: 118, Issue:3

    Topics: Adult; Cost Savings; Cost-Benefit Analysis; Decision Trees; DNA, Viral; Female; Hepatitis B; Humans; Immunoglobulins; Infant, Newborn; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Reverse Transcriptase Inhibitors; Viral Load

2011
Molecular epidemical characteristics of Lamivudine resistance mutations of HBV in southern China.
    Medical science monitor : international medical journal of experimental and clinical research, 2011, Volume: 17, Issue:10

    Topics: Antiviral Agents; China; Drug Resistance, Viral; Enzyme-Linked Immunosorbent Assay; Genotype; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Logistic Models; Mutation; Odds Ratio; Real-Time Polymerase Chain Reaction

2011
Identification of hepatitis B virus rtS117F substitution as a compensatory mutation for rtM204I during lamivudine therapy.
    The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Antiviral Agents; DNA Mutational Analysis; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutagenesis, Site-Directed; Mutation, Missense; Sequence Analysis, DNA; Virus Replication

2012
Nucleoside analogues improve the short-term and long-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure.
    Clinical and experimental medicine, 2012, Volume: 12, Issue:3

    Topics: Adolescent; Adult; Aged; Alanine Transaminase; Antiviral Agents; DNA, Viral; End Stage Liver Disease; Female; Follow-Up Studies; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Prognosis; Retrospective Studies; Secondary Prevention; Time Factors; Treatment Outcome; Young Adult

2012
Long-term outcome of primary non-responders to tenofovir therapy in HIV/HBV-co-infected patients: impact of HBV genotype G.
    Liver international : official journal of the International Association for the Study of the Liver, 2012, Volume: 32, Issue:1

    Topics: Adenine; Adult; Anti-HIV Agents; Coinfection; Deoxycytidine; DNA Mutational Analysis; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Emtricitabine; Female; Genotype; Hepatitis B; Hepatitis B virus; HIV; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Retrospective Studies; Tenofovir; Time Factors; Treatment Outcome

2012
Late hepatitis B virus reactivation after lamivudine prophylaxis interruption in an anti-HBs-positive and anti-HBc-negative patient treated with rituximab-containing therapy.
    The Journal of infection, 2012, Volume: 65, Issue:2

    Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antiviral Agents; Chemoprevention; Drug Therapy; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Lamivudine; Mutation, Missense; Rituximab; Virus Activation; Withholding Treatment

2012
How does hepatitis B virus infection react to hepatocellular carcinoma treatment?
    Journal of gastroenterology and hepatology, 2012, Volume: 27, Issue:1

    Topics: Antiviral Agents; Carcinoma, Hepatocellular; Female; Hepatectomy; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Neoplasms; Male; Virus Activation

2012
Lamivudine-resistant HBV infection in HIV-positive patients receiving antiretroviral therapy in a public routine clinic in Cameroon.
    Antiviral therapy, 2012, Volume: 17, Issue:2

    Topics: Adult; Anti-HIV Agents; Base Sequence; Cameroon; Coinfection; Cross-Sectional Studies; DNA, Viral; Drug Resistance, Viral; Female; Gene Products, pol; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Sequence Analysis, DNA

2012
Sequence analysis of the polymerase gene in hepatitis B virus infected blood donors in Iran.
    Archives of Iranian medicine, 2012, Volume: 15, Issue:2

    Topics: Adult; Aged; Antiviral Agents; Blood Donors; DNA, Viral; Drug Resistance, Viral; Female; Gene Products, pol; Genotype; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Iran; Lamivudine; Male; Middle Aged; Mutation; Polymerase Chain Reaction; Sequence Analysis, DNA

2012
Anti-HBV activities of Streblus asper and constituents of its roots.
    Fitoterapia, 2012, Volume: 83, Issue:4

    Topics: Antiviral Agents; Biphenyl Compounds; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Humans; Inhibitory Concentration 50; Lamivudine; Lignans; Molecular Structure; Moraceae; Phytotherapy; Plant Extracts; Plant Roots; Plant Structures

2012
Hepatitis B virus reactivation in rheumatoid arthritis and ankylosing spondylitis patients treated with anti-TNFα agents: a retrospective analysis of 49 cases.
    Clinical rheumatology, 2012, Volume: 31, Issue:6

    Topics: Adult; Amino Acid Motifs; Antiviral Agents; Arthritis, Rheumatoid; DNA-Directed DNA Polymerase; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Retrospective Studies; Spondylitis, Ankylosing; Tumor Necrosis Factor-alpha; Virus Activation

2012
Strong antiviral activity of the new l-hydroxycytidine derivative, l-Hyd4FC, in HBV-infected human chimeric uPA/SCID mice.
    Antiviral therapy, 2012, Volume: 17, Issue:4

    Topics: Animals; Antiviral Agents; Chimera; Cytidine; DNA, Viral; Hepatitis B; Humans; Lamivudine; Mice; Mice, SCID; Molecular Structure; Urokinase-Type Plasminogen Activator; Viremia; Zalcitabine

2012
[Hungarian consensus guideline for the diagnosis and treatment of B, C, and D viral hepatitis].
    Orvosi hetilap, 2012, Mar-11, Volume: 153, Issue:10

    Topics: Adenine; Antiviral Agents; Comorbidity; Consensus; Drug Administration Schedule; Drug Therapy, Combination; Genotype; Guanine; Hepacivirus; Hepatitis B; Hepatitis C; Hepatitis D; Humans; Hungary; Interferon-alpha; Interferons; Lamivudine; Oligopeptides; Organophosphonates; Polyethylene Glycols; Proline; Recombinant Proteins; Ribavirin; RNA, Viral; Tenofovir; Time Factors; Treatment Outcome

2012
In vitro activity of cepharanthine hydrochloride against clinical wild-type and lamivudine-resistant hepatitis B virus isolates.
    European journal of pharmacology, 2012, May-15, Volume: 683, Issue:1-3

    Topics: Adult; Antiviral Agents; Benzylisoquinolines; Cell Survival; China; DNA, Viral; Down-Regulation; Drug Resistance, Viral; Gene Expression Regulation, Viral; Hep G2 Cells; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Hepatocytes; HSC70 Heat-Shock Proteins; Humans; Inhibitory Concentration 50; Lamivudine; Male; Recombinant Proteins; RNA, Messenger; Virus Replication

2012
The rtL229 substitutions in the reverse transcriptase region of hepatitis B virus (HBV) polymerase are potentially associated with lamivudine resistance as a compensatory mutation.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2012, Volume: 54, Issue:1

    Topics: Adult; Amino Acid Substitution; Antiviral Agents; Cell Line; China; Drug Resistance, Viral; Female; Gene Products, pol; Hepatitis B; Hepatitis B virus; Hepatocytes; Humans; Lamivudine; Male; Middle Aged; Mutation, Missense; Virus Replication

2012
Lamivudine plus adefovir vs. entecavir in HBeAg-positive hepatitis B with sequential treatment failure of lamivudine and adefovir.
    Liver international : official journal of the International Association for the Study of the Liver, 2012, Volume: 32, Issue:7

    Topics: Adenine; Adult; Alanine Transaminase; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Prognosis; Retrospective Studies; Treatment Failure

2012
Antiviral activity of FNC, 2'-deoxy-2'-β-fluoro-4'-azidocytidine, against human and duck HBV replication.
    Antiviral therapy, 2012, Volume: 17, Issue:4

    Topics: Animals; Antiviral Agents; Azides; Cell Line, Tumor; Deoxycytidine; Ducks; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatocytes; Humans; Lamivudine; Liver; Virus Replication

2012
[Prognosis analysis of hepatitis B virus recurrence after liver transplantation: a single-center study of 38 cases].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2012, Volume: 20, Issue:1

    Topics: Adenine; Adult; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Prognosis; Recurrence; Retrospective Studies

2012
Hepatitis B virus variants in HBV mono-infected versus HBV/HIV co-infected patients.
    Current HIV research, 2012, Volume: 10, Issue:3

    Topics: Anti-HIV Agents; Female; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male

2012
Convergence and coevolution of hepatitis B virus drug resistance.
    Nature communications, 2012, Apr-17, Volume: 3

    Topics: Adult; Antiviral Agents; Child; Drug Resistance, Viral; Evolution, Molecular; Female; Genome, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Molecular Sequence Data; Mutation, Missense; Phylogeny; RNA-Directed DNA Polymerase; Viral Proteins

2012
Interruption of mother-to-infant transmission of hepatitis B: time to include selective antiviral prophylaxis?
    Lancet (London, England), 2012, May-26, Volume: 379, Issue:9830

    Topics: Antiviral Agents; Developing Countries; Female; Hepatitis B; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Nucleosides; Pregnancy; Pregnancy Complications, Infectious; Pyrimidinones; Reverse Transcriptase Inhibitors; Telbivudine; Thymidine; Vaccination

2012
Twenty-four year single-center experience of hepatitis B virus infection in heart transplantation.
    Transplantation proceedings, 2012, Volume: 44, Issue:4

    Topics: Adult; Alanine Transaminase; Antiviral Agents; Biomarkers; DNA, Viral; Donor Selection; Female; Heart Failure; Heart Transplantation; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Immunosuppressive Agents; Lamivudine; Male; Middle Aged; Retrospective Studies; Taiwan; Time Factors; Treatment Outcome; Viral Load; Virus Activation; Young Adult

2012
Treatment effects on patient-important outcomes can be small, even with large effects on surrogate markers.
    Journal of clinical epidemiology, 2012, Volume: 65, Issue:9

    Topics: Biomarkers; Hepatitis B; Hepatitis B e Antigens; Humans; Immunologic Factors; Interferon-alpha; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Outcome Assessment, Health Care; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors

2012
Immunological and virological responses to cART in HIV/HBV co-infected patients from a multicenter cohort.
    AIDS (London, England), 2012, Sep-10, Volume: 26, Issue:14

    Topics: Adolescent; Adult; Aged; Anti-Retroviral Agents; CD4 Lymphocyte Count; Coinfection; Disease Progression; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Prospective Studies; Treatment Outcome; Young Adult

2012
Hepatitis B prophylaxis post liver transplantation with newer nucleos(t)ide analogues after hepatitis B immunoglobulin discontinuation.
    Transplant infectious disease : an official journal of the Transplantation Society, 2012, Volume: 14, Issue:5

    Topics: Adenine; Adult; Aged; Antiviral Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Guanine; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Nucleotides; Organophosphonates; Secondary Prevention; Tenofovir; Treatment Outcome; Young Adult

2012
Adherence to hepatitis B screening and prophylactic lamivudine for prevention of rituximab-associated hepatitis B reactivation.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2013, Volume: 19, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antiviral Agents; Female; Guideline Adherence; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Practice Guidelines as Topic; Practice Patterns, Physicians'; Retrospective Studies; Rituximab; Virus Activation; Young Adult

2013
Letter: acute hepatitis B - to treat or not to treat?
    Alimentary pharmacology & therapeutics, 2012, Volume: 36, Issue:1

    Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis B; Humans; Lamivudine; Randomized Controlled Trials as Topic; Survival Rate

2012
Detection of mixed populations of wild-type and YMDD hepatitis B variants by pyrosequencing in acutely and chronically infected patients.
    BMC microbiology, 2012, Jun-06, Volume: 12

    Topics: DNA, Viral; Drug Resistance, Viral; Genotype; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutation; Polymorphism, Single Nucleotide; Sequence Analysis, DNA

2012
Analysis of hepatitis B virus drug-resistant mutant haplotypes by ultra-deep pyrosequencing.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2012, Volume: 18, Issue:10

    Topics: Antiviral Agents; Drug Resistance, Viral; Guanine; Haplotypes; Hepatitis B; Hepatitis B virus; High-Throughput Nucleotide Sequencing; Humans; Lamivudine; Mutation; Reproducibility of Results

2012
Hepatitis B virus and human immunodeficiency virus drugs in pregnancy: findings from the Antiretroviral Pregnancy Registry.
    Journal of hepatology, 2012, Volume: 57, Issue:5

    Topics: Adenine; Adult; Antiviral Agents; Congenital Abnormalities; Female; Hepatitis B; Hepatitis B virus; HIV; HIV Infections; Humans; Lamivudine; Phosphorous Acids; Pregnancy; Pregnancy Complications, Infectious; Prevalence; Prospective Studies; Registries; Retrospective Studies; Risk Factors; Treatment Outcome

2012
Predictive factors of lamivudine treatment success in an hepatitis B virus-infected pediatric cohort: a 10-year study.
    Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2012, Volume: 26, Issue:7

    Topics: Adolescent; Alanine Transaminase; Antiviral Agents; Child; Child, Preschool; Female; Hepatitis B; Humans; Lamivudine; Male; Retrospective Studies; Treatment Outcome

2012
Long-term hepatitis B virus (HBV) response to lamivudine-containing highly active antiretroviral therapy in HIV-HBV co-infected patients in Thailand.
    PloS one, 2012, Volume: 7, Issue:7

    Topics: Adult; Alanine Transaminase; Antiretroviral Therapy, Highly Active; CD4-Positive T-Lymphocytes; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Mutation; Thailand; Viral Load; Virus Replication

2012
Response to antiretroviral therapy in occult hepatitis B and HIV co-infection in West Africa.
    AIDS (London, England), 2013, Jan-02, Volume: 27, Issue:1

    Topics: Anti-HIV Agents; Body Mass Index; CD4 Lymphocyte Count; Coinfection; Disease Progression; Female; Ghana; Hepatitis B; Hepatitis B Surface Antigens; HIV Infections; Humans; Lamivudine; Male; Prevalence; Reverse Transcriptase Inhibitors; Treatment Outcome; Viral Load

2013
Clinical prediction of failure of Lamivudine prophylaxis for hepatitis B virus-infected patients undergoing cytotoxic chemotherapy for malignancy.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:11

    Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Prognosis; Rituximab; Survival Rate; Treatment Failure; Viral Load

2012
Evolution of adefovir-resistant HBV polymerase gene variants after switching to tenofovir disoproxil fumarate monotherapy.
    Antiviral therapy, 2012, Volume: 17, Issue:6

    Topics: Adenine; Adult; Aged; Antiviral Agents; Cloning, Molecular; DNA, Viral; Drug Resistance, Viral; Drug Substitution; Escherichia coli; Evolution, Molecular; Female; Follow-Up Studies; Gene Products, pol; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Tenofovir; Viremia

2012
Does genotype predict response to treatment in children infected with hepatitis B perinatally?
    Journal of medical virology, 2012, Volume: 84, Issue:10

    Topics: Adenine; Adolescent; Anti-Inflammatory Agents; Antiviral Agents; Child; Child, Preschool; Clinical Trials as Topic; DNA, Viral; Genotype; Hepatitis B; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B virus; Humans; Interferons; Lamivudine; Organophosphonates; Prednisolone; Treatment Outcome

2012
Emergence of lamivudine resistance hepatitis B virus mutations in pregnant women infected with HBV and HIV receiving antiretroviral prophylaxis for the prevention of mother-to-infant transmission in Malawi.
    Journal of medical virology, 2012, Volume: 84, Issue:10

    Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Malawi; Mutation; Pregnancy; Pregnancy Complications, Infectious; RNA, Viral; Viral Load; Young Adult

2012
Clinical characteristics and chronicity of acute hepatitis B induced by lamivudine-resistant strains.
    Journal of medical virology, 2012, Volume: 84, Issue:10

    Topics: Adult; Antiviral Agents; China; DNA, Viral; Drug Resistance, Viral; Female; Genotype; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation, Missense; Polymerase Chain Reaction; RNA-Directed DNA Polymerase; Sequence Analysis, DNA

2012
Does interferon-sparing tenofovir disoproxil fumarate-based therapy have a role in the management of severe acute hepatitis delta superinfection?
    Journal of medical microbiology, 2012, Volume: 61, Issue:Pt 12

    Topics: Acute Disease; Adenine; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis D; Hepatitis Delta Virus; Humans; Interferons; Lamivudine; Male; Organophosphonates; RNA, Viral; Superinfection; Tenofovir; Young Adult

2012
Evaluation of anti-HBV drug resistant mutations among patients with acute symptomatic hepatitis B in the United States.
    Journal of hepatology, 2013, Volume: 58, Issue:2

    Topics: Acute Disease; Adenine; Adult; Antiviral Agents; Cohort Studies; Cross-Sectional Studies; Drug Resistance, Viral; Female; Genotype; Guanine; Hepatitis B; Humans; Lamivudine; Male; Mutation; Organophosphonates; Retrospective Studies; Sequence Analysis, DNA; United States

2013
Five-year on-treatment efficacy of lamivudine-, tenofovir- and tenofovir + emtricitabine-based HAART in HBV-HIV-coinfected patients.
    Journal of viral hepatitis, 2012, Volume: 19, Issue:11

    Topics: Adenine; Adult; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Coinfection; Deoxycytidine; Emtricitabine; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Male; Organophosphonates; Retrospective Studies; Tenofovir; Treatment Outcome; Viral Load; Virus Replication

2012
Lamivudine prophylaxis for hepatitis B virus carrier patients with breast cancer during adjuvant chemotherapy.
    Breast cancer (Tokyo, Japan), 2014, Volume: 21, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; DNA, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Function Tests; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Polymerase Chain Reaction; Premedication; Prognosis; Prospective Studies; Reverse Transcriptase Inhibitors; Virus Activation

2014
Efficacy of prophylactic lamivudine to prevent hepatitis B virus reactivation in B-cell lymphoma treated with rituximab-containing chemotherapy.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2013, Volume: 21, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Female; Hepatitis B; Hepatitis B Surface Antigens; Humans; Lamivudine; Liver Function Tests; Lymphoma, B-Cell; Male; Middle Aged; Retrospective Studies; Reverse Transcriptase Inhibitors; Rituximab; Virus Activation

2013
Severe acute hepatitis B in a treatment-naïve patient with antiviral drug resistant mutations in the polymerase gene.
    Journal of medical virology, 2013, Volume: 85, Issue:2

    Topics: Adenine; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Genotype; Hepatitis B; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Italy; Lamivudine; Male; Middle Aged; Mutation, Missense; Organophosphonates; Telbivudine; Tenofovir; Thailand; Thymidine; Travel; Treatment Outcome

2013
Influence of HIV-associated degree of immune suppression on molecular heterogeneity of hepatitis B virus among HIV co-infected patients.
    Virology, 2013, Feb-05, Volume: 436, Issue:1

    Topics: Adult; Amino Acid Sequence; Anti-HIV Agents; CD4 Lymphocyte Count; Coinfection; DNA, Viral; Female; Genetic Variation; Genotype; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; HIV; HIV Infections; Humans; Immunosuppression Therapy; Lamivudine; Male; Sequence Analysis, DNA; Viral Load

2013
An optimized antiviral modification strategy for prevention of hepatitis B reactivation in patients undergoing prophylactic lamivudine and chemotherapy: a pilot study.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2013, Volume: 34, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antiviral Agents; Female; Hepatitis Antigens; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Neoplasms; Pilot Projects; Reverse Transcriptase Inhibitors; Secondary Prevention; Survival Rate; Treatment Outcome; Virus Activation; Young Adult

2013
Efficacy of combined antiviral therapy with lamivudine and tenofovir in a liver transplanted girl with de novo hepatitis B virus infection.
    Transplant infectious disease : an official journal of the Transplantation Society, 2013, Volume: 15, Issue:2

    Topics: Adenine; Antiviral Agents; Child, Preschool; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Organophosphonates; Tenofovir; Treatment Outcome

2013
Lamivudine-induced muscle mitochondrial toxicity.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2002, Volume: 34, Issue:5

    Topics: Antiviral Agents; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Mitochondrial Myopathies

2002
Advances in liver disease. Highlights from the 51st Annual Meeting of the American Association for the Study of Liver Diseases, October 27-31, 2000, Dallas, TX.
    Reviews in gastroenterological disorders, 2001, Volume: 1, Issue:1

    Topics: Antiviral Agents; Carcinoma, Hepatocellular; Hepatitis B; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Neoplasms; Liver Transplantation; Polyethylene Glycols; Recombinant Proteins

2001
Hepatitis B: weighing the costs of treatment.
    Journal of gastroenterology and hepatology, 2002, Volume: 17, Issue:7

    Topics: Antiviral Agents; Cost-Benefit Analysis; Disease Progression; Drug Costs; Hepatitis B; Hepatitis B virus; Humans; Interferon Type I; Lamivudine; Life Expectancy; Recombinant Proteins

2002
[Questions to professeur Patrick Marcellin].
    Gastroenterologie clinique et biologique, 2002, Volume: 26, Issue:5

    Topics: Antiviral Agents; Hepatitis B; Hepatitis B Vaccines; Hepatitis B virus; Humans; Interferon-alpha; Lamivudine; Liver; Mutation

2002
[HBV cirrhosis].
    Gastroenterologie clinique et biologique, 2002, Volume: 26, Issue:5

    Topics: Antiviral Agents; Hepatitis B; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Recurrence

2002
Rebound of hepatitis B virus replication in HepG2 cells after cessation of antiviral treatment.
    Journal of virology, 2002, Volume: 76, Issue:16

    Topics: Antiviral Agents; Arabinofuranosyluracil; Baculoviridae; Cell Line; DNA, Viral; Hepatitis B; Hepatitis B virus; Humans; Kinetics; Lamivudine; Recombination, Genetic; Virus Replication

2002
Tenofovir treatment in patients with lamivudine-resistant hepatitis B mutants strongly affects viral replication.
    Hepatology (Baltimore, Md.), 2002, Volume: 36, Issue:2

    Topics: Adenine; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutation; Organophosphonates; Organophosphorus Compounds; Reverse Transcriptase Inhibitors; Tenofovir; Virus Replication

2002
[Fatal fibrosing cholestatic hepatitis following renal transplantation].
    Nederlands tijdschrift voor geneeskunde, 2002, Jul-20, Volume: 146, Issue:29

    Topics: Aged; Antiviral Agents; Cholestasis; DNA, Viral; Fatal Outcome; Fibrosis; Hepatitis B; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Lamivudine; Male; Reverse Transcriptase Inhibitors; Viral Load

2002
Remission of severe aplastic anemia associated with hepatitis B virus infection after viral clearance: potential role of lamivudine.
    Digestive diseases and sciences, 2002, Volume: 47, Issue:8

    Topics: Adult; Anemia, Aplastic; Antiviral Agents; Hepatitis B; Humans; Lamivudine; Male; Remission, Spontaneous

2002
Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation.
    Journal of medical virology, 2002, Volume: 68, Issue:2

    Topics: Adult; Amino Acid Motifs; Amino Acid Sequence; Antiviral Agents; Base Sequence; DNA, Viral; Drug Resistance, Viral; Female; Genes, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Mutation; Recurrence

2002
Liver transplantation in hepatitis B patients with preoperative resistance formation during lamivudine treatment.
    Transplantation proceedings, 2002, Volume: 34, Issue:6

    Topics: Drug Resistance, Viral; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Recurrence; Reoperation; Treatment Outcome

2002
The use of antiviral monotherapy and combination therapy for patients with hepatitis B virus infection after liver transplantation.
    Transplantation proceedings, 2002, Volume: 34, Issue:6

    Topics: 2-Aminopurine; Antiviral Agents; Drug Therapy, Combination; Famciclovir; Hepatitis B; Hepatitis B Surface Antigens; Humans; Lamivudine; Liver Function Tests; Liver Transplantation; Recurrence

2002
Prophylaxis of hepatitis B recurrence after liver transplantation with lamivudin and hepatitis B immunoglobulin.
    Transplantation proceedings, 2002, Volume: 34, Issue:6

    Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Hepatitis B; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins, Intravenous; Immunosuppression Therapy; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence; Treatment Outcome

2002
Clinical impact and efficacy of lamivudine therapy in de novo hepatitis B infection after liver transplantation.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2002, Volume: 8, Issue:10

    Topics: Biopsy; Female; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Histocompatibility Testing; Humans; Lamivudine; Liver; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Reverse Transcriptase Inhibitors; Safety; Survival Analysis; Treatment Outcome

2002
Treatment of recurrent hepatitis B infection in liver transplant recipients.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2002, Volume: 8, Issue:10 Suppl 1

    Topics: 2-Aminopurine; Adenine; Antiviral Agents; Famciclovir; Hepatitis B; Humans; Interferon-alpha; Lamivudine; Liver Transplantation; Organophosphonates; Recurrence; Reverse Transcriptase Inhibitors

2002
Indefinite passive immunization after liver transplantation for hepatitis B.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2002, Volume: 8, Issue:10 Suppl 1

    Topics: Antiviral Agents; Hepatitis B; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Reverse Transcriptase Inhibitors

2002
Histological improvement with lamivudine therapy for de novo hepatitis B occurring in an anti-HBs-positive child after bone marrow transplantation.
    Bone marrow transplantation, 2002, Volume: 30, Issue:7

    Topics: Adolescent; Antibodies, Viral; Bone Marrow Transplantation; Female; Hepatitis B; Hepatitis B Surface Antigens; Humans; Lamivudine; Leukemia, Myeloid, Acute; Liver Cirrhosis; Virus Activation

2002
Additional benefit of lamivudine treatment as a preventive therapy for hepatic encephalopathy in patients with decompensated liver cirrhosis associated with hepatitis B.
    International journal of molecular medicine, 2002, Volume: 10, Issue:5

    Topics: Antiviral Agents; Female; Hepatic Encephalopathy; Hepatitis B; Humans; Lamivudine; Liver Cirrhosis; Middle Aged; Recurrence

2002
Pulmonary involvement in hepatitis B-related polyarteritis nodosa.
    Chest, 2002, Volume: 122, Issue:4

    Topics: Adrenal Cortex Hormones; Adult; Combined Modality Therapy; Hemorrhage; Hepatitis B; Humans; Lamivudine; Lung Diseases; Male; Plasmapheresis; Polyarteritis Nodosa; Prognosis; Risk Assessment; Treatment Outcome

2002
Prophylactic lamivudine therapy for hepatitis B patients undergoing immunosuppressive therapy.
    Blood, 2002, Oct-15, Volume: 100, Issue:8

    Topics: Antiviral Agents; Hepatitis B; Hepatitis B virus; Humans; Immunosuppressive Agents; Lamivudine; Recurrence; Virus Activation

2002
Editorial comment: a tale of two viruses.
    The AIDS reader, 2002, Volume: 12, Issue:10

    Topics: Adenine; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B Vaccines; HIV Infections; Humans; Lamivudine; Organophosphonates; Organophosphorus Compounds; Reverse Transcriptase Inhibitors; Tenofovir

2002
Evolving experience of hepatitis B virus prophylaxis in liver transplantation.
    Transplant infectious disease : an official journal of the Transplantation Society, 2002, Volume: 4, Issue:3

    Topics: Adult; Chemoprevention; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Incidence; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence; Retrospective Studies; Reverse Transcriptase Inhibitors

2002
Combination of HBIG and lamivudine-resistant mutations: a formula for trouble?
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2002, Volume: 8, Issue:11

    Topics: DNA-Directed DNA Polymerase; Drug Resistance; Drug Therapy, Combination; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Mutation; Postoperative Complications; Reverse Transcriptase Inhibitors; Virus Replication

2002
Characterization of nuclease-resistant ribozymes directed against hepatitis B virus RNA.
    Journal of viral hepatitis, 2002, Volume: 9, Issue:6

    Topics: Animals; Antiviral Agents; DNA, Viral; Endonucleases; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; RNA, Catalytic; RNA, Viral; Tumor Cells, Cultured

2002
Prevention of de novo hepatitis B virus infection in living donor liver transplantation using hepatitis B core antibody positive donors.
    Clinical transplantation, 2002, Volume: 16, Issue:6

    Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Hepatitis B; Hepatitis B Core Antigens; Humans; Infant; Lamivudine; Liver Transplantation; Living Donors; Retrospective Studies

2002
Seroconversion in patients with acute hepatitis B reinfection after liver transplantation with a combined treatment of lamivudine and hepatitis B immune globulin.
    Transplantation proceedings, 2002, Volume: 34, Issue:8

    Topics: Acute Disease; Adult; Base Sequence; DNA Primers; DNA, Viral; Follow-Up Studies; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver; Liver Transplantation; Male; Middle Aged; Polymerase Chain Reaction; Recurrence; Retrospective Studies; Time Factors

2002
[Clinical and histological features of fibrosing cholestatic hepatitis].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2002, Volume: 10, Issue:6

    Topics: Adult; Anti-HIV Agents; Cholestasis, Intrahepatic; DNA, Viral; Female; Fibrosis; Hepatitis B; Hepatitis B virus; Hepatocytes; Humans; Kidney Transplantation; Lamivudine; Male; Middle Aged; Retrospective Studies

2002
[Efficacy and safety of long-term lamivudine therapy in the patients with decompensated liver cirrhosis secondary to hepatitis B].
    Taehan Kan Hakhoe chi = The Korean journal of hepatology, 2002, Volume: 8, Issue:4

    Topics: Adult; Antiviral Agents; Female; Hepatitis B; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Treatment Outcome

2002
A United States compassionate use study of lamivudine treatment in nontransplantation candidates with decompensated hepatitis B virus-related cirrhosis.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2003, Volume: 9, Issue:1

    Topics: Adult; Aged; Alanine Transaminase; DNA, Viral; Female; Hepatitis B; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Prospective Studies; Reverse Transcriptase Inhibitors; United States

2003
Tenofovir disoproxil fumarate in patients with HIV and lamivudine-resistant hepatitis B virus.
    The New England journal of medicine, 2003, Jan-09, Volume: 348, Issue:2

    Topics: Adenine; Adult; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Tenofovir

2003
A renal allograft recipient with viral-burden, steatoviral, and fibroviral hepatitis B who achieved remission with Lamivudine.
    Journal of clinical gastroenterology, 2003, Volume: 36, Issue:2

    Topics: Adult; Alanine Transaminase; DNA, Viral; Fatty Liver; gamma-Glutamyltransferase; Hepatitis B; Hepatitis B virus; Humans; Kidney Transplantation; Lamivudine; Liver Cirrhosis; Male; Remission Induction; Reverse Transcriptase Inhibitors; Transplantation, Homologous

2003
Conversion from intravenous to intramuscular hepatitis B immune globulin in combination with lamivudine is safe and cost-effective in patients receiving long-term prophylaxis to prevent hepatitis B recurrence after liver transplantation.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2003, Volume: 9, Issue:2

    Topics: Adult; Aged; Cost-Benefit Analysis; Drug Costs; Drug Therapy, Combination; Female; Graft Survival; Hepatitis B; Humans; Immunoglobulins; Injections, Intramuscular; Injections, Intravenous; Lamivudine; Liver Transplantation; Male; Middle Aged; Postoperative Period; Reverse Transcriptase Inhibitors; Safety; Secondary Prevention; Survival Analysis; Treatment Outcome

2003
Successful treatment of fibrosing cholestatic hepatitis using adefovir dipivoxil in a patient with cirrhosis and renal insufficiency.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2003, Volume: 9, Issue:2

    Topics: Adenine; Adult; Antiviral Agents; Bacterial Infections; Cholestasis; Drug Resistance, Microbial; Fibrosis; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver; Liver Cirrhosis; Male; Organophosphonates; Peritonitis; Recurrence; Renal Insufficiency; Reverse Transcriptase Inhibitors

2003
Tenofovir disoproxil fumarate exhibits strong antiviral effect in a patient with lamivudine-resistant severe hepatitis B reactivation.
    Gastroenterology, 2003, Volume: 124, Issue:2

    Topics: Adenine; Antiviral Agents; Drug Resistance, Microbial; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Recurrence; Reverse Transcriptase Inhibitors; Tenofovir; Virus Activation

2003
In vivo immunization following virus suppression: a novel approach for inducing immune control in chronic hepatitis B.
    Journal of viral hepatitis, 2003, Volume: 10, Issue:1

    Topics: Adult; Alanine Transaminase; Antiviral Agents; Chronic Disease; DNA, Viral; Drug Therapy, Combination; Hepatitis B; Humans; Immunization; Interferon-alpha; Lamivudine; Virus Replication

2003
Characteristics of and current treatment options for hepatitis B and hepatitis C.
    Journal (Canadian Dental Association), 2000, Volume: 66, Issue:10

    Topics: Adult; Antiviral Agents; Drug Combinations; Hepatitis B; Hepatitis C; Hepatitis C, Chronic; Humans; Interferon-alpha; Lamivudine; Reverse Transcriptase Inhibitors; Ribavirin

2000
The influence of hepatitis B virus genotype on the development of lamivudine resistance during long-term treatment.
    Journal of hepatology, 2003, Volume: 38, Issue:3

    Topics: Adult; Aged; Amino Acid Motifs; Drug Administration Schedule; Drug Resistance, Viral; Female; Genotype; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Reverse Transcriptase Inhibitors; Severity of Illness Index

2003
Combination hepatitis B immune globulin and lamivudine versus hepatitis B immune globulin monotherapy in preventing recurrent hepatitis B virus infection in liver transplant recipients.
    Transplantation proceedings, 2003, Volume: 35, Issue:2

    Topics: Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins, Intravenous; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence; Retrospective Studies

2003
Comparison between levels of anti-HBS with a fixed administration dose of HBIG and a combination of HBIG and lamivudine for the prophylaxis of hepatitis B after liver transplantation.
    Transplantation proceedings, 2003, Volume: 35, Issue:2

    Topics: Adult; Aged; Antibodies, Viral; Antiviral Agents; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Middle Aged; Postoperative Complications; Recurrence; Retrospective Studies

2003
Lamivudine treatment for acute hepatitis B virus infection during allogeneic peripheral blood stem cell transplantation.
    Bone marrow transplantation, 2003, Volume: 31, Issue:6

    Topics: Acute Disease; Adult; Female; Hematopoietic Stem Cell Transplantation; Hepatitis B; Humans; Lamivudine; Reverse Transcriptase Inhibitors

2003
[Genotyping of hepatitis B virus and clinical investigation].
    Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology, 2002, Volume: 16, Issue:4

    Topics: Adult; Antiviral Agents; DNA, Viral; Female; Genotype; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Polymerase Chain Reaction; Treatment Outcome

2002
HBV associated nephrotic syndrome: resolution with oral lamivudine.
    Archives of disease in childhood, 2003, Volume: 88, Issue:5

    Topics: Administration, Oral; Antigens, Viral; Child; Glomerulonephritis, Membranous; Hepatitis B; Humans; Lamivudine; Male; Microscopy, Electron; Nephrotic Syndrome; Reverse Transcriptase Inhibitors

2003
Another case of HBV associated membranous glomerulonephritis resolving on lamivudine.
    Archives of disease in childhood, 2003, Volume: 88, Issue:5

    Topics: Child, Preschool; Female; Glomerulonephritis, Membranous; Hepatitis B; Humans; Lamivudine; Nephrotic Syndrome; Reverse Transcriptase Inhibitors; Treatment Outcome

2003
Use of liver grafts from donors positive for antihepatitis B-core antibody (anti-HBc) in the era of prophylaxis with hepatitis-B immunoglobulin and lamivudine.
    Transplantation, 2003, Apr-27, Volume: 75, Issue:8

    Topics: Adult; Aged; Female; Graft Survival; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Reverse Transcriptase Inhibitors; Tissue Donors; Treatment Outcome

2003
Imatinib Mesylate (Gleevec) is a useful agent in the salvage treatment of adults with relapsed/refractory Philadelphia positive acute leukemias.
    Hematology (Amsterdam, Netherlands), 2003, Volume: 8, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benzamides; Cytarabine; Daunorubicin; Doxorubicin; Enzyme Inhibitors; Female; Fusion Proteins, bcr-abl; Hepatitis B; Humans; Imatinib Mesylate; Immunosuppressive Agents; Lamivudine; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Neoplasm Proteins; Peripheral Blood Stem Cell Transplantation; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Pyrimidines; Remission Induction; Salvage Therapy; Vincristine

2003
Detection of mutations in the hepatitis B virus polymerase gene.
    Clinical chemistry, 2003, Volume: 49, Issue:6 Pt 1

    Topics: Aged; Antiviral Agents; Drug Resistance, Viral; Female; Gene Products, pol; Genotype; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Retrospective Studies

2003
Cost-effective and safe ambulatory long-term immunoprophylaxis with intramuscular instead of intravenous hepatitis B immunoglobulin to prevent reinfection after orthotopic liver transplantation.
    Clinical transplantation, 2003, Volume: 17, Issue:3

    Topics: Adult; Cost-Benefit Analysis; Drug Administration Schedule; Female; Hepatitis B; Humans; Immunization, Passive; Immunoglobulins; Injections, Intramuscular; Injections, Intravenous; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence; Reverse Transcriptase Inhibitors; Time Factors

2003
Decompensated hepatitis B virus-related cirrhosis successfully treated with lamivudine allowing surgery for hepatocellular carcinoma.
    Internal medicine (Tokyo, Japan), 2003, Volume: 42, Issue:5

    Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Hepatectomy; Hepatitis B; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Radiography

2003
Fulminant hepatitis subsequent to reactivation of precore mutant hepatitis B virus in a patient with lymphoma treated with chemotherapy and rituximab.
    Haematologica, 2003, Volume: 88, Issue:6

    Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antiviral Agents; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma, Follicular; Mutation; Rituximab

2003
Combined lamivudine and interferon-alpha therapy for chemotherapy-induced reactivation of hepatitis B virus.
    The American journal of gastroenterology, 2003, Volume: 98, Issue:5

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Hepatitis B; Hepatitis B virus; Humans; Interferon-alpha; Lamivudine; Lymphoma, Non-Hodgkin; Male; Prednisone; Reverse Transcriptase Inhibitors; Vincristine; Virus Activation

2003
Excellent outcome of Lamivudine treatment in patients with chronic renal failure and hepatitis B virus infection.
    Journal of clinical gastroenterology, 2003, Volume: 37, Issue:1

    Topics: Adult; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Kidney Failure, Chronic; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors

2003
Prophylaxis against chemotherapy-induced reactivation of hepatitis B virus infection with Lamivudine.
    Journal of clinical gastroenterology, 2003, Volume: 37, Issue:1

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Reverse Transcriptase Inhibitors; Vincristine; Virus Activation

2003
Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection.
    Journal of viral hepatitis, 2003, Volume: 10, Issue:4

    Topics: Adolescent; Adult; Case-Control Studies; Female; Follow-Up Studies; Hepatitis B; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Probability; Prospective Studies; Reference Values; Reverse Transcriptase Inhibitors; Risk Assessment; Severity of Illness Index; Treatment Outcome; Viral Load

2003
Clinical evaluation of a new enzyme immunoassay for hepatitis B virus core-related antigen; a marker distinct from viral DNA for monitoring lamivudine treatment.
    Journal of viral hepatitis, 2003, Volume: 10, Issue:4

    Topics: Biomarkers; Case-Control Studies; Cohort Studies; DNA, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B virus; Humans; Immunoenzyme Techniques; Lamivudine; Male; Monitoring, Physiologic; Probability; Reference Values; Treatment Outcome

2003
The effect of lamivudine on the replication of hepatitis B virus in HIV-infected patients depends on the host immune status (CD4 cell count).
    AIDS (London, England), 2003, Jul-04, Volume: 17, Issue:10

    Topics: Adult; CD4 Lymphocyte Count; Female; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Male; Retrospective Studies; Reverse Transcriptase Inhibitors; Virus Replication

2003
Inhibition of hepatitis B virus replication in vivo by nucleoside analogues and siRNA.
    Gastroenterology, 2003, Volume: 125, Issue:1

    Topics: Adenine; Animals; Capsid; Combined Modality Therapy; Disease Models, Animal; Gene Expression Regulation, Viral; Genetic Therapy; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Lamivudine; Liver; Male; Mice; Mice, Inbred Strains; Organophosphonates; Reverse Transcriptase Inhibitors; RNA, Small Interfering; Specific Pathogen-Free Organisms; Virus Replication

2003
Prevalence and characterization of lamivudine-resistant hepatitis B virus mutations in HIV-HBV co-infected individuals.
    AIDS (London, England), 2003, Jul-25, Volume: 17, Issue:11

    Topics: Adult; Aged; CD4 Lymphocyte Count; Chronic Disease; Cross-Sectional Studies; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Mutation; Prevalence; Regression Analysis; Retrospective Studies; Reverse Transcriptase Inhibitors; Statistics, Nonparametric; Viremia

2003
Combined lamivudine and hepatitis B immunoglobulin for the prevention of hepatitis B recurrence after liver transplantation: long-term results.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2003, Volume: 3, Issue:8

    Topics: Adolescent; Adult; Cohort Studies; Drug Therapy, Combination; Female; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence; Survival Rate

2003
[Analysis of three lamivudine-resistant HBV mutants with the method of restriction enzyme digestion and its application].
    Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology, 2003, Volume: 17, Issue:1

    Topics: Adolescent; Adult; Antiviral Agents; DNA Mutational Analysis; DNA Primers; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Microbial Sensitivity Tests; Middle Aged; Point Mutation; Polymerase Chain Reaction

2003
[Study the mutations in polymerase gene of hepatitis B virus by three methods].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2003, Volume: 11, Issue:7

    Topics: Alanine Transaminase; DNA, Viral; Gene Products, pol; Hepatitis B; Humans; Lamivudine; Mutation

2003
Liver transplantation in patients with fulminant hepatitis B: experience in Canton, China.
    Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih, 2002, Volume: 17, Issue:1

    Topics: Adult; Hepatic Encephalopathy; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence; Survival Rate

2002
Hepatitis B virus reactivation during fludarabine therapy in non-Hodgkin's lymphoma.
    Leukemia & lymphoma, 2003, Volume: 44, Issue:7

    Topics: Antineoplastic Agents; DNA (Cytosine-5-)-Methyltransferases; DNA, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Remission Induction; Vidarabine; Virus Activation

2003
Successful clearance of hepatitis B virus after allogeneic stem cell transplantation: beneficial combination of adoptive immunity transfer and lamivudine.
    European journal of haematology, 2003, Volume: 71, Issue:3

    Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; DNA, Viral; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunotherapy, Adoptive; Kinetics; Lamivudine; Male; Peripheral Blood Stem Cell Transplantation; Reverse Transcriptase Inhibitors; Transplantation, Homologous

2003
Prophylaxis and treatment of hepatis B virus infection after liver transplantation.
    Transplantation proceedings, 2003, Volume: 35, Issue:3

    Topics: Antiviral Agents; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Postoperative Complications

2003
Use of combined treatment of hepatitis B immune globulin and lamivudine as prevention of hepatitis B virus recurrence in liver allograft.
    Transplantation proceedings, 2003, Volume: 35, Issue:5

    Topics: Adult; Aged; Female; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence; Transplantation, Homologous

2003
Prophylaxis of recurrent hepatitis B virus by vaccination after liver transplant: preliminary results.
    Transplantation proceedings, 2003, Volume: 35, Issue:5

    Topics: Antiviral Agents; Follow-Up Studies; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Vaccines; Humans; Immunization Schedule; Immunoglobulins; Lamivudine; Liver Transplantation; Recurrence; Time Factors

2003
Evolution of hepatitis B virus sequence from a liver transplant recipient with rapid breakthrough despite hepatitis B immune globulin prophylaxis and lamivudine therapy.
    Journal of medical virology, 2003, Volume: 71, Issue:3

    Topics: Base Sequence; Drug Resistance, Viral; Evolution, Molecular; Genome, Viral; Hepatitis B; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Molecular Sequence Data; Mutation; Reverse Transcriptase Inhibitors; Sequence Analysis, DNA

2003
[Clinical evaluation of polymerase chain reaction (PCR) method for the detection of hepatitis B virus (HBV)-DNA].
    Rinsho Biseibutsu Jinsoku Shindan Kenkyukai shi = JARMAM : Journal of the Association for Rapid Method and Automation in Microbiology, 2003, Volume: 13, Issue:2

    Topics: Adolescent; Adult; Aged; Child; Child, Preschool; DNA, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Infant; Lamivudine; Male; Middle Aged; Molecular Probes; Polymerase Chain Reaction

2003
Plasma pituitary adenylate cyclase activating polypeptide (PACAP) levels in chronic hepatitis B patients under lamivudine treatment.
    European journal of gastroenterology & hepatology, 2003, Volume: 15, Issue:11

    Topics: Adult; Antiviral Agents; Biomarkers; Case-Control Studies; DNA, Viral; Female; Hepatitis B; Hepatitis B, Chronic; Humans; Lamivudine; Liver; Male; Middle Aged; Neuropeptides; Pituitary Adenylate Cyclase-Activating Polypeptide; Radioimmunoassay; Viral Load

2003
Rapid and high throughput detection of HBV YMDD mutants with fluorescence polarization.
    World journal of gastroenterology, 2003, Volume: 9, Issue:10

    Topics: Drug Resistance, Viral; Fluorescence Polarization; Genetic Testing; Genotype; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutation; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; Sensitivity and Specificity

2003
Clinical outcome and virologic profiles of severe hepatitis B exacerbation due to YMDD mutations.
    Journal of hepatology, 2003, Volume: 39, Issue:5

    Topics: Adult; Alanine Transaminase; DNA, Viral; Female; Genotype; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Reverse Transcriptase Inhibitors; Severity of Illness Index; Treatment Outcome

2003
HBV resistant to lamivudine: experimental and clinical studies.
    Hepatobiliary & pancreatic diseases international : HBPD INT, 2002, Volume: 1, Issue:4

    Topics: Alanine Transaminase; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance; Hepatitis Antibodies; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Mutation; Reverse Transcriptase Inhibitors; Time Factors

2002
Prophylaxis and treatment of hepatitis B virus reinfection following liver transplantation.
    Hepatobiliary & pancreatic diseases international : HBPD INT, 2002, Volume: 1, Issue:3

    Topics: 2-Aminopurine; Adult; Antiviral Agents; DNA, Viral; Dose-Response Relationship, Drug; Drug Therapy, Combination; Famciclovir; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Male; Postoperative Complications; Reverse Transcriptase Inhibitors; Secondary Prevention

2002
Hepatitis B virus reactivation after fludarabine-based regimens for indolent non-Hodgkin's lymphomas: high prevalence of acquired viral genomic mutations.
    Haematologica, 2003, Volume: 88, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Carrier State; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Antigens; Hepatitis B virus; Hepatitis C Antibodies; Humans; Lamivudine; Liver Failure; Lymphoma, Non-Hodgkin; Male; Middle Aged; Sequence Homology; Vidarabine; Virus Activation

2003
PCR restriction fragment length polymorphism in detection of YMDD variants of viral polymerase in hepatitis B virus patients treated with lamivudine.
    Hepatobiliary & pancreatic diseases international : HBPD INT, 2002, Volume: 1, Issue:2

    Topics: Adolescent; Adult; Amino Acid Motifs; Aspartic Acid; Base Sequence; Child; DNA-Directed DNA Polymerase; Drug Resistance; Genetic Variation; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Methionine; Middle Aged; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Reverse Transcriptase Inhibitors; Tyrosine

2002
Role of lamivudine in the reactivation of hepatitis B virus infection in immunodepressed patients.
    Revista espanola de enfermedades digestivas, 2003, Volume: 95, Issue:11

    Topics: Adult; Female; Hepatitis B; Humans; Immunosuppression Therapy; Lamivudine; Male; Middle Aged; Recurrence; Reverse Transcriptase Inhibitors

2003
Evolution of wild type and mutants of the YMDD motif of hepatitis B virus polymerase during lamivudine therapy.
    Journal of gastroenterology and hepatology, 2003, Volume: 18, Issue:12

    Topics: Alanine Transaminase; Amino Acid Motifs; Cloning, Molecular; DNA, Viral; Drug Resistance, Viral; Gene Products, pol; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutation; Reverse Transcriptase Inhibitors; Time Factors

2003
The prophylactic use of lamivudine can maintain dose-intensity of adriamycin in hepatitis-B surface antigen (HBs Ag)-positive patients with Non-Hodgkin's lymphoma who receive cytotoxic chemotherapy.
    Journal of Korean medical science, 2003, Volume: 18, Issue:6

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Doxorubicin; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Reverse Transcriptase Inhibitors; Survival Rate; Virus Activation

2003
Subclones of drug-resistant hepatitis B virus mutants and the outcome of breakthrough hepatitis in patients treated with lamivudine.
    Intervirology, 2003, Volume: 46, Issue:6

    Topics: Antiviral Agents; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Mutation; Treatment Outcome

2003
Lamivudine therapy for decompensated liver cirrhosis related to hepatitis B virus infection.
    Intervirology, 2003, Volume: 46, Issue:6

    Topics: Carcinoma, Hepatocellular; Hepatitis B; Hepatitis B virus; Humans; Interferon-alpha; Lamivudine; Liver Cirrhosis; Liver Transplantation; Reverse Transcriptase Inhibitors; Severity of Illness Index

2003
Hepatitis B-assocciated adult-onset Still's disease presenting with neutrophilic urticaria.
    European journal of medical research, 2003, Dec-09, Volume: 8, Issue:12

    Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Diagnosis, Differential; Fever of Unknown Origin; Hepatitis B; Humans; Indomethacin; Lamivudine; Male; Prednisolone; Recurrence; Reverse Transcriptase Inhibitors; Still's Disease, Adult-Onset; Time Factors; Urticaria

2003
Hepatitis B virus genotypes B and C do not affect the antiviral response to lamivudine.
    Antiviral therapy, 2003, Volume: 8, Issue:6

    Topics: Adolescent; Adult; Alanine Transaminase; Antiviral Agents; Drug Resistance, Viral; Female; Gene Products, pol; Genotype; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation

2003
Monitoring the emergence of hepatitis B virus polymerase gene variants during lamivudine therapy in human immunodeficiency virus coinfected patients: performance of CLIP sequencing and line probe assay.
    Antiviral therapy, 2003, Volume: 8, Issue:6

    Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; DNA, Viral; Drug Resistance, Viral; Gene Products, pol; Genotype; Hepatitis B; Hepatitis B virus; HIV-1; Humans; Lamivudine; Male; Middle Aged; Mutation; Nucleic Acid Hybridization; Polymerase Chain Reaction; Reagent Kits, Diagnostic; Sequence Analysis, DNA

2003
Designing clinical development programs for anti-hepatitis B virus drugs.
    Methods in molecular medicine, 2004, Volume: 96

    Topics: Antiviral Agents; Clinical Trials as Topic; Drug Resistance, Viral; Genotype; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Interferons; Lamivudine; Research Design

2004
Clinical characteristics of asymptomatic hepatitis B virus carriers with YMDD mutant not treated with lamivudine.
    The Kurume medical journal, 2003, Volume: 50, Issue:3-4

    Topics: Adult; Aged; Amino Acid Sequence; Antiviral Agents; Carrier State; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Viral Proteins

2003
Antiretroviral therapy and HIV/hepatitis B virus coinfection.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Mar-01, Volume: 38 Suppl 2

    Topics: Adenine; Antiretroviral Therapy, Highly Active; Antiviral Agents; Hepatitis B; Hepatitis B virus; HIV; HIV Infections; Humans; Lamivudine; Organophosphonates; Organophosphorus Compounds; Tenofovir

2004
[Viral hepatitis B/C and HIV. Therapy of double infections].
    MMW Fortschritte der Medizin, 2003, Apr-28, Volume: 145 Spec No 1

    Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; Antiviral Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Hepatitis B; Hepatitis C; Humans; Interferon-alpha; Lamivudine; Organophosphonates; Treatment Outcome

2003
Reactivation of hepatitis B virus infection with cytotoxic therapy in non-Hodgkin's lymphoma.
    Medical oncology (Northwood, London, England), 2004, Volume: 21, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Alkaline Phosphatase; Anti-HIV Agents; Antineoplastic Agents; Female; gamma-Glutamyltransferase; Glutamyl Aminopeptidase; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulin G; Immunoglobulin M; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Virus Activation

2004
Treatment of hepatitis B virus-related polyarteritis nodosa: two case reports and a review of the literature.
    Clinical rheumatology, 2004, Volume: 23, Issue:2

    Topics: Adult; Anti-HIV Agents; Antiviral Agents; Combined Modality Therapy; Drug Therapy, Combination; Fatal Outcome; Glucocorticoids; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Magnetic Resonance Imaging; Male; Middle Aged; Plasma Exchange; Polyarteritis Nodosa; Tomography, X-Ray Computed; Treatment Refusal

2004
Horse antilymphocytic globulin in hepatitis B exacerbation after bone marrow transplantation adoptive immunity transfer.
    Bone marrow transplantation, 2004, Volume: 33, Issue:10

    Topics: Adoptive Transfer; Animals; Antilymphocyte Serum; Antiviral Agents; Bone Marrow Transplantation; Child; Disease Progression; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Heterozygote; Histocompatibility Testing; Horses; Humans; Immunotherapy, Adoptive; Lamivudine; Liver; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Time Factors; Tissue Donors

2004
Fibrosing cholestatic hepatitis secondary to precore/core promoter hepatitis B variant with lamivudine resistance: successful retransplantation with combination adefovir dipivoxil and hepatitis B immunoglobulin.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2004, Volume: 10, Issue:4

    Topics: Adenine; Adult; Antiviral Agents; Cholestasis, Intrahepatic; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B Core Antigens; Humans; Immunoglobulins; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Organophosphonates; Promoter Regions, Genetic; Reoperation; Treatment Outcome

2004
Effect of SEN virus coinfection on outcome of lamivudine therapy in patients with hepatitis B.
    World journal of gastroenterology, 2004, Apr-01, Volume: 10, Issue:7

    Topics: Adult; DNA Virus Infections; Hepatitis B; Humans; Lamivudine; Male; Reverse Transcriptase Inhibitors; Treatment Outcome

2004
Preemptive use of lamivudine in breast cancer patients carrying hepatitis B virus undergoing cytotoxic chemotherapy: a longitudinal study.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2004, Volume: 12, Issue:3

    Topics: Adult; Antineoplastic Agents; Antiviral Agents; Breast Neoplasms; Chemoprevention; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Middle Aged; Prospective Studies; Risk Factors; Time Factors

2004
Emergence of YMDD mutant hepatitis B virus after allogeneic stem cell transplantation from a HBsAG-positive donor during lamivudine prophylaxis.
    Haematologica, 2004, Volume: 89, Issue:4

    Topics: Antibodies, Viral; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Lymphoma, T-Cell; Mutation; Premedication; Reverse Transcriptase Inhibitors; Tissue Donors; Transplantation, Homologous

2004
Adefovir dipivoxil as a treatment for hepatic failure caused by lamivudine-resistant HBV strains.
    Digestive diseases and sciences, 2004, Volume: 49, Issue:2

    Topics: Adenine; Antiviral Agents; DNA, Viral; Drug Resistance; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Failure; Male; Middle Aged; Organophosphonates; Retreatment; Reverse Transcriptase Inhibitors; Treatment Outcome

2004
HIV-1 and hepatitis B virus: time for a re-think?
    Lancet (London, England), 2004, Apr-24, Volume: 363, Issue:9418

    Topics: Acute Disease; Adult; Aged; Anti-HIV Agents; Drug Resistance, Viral; Female; Hepatitis B; HIV Infections; HIV-1; Humans; Lamivudine; Male

2004
Low-dose intramuscular hepatitis B immune globulin and lamivudine for long-term prophylaxis of hepatitis B recurrence after liver transplantation.
    Transplantation proceedings, 2004, Volume: 36, Issue:3

    Topics: Antiviral Agents; Costs and Cost Analysis; Female; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins, Intravenous; Italy; Lamivudine; Liver Failure; Liver Transplantation; Male; Middle Aged; Recurrence; Retrospective Studies; Treatment Outcome

2004
Low-dose hepatitis B immunoglobulin given "on demand" in combination with lamivudine: a highly cost-effective approach to prevent recurrent hepatitis B virus infection in the long-term follow-up after liver transplantation.
    Transplantation, 2004, Apr-27, Volume: 77, Issue:8

    Topics: Antiviral Agents; Cost-Benefit Analysis; Hepatitis B; Hepatitis B Antibodies; Humans; Immunoglobulins, Intravenous; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence

2004
Lamivudine-resistant hepatitis B virus and ongoing lamivudine therapy: stop the merry-go-round, it's time to get off!
    Antiviral therapy, 2004, Volume: 9, Issue:2

    Topics: Amino Acid Motifs; Antiviral Agents; Drug Administration Schedule; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; Lamivudine; Mutation; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase

2004
Long-term follow-up of HIV/HBV coinfected patients from a Greek center.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2004, Volume: 30, Issue:3

    Topics: Anti-HIV Agents; Drug Resistance, Viral; Drug Therapy, Combination; Follow-Up Studies; Greece; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Reverse Transcriptase Inhibitors

2004
Outcome of lamivudine resistant hepatitis B virus mutant post-liver transplantation on lamivudine monoprophylaxis.
    Clinical transplantation, 2004, Volume: 18, Issue:3

    Topics: Adult; Antiviral Agents; Chemoprevention; Cohort Studies; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Survival Analysis; Treatment Outcome

2004
Hepatitis B virus reactivation in a case of non-Hodgkin's lymphoma treated with chemotherapy and rituximab: necessity of prophylaxis for hepatitis B virus reactivation in rituximab therapy.
    Leukemia & lymphoma, 2004, Volume: 45, Issue:3

    Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Failure; Lymphoma, Non-Hodgkin; Rituximab; Serologic Tests; Virus Activation

2004
Prospective study on lamivudine-resistant hepatitis B in renal allograft recipients.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2004, Volume: 4, Issue:7

    Topics: Adult; Aged; Alanine Transaminase; Amino Acid Motifs; Codon; DNA Mutational Analysis; DNA, Viral; Drug Resistance, Viral; Female; Follow-Up Studies; Hepatitis; Hepatitis B; Hepatitis B virus; Humans; Immunosuppressive Agents; Kidney Transplantation; Lamivudine; Male; Middle Aged; Prospective Studies; Reverse Transcriptase Inhibitors; Time Factors

2004
Immune reconstitution hepatitis in HIV and hepatitis B coinfection, despite lamivudine therapy as part of HAART.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Jul-01, Volume: 39, Issue:1

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Female; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Immunity; Lamivudine; Middle Aged

2004
Hepatitis B.
    The New England journal of medicine, 2004, Jun-24, Volume: 350, Issue:26

    Topics: Antiviral Agents; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Interferon-alpha; Lamivudine; Remission Induction; Survival Rate; Viral Load

2004
Usefulness of dried blood samples for quantification and molecular characterization of HBV-DNA.
    Hepatology (Baltimore, Md.), 2004, Volume: 40, Issue:1

    Topics: Blood; Carrier State; Desiccation; DNA, Viral; Genetic Variation; Genotype; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutation; Reverse Transcriptase Inhibitors

2004
Cadaveric renal transplantation in hepatitis B antigen-positive recipients using hepatitis B antigen-positive donor organs with lamivudine treatment.
    Transplantation proceedings, 2004, Volume: 36, Issue:5

    Topics: Adult; Antiviral Agents; Brain Death; Cadaver; Female; Hepatitis B; Hepatitis B Antigens; Histocompatibility Testing; Humans; Kidney Transplantation; Lamivudine; Liver; Male; Tissue Donors

2004
Management of the coinfected patient: human immunodeficiency virus/hepatitis B and human immunodeficiency virus/hepatitis C.
    The American journal of the medical sciences, 2004, Volume: 328, Issue:1

    Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; Chronic Disease; Contraindications; Hepatitis B; Hepatitis C; HIV Infections; Humans; Lamivudine; Liver Diseases; Nucleosides; Practice Guidelines as Topic

2004
In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir.
    Antiviral therapy, 2004, Volume: 9, Issue:3

    Topics: Adenine; Adult; Antiviral Agents; Cell Line; DNA-Directed DNA Polymerase; DNA, Viral; Dose-Response Relationship, Drug; Drug Resistance, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Middle Aged; Mutation; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Transfection; Virus Replication

2004
A novel pattern (sW195a) in surface gene of HBV DNA due to YSDD (L180M plus M204S) mutation selected during lamivudine therapy and successful treatment with adefovir dipivoxil.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2004, Volume: 31, Issue:1

    Topics: Adenine; Amino Acid Substitution; Antiviral Agents; Drug Resistance, Viral; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Mutation, Missense; Organophosphonates

2004
Comparison of sequence analysis and a novel discriminatory real-time PCR assay for detection and quantification of Lamivudine-resistant hepatitis B virus strains.
    Journal of clinical microbiology, 2004, Volume: 42, Issue:8

    Topics: Base Sequence; Computer Systems; DNA Primers; Genetic Variation; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Longitudinal Studies; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; Viral Load

2004
Frequency of hepatitis B virus mutant in asymptomatic hepatitis B virus carriers receiving prophylactic lamivudine during chemotherapy for hematologic malignancies.
    The hematology journal : the official journal of the European Haematology Association, 2004, Volume: 5, Issue:4

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Carrier State; DNA, Viral; Female; Hematologic Neoplasms; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Mutation

2004
Suppression of lamivudine-resistant B-domain mutants by adefovir dipivoxil in the woodchuck hepatitis virus model.
    Antiviral research, 2004, Volume: 63, Issue:2

    Topics: Adenine; Administration, Oral; Amino Acid Motifs; Amino Acid Substitution; Animals; Antiviral Agents; Disease Models, Animal; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B Virus, Woodchuck; Lamivudine; Marmota; Mutation, Missense; Organophosphonates; Protein Structure, Tertiary; Viremia; Virus Replication

2004
Adefovir dipivoxil to prevent exacerbation of lamivudine-resistant hepatitis B infection during chemotherapy for non-Hodgkin's lymphoma.
    The American journal of gastroenterology, 2004, Volume: 99, Issue:8

    Topics: Adenine; Adult; Antiviral Agents; Carrier State; Drug Resistance; Female; Hepatitis B; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Organophosphonates; Reverse Transcriptase Inhibitors

2004
Detection of YMDD motif mutants by oligonucleotide chips in lamivudine-untreated patients with chronic hepatitis B virus infection.
    Journal of Korean medical science, 2004, Volume: 19, Issue:4

    Topics: Adolescent; Adult; Amino Acid Motifs; Chronic Disease; Female; Genetic Variation; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Oligonucleotide Array Sequence Analysis; Polymorphism, Restriction Fragment Length; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Sequence Analysis, DNA

2004
Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:9

    Topics: Adult; Amino Acid Substitution; Antiviral Agents; Capsid Proteins; Cell Line, Tumor; Cells, Cultured; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Genotype; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Phenotype; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Treatment Failure; Virus Replication

2004
Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP.
    Annals of hematology, 2004, Volume: 83, Issue:12

    Topics: Adult; Alanine Transaminase; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bilirubin; Cyclophosphamide; DNA-Directed DNA Polymerase; DNA, Viral; Doxorubicin; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma, B-Cell; Male; Mutation; Prednisone; Recurrence; Reverse Transcriptase Inhibitors; Rituximab; Sequence Analysis, DNA; Vincristine; Virus Activation

2004
The use of lamivudine for patients with acute hepatitis B (a series of cases).
    Journal of viral hepatitis, 2004, Volume: 11, Issue:5

    Topics: Acute Disease; Adult; Aged; DNA, Viral; Female; Hepatitis B; Humans; Lamivudine; Liver Failure; Male; Middle Aged; Renal Dialysis; Reverse Transcriptase Inhibitors; Severity of Illness Index; Treatment Outcome

2004
Long-term follow-up study of Chinese patients with YMDD mutations: significance of hepatitis B virus genotypes and characteristics of biochemical flares.
    Journal of clinical microbiology, 2004, Volume: 42, Issue:9

    Topics: Adolescent; Adult; Amino Acid Sequence; Amino Acid Substitution; DNA, Viral; Female; Follow-Up Studies; Genotype; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation, Missense; Recurrence; RNA-Directed DNA Polymerase

2004
Oligonucleotide chip for detection of Lamivudine-resistant hepatitis B virus.
    Journal of clinical microbiology, 2004, Volume: 42, Issue:9

    Topics: DNA Primers; DNA, Viral; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutagenesis, Site-Directed; Oligonucleotide Array Sequence Analysis; Oligonucleotide Probes; Sensitivity and Specificity

2004
Treatment of an HBs-Ag positive stem cell donor with lamivudine to prevent the development of hepatitis B in the recipient.
    Transplantation, 2004, Sep-15, Volume: 78, Issue:5

    Topics: Hepatitis B; Hepatitis B Surface Antigens; Humans; Lamivudine; Leukemia, Myeloid, Acute; Male; Middle Aged; Reverse Transcriptase Inhibitors; Stem Cell Transplantation; Tissue Donors; Transplantation, Homologous; Treatment Outcome

2004
Pyrosequencing for detection of lamivudine-resistant hepatitis B virus.
    Journal of clinical microbiology, 2004, Volume: 42, Issue:10

    Topics: Base Sequence; Diphosphates; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Molecular Sequence Data; Mutation; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; Sequence Analysis, DNA

2004
Outcomes in liver transplant recipients with hepatitis B virus: resistance and recurrence patterns from a large transplant center over the last decade.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2004, Volume: 10, Issue:11

    Topics: Adenine; Adult; Aged; Antiviral Agents; Drug Resistance, Viral; Female; Graft Survival; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Failure; Liver Transplantation; Male; Middle Aged; Organophosphonates; Recurrence; Retrospective Studies; Survival Analysis; Treatment Outcome

2004
Serum lamivudine levels in the presence of a lamivudine-resistant HBV mutant.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2004, Volume: 36, Issue:10

    Topics: Anti-HIV Agents; Chromatography, High Pressure Liquid; Drug Resistance, Viral; Enzyme-Linked Immunosorbent Assay; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Polymerase Chain Reaction; Recurrence

2004
Tenofovir therapy for lamivudine resistance following liver transplantation.
    The Annals of pharmacotherapy, 2004, Volume: 38, Issue:12

    Topics: Adenine; Adult; Antiviral Agents; Chronic Disease; Drug Resistance, Viral; Hepatitis B; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Organophosphonates; Retrospective Studies; Salvage Therapy; Tenofovir; Treatment Outcome

2004
Adefovir dipivoxil as the rescue therapy for lamivudine-resistant hepatitis B post liver transplant.
    Transplantation proceedings, 2004, Volume: 36, Issue:8

    Topics: Adenine; Adolescent; Adult; Aged; Antiviral Agents; Child; Drug Resistance; Follow-Up Studies; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Middle Aged; Organophosphonates; Postoperative Complications; Recurrence; Retrospective Studies

2004
Heart transplantation using donors positive for hepatitis.
    Transplantation proceedings, 2004, Volume: 36, Issue:8

    Topics: Adolescent; Adult; Antiviral Agents; Brain Death; Cause of Death; Child; Child, Preschool; Female; Heart Transplantation; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis C; Humans; Infant; Lamivudine; Male; Middle Aged; Retrospective Studies; Tissue Donors

2004
Adefovir dipivoxil for treatment of breakthrough hepatitis caused by lamivudine-resistant mutants of hepatitis B virus.
    Intervirology, 2004, Volume: 47, Issue:6

    Topics: Adenine; Adult; Alanine Transaminase; Drug Resistance, Microbial; Female; Genotype; Hepatitis B; Hepatitis B virus; Humans; Interferon-alpha; Lamivudine; Male; Middle Aged; Organophosphonates; Safety; Treatment Outcome

2004
Hepatitis B virus reactivation in breast cancer patients undergoing cytotoxic chemotherapy and the role of preemptive lamivudine administration.
    Liver international : official journal of the International Association for the Study of the Liver, 2004, Volume: 24, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Breast Neoplasms; DNA, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Middle Aged; Molecular Sequence Data; Monitoring, Physiologic; Primary Prevention; Prospective Studies; Reverse Transcriptase Polymerase Chain Reaction; Risk Assessment; Secondary Prevention; Serologic Tests; Treatment Outcome

2004
Prophylactic lamivudine administration prevents exacerbation of liver damage in HBe antigen positive patients with hepatocellular carcinoma undergoing transhepatic arterial infusion chemotherapy.
    The American journal of gastroenterology, 2004, Volume: 99, Issue:12

    Topics: Adult; Aged; Carcinoma, Hepatocellular; Chi-Square Distribution; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Function Tests; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Reverse Transcriptase Inhibitors; Statistics, Nonparametric; Treatment Outcome

2004
Successful therapy of hepatitis B with tenofovir in HIV-infected patients failing previous adefovir and lamivudine treatment.
    AIDS (London, England), 2004, Nov-19, Volume: 18, Issue:17

    Topics: Adenine; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Chronic Disease; DNA-Directed DNA Polymerase; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Mutation; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome; Viral Load

2004
Combined interferon plus lamivudine treatment in young patients with dual HBV (HBeAg positive) and HCV chronic infection.
    Journal of hepatology, 2004, Volume: 41, Issue:6

    Topics: Adolescent; Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Interferons; Lamivudine; Male; Reverse Transcriptase Inhibitors

2004
Treatment of polyarteritis nodosa: comment on the article by Guillevin et al.
    Arthritis and rheumatism, 2004, Dec-15, Volume: 51, Issue:6

    Topics: Cyclophosphamide; Diagnosis, Differential; Drug Therapy, Combination; Follow-Up Studies; Glucocorticoids; Hepatitis B; Humans; Lamivudine; Plasma Exchange; Polyarteritis Nodosa; Reverse Transcriptase Inhibitors

2004
Prevention of hepatitis B virus recurrence after living donor liver transplantation.
    Transplantation proceedings, 2004, Volume: 36, Issue:9

    Topics: Antiviral Agents; DNA, Viral; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Living Donors; Preoperative Care; Recurrence; Retrospective Studies; RNA, Viral; Viral Load

2004
Adefovir treatment in posttransplant hepatitis B virus infection resistant to lamivudine plus hepatitis B virus immunoglobulin.
    Transplantation proceedings, 2004, Volume: 36, Issue:9

    Topics: Adenine; Adult; Antibodies, Viral; Antiviral Agents; Drug Resistance; Female; Hepatitis B; Hepatitis B Antibodies; Humans; Lamivudine; Living Donors; Male; Middle Aged; Organophosphonates; Recurrence

2004
Decreased frequency and function of circulating plasmocytoid dendritic cells (pDC) in hepatitis B virus infected humans.
    Journal of clinical immunology, 2004, Volume: 24, Issue:6

    Topics: Adult; Blood Cell Count; Case-Control Studies; CD8-Positive T-Lymphocytes; Cross Infection; Dendritic Cells; Female; Hepatitis B; Humans; Immunity, Innate; Immunocompromised Host; Interferon-alpha; Killer Cells, Natural; Lamivudine; Leukocytes, Mononuclear; Liver Cirrhosis; Male; Middle Aged; Virus Replication

2004
Prevalence of hepatitis B and C virus infection in haematological malignancies and liver injury following chemotherapy.
    European journal of haematology, 2005, Volume: 74, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carrier State; Female; Hematologic Neoplasms; Hepatitis B; Hepatitis B virus; Hepatitis C; Humans; Japan; Lamivudine; Liver; Male; Middle Aged; Prevalence; Reverse Transcriptase Inhibitors; Virus Activation

2005
[Effect of lamivudine for hepatitis B virus reactivation in blood cancer patients undergoing immunosuppressive chemotherapy].
    Fukuoka igaku zasshi = Hukuoka acta medica, 2004, Volume: 95, Issue:10

    Topics: Adult; Aged; Antineoplastic Agents; Antiviral Agents; Bone Marrow Transplantation; Female; Hematologic Neoplasms; Hepatitis B; Hepatitis B virus; Humans; Immunocompromised Host; Immunosuppressive Agents; Lamivudine; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Virus Activation

2004
No hepatitis recurrence using combination prophylaxis in HBV-positive liver transplant recipients with YMDD mutants.
    Transplant international : official journal of the European Society for Organ Transplantation, 2005, Volume: 18, Issue:2

    Topics: Adult; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Immunosuppressive Agents; Lamivudine; Liver Transplantation; Male; Middle Aged; Mutation; Prospective Studies; Recurrence

2005
Hepatitis B virus reactivation and alemtuzumab therapy.
    European journal of haematology, 2005, Volume: 74, Issue:3

    Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; DNA, Viral; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunosuppression Therapy; Lamivudine; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Reverse Transcriptase Inhibitors; Virus Activation

2005
Rhabdomyolysis due to Lamivudine administration in a liver transplant recipient.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2005, Volume: 5, Issue:3

    Topics: Antiviral Agents; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Rhabdomyolysis

2005
Successful pregnancy in a liver transplant recipient treated with lamivudine for de novo hepatitis B in the graft.
    Transplant international : official journal of the European Society for Organ Transplantation, 2005, Volume: 17, Issue:11

    Topics: Adult; Azathioprine; Caroli Disease; Cyclosporine; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B Core Antigens; Humans; Immunosuppressive Agents; Infant, Newborn; Lamivudine; Liver; Liver Transplantation; Male; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Reverse Transcriptase Inhibitors

2005
Quantification of the relative levels of wild-type and lamivudine-resistant mutant virus in serum of HBV-infected patients using microarray.
    Journal of viral hepatitis, 2005, Volume: 12, Issue:2

    Topics: Base Sequence; Cohort Studies; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Molecular Sequence Data; Mutation; Oligonucleotide Array Sequence Analysis; Polymerase Chain Reaction; Sensitivity and Specificity; Treatment Outcome; Viral Load

2005
Viral load at the time of liver transplantation and risk of hepatitis B virus recurrence.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2005, Volume: 11, Issue:4

    Topics: Adult; Antiviral Agents; Female; Hepatitis B; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence; Viral Load

2005
Persistence of acute infection with hepatitis B virus genotype A and treatment in Japan.
    Journal of medical virology, 2005, Volume: 76, Issue:1

    Topics: Adult; Alanine Transaminase; Antiviral Agents; Drug Therapy, Combination; Genotype; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hospitals, Urban; Humans; Interferons; Japan; Lamivudine; Longitudinal Studies; Male; Middle Aged; Risk Factors; Sexual Behavior

2005
[HBV-specific CD8+ T cells for sustained HBeAg seroconversion after lamivudine therapy].
    The Korean journal of hepatology, 2005, Volume: 11, Issue:1

    Topics: Adult; Antiviral Agents; CD8-Positive T-Lymphocytes; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Recurrence; Viral Load

2005
Survival of infantile fulminant hepatitis B and treatment with Lamivudine.
    Journal of pediatric gastroenterology and nutrition, 2005, Volume: 40, Issue:4

    Topics: Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Infant; Lamivudine; Liver Failure; Male; Reverse Transcriptase Inhibitors; Survival Analysis; Treatment Outcome

2005
Preliminary study on the efficacy and safety of lamivudine and interferon alpha therapy in decreasing serum HBV DNA level in HBV positive transgenic mice during pregnancy.
    Journal of medical virology, 2005, Volume: 76, Issue:2

    Topics: Animals; Antiviral Agents; Disease Models, Animal; DNA, Viral; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Interferon-alpha; Lamivudine; Mice; Mice, Transgenic; Pregnancy; Pregnancy Complications, Infectious; Viremia

2005
Lamivudine prophylaxis in HBV carriers with haemato-oncological malignancies who receive chemotherapy.
    The Journal of antimicrobial chemotherapy, 2005, Volume: 55, Issue:6

    Topics: Antiviral Agents; Carrier State; Hematologic Neoplasms; Hepatitis B; Humans; Lamivudine; Time Factors; Virus Activation

2005
Treatment with adefovir dipivoxil in a renal transplant patient with renal insufficiency and lamivudine-resistant hepatitis B infection.
    Transplantation proceedings, 2005, Volume: 37, Issue:3

    Topics: Adenine; Antiviral Agents; Creatinine; Drug Resistance, Viral; Follow-Up Studies; Hepatitis B; Humans; Kidney Failure, Chronic; Kidney Transplantation; Lamivudine; Male; Middle Aged; Organophosphonates; Treatment Outcome

2005
Adefovir dipivoxil therapy in liver transplant recipients with lamivudine-resistant hepatitis B virus.
    Transplantation proceedings, 2005, Volume: 37, Issue:3

    Topics: Adenine; Adult; Aged; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; Humans; Immunosuppression Therapy; Lamivudine; Liver Transplantation; Middle Aged; Organophosphonates; Retrospective Studies; Viral Load

2005
Efficacy of lamivudine therapy for decompensated liver cirrhosis due to hepatitis B virus with or without hepatocellular carcinoma.
    Oncology reports, 2005, Volume: 13, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Reverse Transcriptase Inhibitors; Survival Rate; Treatment Outcome

2005
Prevalence, incidence, and clinical relevance of the reverse transcriptase V207I mutation outside the YMDD motif of the hepatitis B virus polymerase during lamivudine therapy.
    Journal of clinical microbiology, 2005, Volume: 43, Issue:5

    Topics: Amino Acid Sequence; Amino Acid Substitution; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Polyethylene Glycols; Recombinant Proteins; RNA-Directed DNA Polymerase

2005
Safety of using hepatitis B virus core antibody or surface antigen-positive donors in kidney or pancreas transplantation.
    Clinical transplantation, 2005, Volume: 19, Issue:3

    Topics: Adult; Aged; Antiviral Agents; Chemoprevention; Female; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Humans; Kidney Transplantation; Lamivudine; Male; Middle Aged; Pancreas Transplantation

2005
Fatal fulminant hepatitis B after withdrawal of prophylactic lamivudine in hematopoietic stem cell transplantation patients.
    International journal of hematology, 2005, Volume: 81, Issue:4

    Topics: Acute Disease; Adult; Anti-HIV Agents; Fatal Outcome; Female; Hematopoietic Stem Cell Transplantation; Hepatitis B; Humans; Lamivudine; Leukemia, Myeloid; Liver Failure, Acute; Lymphoma, Non-Hodgkin; Male

2005
HBV-DNA suppression and disease course in HBV cirrhosis patients on long-term lamivudine therapy.
    Antiviral therapy, 2005, Volume: 10, Issue:3

    Topics: Adult; Aged; Antiviral Agents; Cohort Studies; DNA, Viral; Drug Administration Schedule; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Mutation; Virus Replication

2005
[Study on efficacy and safety of lamivudine and interferon-alpha in treatment of hepatitis B virus transgenic mice with pregnancy].
    Zhonghua fu chan ke za zhi, 2005, Volume: 40, Issue:5

    Topics: Animals; Antiviral Agents; Disease Models, Animal; Drug Administration Routes; Female; Hepatitis B; Hepatitis B virus; Interferon-alpha; Lamivudine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Pregnancy; Pregnancy Complications, Infectious; Random Allocation; Viral Load

2005
Successful treatment with tenofovir in a child C cirrhotic patient with lamivudine-resistant hepatitis B virus awaiting liver transplantation. Post-transplant results.
    Transplant international : official journal of the European Society for Organ Transplantation, 2005, Volume: 18, Issue:7

    Topics: Adenine; Adult; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Mutation; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome; Waiting Lists

2005
Simultaneous detection of two major lamivudine-resistant mutants using competitively differentiated-PCR.
    Journal of virological methods, 2005, Volume: 128, Issue:1-2

    Topics: Antiviral Agents; DNA Primers; DNA, Viral; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutation; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors

2005
[Efficacy and safety of adefovir dipivoxil in patients with decompensated liver cirrhosis with Lamivudine resistance compared to patients with compensated liver disease].
    The Korean journal of hepatology, 2005, Volume: 11, Issue:2

    Topics: Adenine; Adult; Aged; Antiviral Agents; Drug Resistance, Viral; Female; Hepatitis B; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Organophosphonates

2005
Lamivudine therapy in HBsAg-carrying breast cancer patients undergoing chemotherapy: prophylactic or preemptive?
    Breast cancer research and treatment, 2005, Volume: 92, Issue:1

    Topics: Antineoplastic Agents; Antiviral Agents; Breast Neoplasms; Female; Hepatitis B; Hepatitis B Surface Antigens; Humans; Lamivudine

2005
Reactivation of hepatitis B in an HIV-infected patient with antibodies against hepatitis B core antigen as the only serological marker.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2005, Volume: 24, Issue:7

    Topics: Adult; Alanine Transaminase; Anti-HIV Agents; Aspartate Aminotransferases; Biomarkers; DNA, Viral; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; HIV Infections; Humans; Lamivudine; Male; Recurrence

2005
Hepatitis B reactivation after withdrawal of pre-emptive lamivudine in patients with haematological malignancy on completion of cytotoxic chemotherapy.
    Gut, 2005, Volume: 54, Issue:11

    Topics: Adult; Aged; Antineoplastic Agents; Antiviral Agents; DNA, Viral; Female; Follow-Up Studies; Hematologic Neoplasms; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunocompromised Host; Lamivudine; Male; Middle Aged; Virus Activation

2005
Mutations outside the YMDD motif in the P protein can also cause DHBV resistant to Lamivudine.
    World journal of gastroenterology, 2005, Jul-21, Volume: 11, Issue:27

    Topics: Amino Acid Sequence; Animals; Chick Embryo; Disease Models, Animal; Drug Resistance, Viral; Ducks; Gene Products, pol; Hepatitis B; Hepatitis B virus; Lamivudine; Molecular Sequence Data; Reverse Transcriptase Inhibitors

2005
Lamivudine treatment in a patient with hepatitis B virus reactivation after allogenic peripheral bone marrow transplantation.
    Leukemia & lymphoma, 2005, Volume: 46, Issue:6

    Topics: Antigens, Viral; Antiviral Agents; Bone Marrow Transplantation; DNA Replication; Female; Graft vs Host Disease; Hepatitis B; Hepatitis B virus; Humans; Immunosuppressive Agents; Lamivudine; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Liver; Middle Aged; Mutation

2005
Fatal reactivation of hepatitis B post-chemotherapy for lymphoma in a hepatitis B surface antigen-negative, hepatitis B core antibody-positive patient: potential implications for future prophylaxis recommendations.
    Leukemia & lymphoma, 2005, Volume: 46, Issue:7

    Topics: Aged; Anti-HIV Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fatal Outcome; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Failure; Lymphoma, B-Cell; Male; Prednisone; Rituximab; Vincristine; Virus Activation

2005
[SNaPshot technique for detection of single-nucleotide polymorphisms (SNPs) in HBV polymerase gene region of HBV gene].
    Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology, 2005, Volume: 19, Issue:2

    Topics: Antiviral Agents; Base Sequence; DNA, Viral; Drug Resistance, Viral; Gene Products, pol; Hepatitis B; Humans; Lamivudine; Polymorphism, Single Nucleotide; Sequence Analysis, DNA

2005
High replicative full-length lamivudine-resistant hepatitis B virus isolated during acute exacerbations.
    Journal of medical virology, 2005, Volume: 77, Issue:2

    Topics: Amino Acid Substitution; Antiviral Agents; Cell Line; Drug Resistance, Viral; Female; Gene Expression; Genes, Viral; Genome, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Mutation; Viral Load; Virus Replication

2005
[Adefovir dipivoxil-a new effective treatment for chronic infection with hepatitits B virus.].
    Klinicka mikrobiologie a infekcni lekarstvi, 2005, Volume: 11, Issue:4

    Topics: Antiviral Agents; Drug Interactions; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Herpesvirus 1, Cercopithecine; Humans; Lamivudine; Treatment Outcome

2005
Lamivudine therapy for hepatitis B infection in post-renal transplant patients: results after 36 months follow-up.
    Liver international : official journal of the International Association for the Study of the Liver, 2005, Volume: 25, Issue:5

    Topics: Adult; Aged; Antiviral Agents; DNA, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Surface Antigens; Humans; Kidney Transplantation; Lamivudine; Male; Middle Aged

2005
Dual-probe assay for detection of lamivudine-resistance hepatitis B virus by real-time PCR.
    Journal of virological methods, 2006, Volume: 132, Issue:1-2

    Topics: Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutation; Polymerase Chain Reaction; Sensitivity and Specificity; Sequence Analysis, DNA

2006
Liver targeting of hepatitis-B antiviral lamivudine using the HepDirect prodrug technology.
    Nucleosides, nucleotides & nucleic acids, 2005, Volume: 24, Issue:5-7

    Topics: Animals; Antiviral Agents; Area Under Curve; Cells, Cultured; Hepatitis B; Hepatocytes; Humans; Kinetics; Lamivudine; Liver; Microsomes, Liver; Models, Chemical; Phosphates; Phosphorylation; Prodrugs; Rats; Time Factors

2005
Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis B virus.
    Hepatology (Baltimore, Md.), 2005, Volume: 42, Issue:5

    Topics: Animals; Cell Line, Tumor; Chimera; DNA, Viral; Genetic Engineering; Hepatitis B; Hepatitis B virus; Hepatocytes; Histocytochemistry; Humans; Lamivudine; Liver; Mice; Mutation; Time Factors; Viremia

2005
Rapid and accurate genotyping of YMDD motif variants in the hepatitis B virus genome by an improved reverse dot blot method.
    Journal of clinical microbiology, 2005, Volume: 43, Issue:11

    Topics: Amino Acid Motifs; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Genome, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutation; Nucleic Acid Hybridization; Reverse Transcriptase Inhibitors; Sensitivity and Specificity

2005
Mass needle stick injury in children from the Western cape.
    Journal of tropical pediatrics, 2006, Volume: 52, Issue:3

    Topics: Adolescent; Anti-HIV Agents; Child; Child, Preschool; Communicable Disease Control; Environmental Exposure; Hepatitis B; Hepatitis B Vaccines; HIV Infections; Humans; Lamivudine; Longitudinal Studies; Medical Waste; Needlestick Injuries; South Africa; Treatment Outcome; Zidovudine

2006
Adefovir added to lamivudine for hepatitis B recurrent infection in refractory B-cell chronic lymphocytic leukemia on prolonged therapy with Campath-1H.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2006, Volume: 35, Issue:4

    Topics: Adenine; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Antiviral Agents; Drug Therapy, Combination; Hepatitis B; Humans; Lamivudine; Leukemia, Lymphocytic, Chronic, B-Cell; Organophosphonates; Recurrence; Treatment Outcome

2006
Adefovir rapidly suppresses hepatitis B in HBeAg-negative patients developing genotypic resistance to lamivudine.
    Hepatology (Baltimore, Md.), 2005, Volume: 42, Issue:6

    Topics: Adenine; Adult; Aged; Alanine Transaminase; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Genotype; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Prospective Studies

2005
Prevention of hepatitis B virus infection from hepatitis B core antibody-positive donor graft using hepatitis B immune globulin and lamivudine in living donor liver transplantation.
    Liver international : official journal of the International Association for the Study of the Liver, 2005, Volume: 25, Issue:6

    Topics: Adolescent; Adult; Antiviral Agents; Combined Modality Therapy; DNA, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Living Donors; Male; Middle Aged

2005
Long-term lamivudine therapy is not reasonable for HBV-associated nephropathy.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2006, Volume: 21, Issue:6

    Topics: Drug Resistance; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Nephrosis; Secondary Prevention; Time Factors

2006
Genotypic resistance to lamivudine among hepatitis B virus isolates in Mexico.
    The Journal of antimicrobial chemotherapy, 2006, Volume: 57, Issue:2

    Topics: Codon; DNA, Viral; Drug Resistance, Viral; Gene Amplification; Genotype; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Mexico; Reverse Transcriptase Inhibitors

2006
Occult hepatitis B virus infection before and 1 year after start of HAART in HIV type 1-positive patients.
    AIDS research and human retroviruses, 2005, Volume: 21, Issue:11

    Topics: Adult; Amino Acid Substitution; Antiretroviral Therapy, Highly Active; DNA, Viral; Female; Genotype; Hepatitis B; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Mutation; Sequence Analysis, DNA

2005
Study on the efficacy and safety of adefovir dipivoxil treatment in post-liver transplant patients with hepatitis B virus infection and lamivudine-resistant hepatitis B virus.
    Transplantation proceedings, 2005, Volume: 37, Issue:9

    Topics: Adenine; Alanine Transaminase; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis C; Humans; Lamivudine; Liver Transplantation; Male; Organophosphonates; Recurrence; Retrospective Studies; Safety

2005
Does hepatitis C virus affect the reactivation of hepatitis B virus following renal transplantation?
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2006, Volume: 21, Issue:4

    Topics: Adult; Female; Graft Survival; Hepacivirus; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis C; Humans; Kidney Transplantation; Lamivudine; Male; Reverse Transcriptase Inhibitors; Virus Activation

2006
Wild type and YMDD variant of hepatitis B virus: no difference in viral kinetics on lamivudine/tenofovir therapy in HIV-HBV co-infected patients.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2006, Volume: 36, Issue:1

    Topics: Adenine; Adult; Anti-HIV Agents; DNA, Viral; Drug Resistance, Viral; Genetic Variation; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Kinetics; Lamivudine; Male; Middle Aged; Organophosphonates; RNA, Viral; Tenofovir

2006
Clinical and virological features of non-breakthrough and severe exacerbation due to lamivudine-resistant hepatitis B virus mutants.
    Journal of medical virology, 2006, Volume: 78, Issue:3

    Topics: Adult; Aged; Amino Acid Substitution; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Genome, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Japan; Lamivudine; Male; Middle Aged; Mutation, Missense; RNA-Directed DNA Polymerase; Sequence Analysis, DNA; Viral Load

2006
Measurement of hepatitis B virus core-related antigen is valuable for identifying patients who are at low risk of lamivudine resistance.
    Liver international : official journal of the International Association for the Study of the Liver, 2006, Volume: 26, Issue:1

    Topics: Adult; Aged; Cohort Studies; DNA, Viral; Drug Resistance; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Function Tests; Male; Middle Aged; Predictive Value of Tests; Probability; Prognosis; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Statistics, Nonparametric; Viral Core Proteins

2006
A case of emphysematous pyelonephritis in a renal allograft.
    Transplantation, 2006, Jan-27, Volume: 81, Issue:2

    Topics: Abscess; Antiviral Agents; Fatal Outcome; Hepatitis B; Humans; Kidney Transplantation; Lamivudine; Liver Failure, Acute; Male; Middle Aged; Pyelonephritis

2006
Adefovir therapy for lamivudine escape and hepatitis B virus reactivation after reduced intensity conditioning allogeneic stem cell transplantation.
    Bone marrow transplantation, 2006, Volume: 37, Issue:6

    Topics: Adenine; Adult; Antineoplastic Agents; Combined Modality Therapy; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Leukemia, Myeloid, Acute; Organophosphonates; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Viral Load; Virus Activation

2006
[The safety and effect of lamivudine in treating pregnant women infected with hepatitis B virus].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2006, Volume: 14, Issue:2

    Topics: Adult; Female; Hepatitis B; Humans; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors

2006
YMDD mutations and genotypes of hepatitis B virus in northern China.
    Japanese journal of infectious diseases, 2006, Volume: 59, Issue:1

    Topics: Antiviral Agents; China; DNA Mutational Analysis; Genes, Viral; Genotype; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutation; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors

2006
Anti-hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV-infected patients.
    Hepatology (Baltimore, Md.), 2006, Volume: 43, Issue:3

    Topics: Adenine; Adult; Antiviral Agents; Cohort Studies; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Retrospective Studies; Tenofovir; Treatment Outcome

2006
Hepatitis B-related polyarteritis nodosa presenting necrotizing vasculitis in the hepatobiliary system successfully treated with lamivudine, plasmapheresis and glucocorticoid.
    Internal medicine (Tokyo, Japan), 2006, Volume: 45, Issue:3

    Topics: Antiviral Agents; Cholecystitis; Gallbladder Diseases; Glucocorticoids; Hepatitis B; Humans; Lamivudine; Liver Diseases; Male; Middle Aged; Plasmapheresis; Polyarteritis Nodosa

2006
Long-term lamivudine therapy in hepatitis B-associated membranous nephropathy?
    Kidney international, 2006, Volume: 69, Issue:4

    Topics: Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Glomerulonephritis, Membranous; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutation; Remission Induction; Time Factors

2006
Lamivudine therapy in kidney allograft recipients who are seropositive for hepatitis B surface antigen.
    Transplantation proceedings, 2006, Volume: 38, Issue:2

    Topics: Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B Surface Antigens; Humans; Kidney Transplantation; Lamivudine; Polymerase Chain Reaction; Recurrence; Retrospective Studies

2006
Prophylactic use of low-dose, on-demand, intramuscular hepatitis B immunoglobulin and lamivudine after liver transplantation.
    Transplantation proceedings, 2006, Volume: 38, Issue:2

    Topics: Antiviral Agents; DNA, Viral; Drug Administration Schedule; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Immunosuppressive Agents; Lamivudine; Liver Failure; Liver Transplantation; Recurrence; Retrospective Studies; Time Factors

2006
Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy.
    AIDS (London, England), 2006, Apr-04, Volume: 20, Issue:6

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Drug Resistance, Viral; Genes, pol; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Immune Tolerance; Lamivudine; Male; Middle Aged; Mutation; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; Viral Envelope Proteins; Viral Load; Viremia

2006
Lamivudine for nephrotic syndrome related to hepatitis B virus (HBV) infection.
    Clinical nephrology, 2006, Volume: 65, Issue:3

    Topics: Biopsy; Diagnosis, Differential; DNA, Viral; Follow-Up Studies; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Nephrotic Syndrome; Reverse Transcriptase Inhibitors

2006
Fatal hepatic decompensation in a bone marrow transplant recipient with HBV-related cirrhosis following lamivudine withdrawal.
    Gastroenterologie clinique et biologique, 2006, Volume: 30, Issue:2

    Topics: Bone Marrow Transplantation; Fatal Outcome; Hepatitis B; Hepatitis B virus; Humans; Immunocompromised Host; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Multiple Myeloma; Renal Insufficiency; Reverse Transcriptase Inhibitors; Sepsis; Virus Activation

2006
HBV genotypes and antiviral-resistant variants in HBV infected subjects in Northern Italy.
    The new microbiologica, 2006, Volume: 29, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cohort Studies; DNA, Viral; Drug Resistance, Viral; Female; Genotype; Hepatitis B; Hepatitis B virus; Humans; Italy; Lamivudine; Male; Middle Aged; Sequence Analysis, DNA

2006
Case report of lamivudine-resistant hepatitis B virus infection post liver transplantation from a hepatitis B core antibody donor.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2006, Volume: 6, Issue:5 Pt 1

    Topics: Antiviral Agents; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Middle Aged; Tissue Donors

2006
Prophylactic strategies for hepatitis B patients undergoing liver transplant: a cost-effectiveness analysis.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2006, Volume: 12, Issue:5

    Topics: Adenine; Adult; Aged; Antiviral Agents; Cost-Benefit Analysis; Drug Therapy, Combination; Health Care Costs; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Markov Chains; Middle Aged; Organophosphonates; Recurrence

2006
Lamivudine prophylaxis for hepatitis B virus infection after lung transplantation.
    The Annals of thoracic surgery, 2006, Volume: 81, Issue:5

    Topics: Adolescent; Adult; Aged; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Humans; Lamivudine; Lung Transplantation; Middle Aged; Reverse Transcriptase Inhibitors

2006
[Relationship between Shenzhen HBV genotype and precore/core promoter mutation and antiviral effects].
    Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology, 2006, Volume: 20, Issue:1

    Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Child, Preschool; DNA, Viral; Female; Genotype; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferons; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Mutation; Promoter Regions, Genetic; Treatment Outcome; Viral Core Proteins; Young Adult

2006
[Development of acute type, CD 8 positive adult T-cell leukemia in a carrier of hepatitis B virus--possible therapeutic effect of lamivudine combined with chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:5

    Topics: Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carrier State; CD8-Positive T-Lymphocytes; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Hepatitis B; HTLV-I Antibodies; Humans; Irinotecan; Lamivudine; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Mitoxantrone; Nitrosourea Compounds; Pentostatin; Prednisone; Vincristine

2006
Lamivudine-resistant hepatitis B virus infection post-liver transplantation from a hepatitis B core antibody donor.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2006, Volume: 6, Issue:8

    Topics: Disease Transmission, Infectious; Drug Resistance, Viral; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Tissue Donors

2006
[Hepatitis B virus reactivation after cessation of prophylaxis with lamivudine in a patient with non-Hodgkins lymphoma treated with chemotherapy and rituximab].
    Medicina clinica, 2006, Jun-03, Volume: 127, Issue:1

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Female; Hepatitis B; Hepatitis B Antigens; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Middle Aged; Recurrence; Reverse Transcriptase Inhibitors; Rituximab; Virus Activation

2006
[Prevention and treatment of hepatitis B virus reinfection after liver transplantation].
    Zhonghua wai ke za zhi [Chinese journal of surgery], 2006, Jun-01, Volume: 44, Issue:11

    Topics: Antiviral Agents; Combined Modality Therapy; Female; Follow-Up Studies; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Humans; Immunization, Passive; Lamivudine; Liver Transplantation; Male; Prospective Studies; Risk Factors; Secondary Prevention; Time Factors

2006
Performance of sequence analysis, INNO-LiPA line probe assays and AFFIGENE assays in the detection of hepatitis B virus polymerase and precore/core promoter mutations.
    Journal of viral hepatitis, 2006, Volume: 13, Issue:6

    Topics: DNA Probes; DNA, Viral; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B virus; Humans; Lamivudine; Mutation; Promoter Regions, Genetic; Protein Precursors; Reagent Kits, Diagnostic; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Sequence Analysis, DNA

2006
Duration of lamivudine prophylaxis in inactive hepatitis B virus carriers with haemato/oncological malignancies who receive chemotherapy.
    Gut, 2006, Volume: 55, Issue:8

    Topics: Antineoplastic Agents; Antiviral Agents; Drug Administration Schedule; Hematologic Neoplasms; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Virus Activation

2006
Lamivudine enabled isoniazid and rifampicin treatment in pulmonary tuberculosis and hepatitis B co-infection.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2006, Volume: 10, Issue:7

    Topics: Antitubercular Agents; Antiviral Agents; Drug Therapy, Combination; Hepatitis B; Humans; Isoniazid; Lamivudine; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary

2006
Tenofovir for patients with lamivudine-resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy.
    Hepatology (Baltimore, Md.), 2006, Volume: 44, Issue:2

    Topics: Adenine; Adult; Disease Progression; DNA, Viral; Drug Resistance, Viral; Female; Follow-Up Studies; Gene Products, pol; Genotype; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Retrospective Studies; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome; Virus Replication

2006
Efficient treatment of crescentric glomerulonephritis associated with hepatitis B virus with lamivudin in a case referred with acute renal failure.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2006, Volume: 21, Issue:12

    Topics: Acute Kidney Injury; Adult; Female; Glomerulonephritis; Hepatitis B; Humans; Lamivudine; Reverse Transcriptase Inhibitors

2006
Hepatitis B-related membranous nephropathy should be treated with a specific anti-viral agent.
    Kidney international, 2006, Volume: 70, Issue:4

    Topics: Antiviral Agents; Dose-Response Relationship, Drug; Drug Resistance, Viral; Glomerulonephritis, Membranous; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Remission Induction; Secondary Prevention; Time Factors; Treatment Outcome

2006
Intramuscular hepatitis B immune globulin combined with lamivudine in prevention of hepatitis B recurrence after liver transplantation.
    Hepatobiliary & pancreatic diseases international : HBPD INT, 2006, Volume: 5, Issue:3

    Topics: Antiviral Agents; Combined Modality Therapy; Drug Therapy, Combination; Female; Hepatitis B; Humans; Immunoglobulins; Injections, Intramuscular; Lamivudine; Liver Transplantation; Male; Middle Aged; Secondary Prevention; Survival Rate

2006
Extended double-dosage HBV vaccination after liver transplantation is ineffective, in the absence of lamivudine and prior wash-out of human Hepatitis B immunoglobulins.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2006, Volume: 38, Issue:10

    Topics: Adult; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Vaccines; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Reverse Transcriptase Inhibitors

2006
Reactivation of hepatitis B virus in rheumatologic patients receiving immunosuppressive agents.
    Digestive diseases and sciences, 2006, Volume: 51, Issue:9

    Topics: DNA, Viral; Fatal Outcome; Female; Hepatitis Antibodies; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunosuppressive Agents; Lamivudine; Liver Function Tests; Male; Middle Aged; Reverse Transcriptase Inhibitors; Rheumatic Diseases; Treatment Outcome; Virus Activation

2006
Therapy with lamivudine and steroids in a patient with acute hepatitis B and rapidly progressive glomerulonephritis.
    Kidney international, 2006, Volume: 70, Issue:6

    Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Female; Follow-Up Studies; Glomerulonephritis; Glucocorticoids; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Humans; Hypertension; Kidney Glomerulus; Kidney Tubules, Proximal; Lamivudine; Methylprednisolone; Prednisone; Reverse Transcriptase Inhibitors; Time Factors; Treatment Outcome

2006
Prevention of mortality from hepatitis B and hepatitis C.
    Lancet (London, England), 2006, Sep-09, Volume: 368, Issue:9539

    Topics: Carcinoma, Hepatocellular; Female; Hepatitis B; Hepatitis C, Chronic; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Liver Cirrhosis; Liver Neoplasms

2006
Impact of lamivudine on the risk of liver-related death in 2,041 HBsAg- and HIV-positive individuals: results from an inter-cohort analysis.
    Antiviral therapy, 2006, Volume: 11, Issue:5

    Topics: Adult; Carcinoma, Hepatocellular; CD4 Lymphocyte Count; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis C Antibodies; HIV Infections; Humans; Lamivudine; Liver Neoplasms; Male; Retrospective Studies; Reverse Transcriptase Inhibitors; Risk Factors; Survival Analysis

2006
Outcomes of hepatitis B virus recurrence after liver transplantation.
    Transplantation proceedings, 2006, Volume: 38, Issue:7

    Topics: Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Function Tests; Liver Transplantation; Recurrence; Retrospective Studies; Time Factors

2006
Successful treatment of hepatitis B virus infection with Lamivudine after heart transplantation.
    Transplantation proceedings, 2006, Volume: 38, Issue:7

    Topics: Adult; Antiviral Agents; Female; Follow-Up Studies; Heart Transplantation; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis C; Humans; Lamivudine; Male; Middle Aged; Retrospective Studies; Survival Analysis; Time Factors; Treatment Outcome

2006
Detection of YMDD mutation using mutant-specific primers in chronic hepatitis B patients before and after lamivudine treatment.
    World journal of gastroenterology, 2006, Sep-07, Volume: 12, Issue:33

    Topics: Amino Acid Motifs; Antiviral Agents; Cloning, Molecular; DNA Primers; Genes, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutation; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Viral Proteins

2006
Severe reactivation of hepatitis B virus infection in a patient with hairy cell leukemia: Should lamivudine prophylaxis be recommended to HBsAg-negative, anti-HBc-positive patients?
    Infection, 2006, Volume: 34, Issue:5

    Topics: Aged; Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Leukemia, Hairy Cell; Male; Virus Activation

2006
Beneficial effects of short-term lamivudine treatment for de novo hepatitis B virus reactivation after liver transplantation.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2006, Volume: 6, Issue:11

    Topics: Adolescent; Adult; Child; Child, Preschool; Female; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Male; Recurrence; Retrospective Studies; Reverse Transcriptase Inhibitors; Treatment Outcome

2006
Discontinuation of lamivudine treatment for hepatitis flare after kidney or heart transplantation in hepatitis B surface antigen-positive patients: A retrospective case series.
    Clinical therapeutics, 2006, Volume: 28, Issue:9

    Topics: DNA, Viral; Female; Follow-Up Studies; Heart Transplantation; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Kidney Transplantation; Lamivudine; Male; Middle Aged; Polymerase Chain Reaction; Retrospective Studies; Reverse Transcriptase Inhibitors; Time Factors; Treatment Outcome

2006
Lamivudine prophylaxis and treatment of hepatitis B Virus-exposed recipients receiving reduced intensity conditioning hematopoietic stem cell transplants with alemtuzumab.
    Journal of medical virology, 2006, Volume: 78, Issue:12

    Topics: Adolescent; Adult; Aged; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Chemoprevention; Female; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; Treatment Outcome; Virus Activation

2006
Patterns of hepatitis B virus infection in Brazilian human immunodeficiency virus infected patients: high prevalence of occult infection and low frequency of lamivudine resistant mutations.
    Memorias do Instituto Oswaldo Cruz, 2006, Volume: 101, Issue:6

    Topics: Adult; Anti-HIV Agents; Brazil; DNA, Viral; Drug Resistance, Viral; Enzyme-Linked Immunosorbent Assay; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Mutation; Polymerase Chain Reaction; Risk Factors; Viral Load

2006
Hepatitis B immunoglobulin in combination with lamivudine for prevention of hepatitis B virus reactivation in children undergoing bone marrow transplantation.
    Pediatric transplantation, 2006, Volume: 10, Issue:8

    Topics: beta-Thalassemia; Bone Marrow Transplantation; Child; Child, Preschool; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Immunologic Factors; Lamivudine; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Reverse Transcriptase Inhibitors; Secondary Prevention; Transplantation, Homologous; Virus Activation

2006
Ribavirin and mycophenolic acid markedly potentiate the anti-hepatitis B virus activity of entecavir.
    Antiviral research, 2007, Volume: 73, Issue:3

    Topics: Cell Line; DNA-Directed DNA Polymerase; DNA, Viral; Drug Synergism; Drug Therapy, Combination; Guanine; Hepacivirus; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mycophenolic Acid; Ribavirin; RNA-Directed DNA Polymerase

2007
Treatment of lamivudine-resistant hepatitis B infection in post-renal transplant patients with adefovir dipivoxil: preliminary results.
    Transplantation proceedings, 2006, Volume: 38, Issue:9

    Topics: Adenine; Alanine Transaminase; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Follow-Up Studies; Hepatitis B; Hepatitis B Core Antigens; Humans; Kidney; Kidney Transplantation; Lamivudine; Middle Aged; Organophosphonates; Postoperative Complications

2006
Lamivudine reverses severe acute hepatitis B and pancytopenia after renal transplantation: a case report.
    Transplantation proceedings, 2006, Volume: 38, Issue:9

    Topics: Adult; Female; Hepatitis B; Humans; Kidney Failure, Chronic; Kidney Transplantation; Lamivudine; Liver Function Tests; Pancytopenia; Treatment Outcome

2006
Successful treatment with adefovir of one patient whose cryoglobulinemic vasculitis relapsed under lamivudine therapy and who was diagnosed to have HBV virologic breakthrough with YMDD mutations.
    Internal medicine (Tokyo, Japan), 2006, Volume: 45, Issue:21

    Topics: Adenine; Amino Acid Motifs; Aspartic Acid; Cryoglobulinemia; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Methionine; Middle Aged; Mutation; Organophosphonates; Recurrence; Tyrosine; Vasculitis

2006
[Hepatitis B and C virus infection and liver dysfunction in patients receiving chemotherapy].
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2006, Volume: 48, Issue:6

    Topics: Adult; Antineoplastic Agents; Antiviral Agents; Chemical and Drug Induced Liver Injury; Female; Hepatitis B; Hepatitis C; Humans; Lamivudine; Liver Diseases; Male; Middle Aged; Neoplasms; Prevalence

2006
Aminotransferase elevation in HIV/hepatitis B virus co-infected patients treated with two active hepatitis B virus drugs.
    AIDS patient care and STDs, 2006, Volume: 20, Issue:12

    Topics: Adenine; Adult; Antiretroviral Therapy, Highly Active; DNA, Viral; Female; Hepatitis B; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Tenofovir; Transaminases

2006
Lamivudine and famciclovir treatment in HIV patients with acute hepatitis B virus infection and hepatitis B reactivation.
    Journal of clinical gastroenterology, 2007, Volume: 41, Issue:2

    Topics: 2-Aminopurine; Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; Famciclovir; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Reverse Transcriptase Inhibitors; Virus Activation

2007
Successful treatment of hepatitis B-associated leukocytoclastic vasculitis with lamivudine treatment in a child patient.
    Rheumatology international, 2007, Volume: 27, Issue:9

    Topics: Antiviral Agents; Blood Vessels; Child; Drug Administration Schedule; Female; Hepatitis B; Humans; Lamivudine; Liver; Reverse Transcriptase Inhibitors; Treatment Outcome; Turkey; Vasculitis, Leukocytoclastic, Cutaneous

2007
Comparison of hepatitis B virus subgenotypes in patients with acute and chronic hepatitis B and absence of lamivudine-resistant strains in acute hepatitis B in Japan.
    Journal of medical virology, 2007, Volume: 79, Issue:4

    Topics: Acute Disease; Adolescent; Adult; Aged; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Japan; Lamivudine; Male; Middle Aged; Mutation; Odds Ratio; Reverse Transcriptase Inhibitors; Species Specificity; Viral Proteins

2007
Recurrence of hepatitis B is associated with cumulative corticosteroid dose and chemotherapy against hepatocellular carcinoma recurrence after liver transplantation.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2007, Volume: 13, Issue:3

    Topics: Adrenal Cortex Hormones; Adult; Antineoplastic Agents; Carcinoma, Hepatocellular; Dose-Response Relationship, Drug; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Recurrence; Retrospective Studies; Risk Factors

2007
Antiviral therapy for pre- and post-liver transplantation patients with hepatitis B.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2007, Volume: 13, Issue:3

    Topics: Adenine; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Guanine; Hepatitis B; Hepatitis B virus; Humans; Kidney Diseases; Lamivudine; Liver Transplantation; Organophosphonates; Secondary Prevention; Tenofovir

2007
Long-term outcome after prophylactic lamivudine treatment on hepatitis B virus reactivation in non-Hodgkin's lymphoma.
    Yonsei medical journal, 2007, Feb-28, Volume: 48, Issue:1

    Topics: Adult; Aged; Drug Administration Schedule; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Lamivudine; Liver; Lymphoma, Non-Hodgkin; Male; Middle Aged; Reverse Transcriptase Inhibitors; Survival Analysis; Treatment Outcome; Virus Activation

2007
Real-time PCR detection of multiple lamivudine-resistant mutations with displacing probes in a single tube.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2007, Volume: 38, Issue:4

    Topics: Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutation; Polymerase Chain Reaction; Sensitivity and Specificity; Sequence Analysis, DNA; Serum; Statistics as Topic

2007
A homosexual Japanese man with acute hepatitis due to hepatitis B virus genotype ae, concurrent with amebic colitis.
    Acta medica Okayama, 2007, Volume: 61, Issue:1

    Topics: Acute Disease; Adult; Antiprotozoal Agents; Asian People; Dysentery, Amebic; Genotype; Hepatitis B; Hepatitis B virus; Homosexuality, Male; Humans; Lamivudine; Male; Metronidazole; Reverse Transcriptase Inhibitors

2007
Fatal liver failure caused by reactivation of lamivudine-resistant hepatitis B virus: a case report.
    World journal of gastroenterology, 2007, Feb-14, Volume: 13, Issue:6

    Topics: Amino Acid Sequence; Antiviral Agents; Drug Resistance, Viral; Fatal Outcome; Gene Products, pol; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Failure; Male; Middle Aged; Molecular Sequence Data; Mutation

2007
Reactivation of lamivudine-resistant occult hepatitis B in an HIV-infected patient undergoing cytotoxic chemotherapy.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2007, Volume: 39, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; HIV; HIV Infections; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Virus Activation

2007
Hepatitis B reactivation during glioblastoma treatment with temozolomide: a cautionary note.
    Neurology, 2007, Mar-20, Volume: 68, Issue:12

    Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; DNA, Viral; Glioblastoma; Hepatitis B; Humans; Immunocompromised Host; Immunosuppression Therapy; Lamivudine; Liver; Male; Middle Aged; Patient Selection; Reverse Transcriptase Inhibitors; Risk Factors; Spinal Neoplasms; Temozolomide; Treatment Outcome; Viral Load; Virus Activation

2007
A prophylactic approach for bone marrow transplantation from a hepatitis B surface antigen-positive donor.
    World journal of gastroenterology, 2007, Feb-21, Volume: 13, Issue:7

    Topics: Adult; Antiviral Agents; Bone Marrow Transplantation; Follow-Up Studies; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Humans; Lamivudine; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Tissue Donors; Viral Load

2007
Changes in serologic markers of hepatitis B following autologous hematopoietic stem cell transplantation.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2007, Volume: 13, Issue:4

    Topics: Adolescent; Adult; Aged; Antiviral Agents; Biomarkers; DNA, Viral; Endemic Diseases; Female; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Humans; Immunocompromised Host; Korea; Lamivudine; Male; Middle Aged; Retrospective Studies; Serologic Tests; Transplantation, Autologous

2007
Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation.
    Gastroenterology, 2007, Volume: 132, Issue:3

    Topics: Adult; Aged; Antiviral Agents; Australia; Disease-Free Survival; DNA, Viral; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Immunoglobulins; Injections, Intramuscular; Kaplan-Meier Estimate; Lamivudine; Liver Diseases; Liver Transplantation; Male; Middle Aged; New Zealand; Postoperative Complications; Predictive Value of Tests; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Secondary Prevention; Time Factors; Treatment Outcome

2007
Combination therapy in liver transplant recipients with hepatitis B virus without hepatitis B immune globulin.
    Digestive diseases and sciences, 2007, Volume: 52, Issue:10

    Topics: Adenine; Adult; Aged; Antibodies, Viral; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Immunosuppressive Agents; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Retrospective Studies; Reverse Transcriptase Inhibitors; Secondary Prevention; Treatment Outcome

2007
Response to Schmutz et al., 'Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection'.
    AIDS (London, England), 2007, Mar-30, Volume: 21, Issue:6

    Topics: Adenine; Drug Therapy, Combination; Hepatitis B; HIV Infections; Humans; Lamivudine; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Failure

2007
Mutation analysis of lamivudine resistant hepatitis B virus strains by TaqMan PCR.
    Journal of virological methods, 2007, Volume: 143, Issue:2

    Topics: Antiviral Agents; DNA Mutational Analysis; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Microbial Sensitivity Tests; Mutation, Missense; Oligonucleotide Probes; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Sensitivity and Specificity

2007
Whole genome expression profiling of hepatitis B virus-transfected cell line reveals the potential targets of anti-HBV drugs.
    The pharmacogenomics journal, 2008, Volume: 8, Issue:1

    Topics: Antiviral Agents; Cell Line; Cell Survival; DNA Primers; Down-Regulation; Gene Expression Regulation, Viral; Genes, Viral; Genome, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Image Processing, Computer-Assisted; Lamivudine; Oligonucleotide Array Sequence Analysis; Oligonucleotides, Antisense; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transfection

2008
Combination of small interfering RNA and lamivudine on inhibition of human B virus replication in HepG2.2.15 cells.
    World journal of gastroenterology, 2007, Apr-28, Volume: 13, Issue:16

    Topics: Antiviral Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; DNA Replication; DNA, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Neoplasms; RNA, Messenger; RNA, Small Interfering; RNA, Viral; Transfection; Virus Replication

2007
[Clinical case of the month. Hepatitis B reactivation in an Ag HBs negative patient].
    Revue medicale de Liege, 2007, Volume: 62, Issue:3

    Topics: Adrenal Cortex Hormones; Aged; Glomerulonephritis; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunocompromised Host; Lamivudine; Male; Reverse Transcriptase Inhibitors; Treatment Outcome; Virus Activation

2007
Rapid emergence of a viral resistant mutant in WHV chronically infected woodchucks treated with lamivudine and a pre-S/S CHO-derived hepatitis B virus vaccine.
    Vaccine, 2007, Jun-21, Volume: 25, Issue:26

    Topics: Animals; CHO Cells; Cricetinae; Cricetulus; DNA, Viral; Drug Resistance, Viral; Hepatitis B; Hepatitis B Vaccines; Hepatitis B Virus, Woodchuck; Inflammation; Kinetics; Lamivudine; Liver; Marmota; Monocytes; Mutation; Reverse Transcriptase Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; Vaccination

2007
Emergence of hepatitis B virus quasispecies with lower susceptibility to nucleos(t)ide analogues during lamivudine treatment.
    The Journal of antimicrobial chemotherapy, 2007, Volume: 60, Issue:2

    Topics: Adenine; Adult; Aged; Antiviral Agents; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Molecular Sequence Data; Nucleosides; Nucleotides; Organophosphonates; Reverse Transcriptase Polymerase Chain Reaction; RNA-Directed DNA Polymerase; Viremia

2007
Long-term surveillance of haematopoietic stem cell recipients with resolved hepatitis B: high risk of viral reactivation even in a recipient with a vaccinated donor.
    Journal of viral hepatitis, 2007, Volume: 14, Issue:7

    Topics: Adult; Antiviral Agents; Blood Donors; Female; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Population Surveillance; Time Factors; Transplantation, Homologous; Virus Activation

2007
Living donor liver transplantation from hepatitis B core antibody positive donors.
    Transplantation proceedings, 2007, Volume: 39, Issue:5

    Topics: Hepatitis B; Hepatitis B Core Antigens; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Living Donors; Patient Selection; Prevalence; Retrospective Studies; Reverse Transcriptase Inhibitors; Turkey

2007
Lack of hepatotoxicity upon sirolimus addition to a calcineurin inhibitor-based regimen in hepatitis virus-positive renal transplant recipients.
    Transplantation proceedings, 2007, Volume: 39, Issue:5

    Topics: Adult; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis C; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kidney Transplantation; Lamivudine; Liver; Male; Middle Aged; Monitoring, Immunologic; Mycophenolic Acid; Retrospective Studies; Sirolimus; Tacrolimus

2007
Prophylaxis of recurrent hepatitis B in Chinese patients after liver transplantation using lamivudine combined with hepatitis B immune globulin according to the titer of antibody to hepatitis B surface antigen.
    Transplantation proceedings, 2007, Volume: 39, Issue:5

    Topics: Adult; China; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Immunosuppressive Agents; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence; Retrospective Studies; Survival Analysis

2007
The HBV drug entecavir - effects on HIV-1 replication and resistance.
    The New England journal of medicine, 2007, Jun-21, Volume: 356, Issue:25

    Topics: Adult; Antiviral Agents; CD4 Lymphocyte Count; Drug Resistance, Viral; Guanine; Hepatitis B; Hepatitis B virus; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Male; Middle Aged; Mutation; Phylogeny; Reverse Transcriptase Inhibitors; Reverse Transcription; RNA, Viral; Virus Replication; Zidovudine

2007
[Hepatitis B immunoglobulin treatment after liver transplantation--our experiences].
    Klinicka mikrobiologie a infekcni lekarstvi, 2007, Volume: 13, Issue:2

    Topics: Antiviral Agents; Hepatitis B; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Secondary Prevention

2007
The relationship of hepatitis B virus infection and non-Hodgkin's lymphoma and its impact on clinical characteristics and prognosis.
    European journal of haematology, 2007, Volume: 79, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anthracyclines; Drug Therapy, Combination; Female; Hepatitis B; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prevalence; Prognosis; Steroids; Survival Rate

2007
[Clinical application of microarray technique to quantify the lamivudine-resistant gene mutant of hepatitis B virus].
    Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology, 2007, Volume: 21, Issue:2

    Topics: Antiviral Agents; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Mutation; Oligonucleotide Array Sequence Analysis

2007
Treating acute hepatitis B.
    Hepatology (Baltimore, Md.), 2007, Volume: 46, Issue:2

    Topics: Acute Disease; Hepatitis B; Humans; Lamivudine; Reverse Transcriptase Inhibitors

2007
Hepatitis B serological evaluation in diagnostic work up of lymphoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2007, Volume: 18, Issue:7

    Topics: Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma; Reverse Transcriptase Inhibitors; Virus Activation

2007
Hepatitis B prophylaxis in patients undergoing chemotherapy for lymphoma: a decision analysis model.
    Hepatology (Baltimore, Md.), 2007, Volume: 46, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cost-Benefit Analysis; Cyclophosphamide; Decision Support Techniques; Doxorubicin; Health Care Costs; Hepatitis B; Humans; Lamivudine; Liver Neoplasms; Lymphoma; Prednisolone; Treatment Outcome; Vincristine

2007
Hepatitis B viral infection with nephrotic syndrome treated with lamivudine.
    Mymensingh medical journal : MMJ, 2007, Volume: 16, Issue:2

    Topics: Child, Preschool; Hepatitis B; Humans; Lamivudine; Male; Nephrotic Syndrome; Reverse Transcriptase Inhibitors

2007
Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons.
    Journal of medical virology, 2007, Volume: 79, Issue:10

    Topics: Adenine; Adult; Alanine Transaminase; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Biomarkers; Carrier State; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cohort Studies; DNA, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; London; Male; Organophosphonates; Prevalence; Tenofovir

2007
Lamivudine resistance and exacerbation of hepatitis B in infliximab-treated Crohn's disease patient.
    Inflammatory bowel diseases, 2007, Volume: 13, Issue:11

    Topics: Adult; Antibodies, Monoclonal; Crohn Disease; Drug Resistance; Follow-Up Studies; Hepatitis B; Humans; Infliximab; Lamivudine; Male; Practice Guidelines as Topic; Virus Activation

2007
[Hepatitis B associated polyarteriitis nodosa with cerebral vasculitis].
    Deutsche medizinische Wochenschrift (1946), 2007, Volume: 132, Issue:34-35

    Topics: Anti-Inflammatory Agents; Antiviral Agents; Diagnosis, Differential; Hepatitis B; Hepatitis B Surface Antigens; Humans; Immunosuppressive Agents; Lamivudine; Male; Middle Aged; Polyarteritis Nodosa; Prednisolone; Reverse Transcriptase Inhibitors; Treatment Outcome; Vasculitis, Central Nervous System

2007
[Relationship between hepatitis B virus YMDD mutation and serum viral DNA loadings].
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2007, Volume: 27, Issue:8

    Topics: Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Viral Load

2007
Prophylaxis of hepatitis B recurrence in post-liver transplantation patients with lamivudine-resistant YMDD mutant.
    Chinese medical journal, 2007, Aug-20, Volume: 120, Issue:16

    Topics: Adenine; Adult; Aged; Antiviral Agents; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Mutation; Organophosphonates; Recurrence

2007
Clinical outcome of renal transplantation in patients with positive pre-transplant hepatitis B surface antigen.
    Journal of medical virology, 2007, Volume: 79, Issue:11

    Topics: Adolescent; Adult; Antiviral Agents; Child; Female; Graft Survival; Hepatitis B; Hepatitis B Surface Antigens; Humans; Kidney Transplantation; Lamivudine; Liver; Liver Function Tests; Male; Middle Aged; Reverse Transcriptase Inhibitors; Survival Rate; Treatment Outcome

2007
[Reactivation of hepatitis B virus due to rituximab plus CHOP after preemptive lamivudine administration in a patient with diffuse large B-cell lymphoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:9

    Topics: Anti-HIV Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; DNA, Viral; Doxorubicin; Female; Hepatitis B; Hepatitis B virus; Humans; Interferon-beta; Lamivudine; Lymphoma, B-Cell; Middle Aged; Prednisone; Rituximab; Vincristine; Virus Activation

2007
[New German and American guidelines for therapy of hepatitis B. Discrepancies and similarities].
    Medizinische Klinik (Munich, Germany : 1983), 2007, Sep-15, Volume: 102, Issue:9

    Topics: Adenine; Alanine Transaminase; Antiviral Agents; Biopsy; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Germany; Guanine; Hepatitis B; Humans; Lamivudine; Liver; Liver Cirrhosis; Nucleosides; Organophosphonates; Practice Guidelines as Topic; Pyrimidinones; Telbivudine; Thymidine; United States

2007
[An analysis of long term prophylaxis of virus recurrence with antiviral treatment in HBV infected liver transplant recipient patients].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2007, Volume: 15, Issue:9

    Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Female; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Postoperative Period; Prognosis; Retrospective Studies; Secondary Prevention; Treatment Outcome; Young Adult

2007
Development of a novel mouse model to evaluate drug candidates against hepatitis B virus.
    Antiviral chemistry & chemotherapy, 2007, Volume: 18, Issue:4

    Topics: Adenine; Animals; Antiviral Agents; Cell Line; Disease Models, Animal; Drug Evaluation, Preclinical; Hepatitis B; Hepatitis B virus; Lamivudine; Mice; Mice, Nude; Organophosphonates; Reproducibility of Results; Tenofovir

2007
Successful treatment of an entecavir-resistant hepatitis B virus variant.
    Journal of medical virology, 2007, Volume: 79, Issue:12

    Topics: Adenine; Adult; Antiviral Agents; Drug Administration Schedule; Drug Resistance, Multiple, Viral; Female; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutation; Organophosphonates; Viral Load

2007
Prophylaxsis against recurrance of hepatitis B virus after liver transplantation: a retrospective analysis spanning 20 years.
    Liver international : official journal of the International Association for the Study of the Liver, 2008, Volume: 28, Issue:1

    Topics: Adenine; Adult; Antiviral Agents; Dose-Response Relationship, Drug; Female; Hepatitis B; Hepatitis B e Antigens; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Retrospective Studies; Secondary Prevention; Virginia

2008
Liver enzymes elevation and immune reconstitution among treatment-naïve HIV-infected patients instituting antiretroviral therapy.
    The American journal of the medical sciences, 2007, Volume: 334, Issue:5

    Topics: Adult; Alanine Transaminase; Alkynes; Anti-HIV Agents; Anti-Retroviral Agents; Aspartate Aminotransferases; Benzoxazines; CD4-Positive T-Lymphocytes; Cyclopropanes; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis C; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Lamivudine; Linear Models; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Risk Factors; Stavudine; Zidovudine

2007
Preoperative lamivudine therapy in HBV DNA positive recipients: is it always necessary?
    Hepato-gastroenterology, 2007, Volume: 54, Issue:78

    Topics: Adult; DNA, Viral; Female; Hepatitis B; Humans; Immunoglobulins; Immunosuppressive Agents; Lamivudine; Liver Transplantation; Male; Middle Aged; Models, Statistical; Recurrence; Treatment Outcome

2007
Prolonged hepatitis after acute infection with genotype H hepatitis B virus.
    Internal medicine (Tokyo, Japan), 2007, Volume: 46, Issue:22

    Topics: Acute Disease; Antiviral Agents; Genotype; Hepatitis B; Hepatitis B virus; Humans; Interferons; Lamivudine; Male; Middle Aged; Salvage Therapy; Treatment Failure

2007
Adefovir dipivoxil therapy in liver transplant recipients for recurrence of hepatitis B virus infection despite lamivudine plus hepatitis B immunoglobulin prophylaxis.
    Journal of gastroenterology and hepatology, 2007, Volume: 22, Issue:12

    Topics: Adenine; Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Recurrence; Serologic Tests

2007
[Diagnosis and therapy for attention-getting infections (discussion)].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2007, Nov-10, Volume: 96, Issue:11

    Topics: Antiretroviral Therapy, Highly Active; Antiviral Agents; Cause of Death; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Drug Resistance, Viral; Global Health; Hepatitis B; HIV Infections; Humans; Japan; Lamivudine; Measles; Practice Guidelines as Topic; Pseudomonas Infections; Reverse Transcriptase Inhibitors; Viral Vaccines

2007
Clearance of chronic HCV infection during acute delta hepatitis.
    Infection, 2009, Volume: 37, Issue:2

    Topics: Acute Disease; Adult; Antiviral Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Hepatitis B; Hepatitis C, Chronic; Hepatitis D; Humans; Lamivudine; Liver Function Tests; Male; Substance Abuse, Intravenous; Superinfection

2009
The incidence and clinical outcome of YMDD mutants in hepatitis B surface antigen-positive renal allograft recipients after prolonged lamivudine therapy.
    Transplantation proceedings, 2007, Volume: 39, Issue:10

    Topics: Adult; Antiviral Agents; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Female; Follow-Up Studies; Genotype; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Kidney Transplantation; Lamivudine; Male; Middle Aged; Retrospective Studies; Transplantation, Homologous; Treatment Outcome; Viral Proteins

2007
Antiviral prophylaxis and recurrence of hepatocellular carcinoma following liver transplantation in patients with hepatitis B.
    Transplantation proceedings, 2007, Volume: 39, Issue:10

    Topics: Analysis of Variance; Antiviral Agents; Carcinoma, Hepatocellular; Disease-Free Survival; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Neoplasms; Neoplasm Staging; Postoperative Complications; Recurrence; Retrospective Studies; Survival Analysis; Survivors; Time Factors; Virus Diseases

2007
Potency of tenofovir in chronic hepatitis B: mono or combination therapy?
    Journal of hepatology, 2008, Volume: 48, Issue:3

    Topics: Adenine; Antiviral Agents; Deoxycytidine; DNA, Viral; Drug Therapy, Combination; Emtricitabine; Guanine; Hepatitis B; Hepatitis B, Chronic; Humans; Lamivudine; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome; Viral Load

2008
Matrix metalloproteinases and their tissue inhibitors in children with chronic hepatitis B treated with lamivudine.
    Advances in medical sciences, 2007, Volume: 52

    Topics: Adolescent; Antiviral Agents; Biopsy; Child; Female; Fibrosis; Hepatitis B; Humans; Lamivudine; Liver; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; ROC Curve; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2

2007
[A 40-year-old female patient with seronegative autoimmune hepatitis following a newly acquired hepatitis B infection].
    Zeitschrift fur Gastroenterologie, 2008, Volume: 46, Issue:2

    Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Autoimmunity; Biopsy; Female; Glucocorticoids; Hepatitis B; Hepatitis, Autoimmune; Humans; Immunosuppression Therapy; Lamivudine; Liver; Prednisolone; Reverse Transcriptase Inhibitors; Time Factors; Treatment Outcome

2008
Prevention of hepatitis B recurrence after liver transplantation using lamivudine and hepatitis B immune globulin.
    Annals of transplantation, 2007, Volume: 12, Issue:3

    Topics: Adult; Antiviral Agents; Cohort Studies; Female; Hepatitis B; Hepatitis B Antibodies; Humans; Immunologic Factors; Lamivudine; Liver Transplantation; Male; Retrospective Studies; Secondary Prevention; Treatment Outcome

2007
The effectiveness of lamivudine in preventing hepatitis B viral reactivation in rituximab-containing regimen for lymphoma.
    Annals of hematology, 2008, Volume: 87, Issue:6

    Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; DNA, Viral; Female; Hepatitis B; Humans; Lamivudine; Lymphoma; Male; Middle Aged; Recurrence; Rituximab; Salvage Therapy; Virus Activation

2008
Efficacies of beta-L-D4A against Hepatitis B virus in 2.2.15 cells.
    World journal of gastroenterology, 2008, Feb-28, Volume: 14, Issue:8

    Topics: Antiviral Agents; Cell Line; Dideoxyadenosine; DNA Replication; DNA, Viral; Dose-Response Relationship, Drug; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Models, Chemical; Tetrazolium Salts; Thiazoles; Virus Replication

2008
Impact of hepatitis B virus rtA181V/T mutants on hepatitis B treatment failure.
    Journal of hepatology, 2008, Volume: 48, Issue:5

    Topics: Adenine; Amino Acid Sequence; DNA, Viral; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Molecular Sequence Data; Mutation; Organophosphonates; RNA-Directed DNA Polymerase; Treatment Failure

2008
Adefovir and lamivudine in combination compared with adefovir monotherapy in HBeAg-negative adults with chronic hepatitis B virus infection and clinical or virologic resistance to lamivudine: a retrospective, multicenter, nonrandomized, open-label study.
    Clinical therapeutics, 2008, Volume: 30, Issue:2

    Topics: Adenine; Adult; Aged; Alanine Transaminase; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Multicenter Studies as Topic; Organophosphonates; Retrospective Studies; Time Factors; Treatment Outcome; Viral Load

2008
Hepatitis B virus quasispecies susceptibility to entecavir confirms the relationship between genotypic resistance and patient virologic response.
    Journal of hepatology, 2008, Volume: 48, Issue:6

    Topics: Antiviral Agents; DNA, Viral; Drug Monitoring; Drug Resistance, Viral; Genetic Predisposition to Disease; Genotype; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Longitudinal Studies; Mutation; Phenotype

2008
Hepatitis B caused by a hepatitis B surface antigen escape mutant.
    Journal of gastroenterology, 2008, Volume: 43, Issue:3

    Topics: Aged; Amino Acid Substitution; Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunity, Innate; Lamivudine; Male; Mutation; Sequence Analysis, Protein

2008
[A study on mutations of the overlapping hepatitis B virus surface and polymerase gene in patients with HBV reinfection after liver transplantations].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2008, Volume: 16, Issue:4

    Topics: Adult; Female; Gene Frequency; Genome, Viral; Genotype; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Mutation; Nested Genes; Recurrence

2008
Viral persistence after liver transplantation for hepatitis B virus: a cross-sectional study.
    Transplantation, 2008, Apr-27, Volume: 85, Issue:8

    Topics: Adenine; Adult; Aged; Cross-Sectional Studies; DNA, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates

2008
Monitoring antiviral resistance in patients receiving nucleos(t)ide analog therapies for hepatitis B: which method should be used?
    Journal of hepatology, 2008, Volume: 48, Issue:6

    Topics: Antiviral Agents; DNA, Viral; Drug Monitoring; Drug Resistance, Viral; Genetic Predisposition to Disease; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutation; Nucleosides; Nucleotides; Phenotype

2008
Determination of lamivudine-resistant variants of hepatitis B virus by denaturing gradient gel electrophoresis: a novel approach to monitoring drug resistance.
    Medical science monitor : international medical journal of experimental and clinical research, 2008, Volume: 14, Issue:5

    Topics: Amino Acid Motifs; Anti-HIV Agents; Automation; Base Sequence; Drug Resistance, Viral; Electrophoresis; Feasibility Studies; Gene Products, pol; Genome, Viral; Genotype; Hepatitis B; Humans; Lamivudine; Molecular Sequence Data; Mutation

2008
Changes in serological markers of hepatitis B virus after renal transplantation.
    Transplantation proceedings, 2008, Volume: 40, Issue:3

    Topics: Antiviral Agents; Hepatitis B; Hepatitis B e Antigens; Humans; Kidney Transplantation; Lamivudine; Postoperative Complications; Prevalence; Retrospective Studies; Treatment Outcome

2008
[Acute hepatitis B: is antiviral therapy indicated? Two case reports].
    Deutsche medizinische Wochenschrift (1946), 2008, Volume: 133, Issue:22

    Topics: Acute Disease; Adenine; Adult; Algorithms; Antiviral Agents; Bilirubin; DNA, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver; Middle Aged; Organophosphonates; Prothrombin Time; Transaminases; Treatment Failure; Treatment Outcome

2008
Should treatment of hepatitis B depend on hepatitis B virus genotypes? A hypothesis generated from an explorative analysis of published evidence.
    Antiviral therapy, 2008, Volume: 13, Issue:2

    Topics: Antiviral Agents; Clinical Trials as Topic; Epidemiologic Research Design; Genotype; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Interferons; Lamivudine; Reverse Transcriptase Inhibitors; Treatment Outcome

2008
Hepatitis B reactivation after lamivudine.
    Lancet (London, England), 1995, Oct-28, Volume: 346, Issue:8983

    Topics: Adult; Alanine Transaminase; Antiviral Agents; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Prednisone; Recurrence; Virus Activation; Zalcitabine

1995
A quarter-century of antiviral therapy.
    The New England journal of medicine, 1995, Dec-21, Volume: 333, Issue:25

    Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis B; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Zalcitabine; Zidovudine

1995
Viral dynamics in hepatitis B virus infection.
    Proceedings of the National Academy of Sciences of the United States of America, 1996, Apr-30, Volume: 93, Issue:9

    Topics: Alanine Transaminase; Antiviral Agents; Dose-Response Relationship, Drug; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; HIV Infections; Humans; Kinetics; Lamivudine; Models, Biological; Regression Analysis; Reverse Transcriptase Inhibitors; Time Factors; Viremia; Virus Replication; Zalcitabine

1996
Lamivudine: a magic bullet for chronic hepatitis B?
    Gastroenterology, 1996, Volume: 111, Issue:1

    Topics: Antiviral Agents; Chronic Disease; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Reverse Transcriptase Inhibitors; Zalcitabine

1996
In vitro evaluation of combination therapies against hepatitis B virus replication.
    Antiviral research, 1996, Volume: 29, Issue:1

    Topics: Acyclovir; Antiviral Agents; Drug Synergism; Drug Therapy, Combination; Guanine; Hepatitis B; Hepatitis B virus; Hepatoblastoma; Humans; Interferon-alpha; Lamivudine; Tumor Cells, Cultured; Virus Replication; Zalcitabine

1996
Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo.
    Hepatology (Baltimore, Md.), 1996, Volume: 24, Issue:3

    Topics: Adult; Antiviral Agents; Base Sequence; Conserved Sequence; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Molecular Probes; Molecular Sequence Data; Mutation; Postoperative Complications; Recurrence; RNA, Viral; Viremia

1996
Potential role of lamivudine (3TC) in the clearance of chronic hepatitis B virus infection in a patient coinfected with human immunodeficiency virus type.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1996, Volume: 23, Issue:3

    Topics: Adult; Anti-HIV Agents; Chronic Disease; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Male

1996
Impact of complete inhibition of viral replication on the cellular immune response in chronic hepatitis B virus infection.
    Hepatology (Baltimore, Md.), 1996, Volume: 24, Issue:5

    Topics: Adult; Antiviral Agents; Chronic Disease; DNA, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B Core Antigens; Humans; Interferon-alpha; Lamivudine; Male; T-Lymphocytes, Helper-Inducer; Virus Replication

1996
Effects of lamivudine on replication of hepatitis B virus in HIV-infected men.
    Annals of internal medicine, 1996, Nov-01, Volume: 125, Issue:9

    Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Retrospective Studies; Reverse Transcriptase Inhibitors; Virus Replication

1996
Efficacy of lamivudine in chronic hepatitis B patients with active viral replication and decompensated cirrhosis undergoing liver transplantation.
    Transplantation, 1996, Nov-27, Volume: 62, Issue:10

    Topics: Adult; Female; Hepatitis B; Hepatitis, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Failure; Liver Transplantation; Male; Middle Aged; Neural Conduction; Pilot Projects; Treatment Outcome; Virus Replication

1996
Clinical implications of lamivudine resistance by HBV.
    Lancet (London, England), 1997, Jan-04, Volume: 349, Issue:9044

    Topics: Antiviral Agents; Drug Resistance, Microbial; Hepatitis B; Hepatitis B virus; Humans; Immunocompetence; Lamivudine; Liver Failure; Liver Transplantation; Mutation

1997
Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation.
    Lancet (London, England), 1997, Jan-04, Volume: 349, Issue:9044

    Topics: Antiviral Agents; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Microbial; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Failure; Liver Transplantation; Male; Microbial Sensitivity Tests; Middle Aged; Point Mutation; Polymerase Chain Reaction; Recurrence

1997
Beneficial effect of lamivudine in recurrent hepatitis B after liver transplantation.
    Transplantation, 1997, Feb-15, Volume: 63, Issue:3

    Topics: Adult; Chronic Disease; Female; Hepatitis B; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Recurrence

1997
Hepatitis B virus infection and liver transplantation.
    Gut, 1997, Volume: 40, Issue:5

    Topics: 2-Aminopurine; Antiviral Agents; Famciclovir; Hepatitis B; Hepatitis B Vaccines; Humans; Immunization, Passive; Immunoglobulins; Immunosuppression Therapy; Interferon-gamma; Lamivudine; Liver Transplantation; Patient Selection

1997
Lamivudine resistance in immunocompetent chronic hepatitis B. Incidence and patterns.
    Journal of hepatology, 1997, Volume: 26, Issue:6

    Topics: Adolescent; Adult; DNA Primers; Drug Resistance, Microbial; Genome, Viral; Hepatitis B; Hepatitis B virus; Humans; Immunocompetence; Lamivudine; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors

1997
Combination therapy for chronic hepatitis B.
    Hepatology (Baltimore, Md.), 1997, Volume: 26, Issue:1

    Topics: Acyclovir; Animals; Antiviral Agents; Cells, Cultured; Chronic Disease; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Guanine; Hepatitis B; Hepatitis B Virus, Duck; Humans; Lamivudine; Liver; Virus Replication

1997
[Lamivudine resistance impedes hepatitis B therapy].
    Fortschritte der Medizin, 1997, Apr-30, Volume: 115, Issue:12

    Topics: Drug Resistance, Microbial; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Reverse Transcriptase Inhibitors

1997
[Preventive lamivudine against reinfection by hepatitis B after liver transplantation].
    Zeitschrift fur Gastroenterologie, 1997, Volume: 35, Issue:5

    Topics: Follow-Up Studies; Hepatitis B; Hepatitis, Chronic; Humans; Lamivudine; Liver Transplantation; Postoperative Complications; Premedication; Recurrence; Reverse Transcriptase Inhibitors

1997
The University of Toronto liver transplant program.
    Clinical transplants, 1996

    Topics: Adult; Alprostadil; Antiviral Agents; Child; Graft Survival; Hepatitis B; Hepatitis C; Hospitals, University; Humans; Immunization, Passive; Immunoglobulins; Immunosuppression Therapy; Lamivudine; Liver Neoplasms; Liver Transplantation; Ontario; Patient Selection; Recurrence; Retrospective Studies; Ribavirin; Survival Rate; Transplantation, Heterologous

1996
Beneficial effect of lamivudine pre- and post-liver transplantation for hepatitis B infection.
    Transplantation proceedings, 1997, Volume: 29, Issue:6

    Topics: Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Reverse Transcriptase Inhibitors; Transplantation, Homologous

1997
Lamivudine-stavudine-induced liver failure in hepatitis B cirrhosis.
    The American journal of gastroenterology, 1997, Volume: 92, Issue:9

    Topics: Aged; Anti-HIV Agents; Ascites; Drug Combinations; Hepatitis B; Hepatitis, Chronic; HIV Infections; Humans; Jaundice; Lamivudine; Liver Cirrhosis; Liver Failure; Male; Reverse Transcriptase Inhibitors; Stavudine

1997
Alteration of the dismal natural history of fibrosing cholestatic hepatitis secondary to hepatitis B virus with the use of lamivudine.
    Transplantation, 1997, Sep-27, Volume: 64, Issue:6

    Topics: Antiviral Agents; Cholestasis, Intrahepatic; Diabetic Nephropathies; DNA, Viral; Graft Survival; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Kidney Failure, Chronic; Kidney Transplantation; Lamivudine; Liver; Liver Function Tests; Living Donors; Male; Middle Aged; Recurrence; Transplantation, Homologous; Virus Replication

1997
Evaluation of anti-hepatitis B virus (HBV) drugs using the HBV transgenic mouse: application of the semiquantitative polymerase chain reaction (PCR) for serum HBV DNA to monitor the drug efficacy.
    Biochemical and biophysical research communications, 1997, Dec-08, Volume: 241, Issue:1

    Topics: Adenine; Animals; Antiviral Agents; DNA Replication; DNA, Viral; Drug Monitoring; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Lamivudine; Liver; Mice; Mice, Transgenic; Polymerase Chain Reaction; Virion; Virus Replication

1997
[Chronic HIV- and chronic HBV infection with hematuria and proteinuria].
    Deutsche medizinische Wochenschrift (1946), 1998, Feb-13, Volume: 123, Issue:7

    Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Chronic Disease; Environmental Monitoring; Erythrocyte Count; Hazardous Substances; Hematuria; Hepatitis B; HIV-1; Humans; Lamivudine; Male; Occupational Exposure; Proteinuria; Zidovudine

1998
Postliver transplant allograft reinfection with a lamivudine-resistant strain of hepatitis B virus: long-term follow-up.
    Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 1998, Volume: 12, Issue:2

    Topics: 2-Aminopurine; Adult; Antiviral Agents; Drug Resistance, Microbial; Famciclovir; Female; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recurrence; Time Factors

1998
[Prevention of hepatitis B--analysis of cost-effectiveness after liver transplantation].
    Langenbecks Archiv fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress, 1997, Volume: 114

    Topics: 2-Aminopurine; Adult; Antiviral Agents; Cost-Benefit Analysis; Famciclovir; Female; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recurrence

1997
Identification of more than one mutation in the hepatitis B virus polymerase gene arising during prolonged lamivudine treatment.
    The Journal of infectious diseases, 1998, Volume: 177, Issue:5

    Topics: Amino Acid Substitution; DNA Primers; DNA-Directed DNA Polymerase; DNA, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Point Mutation; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors

1998
Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group.
    Hepatology (Baltimore, Md.), 1998, Volume: 27, Issue:6

    Topics: Amino Acid Sequence; Amino Acid Substitution; Drug Resistance, Microbial; Genes, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Molecular Sequence Data; Mutation; Reverse Transcriptase Inhibitors

1998
Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy.
    Hepatology (Baltimore, Md.), 1998, Volume: 27, Issue:6

    Topics: Adult; Amino Acid Sequence; Base Sequence; Drug Resistance, Microbial; Female; Genes, Viral; Genome, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Molecular Sequence Data; Mutation; Reverse Transcriptase Inhibitors; Time Factors

1998
Effectiveness of lamivudine in treatment of acute recurrent hepatitis B after liver transplantation.
    Digestive diseases and sciences, 1998, Volume: 43, Issue:6

    Topics: Acute Disease; Bilirubin; DNA, Viral; Hepatitis B; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Postoperative Complications; Recurrence; Reverse Transcriptase Inhibitors; Transaminases

1998
Successful treatment with lamivudine for fulminant reactivated hepatitis B infection following intensive therapy for high-grade non-Hodgkin's lymphoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1998, Volume: 9, Issue:4

    Topics: Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Carrier State; Fatal Outcome; Hepatitis B; Humans; Lamivudine; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Recurrence

1998
Efficacy of lamivudine re-treatment in a patient with hepatitis B virus (HBV) recurrence after liver transplantation and HBV-DNA breakthrough during the first treatment.
    Transplantation, 1998, Jun-15, Volume: 65, Issue:11

    Topics: Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recurrence; Retreatment

1998
Treatment of fibrosing cholestatic hepatitis with lamivudine.
    Gastroenterology, 1998, Volume: 115, Issue:1

    Topics: Adult; Cholestasis; DNA, Viral; Female; Fibrosis; Hepatitis B; Humans; Kidney Transplantation; Lamivudine; Reverse Transcriptase Inhibitors

1998
Efficacy of lamivudine in controlling hepatitis B virus recurrence after liver transplantation.
    Transplantation, 1998, Jun-27, Volume: 65, Issue:12

    Topics: Adult; Aged; Antiviral Agents; DNA, Viral; Female; Health Care Costs; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence

1998
Lamivudine treatment for chronic replicative hepatitis B virus infection after allogeneic bone marrow transplantation.
    Bone marrow transplantation, 1998, Volume: 21, Issue:12

    Topics: Adult; Antiviral Agents; Bone Marrow Transplantation; Chronic Disease; DNA, Viral; Female; Hepatitis B; Humans; Lamivudine; Transplantation, Homologous

1998
Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin.
    Hepatology (Baltimore, Md.), 1998, Volume: 28, Issue:2

    Topics: Adult; Aged; Female; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver; Liver Function Tests; Liver Transplantation; Male; Middle Aged; Postoperative Care; Postoperative Complications; Preoperative Care; Reverse Transcriptase Inhibitors; Secondary Prevention; Virus Replication

1998
Lamivudine inhibits hepatitis B virus replication in kidney graft recipients.
    Transplantation, 1998, Aug-15, Volume: 66, Issue:3

    Topics: Adult; Antiviral Agents; Drug Resistance, Microbial; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Humans; Kidney Transplantation; Lamivudine; Male; Middle Aged; Postoperative Complications; Substance Withdrawal Syndrome; Virus Replication

1998
Reactivation of hepatitis B in a long-term anti-HBs-positive patient with AIDS following lamivudine withdrawal.
    Journal of hepatology, 1998, Volume: 29, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; DNA, Viral; Drug Administration Schedule; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Homosexuality, Male; Humans; Lamivudine; Male; Middle Aged; Recurrence; Virus Activation

1998
Advances in the treatment of viral hepatitis.
    Hospital medicine (London, England : 1998), 1998, Volume: 59, Issue:4

    Topics: 2-Aminopurine; Antiviral Agents; Famciclovir; Hepatitis B; Hepatitis C; Hepatitis, Viral, Human; Humans; Interferon-alpha; Lamivudine

1998
Recovery from life-threatening, corticosteroid-unresponsive, chemotherapy-related reactivation of hepatitis B associated with lamivudine therapy.
    Digestive diseases and sciences, 1998, Volume: 43, Issue:10

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Female; Glucocorticoids; Hepatitis B; Humans; Lamivudine; Lung Neoplasms; Prednisolone; Reverse Transcriptase Inhibitors; Treatment Failure; Treatment Outcome

1998
[Successful treatment of an HB carrier developing severe hepatitis using lamivudine--case report].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 1998, Volume: 95, Issue:10

    Topics: Adult; Antiviral Agents; Carrier State; Hepatitis B; Humans; Lamivudine; Male

1998
The sequential occurrence of viral mutations in a liver transplant recipient re-infected with hepatitis B: hepatitis B immune globulin escape, famciclovir non-response, followed by lamivudine resistance resulting in graft loss.
    Journal of hepatology, 1998, Volume: 29, Issue:4

    Topics: 2-Aminopurine; Amino Acid Sequence; Antiviral Agents; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance; Famciclovir; Hepatitis B; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver; Liver Transplantation; Male; Middle Aged; Molecular Sequence Data; Mutation; Recurrence; Viral Proteins

1998
Oral treatment for hepatitis B gets approval in the United States.
    BMJ (Clinical research ed.), 1998, Oct-17, Volume: 317, Issue:7165

    Topics: Administration, Oral; Antiviral Agents; Drug Approval; Hepatitis B; Humans; Lamivudine; United States; United States Food and Drug Administration

1998
Lamivudine treatment for acute hepatitis B after liver transplantation.
    Journal of hepatology, 1998, Volume: 29, Issue:6

    Topics: Acute Disease; Adult; Antiviral Agents; Female; Hepatitis B; Humans; Lamivudine; Liver Failure; Liver Transplantation; Male; Middle Aged; Recurrence

1998
The hepatitis B virus-trimera mouse: a model for human HBV infection and evaluation of anti-HBV therapeutic agents.
    Hepatology (Baltimore, Md.), 1999, Volume: 29, Issue:2

    Topics: Animals; Antibodies, Viral; Antiviral Agents; Deoxycytidine; Disease Models, Animal; DNA, Viral; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Kidney; Lamivudine; Liver; Liver Transplantation; Mice; Mice, Inbred NOD; Mice, SCID; Polymerase Chain Reaction; RNA, Messenger; Serum Albumin; Viremia

1999
Lamivudine therapy for chemotherapy-induced reactivation of hepatitis B virus infection.
    The American journal of gastroenterology, 1999, Volume: 94, Issue:1

    Topics: Acute Disease; Antineoplastic Agents; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma, Follicular; Male; Middle Aged; Reverse Transcriptase Inhibitors; Virus Activation

1999
[HIV, hepatitis, influenza: new antiviral agents].
    Deutsche medizinische Wochenschrift (1946), 1999, Jan-08, Volume: 124, Issue:1-2

    Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Antiviral Agents; Child; Clinical Trials as Topic; Dideoxynucleosides; Enzyme Inhibitors; Guanidines; Hepatitis B; Humans; Influenza, Human; Lamivudine; Neuraminidase; Pyrans; Reverse Transcriptase Inhibitors; Sialic Acids; Zanamivir

1999
Efficacy of lamivudine in patients with hepatitis B virus precore mutant infection before and after liver transplantation.
    The American journal of gastroenterology, 1999, Volume: 94, Issue:3

    Topics: Antiviral Agents; DNA, Viral; Drug Evaluation; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Point Mutation; Recurrence; Virus Replication

1999
Lamivudine is safe and effective in fulminant hepatitis B.
    Journal of hepatology, 1999, Volume: 30, Issue:3

    Topics: Acute Disease; Adult; Antineoplastic Agents; Hepatitis B; Humans; Lamivudine; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Reverse Transcriptase Inhibitors

1999
Hepatitis B virus variants with lamivudine-related mutations in the DNA polymerase and the 'a' epitope of the surface antigen are sensitive to ganciclovir.
    Antiviral research, 1999, Volume: 41, Issue:3

    Topics: Adult; Amino Acid Sequence; Antiviral Agents; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Microbial; Drug Therapy, Combination; Epitopes; Ganciclovir; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Molecular Sequence Data; Mutation

1999
Successful use of lamivudine for severe acute hepatitis B virus infection in a cardiac transplant recipient.
    Transplantation, 1999, May-15, Volume: 67, Issue:9

    Topics: Acute Disease; Antiviral Agents; Heart Transplantation; Hepatitis B; Humans; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors

1999
Successful treatment of polyarteritis nodosa related to hepatitis B virus with a combination of lamivudine and interferon alpha.
    Rheumatology (Oxford, England), 1999, Volume: 38, Issue:2

    Topics: Drug Therapy, Combination; Hepatitis B; Hepatitis B virus; Humans; Interferon-alpha; Lamivudine; Male; Middle Aged; Polyarteritis Nodosa

1999
Food and Drug Administration approves lamivudine for hepatitis B.
    Frontiers of medical and biological engineering : the international journal of the Japan Society of Medical Electronics and Biological Engineering, 1999, Volume: 9, Issue:1

    Topics: Antiviral Agents; Hepatitis B; Humans; Lamivudine; Reverse Transcriptase Inhibitors; United States; United States Food and Drug Administration

1999
Does Asian race affect hepatitis B virus recurrence or survival following liver transplantation for hepatitis B cirrhosis?
    Journal of gastroenterology and hepatology, 1999, Volume: 14 Suppl

    Topics: Adolescent; Adult; Asian People; Carcinoma, Hepatocellular; Hepatitis B; Hepatitis B e Antigens; Humans; Immunization, Passive; Immunoglobulins; Immunosuppression Therapy; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Methylprednisolone; Middle Aged; Recurrence; Reverse Transcriptase Inhibitors; Survival Rate

1999
Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation.
    Hepatology (Baltimore, Md.), 1999, Volume: 30, Issue:1

    Topics: 2-Aminopurine; Adult; Amino Acid Substitution; Antiviral Agents; DNA Primers; DNA-Directed DNA Polymerase; Famciclovir; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Methionine; Middle Aged; Point Mutation; Polymerase Chain Reaction; Prodrugs; Recurrence; Risk Factors; Valine

1999
Emergence of drug-resistant populations of woodchuck hepatitis virus in woodchucks treated with the antiviral nucleoside lamivudine.
    Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:8

    Topics: Amino Acid Sequence; Animals; Antiviral Agents; Cells, Cultured; Drug Resistance, Microbial; Genotype; Hepatitis B; Hepatitis B Virus, Woodchuck; Humans; Lamivudine; Marmota; Molecular Sequence Data; Mutagenesis, Site-Directed; Mutation; Reverse Transcriptase Inhibitors; Sequence Homology, Amino Acid

1999
Association of lamivudine resistance in recurrent hepatitis B after liver transplantation with advanced hepatic fibrosis.
    Transplantation, 1999, Jul-27, Volume: 68, Issue:2

    Topics: Adult; Anti-HIV Agents; DNA, Viral; Drug Resistance, Microbial; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Recurrence; Treatment Outcome

1999
Human immunodeficiency virus and hepatitis B virus co-infection in two siblings: viral loads markedly reduced by triple-therapy including lamivudine.
    European journal of pediatrics, 1999, Volume: 158, Issue:8

    Topics: Anti-HIV Agents; Child, Preschool; Comorbidity; DNA, Viral; Drug Therapy, Combination; Hepatitis B; HIV Infections; HIV-1; Humans; Lamivudine; Male; Reverse Transcriptase Inhibitors; Treatment Outcome; Viral Load

1999
Is nucleoside analogue monotherapy sufficient for treatment of HBV infection? Lessons from HIV.
    Sexually transmitted infections, 1999, Volume: 75, Issue:2

    Topics: 2-Aminopurine; Anti-HIV Agents; Antiviral Agents; Deoxyguanosine; Famciclovir; Hepatitis B; HIV Infections; Humans; Lamivudine

1999
Hepatitis B virus (HBV) mutations associated with resistance to lamivudine in patients coinfected with HBV and human immunodeficiency virus.
    Journal of clinical microbiology, 1999, Volume: 37, Issue:9

    Topics: Anti-HIV Agents; Drug Resistance, Microbial; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Mutation

1999
European CPMP gives positive opinion on lamivudine for chronic hepatitis B.
    Reviews in medical virology, 1999, Volume: 9, Issue:3

    Topics: Chronic Disease; Clinical Trials, Phase II as Topic; DNA, Viral; Drug Approval; European Union; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Reverse Transcriptase Inhibitors

1999
Lamivudine therapy of hepatitis B virus-related liver disease: cirrhosis, posttransplantation recurrence, and de novo infection.
    Transplantation proceedings, 1999, Volume: 31, Issue:6

    Topics: Adult; Aged; Female; Follow-Up Studies; Hepatitis B; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recurrence; Reverse Transcriptase Inhibitors

1999
Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors.
    Transplantation, 1999, Oct-15, Volume: 68, Issue:7

    Topics: Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Prospective Studies; Reverse Transcriptase Inhibitors; Tissue Donors; Transplantation, Homologous

1999
Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients.
    Hepatology (Baltimore, Md.), 1999, Volume: 30, Issue:5

    Topics: Adult; Amino Acid Sequence; Anti-HIV Agents; Cohort Studies; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Microbial; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Polymerase Chain Reaction

1999
Intramuscular hepatitis B immune globulin combined with lamivudine for prophylaxis against hepatitis B recurrence after liver transplantation.
    Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 1999, Volume: 5, Issue:6

    Topics: Administration, Oral; DNA, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Injections, Intramuscular; Lamivudine; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recurrence; Reverse Transcriptase Inhibitors; Time Factors

1999
Lamivudine therapy in patients undergoing liver transplantation for hepatitis B virus precore mutant-associated infection: high resistance rates in treatment of recurrence but universal prevention if used as prophylaxis with very low dose hepatitis B immu
    Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 1999, Volume: 5, Issue:6

    Topics: Adult; Case-Control Studies; Female; Hepatitis B; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Polymerase Chain Reaction; Recurrence; Reverse Transcriptase Inhibitors; Viral Core Proteins

1999
Emergence of YMDD motif mutants of hepatitis B virus during lamivudine treatment of immunocompetent type B hepatitis patients.
    Journal of medical virology, 2000, Volume: 60, Issue:1

    Topics: Adult; Alanine Transaminase; Amino Acid Motifs; Amino Acid Sequence; Antiviral Agents; DNA-Directed DNA Polymerase; DNA, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Immunocompetence; Lamivudine; Male; Middle Aged; Molecular Sequence Data; Mutation; Polymerase Chain Reaction; Sequence Analysis, DNA

2000
[Treatment of liver cirrhosis due to hepatitis B with lamivudine].
    Gastroenterologia y hepatologia, 1999, Volume: 22, Issue:8

    Topics: Antiviral Agents; Hepatitis B; Humans; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors

1999
Rapid detection of lamivudine-resistant hepatitis B virus polymerase gene variants.
    Journal of virological methods, 1999, Volume: 83, Issue:1-2

    Topics: Antiviral Agents; Base Sequence; DNA Primers; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Microbial; Genes, Viral; Genetic Variation; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Time Factors; Virology

1999
Outcome of lamivudine resistant hepatitis B virus infection in the liver transplant recipient.
    Gut, 2000, Volume: 46, Issue:1

    Topics: Adult; Antiviral Agents; Drug Resistance, Microbial; Female; Follow-Up Studies; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Postoperative Complications

2000
Fulminant hepatic failure resulting from lamivudine-resistant hepatitis B virus in a renal transplant recipient: durable response after orthotopic liver transplantation on adefovir dipivoxil and hepatitis B immune globulin.
    Transplantation, 1999, Dec-27, Volume: 68, Issue:12

    Topics: Adenine; Adult; Antiviral Agents; Carrier State; DNA-Directed DNA Polymerase; Drug Resistance; Female; Hepatitis B; Hepatitis B virus; Humans; Immunization, Passive; Kidney Transplantation; Lamivudine; Liver Failure; Liver Transplantation; Mutation; Organophosphonates

1999
Hepatitis B virus reactivation in patients undergoing cytotoxic chemotherapy for solid tumours: precore/core mutations may play an important role.
    Journal of medical virology, 2000, Volume: 60, Issue:3

    Topics: Adult; Amino Acid Sequence; Antineoplastic Agents; Base Sequence; Breast Neoplasms; Carcinoma, Small Cell; DNA Mutational Analysis; DNA, Viral; Female; Germinoma; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Molecular Sequence Data; Mutation, Missense; Promoter Regions, Genetic; Reverse Transcriptase Inhibitors; Trans-Activators; Viral Regulatory and Accessory Proteins; Virus Activation

2000
Successful treatment of hepatitis B-associated polyarteritis nodosa with a combination of lamivudine and conventional immunosuppressive therapy: a case report.
    Rheumatology (Oxford, England), 2000, Volume: 39, Issue:1

    Topics: Hepatitis B; Humans; Immunosuppression Therapy; Lamivudine; Male; Polyarteritis Nodosa

2000
Selection of multiresistant hepatitis B virus during sequential nucleoside-analogue therapy.
    The Journal of infectious diseases, 2000, Volume: 181, Issue:2

    Topics: 2-Aminopurine; Antiviral Agents; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Famciclovir; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Mutation; Reverse Transcriptase Inhibitors; Viral Load

2000
[Emergence of resistant hepatitis B virus strains during long-term lamivudine therapy in human immunodeficiency virus co-infected patients].
    Gastroenterologie clinique et biologique, 2000, Volume: 24, Issue:1

    Topics: Adult; Anti-HIV Agents; Drug Resistance, Microbial; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Middle Aged; Prospective Studies; Time Factors

2000
Analysis of hepatitis B virus quasispecies changes during emergence and reversion of lamivudine resistance in liver transplantation.
    Antiviral therapy, 1999, Volume: 4, Issue:1

    Topics: Antiviral Agents; DNA, Viral; Drug Resistance; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Mutation

1999
Lamivudine allows completion of chemotherapy in lymphoma patients with hepatitis B reactivation.
    British journal of haematology, 2000, Volume: 108, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Hepatitis B; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Reverse Transcriptase Inhibitors; Virus Activation

2000
Lamivudine for the prevention of hepatitis B virus reactivation during autologous stem cell transplantation. A case report.
    Haematologica, 2000, Volume: 85, Issue:3

    Topics: Adult; Antiviral Agents; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Transplantation, Autologous; Virus Activation

2000
Lamivudine for hepatitis B in liver transplantation: a single-center experience.
    Transplantation, 2000, Apr-15, Volume: 69, Issue:7

    Topics: Adult; Aged; DNA, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver; Liver Transplantation; Longitudinal Studies; Male; Middle Aged; Postoperative Care; Postoperative Complications; Preoperative Care; Recurrence; Reverse Transcriptase Inhibitors; Virus Replication

2000
Additional interferon alpha for lamivudine resistant hepatitis B infection after liver transplantation: a preliminary report.
    Transplantation, 2000, Apr-27, Volume: 69, Issue:8

    Topics: Adult; Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; Drug Resistance; Drug Therapy, Combination; Hepatitis B; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recombinant Proteins; Retrospective Studies; Reverse Transcriptase Inhibitors

2000
HBV genotypic resistance to lamivudine in kidney recipients and hemodialyzed patients.
    Transplantation, 2000, May-27, Volume: 69, Issue:10

    Topics: Adult; Aged; Amino Acid Sequence; Base Sequence; DNA, Viral; Drug Resistance, Microbial; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Kidney Transplantation; Lamivudine; Male; Middle Aged; Renal Dialysis; Reverse Transcriptase Inhibitors; Viremia

2000
Assessing virologic efficacy of combination lamivudine and low-dose hepatitis B immune globulin posttransplantation with the ultrasensitive digene hybrid capture II assay.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2000, Volume: 6, Issue:3

    Topics: DNA, Viral; Hepatitis B; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Postoperative Complications

2000
Extension of transplantation free time by lamivudine in patients with hepatitis B-induced decompensated cirrhosis.
    Transplantation, 2000, Jun-15, Volume: 69, Issue:11

    Topics: Adult; Hepatitis B; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Preoperative Care; Reverse Transcriptase Inhibitors; Time Factors; Treatment Outcome; Virus Replication

2000
Evolution of lamivudine-resistant hepatitis B virus and HIV-1 in co-infected individuals: an analysis of the CAESAR study. CAESAR co-ordinating committee.
    AIDS (London, England), 2000, Jun-16, Volume: 14, Issue:9

    Topics: CD4 Lymphocyte Count; Drug Resistance, Microbial; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Retrospective Studies; Reverse Transcriptase Inhibitors; Viral Load

2000
Organ transplantation and discrimination. Patients with hepatitis B should not be given low priority.
    BMJ (Clinical research ed.), 2000, Jun-10, Volume: 320, Issue:7249

    Topics: Antiviral Agents; Contraindications; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Patient Selection; Refusal to Treat

2000
Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2000, Volume: 6, Issue:4

    Topics: Adult; Combined Modality Therapy; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Immunoglobulins, Intravenous; Lamivudine; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Secondary Prevention

2000
Lamivudine after hepatitis B immune globulin is effective in preventing hepatitis B recurrence after liver transplantation.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2000, Volume: 6, Issue:4

    Topics: Adult; Aged; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B Surface Antigens; Humans; Immunization, Passive; Immunoglobulins; Immunoglobulins, Intravenous; Lamivudine; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Secondary Prevention

2000
Development of a quantitative real-time detection assay for hepatitis B virus DNA and comparison with two commercial assays.
    Journal of clinical microbiology, 2000, Volume: 38, Issue:8

    Topics: Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Polymerase Chain Reaction; Reagent Kits, Diagnostic; Reproducibility of Results; Sensitivity and Specificity; Taq Polymerase

2000
Lamivudine and hepatitis B: is the bloom already fading?
    The American journal of gastroenterology, 2000, Volume: 95, Issue:7

    Topics: Adult; Hepatitis B; Humans; Lamivudine; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors

2000
Prevention of de novo hepatitis B infection after liver transplantation with allografts from hepatitis B core antibody positive donors.
    Clinical transplantation, 2000, Volume: 14 Suppl 2

    Topics: Antiviral Agents; Disease Susceptibility; Graft Survival; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Probability; Survival Rate; Tissue Donors; Transplantation, Homologous

2000
Lamivudine without HBIg for prevention of graft reinfection by hepatitis B: long-term follow-up.
    Transplantation, 2000, Sep-15, Volume: 70, Issue:5

    Topics: Biopsy; DNA, Viral; Follow-Up Studies; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Survival Rate

2000
Genotypic succession of mutations of the hepatitis B virus polymerase associated with lamivudine resistance.
    Journal of hepatology, 2000, Volume: 33, Issue:3

    Topics: Adult; Antiviral Agents; Base Sequence; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Microbial; Female; Genotype; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Transaminases

2000
Fatal hepatitis B reinfection after orthotopic liver transplantation in an HBsAg negative patient following withdrawal of lamivudine.
    Journal of hepatology, 2000, Volume: 33, Issue:3

    Topics: Antiviral Agents; Fatal Outcome; Female; Hepatitis B; Hepatitis B Surface Antigens; Humans; Lamivudine; Middle Aged; Postoperative Period; Recurrence

2000
Lamivudine in the treatment of acute hepatitis B.
    The New England journal of medicine, 2000, Oct-12, Volume: 343, Issue:15

    Topics: Acute Disease; Aged; Female; Hepatitis B; Hepatitis B Antibodies; Humans; Lamivudine; Reverse Transcriptase Inhibitors

2000
Continuous lamivudine treatment in an OLT patient despite the appearance of HBV resistant strain: longitudinal analysis.
    Transplantation, 2000, Oct-15, Volume: 70, Issue:7

    Topics: Antiviral Agents; Hepatitis B; Humans; Immunity, Innate; Lamivudine; Liver Transplantation; Longitudinal Studies; Male; Middle Aged

2000
Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors.
    Journal of medical virology, 2000, Volume: 62, Issue:3

    Topics: Adult; Age Factors; Alanine Transaminase; Female; Hepatitis Antibodies; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C; Humans; Immunosuppressive Agents; Incidence; Lamivudine; Liver Neoplasms; Male; Middle Aged; Neoplasms; Prospective Studies; Risk Factors; Sex Factors; Virus Activation

2000
Successful treatment of hepatitis B virus associated polyarteritis nodosa with a combination of prednisolone, alpha-interferon and lamivudine.
    Journal of hepatology, 2000, Volume: 33, Issue:4

    Topics: Antiviral Agents; Base Sequence; Biopsy; DNA Primers; DNA, Viral; Drug Therapy, Combination; Genome, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Interferon-alpha; Lamivudine; Liver Function Tests; Male; Middle Aged; Molecular Sequence Data; Polyarteritis Nodosa; Prednisolone

2000
[Prevention of hepatitis B flare-up using lamivudine in a patient with non-Hodgkin's lymphoma after allogeneic bone marrow transplantation].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2000, Volume: 41, Issue:9

    Topics: Adult; Bone Marrow Transplantation; Hepatitis B; Humans; Lamivudine; Lymphoma, B-Cell; Male; Postoperative Period; Reverse Transcriptase Inhibitors; Transplantation, Homologous

2000
An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2000, Volume: 6, Issue:6

    Topics: Adolescent; Adult; Aged; Cost-Benefit Analysis; DNA, Viral; Drug Therapy, Combination; Female; Graft Survival; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Reverse Transcriptase Inhibitors; Secondary Prevention; Treatment Outcome; Virus Replication

2000
Reactivation of hepatitis B virus replication accompanied by acute hepatitis in patients receiving highly active antiretroviral therapy.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001, Volume: 32, Issue:1

    Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Amino Acid Sequence; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; DNA, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Molecular Sequence Data; Reverse Transcriptase Inhibitors; Virus Activation; Virus Replication

2001
Managing hepatitis B reactivation in renal transplant recipients: a 12-year review with emphasis on early detection and early use of lamivudine.
    Transplantation proceedings, 2000, Volume: 32, Issue:7

    Topics: Adult; Antiviral Agents; Carrier State; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B e Antigens; Humans; Immunosuppressive Agents; Kidney Transplantation; Lamivudine; Liver Function Tests; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Survival Analysis; Treatment Outcome

2000
Lamivudine improves the prognosis of patients with hepatitis B after liver transplantation.
    Transplantation proceedings, 2000, Volume: 32, Issue:7

    Topics: 2-Aminopurine; Antiviral Agents; Famciclovir; Follow-Up Studies; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Postoperative Complications; Prodrugs; Prognosis; Recurrence; Retrospective Studies; Time Factors; Treatment Failure; Treatment Outcome

2000
Liver transplantation for patients with hepatitis B: prevention of hepatitis B recurrence by intravenous antihepatitis B immunoglobulin and lamivudine.
    Transplantation proceedings, 2000, Volume: 32, Issue:7

    Topics: Adult; Antiviral Agents; Cyclosporine; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Humans; Immunization, Passive; Immunoglobulins; Immunosuppressive Agents; Kidney Transplantation; Lamivudine; Liver Transplantation; Male; Middle Aged; Monitoring, Physiologic; Recurrence; Time Factors; Treatment Outcome

2000
Prophylaxis against hepatitis B recurrence following liver transplantation in HBs Ag(+) patients.
    Transplantation proceedings, 2000, Volume: 32, Issue:7

    Topics: Adult; Antiviral Agents; Cadaver; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B Surface Antigens; Humans; Immunization, Passive; Immunoglobulins; Immunosuppressive Agents; Lamivudine; Liver Transplantation; Living Donors; Male; Middle Aged; Recurrence; Retrospective Studies; Survival Rate; Tissue Donors

2000
Lamivudine: a new strategy to suppress HBV replication in the pretransplant setting.
    Transplantation proceedings, 2000, Volume: 32, Issue:8

    Topics: Adult; Antiviral Agents; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Middle Aged; Premedication; Recurrence; Virus Replication

2000
Lamivudine therapy for a hepatitis B surface antigen (HBsAg)-positive leukemia patient receiving myeloablative chemotherapy and autologous stem cell transplantation.
    Bone marrow transplantation, 2000, Volume: 26, Issue:11

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carrier State; Combined Modality Therapy; DNA, Viral; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Leukemia, Myeloid, Acute; Liver Failure; Male; Reverse Transcriptase Inhibitors

2000
Long-term experience with lamivudine therapy for hepatitis B virus infection after liver transplantation.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2001, Volume: 7, Issue:2

    Topics: Adult; Antiviral Agents; DNA, Viral; Female; Fibrosis; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver; Liver Transplantation; Male; Middle Aged; Postoperative Complications

2001
Liver transplantation in Asian patients with chronic hepatitis B using lamivudine prophylaxis.
    Annals of surgery, 2001, Volume: 233, Issue:2

    Topics: Adolescent; Adult; Female; Graft Rejection; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hong Kong; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Reverse Transcriptase Inhibitors; Secondary Prevention; Treatment Outcome

2001
Comparison of famciclovir and lamivudine in the long-term treatment of hepatitis B infection after liver transplantation.
    Transplantation, 2001, Jan-15, Volume: 71, Issue:1

    Topics: 2-Aminopurine; Adult; Aged; Antiviral Agents; DNA, Viral; Famciclovir; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Multivariate Analysis; Time Factors

2001
Hepatitis B virus transgenic mice for the model of anti-hepatitis B virus drug study.
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2001, Volume: 9, Issue:1

    Topics: Animals; Antiviral Agents; Disease Models, Animal; Female; Hepatitis B; Hepatitis B virus; Lamivudine; Male; Mice; Mice, Transgenic; Thymosin; Vaccines, DNA

2001
The real danger of lamivudine-resistant hepatitis B virus infection in the immunocompromised host.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2001, Volume: 7, Issue:3

    Topics: Antiviral Agents; Chronic Disease; Drug Resistance, Microbial; Hepatitis B; Hepatitis B virus; Humans; Immunocompromised Host; Lamivudine; Liver Cirrhosis; Liver Transplantation; Postoperative Complications

2001
[Current treatment of hepatitis B].
    Gastroenterologia y hepatologia, 2001, Volume: 24 Suppl 1

    Topics: 2-Aminopurine; Adenine; Anti-Inflammatory Agents; Antiviral Agents; DNA Replication; Famciclovir; Forecasting; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Organophosphonates; Prednisone; Prognosis; Reverse Transcriptase Inhibitors; Time Factors; Virus Replication

2001
[Laboratory diagnosis of hepatitis B].
    Gastroenterologia y hepatologia, 2001, Volume: 24 Suppl 1

    Topics: 2-Aminopurine; Acute Disease; Antiviral Agents; DNA Replication; DNA, Viral; Drug Resistance; Famciclovir; Genetic Variation; Genotype; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunohistochemistry; Lamivudine; Virus Replication

2001
Monitoring the emergence of hepatitis B virus polymerase gene variants during lamivudine therapy using the LightCycler.
    Journal of clinical microbiology, 2001, Volume: 39, Issue:4

    Topics: Antiviral Agents; Drug Resistance, Microbial; Fluorescence; Gene Products, pol; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutation; Polymerase Chain Reaction

2001
[Management of pregnant women infected with HIV at Bichat Hospital between 1990 and 1998: analysis of 202 pregnancies].
    Gynecologie, obstetrique & fertilite, 2001, Volume: 29, Issue:3

    Topics: Africa South of the Sahara; Antiviral Agents; Cesarean Section; Female; France; Hepatitis B; Hepatitis C; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Papillomaviridae; Papillomavirus Infections; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; Sexually Transmitted Diseases; Zidovudine

2001
A possible role for lamivudine as prophylaxis against hepatitis B reactivation in carriers of hepatitis B who undergo chemotherapy and autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.
    Bone marrow transplantation, 2001, Volume: 27, Issue:4

    Topics: Adult; Antineoplastic Agents; DNA, Viral; Drug Therapy, Combination; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Reverse Transcriptase Inhibitors; Transplantation, Autologous; Virus Activation

2001
Successful orthotopic liver transplantation.
    Gastroenterology, 2001, Volume: 120, Issue:6

    Topics: Antiviral Agents; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Mutation; Recurrence

2001
Lamivudine and glycyrrhizin for treatment of chemotherapy-induced hepatitis B virus (HBV) hepatitis in a chronic HBV carrier with non-Hodgkin lymphoma.
    Leukemia & lymphoma, 2001, Volume: 41, Issue:1-2

    Topics: Anti-HIV Agents; Antineoplastic Agents; Chronic Disease; DNA, Viral; Drug Therapy, Combination; Glycyrrhizic Acid; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Reverse Transcriptase Inhibitors; Testicular Neoplasms; Virus Activation

2001
Lamivudine useful against hepatitis B-HIV co-infection.
    Journal of the International Association of Physicians in AIDS Care, 1995, Volume: 1, Issue:5

    Topics: Antiviral Agents; CD4 Lymphocyte Count; DNA, Viral; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Virus Replication; Zalcitabine; Zidovudine

1995
A closer look at 3TC. Interview by Mark Mascolini.
    Journal of the International Association of Physicians in AIDS Care, 1995, Volume: 1, Issue:6

    Topics: Antiviral Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; Hepatitis B; HIV Infections; Humans; Lamivudine; Zalcitabine; Zidovudine

1995
3TC recommended for hepatitis B.
    The Body positive, 1999, Volume: 12, Issue:4

    Topics: Drug Approval; Hepatitis B; Lamivudine; Reverse Transcriptase Inhibitors; United States; United States Food and Drug Administration

1999
Opportunistic infections update.
    Project Inform perspective, 1998, Issue:26

    Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; Drug Interactions; Drug Resistance, Microbial; Drug Therapy, Combination; Hepatitis B; Hepatitis C; HIV Infections; Humans; Interferon-alpha; Lamivudine; Liver; Ribavirin

1998
Lamivudine-resistant hepatitis B detected in HIV-infected patients.
    Newsline (People with AIDS Coalition of New York), 1999

    Topics: Anti-HIV Agents; Drug Resistance, Microbial; Hepatitis B; HIV Infections; Humans; Lamivudine; Mutation; Polymerase Chain Reaction

1999
Lamivudine in the treatment of polyarteritis nodosa associated with acute hepatitis B.
    The New England journal of medicine, 2001, May-24, Volume: 344, Issue:21

    Topics: Acute Disease; Adult; Antiviral Agents; Combined Modality Therapy; Female; Glucocorticoids; Hepatitis B; Humans; Lamivudine; Plasmapheresis; Polyarteritis Nodosa; Prednisone

2001
Failure of lamivudine therapy for chemotherapy-induced reactivation of hepatitis B.
    The American journal of gastroenterology, 2001, Volume: 96, Issue:5

    Topics: Antineoplastic Agents; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; Virus Activation

2001
Evans syndrome related to hepatitis B virus infection: a case that responded only to lamivudine therapy.
    Journal of pediatric gastroenterology and nutrition, 2001, Volume: 32, Issue:4

    Topics: Anemia, Hemolytic; Child, Preschool; Hepatitis B; Humans; Lamivudine; Male; Reverse Transcriptase Inhibitors; Syndrome; Thrombocytopenia

2001
Orthotopic liver transplantation in patients with hepatitis B-related liver disease.
    Transplantation proceedings, 2001, Volume: 33, Issue:4

    Topics: Adolescent; Adult; Antiviral Agents; Carcinoma, Hepatocellular; Follow-Up Studies; Graft Rejection; Hepatitis B; Humans; Lamivudine; Liver Neoplasms; Liver Transplantation; Middle Aged; Postoperative Complications; Retrospective Studies; Survival Rate; Time Factors

2001
Severe clinical course of de novo hepatitis B infection after liver transplantation.
    Transplantation proceedings, 2001, Volume: 33, Issue:4

    Topics: 2-Aminopurine; Adult; Antiviral Agents; Famciclovir; Fatal Outcome; Female; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Middle Aged; Postoperative Complications; Recurrence; Reoperation; Retrospective Studies; Treatment Outcome

2001
Liver transplantation in patients with hepatitis B virus infection: outcome in Asian versus white patients.
    Hepatology (Baltimore, Md.), 2001, Volume: 34, Issue:1

    Topics: Antiviral Agents; Asia; Asian People; Drug Resistance; Female; Hepatitis B; Hepatitis C; Hepatitis D; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence; Retrospective Studies; Survival Rate; Treatment Outcome; White People

2001
[Epidemiology of HBV infections and possibilities for therapeutic actions in children and adolescents with end-stage renal failure treated with dialysis].
    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2001, Volume: 10, Issue:58

    Topics: Adolescent; Adult; Child; Child, Preschool; Comorbidity; Female; Hepatitis B; Hepatitis B Vaccines; Hepatitis C; Humans; Incidence; Interferon-alpha; Kidney Failure, Chronic; Lamivudine; Male; Poland; Renal Dialysis

2001
Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2001, Volume: 7, Issue:6

    Topics: Adult; Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Humans; Lamivudine; Liver Transplantation; Middle Aged; Tissue Donors

2001
Limitations and improvements of the quantiplex branched-DNA assay in Hepatitis B virus-infected patients receiving lamivudine.
    Journal of virological methods, 2001, Volume: 96, Issue:2

    Topics: Branched DNA Signal Amplification Assay; DNA, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Reproducibility of Results; Reverse Transcriptase Inhibitors; Sensitivity and Specificity

2001
Lamivudine and low-dose hepatitis B immune globulin for prophylaxis of hepatitis B reinfection after liver transplantation possible role of mutations in the YMDD motif prior to transplantation as a risk factor for reinfection.
    Journal of hepatology, 2001, Volume: 34, Issue:6

    Topics: Adolescent; Adult; Amino Acid Motifs; Antiviral Agents; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Mutation; Recurrence; Risk Factors; Time Factors

2001
Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis.
    Journal of hepatology, 2001, Volume: 34, Issue:6

    Topics: Adult; Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Recurrence

2001
Hepatitis B, lamivudine, and HIV.
    BMJ (Clinical research ed.), 2001, Jul-07, Volume: 323, Issue:7303

    Topics: Anti-HIV Agents; Drug Resistance, Microbial; Hepatitis B; HIV Infections; Humans; Lamivudine; Reverse Transcriptase Inhibitors

2001
Hepatitis B virus subtypes and lamivudine resistance.
    Lancet (London, England), 2001, Jul-14, Volume: 358, Issue:9276

    Topics: Carrier State; DNA, Viral; Drug Resistance; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Mutation; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; Risk Factors; Sequence Alignment; Serotyping

2001
Serum zinc status in chronic hepatitis B and its relationship to liver histology and treatment results.
    Pediatrics international : official journal of the Japan Pediatric Society, 2001, Volume: 43, Issue:4

    Topics: Alanine Transaminase; DNA, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Infant, Newborn; Interferon-alpha; Lamivudine; Liver; Reverse Transcriptase Inhibitors; Zinc

2001
Much remains to be solved in lamivudine treatment for HBV-associated liver diseases.
    Journal of gastroenterology, 2001, Volume: 36, Issue:7

    Topics: Antiviral Agents; Carcinoma, Hepatocellular; Hepatitis B; Hepatitis Viruses; Humans; Lamivudine; Liver Neoplasms; Reverse Transcriptase Inhibitors; Treatment Outcome

2001
Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: a comparative study using a matched, untreated cohort.
    Hepatology (Baltimore, Md.), 2001, Volume: 34, Issue:2

    Topics: Adolescent; Adult; Aged; Cohort Studies; DNA, Viral; Drug Resistance; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Reverse Transcriptase Inhibitors; Severity of Illness Index; Survival Analysis; Virus Replication; Waiting Lists

2001
T-helper cell response to woodchuck hepatitis virus antigens after therapeutic vaccination of chronically-infected animals treated with lamivudine.
    Journal of hepatology, 2001, Volume: 35, Issue:1

    Topics: Animals; Antigens, Viral; Chronic Disease; Hepatitis B; Hepatitis B Virus, Woodchuck; Immunotherapy, Active; Lamivudine; Liver; Marmota; Reverse Transcriptase Inhibitors; T-Lymphocytes, Helper-Inducer; Viral Load; Viremia

2001
Emergence of YMDD motif mutant of hepatitis B virus during short-term lamivudine therapy in South Korea.
    Journal of hepatology, 2001, Volume: 35, Issue:1

    Topics: Adult; DNA, Viral; Drug Administration Schedule; Drug Resistance, Microbial; Female; Hepatitis B; Hepatitis B virus; Humans; Korea; Lamivudine; Male; Middle Aged; Polymerase Chain Reaction; Prospective Studies; Reverse Transcriptase Inhibitors; Sequence Analysis, DNA; Time Factors

2001
Outcome of liver transplantation for hepatitis B: report of a single center's experience.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2001, Volume: 7, Issue:8

    Topics: Adult; Female; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Longitudinal Studies; Male; Retrospective Studies; Reverse Transcriptase Inhibitors; Secondary Prevention; Treatment Outcome

2001
[HIV-HBV coinfection and the liver].
    Gastroenterologie clinique et biologique, 2001, Volume: 25, Issue:5

    Topics: Biopsy; Didanosine; Drug Therapy, Combination; Hepatitis B; HIV Infections; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Ritonavir; Saquinavir; Stavudine

2001
Life-threatening complications of hepatitis B virus-related polyarteritis nodosa developing despite interferon-alpha2b therapy: successful treatment with a combination of interferon, lamivudine, plasma exchanges and steroids.
    Clinical rheumatology, 2001, Volume: 20, Issue:4

    Topics: Adult; Combined Modality Therapy; Critical Illness; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Plasma Exchange; Polyarteritis Nodosa; Recombinant Proteins; Risk Assessment; Steroids; Treatment Outcome

2001
Real-time PCR for detection and quantitation of hepatitis B virus DNA.
    Journal of medical virology, 2001, Volume: 65, Issue:2

    Topics: Acute Disease; Antiviral Agents; Computers; DNA, Viral; Drug Therapy, Combination; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Polymerase Chain Reaction; Predictive Value of Tests; Sensitivity and Specificity

2001
Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study.
    Lancet (London, England), 2001, Sep-01, Volume: 358, Issue:9283

    Topics: Adenine; Adult; Alanine Transaminase; Anti-HIV Agents; Antiviral Agents; DNA, Viral; Drug Administration Schedule; Drug Resistance, Microbial; Female; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Male; Organophosphonates; Pilot Projects; Viral Load

2001
Recent advances in the management and treatment of GI and hepatic diseases associated with HIV: Part 2.
    The AIDS reader, 2001, Volume: 11, Issue:8

    Topics: Amantadine; Antiviral Agents; Hepatitis B; Hepatitis C; HIV; HIV Infections; Humans; Interferon-alpha; Lamivudine; Risk Factors

2001
Living-related partial liver transplantation for decompensated hepatitis B without reactivation of hepatitis B in the following 30 months.
    Journal of gastroenterology, 2001, Volume: 36, Issue:9

    Topics: Adult; Antibodies; Female; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Cirrhosis; Liver Transplantation; Living Donors; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; Secondary Prevention

2001
HIV/Hepatitis B and C co-infection: pathogenic interactions, natural history and therapy.
    Antiviral chemistry & chemotherapy, 2001, Volume: 12 Suppl 1

    Topics: Antiretroviral Therapy, Highly Active; Antiviral Agents; Hepatitis B; Hepatitis C; HIV Infections; Humans; Interferon-alpha; Lamivudine

2001
Hepatitis B surface antigen-positive organ transplantation recipients: can lamivudine alter their fate?
    Journal of gastroenterology and hepatology, 2001, Volume: 16, Issue:9

    Topics: Carrier State; Disease Progression; Hepatitis B; Hepatitis B Surface Antigens; Humans; Lamivudine; Liver Function Tests; Organ Transplantation; Postoperative Complications; Survival Rate; Transplantation Immunology; Treatment Outcome; Virus Activation

2001
Lamivudine treatment for hepatitis B reactivation in HBsAg carriers after organ transplantation: a 4-year experience.
    Journal of gastroenterology and hepatology, 2001, Volume: 16, Issue:9

    Topics: Adult; Carrier State; DNA, Viral; Drug Resistance, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Function Tests; Male; Middle Aged; Organ Transplantation; Postoperative Complications; Retrospective Studies; Survival Rate; Transplantation Immunology; Virus Activation

2001
Residual hepatitis B virus particles in liver transplant recipients receiving lamivudine: PCR quantitation of HBV DNA and ELISA of preS1 antigen.
    Journal of medical virology, 2001, Volume: 65, Issue:3

    Topics: Adult; Aged; Alanine Transaminase; Antiviral Agents; DNA, Viral; Enzyme-Linked Immunosorbent Assay; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Polymerase Chain Reaction; Protein Precursors; Virion; Virus Replication

2001
Acute hepatitis B by sexual transmission after interruption of lamivudine-containing antiretroviral regimen.
    AIDS (London, England), 2001, Oct-19, Volume: 15, Issue:15

    Topics: Acute Disease; Adult; Anti-HIV Agents; Coitus; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepatitis B; HIV Infections; Humans; Lamivudine; Male; Pregnancy; Reverse Transcriptase Inhibitors; Sexually Transmitted Diseases, Viral

2001
Analysis of hepatitis B viral load decline under potent therapy: complex decay profiles observed.
    Hepatology (Baltimore, Md.), 2001, Volume: 34, Issue:5

    Topics: 2-Aminopurine; Antiviral Agents; Computer Systems; DNA, Viral; Drug Therapy, Combination; Famciclovir; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Polymerase Chain Reaction; Reproducibility of Results; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Time Factors; Viral Load

2001
Preoperative antiviral treatment and postoperative prophylaxis in HBV-DNA positive patients undergoing liver transplantation.
    Transplantation, 2001, Oct-27, Volume: 72, Issue:8

    Topics: 2-Aminopurine; Adult; Antiviral Agents; DNA, Viral; Famciclovir; Female; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence; Retrospective Studies

2001
Failure of combination therapy with lamivudine and famciclovir following lamivudine monotherapy for hepatitis B virus infection in patients coinfected with human immunodeficiency virus-1.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001, Dec-15, Volume: 33, Issue:12

    Topics: 2-Aminopurine; Antiviral Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Famciclovir; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Male; Mutation; Treatment Failure

2001
Occurrence and clinical outcome of lamivudine-resistant hepatitis B infection after liver transplantation.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2001, Volume: 7, Issue:11

    Topics: Drug Resistance, Microbial; Female; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver; Liver Transplantation; Male; Reoperation; Reverse Transcriptase Inhibitors; Survival Analysis; Treatment Outcome

2001
Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy.
    British journal of haematology, 2001, Volume: 115, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hodgkin Disease; Humans; Lamivudine; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Pilot Projects; Prednisone; Vidarabine; Vincristine; Virus Activation

2001
Lamivudine treatment failure in preventing fatal outcome of de novo severe acute hepatitis B in patients with haematological diseases.
    Journal of hepatology, 2001, Volume: 35, Issue:6

    Topics: Acute Disease; Adult; Aged; Child; Cross Infection; Disease Outbreaks; Fatal Outcome; Female; Hematologic Diseases; Hepatitis B; Humans; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; Treatment Failure

2001
Primary infection with a lamivudine-resistant hepatitis B virus.
    AIDS (London, England), 2002, Jan-04, Volume: 16, Issue:1

    Topics: Adult; Anti-HIV Agents; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Male; Reverse Transcriptase Inhibitors

2002
Prophylaxis of hepatitis B reactivation using lamivudine in a patient receiving rituximab.
    American journal of hematology, 2001, Volume: 68, Issue:4

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Reverse Transcriptase Inhibitors; Rituximab; Treatment Outcome; Virus Activation

2001
Successful control of subfulminant hepatitis related to lamivudine-resistant hepatitis B virus in an HIV-infected patient.
    AIDS (London, England), 2001, Dec-07, Volume: 15, Issue:18

    Topics: Adult; Antiviral Agents; Ganciclovir; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Treatment Outcome

2001
Prevention and treatment of hepatitis B relapse after liver transplantation.
    Chinese medical journal, 2001, Volume: 114, Issue:1

    Topics: Adult; Carcinoma, Hepatocellular; Female; Hepatitis B; Humans; Lamivudine; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Recurrence

2001
Vaccination for hepatitis B after transplantation: a realistic goal?
    Hepatology (Baltimore, Md.), 2002, Volume: 35, Issue:1

    Topics: DNA, Viral; Hepatitis B; Hepatitis B Vaccines; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation

2002
[Effective treatment with Lamivudine of patients with reactivation of hepatitis B following chemotherapy administration].
    Harefuah, 2001, Volume: 140, Issue:12

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Leukemia-Lymphoma, Adult T-Cell; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Reverse Transcriptase Inhibitors; Vincristine; Virus Activation

2001
Efficacy of famciclovir in the treatment of lamivudine resistance related to an atypical hepatitis B virus mutant.
    Transplantation, 2002, Jan-15, Volume: 73, Issue:1

    Topics: 2-Aminopurine; Adult; DNA, Viral; Drug Resistance, Microbial; Famciclovir; Female; Hepatitis B; Hepatitis B virus; Humans; Kidney Failure, Chronic; Kidney Transplantation; Lamivudine; Mutation; Postoperative Complications

2002
Fulminant hepatitis B due to a lamivudine-resistant mutant of HBV in a patient coinfected with HIV.
    Gastroenterology, 2002, Volume: 122, Issue:1

    Topics: Anti-HIV Agents; Drug Resistance, Viral; Fatal Outcome; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Liver Failure; Male; Middle Aged; Mutation

2002
Persistence of YMDD variants after withdrawal of Lamivudine.
    Journal of hepatology, 2002, Volume: 36, Issue:2

    Topics: DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Middle Aged; Reverse Transcriptase Inhibitors

2002
Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplantation.
    Gastroenterology, 2002, Volume: 122, Issue:2

    Topics: Amino Acid Sequence; Carcinoma, Hepatocellular; DNA, Viral; Drug Resistance, Viral; Gene Products, pol; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Neoplasms; Liver Transplantation; Molecular Sequence Data; Reverse Transcriptase Inhibitors; RNA, Messenger; RNA, Viral; Transfection; Tumor Cells, Cultured; Virus Replication

2002
Lamivudine therapy for acute hepatitis B infection following peripheral blood stem cell transplantation.
    American journal of hematology, 2002, Volume: 69, Issue:2

    Topics: Hematopoietic Stem Cell Transplantation; Hepatitis B; Humans; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors

2002
Lamivudine therapy for hepatitis B in renal transplantation.
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2002, Volume: 35, Issue:2

    Topics: Adult; Antiviral Agents; Female; Follow-Up Studies; Graft Rejection; Hepatitis B; Hepatitis B virus; Humans; Kidney Transplantation; Lamivudine; Male; Prospective Studies; Reverse Transcriptase Inhibitors; Treatment Outcome; Viral Load; Virus Replication

2002
[Orthotopic liver transplantation for end-stage liver diseases in 71 cases].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2002, Volume: 10, Issue:1

    Topics: Adolescent; Adult; Biliary Tract Diseases; Child; Female; Follow-Up Studies; Hepatitis B; Humans; Lamivudine; Liver Diseases; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Survival Rate; Vascular Diseases

2002
Successful allogeneic bone marrow transplantation from an HBV-positive donor into an HBV-positive recipient using lamivudine.
    Bone marrow transplantation, 2002, Volume: 29, Issue:3

    Topics: Adult; Anemia, Aplastic; Antiviral Agents; Bone Marrow Transplantation; Disease-Free Survival; DNA, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Diseases; Tissue Donors; Transplantation, Homologous; Virus Activation

2002
Is hepatitis B virus subtype testing useful in predicting virological response and resistance to lamivudine?
    Journal of hepatology, 2002, Volume: 36, Issue:3

    Topics: Drug Resistance, Microbial; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Predictive Value of Tests; Reverse Transcriptase Inhibitors

2002
[Hepatitis B virus infection: diagnosis, clinical sequelae, therapy and prevention].
    Praxis, 2002, Feb-20, Volume: 91, Issue:8

    Topics: Adolescent; Adult; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Antigens; Hepatitis B Vaccines; Humans; Infant, Newborn; Interferons; Lamivudine; Liver Function Tests; Male; Pregnancy; Prognosis

2002
Lamivudine treatment for reverse seroconversion of hepatitis B 4 years after allogeneic bone marrow transplantation.
    Bone marrow transplantation, 2002, Volume: 29, Issue:4

    Topics: Adult; Antiviral Agents; Bone Marrow Transplantation; DNA, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Antigens; Humans; Immunosuppression Therapy; Lamivudine; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Recurrence; Time Factors; Transplantation, Homologous

2002
Transplantation of livers from hbc Ab positive donors into HBc Ab negative recipients: a strategy and preliminary results.
    Clinical transplantation, 2001, Volume: 15 Suppl 6

    Topics: Adult; Aged; Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Vaccines; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Polymerase Chain Reaction; Tissue Donors

2001
Seroconversion after the addition of famciclovir therapy in a child with hepatitis B virus infection after liver transplantation who developed lamivudine resistance.
    Transplantation, 2002, Mar-15, Volume: 73, Issue:5

    Topics: 2-Aminopurine; Alanine Transaminase; Antiviral Agents; Child, Preschool; DNA, Viral; Drug Resistance, Viral; Famciclovir; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Male

2002
[Toward the expected development of therapeutic combinations in hepatitis B?].
    Gastroenterologie clinique et biologique, 2002, Volume: 26, Issue:1

    Topics: Drug Therapy, Combination; Hepatitis B; Humans; Interferon-alpha; Lamivudine

2002
Use of hepatitis B core antibody-positive donors in orthotopic liver transplantation.
    Archives of surgery (Chicago, Ill. : 1960), 2002, Volume: 137, Issue:5

    Topics: Adult; Aged; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Humans; Immunization, Passive; Immunoglobulins; Incidence; Lamivudine; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Tissue Donors; Transplantation, Homologous

2002
Four cases of hepatitis B virus-related fibrosing cholestatic hepatitis treated with lamivudine.
    Journal of gastroenterology and hepatology, 2002, Volume: 17, Issue:3

    Topics: Adult; Biopsy; Cholestasis; Fibrosis; Hepatitis B; Humans; Lamivudine; Liver; Male; Middle Aged; Reverse Transcriptase Inhibitors

2002
Hepatitis B associated fulminant polyarteritis nodosa: successful treatment with pulse cyclophosphamide, prednisolone and lamivudine following emergency surgery.
    European journal of gastroenterology & hepatology, 2002, Volume: 14, Issue:5

    Topics: Adult; Anti-Inflammatory Agents; Cyclophosphamide; Gastrointestinal Hemorrhage; Hepatitis B; Hepatitis B Surface Antigens; Humans; Immunosuppressive Agents; Lamivudine; Male; Polyarteritis Nodosa; Prednisolone; Pulse Therapy, Drug; Reverse Transcriptase Inhibitors

2002
Vertical transmission of hepatitis B virus despite maternal lamivudine therapy.
    Lancet (London, England), 2002, Apr-27, Volume: 359, Issue:9316

    Topics: Adult; Alanine Transaminase; Antiviral Agents; Base Sequence; DNA, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Point Mutation; Pregnancy; Pregnancy Complications, Infectious; Sequence Analysis, DNA

2002
Successful long-term control with lamivudine against reactivated hepatitis B infection following intensive chemotherapy and autologous peripheral blood stem cell transplantation in non-Hodgkin's lymphoma: experience of 2 cases.
    American journal of hematology, 2002, Volume: 70, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carrier State; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Reverse Transcriptase Inhibitors; Secondary Prevention; Time Factors; Virus Activation

2002
Beneficial effect of lamivudine for hepatitis B transplant recipients.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2002, Volume: 8, Issue:5

    Topics: Antiviral Agents; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Waiting Lists

2002
Lamivudine for chemotherapy-induced reactivation of HBV: prophylaxis or treatment?
    The American journal of gastroenterology, 2002, Volume: 97, Issue:5

    Topics: Antineoplastic Agents; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Reverse Transcriptase Inhibitors; Virus Activation

2002
Safe use of livers from donors with positive hepatitis B core antibody.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2002, Volume: 8, Issue:6

    Topics: Adolescent; Adult; Aged; Female; Hepatitis B; Hepatitis B Core Antigens; Humans; Immunosuppressive Agents; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence; Tissue Donors

2002
Impact of anti-hepatitis Bc-positive grafts on the outcome of liver transplantation for HBV-related cirrhosis.
    Transplantation, 2002, May-27, Volume: 73, Issue:10

    Topics: Adult; Aged; Alkaline Phosphatase; Antiviral Agents; Disease-Free Survival; Female; Hepatitis B; Hepatitis B Core Antigens; Humans; Immunoglobulins; Lamivudine; Liver; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Recurrence; Retrospective Studies; Treatment Outcome

2002
Characterizing antiviral activity of adefovir dipivoxil in transgenic mice expressing hepatitis B virus.
    Antiviral research, 2002, Volume: 55, Issue:1

    Topics: Adenine; Administration, Oral; Animals; Antiviral Agents; Disease Models, Animal; DNA, Viral; Dose-Response Relationship, Drug; Hepatitis B; Hepatitis B virus; Lamivudine; Liver; Mice; Mice, Transgenic; Organophosphonates; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; RNA, Viral; Time Factors; Viral Load

2002
Incidence of and risk factors for severe hepatotoxicity associated with antiretroviral combination therapy.
    The Journal of infectious diseases, 2002, Jul-01, Volume: 186, Issue:1

    Topics: Adult; Alanine Transaminase; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Chemical and Drug Induced Liver Injury; Cohort Studies; Female; Hepatitis B; Hepatitis C; HIV Infections; HIV-1; Humans; Incidence; Lamivudine; Liver Function Tests; Male; Nevirapine; Proportional Hazards Models; Retrospective Studies; Reverse Transcriptase Inhibitors; Risk Factors; Ritonavir; Sex Factors; Transaminases

2002
Successful antiviral treatment for fulminant reactivated hepatitis B after autologous stem cell transplantation and prophylaxis during subsequent allogeneic stem cell transplantation.
    Annals of hematology, 2002, Volume: 81, Issue:6

    Topics: 2-Aminopurine; Adult; Antiviral Agents; Famciclovir; Female; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Transplantation, Autologous; Transplantation, Homologous; Virus Activation

2002
[Lamivudine treatment consensus from relative experts].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2002, Volume: 10, Issue:2

    Topics: Alanine Transaminase; Antibodies, Viral; Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Polymerase Chain Reaction

2002
Biochemical pharmacology of (+)- and (-)-2',3'-dideoxy-3'-thiacytidine as anti-hepatitis B virus agents.
    The Journal of biological chemistry, 1992, Nov-05, Volume: 267, Issue:31

    Topics: Antiviral Agents; Base Sequence; Biological Transport; Cells, Cultured; Deoxycytidine Kinase; Hepatitis B; Hepatitis B virus; Humans; In Vitro Techniques; Lamivudine; Mitochondria; Molecular Sequence Data; Nucleic Acid Synthesis Inhibitors; Oligodeoxyribonucleotides; Phosphorylation; Zalcitabine

1992